data_1bnb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bnb _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 120.791 0.329 . . . . 0.40000000000000002 110.386 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.81 -55.57 3.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.801 -1.72 . . . . 0.41999999999999998 108.801 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.37 93.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.461 -1.023 . . . . 2.4700000000000002 108.778 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -66.99 -39.78 87.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.69999999999999996 108.921 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 59.44 3.25 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.157 -1.577 . . . . 0.37 109.157 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.24 -170.91 15.87 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.101 -1.6 . . . . 0.34000000000000002 109.101 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.02 150.6 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -1.149 . . . . 1.54 109.242 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 5' ' ' CYS . 89.3 m -93.96 94.0 8.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -0.806 . . . . 0.34000000000000002 110.078 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -96.18 128.97 35.01 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.176 -0.952 . . . . 1.1200000000000001 108.846 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.3 Cg_endo -77.76 178.34 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.558 2.172 . . . . 0.46000000000000002 110.57 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.494 HG22 HD12 ' A' ' 15' ' ' ILE . 3.1 mt 61.84 -93.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 1.5600000000000001 109.703 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.18 168.98 21.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.615 -1.303 . . . . 1.7 109.546 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.48 122.95 87.59 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.49 -0.756 . . . . 0.42999999999999999 109.214 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.22 125.28 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.597 2.198 . . . . 0.56999999999999995 109.936 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 26.9 m -68.76 158.97 84.29 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.251 -0.906 . . . . 1.1699999999999999 108.906 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.528 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -81.6 10.78 33.86 Favored 'Cis proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.525 -1.448 . . . . 0.63 111.641 -0.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 20.7 ttm -63.32 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 1.53 109.25 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -107.09 149.87 27.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.818 . . . . 0.85999999999999999 109.22 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.99 142.85 47.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.416 -0.802 . . . . 1.1000000000000001 109.255 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -139.44 39.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.847 . . . . 1.1200000000000001 109.403 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.6 -169.23 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.986 -1.646 . . . . 0.37 108.986 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.9 p -131.43 167.15 19.79 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.234 -1.156 . . . . 1.1599999999999999 109.451 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 54.5 m -139.5 140.46 37.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.32000000000000001 109.441 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HB2' HG22 ' A' ' 32' ' ' VAL . 90.9 m-85 55.64 26.92 9.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.562 -0.711 . . . . 1.02 110.05 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.3 -124.35 8.04 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.491 -1.443 . . . . 0.55000000000000004 109.491 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.734 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.0 mmp_? -103.04 -11.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.305 -1.114 . . . . 2.0899999999999999 113.955 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.734 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.1 Cg_endo -72.77 -44.26 0.7 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 CA-C-N 120.061 1.057 . . . . 0.5 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 12' ' ' CYS . 2.7 t -106.11 155.87 6.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.994 -1.066 . . . . 1.1200000000000001 108.34 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.8 mttp -134.13 164.45 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 1.53 109.995 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.9 m -90.96 138.04 31.9 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.47 -0.937 . . . . 0.32000000000000001 108.47 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -134.15 133.34 40.89 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.39000000000000001 109.808 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HB2' HG12 ' A' ' 24' ' ' ILE . 13.0 ttp180 -150.08 157.65 43.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.93999999999999995 109.102 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -33.46 33.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.361 -0.837 . . . . 0.94999999999999996 109.236 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 37.6 p90 . . . . . 0 N--CA 1.487 1.394 0 O-C-N 121.36 -0.837 . . . . 1.28 108.855 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.568 -0.53 . . . . 0.76000000000000001 109.568 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.34 -47.29 91.85 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.395 -1.482 . . . . 0.80000000000000004 109.395 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.28 -28.91 69.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.219 -1.165 . . . . 2.29 109.752 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.438 ' HB2' HG13 ' A' ' 24' ' ' ILE . 19.0 m120 -85.12 -13.33 50.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.034 -1.041 . . . . 1.0900000000000001 109.913 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.68 11.22 64.18 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.757 -1.337 . . . . 0.82999999999999996 109.757 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -96.02 155.62 21.15 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.072 -1.611 . . . . 0.95999999999999996 109.072 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.37 158.92 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -1.086 . . . . 1.5800000000000001 109.176 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -77.76 93.63 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.70999999999999996 109.319 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -100.52 123.3 46.64 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.321 -0.862 . . . . 1.3 108.986 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 33.9 Cg_endo -78.62 174.2 12.63 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.504 2.136 . . . . 0.76000000000000001 110.04 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.431 HD12 HG22 ' A' ' 15' ' ' ILE . 0.4 OUTLIER 53.49 -126.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.91 -0.774 . . . . 1.96 108.91 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.77 164.94 11.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.422 -1.424 . . . . 2.0899999999999999 109.065 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -114.11 154.26 46.18 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.284 -0.885 . . . . 0.77000000000000002 109.054 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.8 168.73 23.02 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.719 2.28 . . . . 0.96999999999999997 110.651 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.23 153.93 91.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.677 . . . . 1.5 109.418 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -80.56 10.1 29.9 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.413 -1.494 . . . . 0.65000000000000002 111.344 -0.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttp 59.47 59.37 2.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.917 . . . . 2.2000000000000002 109.341 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -90.02 89.08 7.54 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.391 -0.966 . . . . 1.8100000000000001 108.391 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.19 123.57 24.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 2.1400000000000001 109.815 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.591 HD12 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -128.06 34.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.491 -0.755 . . . . 1.47 109.041 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 179.53 22.96 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.404 -1.479 . . . . 0.80000000000000004 109.404 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.4 p -126.79 165.12 19.91 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -1.115 . . . . 1.21 109.386 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -134.39 131.09 37.81 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.212 -0.93 . . . . 0.70999999999999996 109.628 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 56.36 34.68 24.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.719 -0.613 . . . . 1.28 110.24 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.478 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.27 -133.89 11.71 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.47 -1.452 . . . . 0.81000000000000005 109.47 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -101.73 -2.18 0.1 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.324 -1.104 . . . . 2.5800000000000001 113.888 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.7 Cg_endo -74.56 -45.22 0.33 Allowed 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 120.239 1.121 . . . . 0.58999999999999997 109.821 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.8 t -108.69 149.59 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 1.23 108.093 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.94 -1.1 . . . . 1.1599999999999999 109.653 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 37.1 m -89.97 83.95 6.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.449 -0.945 . . . . 0.71999999999999997 108.449 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 m -97.44 141.76 30.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.272 -0.892 . . . . 0.40999999999999998 109.71 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -108.17 151.83 25.39 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.775 -0.824 . . . . 1.6799999999999999 108.775 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 18.78 13.4 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.381 -0.824 . . . . 1.45 109.525 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.486 1.327 0 O-C-N 121.202 -0.936 . . . . 1.96 108.505 179.734 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.487 -0.931 . . . . 0.46999999999999997 108.487 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.56 -24.51 73.9 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.185 -1.166 . . . . 0.59999999999999998 110.185 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -55.88 -47.33 77.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 1.1299999999999999 109.871 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.553 ' CB ' HG13 ' A' ' 24' ' ' ILE . 13.2 m120 -110.07 6.18 22.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.83999999999999997 110.094 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.77 51.44 40.81 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.51 -1.436 . . . . 0.56000000000000005 109.51 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.34 -161.4 9.07 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.985 -1.646 . . . . 0.46000000000000002 108.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.33 140.85 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -1.234 . . . . 1.5600000000000001 109.29 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m -83.05 85.6 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.767 . . . . 0.45000000000000001 109.053 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -98.77 126.65 38.01 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.236 -0.915 . . . . 1.26 109.346 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.5 Cg_endo -79.66 179.46 6.3 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.629 2.219 . . . . 0.70999999999999996 110.081 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt 51.05 -136.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.987 -0.746 . . . . 1.5900000000000001 108.987 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.32 139.55 40.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.726 -1.234 . . . . 1.28 109.326 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 9.6 m -84.66 159.72 57.6 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.226 -0.921 . . . . 0.53000000000000003 109.073 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 35.1 Cg_endo -78.34 168.28 21.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.657 2.238 . . . . 0.63 110.305 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 20' ' ' PRO . 2.6 t -58.39 145.69 74.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.231 -0.655 . . . . 1.48 109.231 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HA ' HG12 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -79.89 -7.09 40.69 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.546 -1.439 . . . . 0.64000000000000001 111.378 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 ttm 63.18 77.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.301 -0.874 . . . . 1.6100000000000001 110.119 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.434 ' HD2' ' CD2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -105.54 93.58 4.74 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.099 -1.001 . . . . 1.0600000000000001 108.867 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.87 121.45 20.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 1.5700000000000001 109.106 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.553 HG13 ' CB ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -124.35 14.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 1.48 110.077 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.06 40.47 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.46000000000000002 109.095 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 35.8 p -115.95 167.65 10.78 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.129 -1.218 . . . . 0.89000000000000001 109.405 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 71.9 m -139.38 129.54 25.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.863 . . . . 0.41999999999999998 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 54.4 43.94 29.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 1.3600000000000001 109.96 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.08 -140.18 14.92 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.068 -1.613 . . . . 0.62 109.068 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -102.67 0.22 0.1 OUTLIER Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.3 -1.117 . . . . 2.0099999999999998 113.676 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.2 Cg_endo -75.57 -46.62 0.2 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-N 120.168 1.096 . . . . 0.76000000000000001 110.058 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.2 t -103.82 155.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.218 -1.03 . . . . 1.1299999999999999 108.218 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -139.4 160.66 39.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 1.0700000000000001 109.593 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 64.6 m -89.97 103.06 15.76 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.371 -0.974 . . . . 0.37 108.371 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.9 m -102.71 153.8 19.78 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 0.42999999999999999 109.853 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HB3' ' CE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -135.61 176.24 8.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.236 -1.024 . . . . 1.5700000000000001 108.236 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.77 70.89 1.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.98999999999999999 110.014 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 36' ' ' ARG . 5.7 p90 . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.113 -0.992 . . . . 1.1100000000000001 108.52 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 121.06 0.457 . . . . 0.73999999999999999 109.909 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.76 -45.08 66.8 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.2 -1.56 . . . . 0.52000000000000002 109.2 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -63.59 -49.64 72.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.958 . . . . 1.8899999999999999 109.236 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.29 -34.31 76.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.541 -0.724 . . . . 1.4099999999999999 109.399 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.58 32.15 28.33 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.305 -1.518 . . . . 0.67000000000000004 109.305 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.13 178.21 17.71 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.273 -1.531 . . . . 0.52000000000000002 109.273 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.89 135.13 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 1.5800000000000001 109.019 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.598 ' HB3' HG13 ' A' ' 32' ' ' VAL . 51.1 m -79.97 90.03 5.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.411 -0.806 . . . . 0.46999999999999997 109.032 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 17' ' ' CYS . 12.1 mt -104.16 126.14 32.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.309 -0.869 . . . . 1.25 109.404 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.4 Cg_endo -78.65 174.84 11.74 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.66 2.24 . . . . 0.59999999999999998 110.106 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 51.37 -129.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.143 -0.688 . . . . 1.6100000000000001 109.143 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.61 149.64 29.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.536 -1.352 . . . . 1.1299999999999999 109.458 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.503 ' HB3' HD11 ' A' ' 13' ' ' ILE . 3.0 m -101.59 162.84 19.19 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.342 -0.849 . . . . 0.48999999999999999 109.07 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.6 Cg_endo -78.19 167.5 23.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.516 2.144 . . . . 0.78000000000000003 109.999 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.98 152.2 84.14 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.505 -0.747 . . . . 1.27 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.89 -5.67 32.83 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.361 -1.516 . . . . 0.60999999999999999 111.191 -0.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.1 ttm 60.36 58.49 2.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 1.6000000000000001 109.61 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -90.04 93.85 9.55 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.172 -0.955 . . . . 1.3400000000000001 108.89 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.3 112.77 5.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.366 -0.833 . . . . 2.3100000000000001 109.897 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 pt -104.14 -1.38 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.827 . . . . 1.0600000000000001 109.49 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.12 -168.34 40.11 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.989 -1.645 . . . . 0.47999999999999998 108.989 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.3 p -122.08 168.61 11.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.274 -1.133 . . . . 1.1200000000000001 109.41 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 81.0 m -138.09 126.37 23.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.54000000000000004 109.589 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 55.84 36.94 28.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.679 -0.638 . . . . 1.1499999999999999 110.072 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.503 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -137.38 13.38 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.677 -1.369 . . . . 0.67000000000000004 109.677 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -99.45 -3.12 0.11 Allowed Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 113.859 1.059 . . . . 1.5900000000000001 113.859 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.6 Cg_endo -74.84 -46.95 0.22 Allowed 'Trans proline' 0 C--N 1.325 -0.688 0 CA-C-N 120.299 1.143 . . . . 0.58999999999999997 110.034 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 12' ' ' CYS . 5.3 t -107.49 150.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.993 -1.114 . . . . 1.03 107.993 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.44 162.65 31.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.87 -1.144 . . . . 1.05 109.865 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 56.3 m -90.4 88.98 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.944 -0.761 . . . . 0.40999999999999998 108.944 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.4 m -91.55 136.01 33.44 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.123 -0.986 . . . . 0.41999999999999998 109.533 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.71 147.51 28.47 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.299 -0.876 . . . . 1.3999999999999999 109.053 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.05 -12.44 50.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.792 . . . . 0.72999999999999998 109.245 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 117.602 -1.19 . . . . 1.28 108.401 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 7' ' ' ARG . 34.7 t . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 108.727 -0.842 . . . . 0.66000000000000003 108.727 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.09 -2.26 77.47 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.267 -0.968 . . . . 0.81000000000000005 111.018 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -58.75 -60.35 3.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.833 -1.392 . . . . 1.9099999999999999 109.637 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 22.6 m120 -133.61 35.93 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.158 -0.964 . . . . 1.8300000000000001 109.483 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.19 59.53 9.86 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.454 -1.459 . . . . 0.68999999999999995 109.454 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.587 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -132.83 -167.71 11.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.173 -1.571 . . . . 0.5 109.173 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.03 151.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.197 -1.178 . . . . 1.4199999999999999 109.276 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.477 ' HB3' HG13 ' A' ' 32' ' ' VAL . 67.9 m -91.42 97.97 11.41 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.994 -0.743 . . . . 0.44 108.994 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.561 HG21 ' HD2' ' A' ' 14' ' ' PRO . 3.3 mt -100.28 127.97 31.74 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.394 -0.816 . . . . 1.26 109.02 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.561 ' HD2' HG21 ' A' ' 13' ' ' ILE . 34.2 Cg_endo -76.76 163.51 31.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.422 2.081 . . . . 0.62 110.147 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.9 mm 61.46 -94.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.728 -0.607 . . . . 1.3200000000000001 109.374 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.92 165.24 31.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.759 -1.213 . . . . 1.9199999999999999 109.201 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HB3' HD11 ' A' ' 13' ' ' ILE . 2.3 m -109.72 163.69 16.5 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.53000000000000003 109.064 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 33.9 Cg_endo -76.73 160.38 34.48 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.543 2.162 . . . . 0.79000000000000004 110.086 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 24.7 m -64.82 152.49 90.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 1.3799999999999999 109.347 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 34.6 Cg_endo -77.06 -8.27 30.4 Favored 'Cis proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.254 -1.561 . . . . 0.66000000000000003 111.219 0.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 46.2 ttp 58.89 84.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.419 -0.801 . . . . 2.02 110.501 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER -94.34 96.61 9.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.892 -1.13 . . . . 0.81999999999999995 108.38 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 130.8 46.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.529 -0.732 . . . . 1.74 109.481 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -139.56 34.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.628 -0.67 . . . . 1.1599999999999999 109.38 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.7 -177.77 19.0 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.347 -1.501 . . . . 0.46000000000000002 109.347 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.4 p -132.58 164.49 26.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.238 -1.154 . . . . 1.02 109.084 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 21.9 m -131.85 138.78 48.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.187 -0.945 . . . . 0.54000000000000004 109.607 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 57.9 32.26 21.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.894 -0.504 . . . . 1.1399999999999999 109.96 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.46 -128.96 9.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.153 -1.579 . . . . 0.53000000000000003 109.153 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.42 0.82 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -1.145 . . . . 1.73 113.645 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.5 Cg_endo -74.97 -43.88 0.37 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 CA-C-N 120.328 1.153 . . . . 0.63 110.058 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 15.9 t -107.91 147.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.097 -1.075 . . . . 1.1499999999999999 108.097 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.8 mttp -126.58 158.51 36.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 1.4399999999999999 109.926 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 73.7 m -92.48 118.14 30.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.479 -0.934 . . . . 0.38 108.479 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -122.83 138.48 54.63 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.35999999999999999 109.534 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.587 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 6.8 ttm180 -141.81 -171.55 3.37 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.588 -0.893 . . . . 1.29 108.588 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER 52.29 53.64 12.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.604 -0.685 . . . . 1.0800000000000001 109.252 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.563 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.0 p90 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.99 -1.005 . . . . 1.48 108.994 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 75.9 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.8 -0.444 . . . . 0.55000000000000004 109.8 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.94 -25.91 54.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.004 -1.239 . . . . 0.55000000000000004 110.004 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -52.63 -34.85 53.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.292 -1.123 . . . . 0.88 110.185 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.481 ' CB ' HD11 ' A' ' 24' ' ' ILE . 38.3 m-80 -136.94 16.35 3.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.982 -1.074 . . . . 0.67000000000000004 110.351 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.66 62.0 6.8 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.781 -1.328 . . . . 0.46999999999999997 109.781 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -128.0 -151.26 7.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.331 -1.508 . . . . 0.52000000000000002 109.331 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.02 143.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 1.28 109.248 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 66.3 m -82.65 87.65 6.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.44 -0.787 . . . . 0.46000000000000002 108.993 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 17' ' ' CYS . 3.7 mt -100.06 123.14 48.14 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.211 -0.931 . . . . 1.0900000000000001 109.198 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.2 Cg_endo -79.31 172.14 15.06 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.756 2.304 . . . . 0.71999999999999997 110.378 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 15' ' ' ILE . 24.6 mm 58.85 -93.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.367 -0.605 . . . . 1.76 109.367 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 -178.84 5.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.671 -1.268 . . . . 1.9199999999999999 108.804 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.489 ' HB3' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -131.64 162.39 56.53 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.213 -0.929 . . . . 0.56000000000000005 109.026 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -77.31 163.88 29.62 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.494 2.129 . . . . 0.87 109.813 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.9 150.91 75.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.773 . . . . 1.4399999999999999 109.353 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.597 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.71 -2.1 33.9 Favored 'Cis proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.41 -1.496 . . . . 0.71999999999999997 111.455 0.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.3 ttp 60.84 65.19 1.05 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.143 -0.973 . . . . 1.8700000000000001 109.345 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.04 105.58 17.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.078 -1.014 . . . . 1.48 109.454 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.84 123.26 23.03 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.892 . . . . 1.6399999999999999 109.092 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 34' ' ' CYS . 11.4 pt -123.63 -0.33 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.468 -0.77 . . . . 1.52 110.077 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.52 -171.21 43.1 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.972 -1.651 . . . . 0.56999999999999995 108.972 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.9 p -124.37 164.72 19.06 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.263 -1.139 . . . . 1.25 109.383 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -135.3 132.7 38.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.257 -0.902 . . . . 0.46000000000000002 109.531 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 56.66 34.0 23.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.94999999999999996 110.109 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.87 -134.32 11.83 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.502 -1.439 . . . . 0.54000000000000004 109.502 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -100.38 -4.0 0.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.387 -1.067 . . . . 1.6399999999999999 113.803 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.81 -48.65 0.18 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 CA-C-N 120.23 1.118 . . . . 0.71999999999999997 110.074 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.3 t -101.2 148.98 6.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.021 -1.103 . . . . 1.1000000000000001 108.021 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 18.4 mtmm -128.38 170.35 13.21 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.989 -1.069 . . . . 1.21 109.542 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.56 ' HB3' HG13 ' A' ' 24' ' ' ILE . 46.7 m -100.52 105.12 16.52 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.397 -0.964 . . . . 0.46999999999999997 108.397 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -106.23 146.37 30.39 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.38 109.237 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 3.0 ttp180 -138.67 161.21 37.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.97999999999999998 109.046 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.597 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.54 -24.79 20.52 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.4 -0.813 . . . . 1.1299999999999999 109.271 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 42.9 p90 . . . . . 0 C--N 1.305 -1.355 0 O-C-N 121.314 -0.866 . . . . 1.25 108.71 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.428 -0.582 . . . . 0.69999999999999996 109.428 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 150.7 16.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.519 -1.433 . . . . 0.60999999999999999 109.519 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -27.06 68.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 2.5600000000000001 109.337 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -68.84 -52.8 26.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -0.839 . . . . 0.68999999999999995 109.235 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.67 58.66 0.25 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.329 -1.509 . . . . 0.53000000000000003 109.329 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -98.36 164.83 21.32 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.318 -1.513 . . . . 0.51000000000000001 109.318 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.68 153.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.337 -1.096 . . . . 1.3600000000000001 108.777 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.553 ' HB3' HG13 ' A' ' 32' ' ' VAL . 72.1 m -77.65 87.3 3.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.403 -0.811 . . . . 0.40000000000000002 109.236 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.46 115.81 51.41 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.348 -0.845 . . . . 1.26 109.275 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.576 ' HB3' HG23 ' A' ' 32' ' ' VAL . 35.0 Cg_endo -78.85 172.17 15.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.636 2.224 . . . . 0.62 110.492 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 15' ' ' ILE . 5.0 mm 60.48 -92.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.536 -0.542 . . . . 1.8200000000000001 109.536 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -133.62 176.8 8.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.714 -1.241 . . . . 1.8899999999999999 109.127 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 162.33 57.58 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.19 -0.944 . . . . 0.47999999999999998 109.069 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.99 165.91 25.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.581 2.187 . . . . 0.54000000000000004 109.926 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.36 153.08 87.27 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 1.2 109.394 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -79.65 4.15 34.08 Favored 'Cis proline' 0 C--N 1.309 -1.524 0 C-N-CA 123.372 -1.512 . . . . 0.46999999999999997 111.315 0.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.9 ttp 61.02 56.49 2.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 1.6899999999999999 109.692 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -89.87 89.65 7.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.044 -1.035 . . . . 0.87 108.47 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.21 121.48 19.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.376 -0.827 . . . . 0.81999999999999995 109.451 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.549 HD12 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -129.16 35.18 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.429 -0.794 . . . . 1.02 109.412 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.33 -172.23 26.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.421 -1.472 . . . . 0.44 109.421 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.7 p -141.19 162.11 36.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 1.01 109.261 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 56.8 m -120.23 146.33 46.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.101 -0.999 . . . . 0.40000000000000002 109.818 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' HD2' HG22 ' A' ' 32' ' ' VAL . 21.1 m-85 55.08 41.29 31.84 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.147 0.499 . . . . 1.01 109.838 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.61 -134.89 12.19 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.46 -1.856 . . . . 0.69999999999999996 108.46 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.733 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.2 mmm180 -108.61 9.11 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.208 -1.172 . . . . 1.3200000000000001 113.391 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 36.0 Cg_endo -77.17 -47.12 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 CA-C-N 120.12 1.078 . . . . 0.60999999999999999 110.079 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 14' ' ' PRO . 48.2 t -98.6 148.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.268 -1.012 . . . . 1.1100000000000001 108.268 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -118.68 153.26 34.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.032 -1.042 . . . . 1.0800000000000001 109.965 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 m -94.21 85.19 4.59 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.532 -0.914 . . . . 0.42999999999999999 108.532 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -93.32 136.2 33.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.96 . . . . 0.37 110.083 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -91.92 136.59 33.04 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.366 -0.976 . . . . 1.3200000000000001 108.366 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.63 23.14 4.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.91000000000000003 109.566 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 108.106 -1.072 . . . . 1.03 108.106 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 109.352 -0.611 . . . . 0.59999999999999998 109.352 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.34 -21.88 70.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.816 -1.313 . . . . 0.96999999999999997 109.816 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -42.99 74.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 2.02 109.627 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.406 ' CB ' HG13 ' A' ' 24' ' ' ILE . 86.6 m-20 -108.69 4.66 24.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 1.27 110.017 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.7 41.28 99.85 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.551 -1.42 . . . . 0.65000000000000002 109.551 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -119.25 162.95 13.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.439 -1.464 . . . . 0.46000000000000002 109.439 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.59 154.43 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.351 -1.088 . . . . 1.1899999999999999 109.073 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.458 ' HB3' HG12 ' A' ' 32' ' ' VAL . 97.7 m -96.01 98.27 10.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.186 -0.946 . . . . 0.38 109.422 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.5 HG21 ' HD2' ' A' ' 14' ' ' PRO . 1.6 mt -105.45 127.21 29.02 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.346 -0.846 . . . . 1.1699999999999999 109.087 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.5 ' HD2' HG21 ' A' ' 13' ' ' ILE . 35.3 Cg_endo -78.88 165.65 24.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.567 2.178 . . . . 0.57999999999999996 110.603 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mt 61.89 -92.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.834 -0.541 . . . . 1.77 109.691 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.66 160.04 43.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.579 -1.325 . . . . 2.1299999999999999 108.818 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HB2' ' HG3' ' A' ' 21' ' ' MET . 0.8 OUTLIER -110.56 159.04 33.75 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.157 -0.964 . . . . 0.47999999999999998 109.435 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.69 172.1 15.64 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.731 2.287 . . . . 0.68999999999999995 110.199 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 20' ' ' PRO . 3.6 t -58.51 145.52 76.07 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.066 -0.716 . . . . 1.4099999999999999 109.066 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HA ' HG12 ' A' ' 19' ' ' VAL . 36.3 Cg_endo -80.33 -9.77 40.5 Favored 'Cis proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.596 -1.418 . . . . 0.58999999999999997 111.481 -0.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.477 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 33.1 ttp 62.64 63.71 0.97 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 2.1699999999999999 109.347 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -89.88 92.75 9.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.106 -0.996 . . . . 1.05 108.684 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.04 122.2 20.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 1.74 109.559 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.406 HG13 ' CB ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -126.53 25.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.064 -0.717 . . . . 0.92000000000000004 109.064 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 -171.74 27.47 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.609 -1.796 . . . . 0.48999999999999999 108.609 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.1 p -137.83 168.88 18.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.986 -1.302 . . . . 1.1499999999999999 109.697 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 17.9 m -129.32 142.33 50.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.371 -0.83 . . . . 0.47999999999999998 109.553 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 58.31 34.34 23.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.91 -0.494 . . . . 1.1299999999999999 110.095 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.22 10.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.03 -1.628 . . . . 0.75 109.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.88 5.02 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.166 -1.197 . . . . 2.2200000000000002 113.517 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -76.1 -47.52 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 CA-C-N 120.253 1.126 . . . . 0.68000000000000005 109.969 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 13.0 t -102.19 151.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.134 -0.979 . . . . 1.1699999999999999 108.496 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -124.41 157.17 35.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 1.53 110.218 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 88.7 m -93.59 96.4 9.83 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.729 -0.841 . . . . 0.44 108.729 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.5 m -102.51 149.07 24.77 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.045 -1.034 . . . . 0.39000000000000001 109.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 2.9 ttp180 -136.98 166.44 23.66 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.924 -0.769 . . . . 0.69999999999999996 108.924 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -26.54 18.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.452 -0.78 . . . . 1.01 108.962 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.777 -1.106 . . . . 0.92000000000000004 108.717 179.729 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 4.0 m . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.279 -0.637 . . . . 0.93000000000000005 109.279 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.37 -42.21 96.13 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.749 -1.341 . . . . 0.63 109.749 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.7 mmm180 -65.08 -32.84 74.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.122 -1.222 . . . . 2.21 108.934 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.525 ' CB ' HG13 ' A' ' 24' ' ' ILE . 2.6 m120 -81.17 -25.22 36.98 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.416 -0.803 . . . . 1.1899999999999999 109.129 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.33 37.24 11.19 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.574 -1.41 . . . . 0.68000000000000005 109.574 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' HA3' HD13 ' A' ' 24' ' ' ILE . . . -138.83 -160.48 8.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.178 -1.569 . . . . 0.66000000000000003 109.178 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.57 157.48 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.228 -1.16 . . . . 1.54 109.138 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 56.0 m -87.11 92.14 8.95 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.358 -0.839 . . . . 0.81999999999999995 109.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 17' ' ' CYS . 8.3 mt -101.38 123.65 43.84 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.344 -0.847 . . . . 1.3500000000000001 109.31 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.21 172.11 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.792 2.328 . . . . 0.80000000000000004 110.274 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.4 mm 54.92 -116.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.947 -0.76 . . . . 1.28 108.947 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.31 161.36 19.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.592 -1.317 . . . . 1.71 109.241 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HB3' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.44 165.14 13.39 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.391 -0.818 . . . . 0.69999999999999996 109.228 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.03 164.03 27.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.666 2.244 . . . . 0.91000000000000003 110.021 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.75 147.82 77.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 109.195 -0.669 . . . . 1.6699999999999999 109.195 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.573 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.5 Cg_endo -80.61 -2.97 42.93 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.457 -1.476 . . . . 0.73999999999999999 111.18 -0.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.9 ttm 63.26 59.08 1.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 1.6499999999999999 109.849 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -90.36 104.24 16.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.16 -0.963 . . . . 1.25 108.869 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 122.71 23.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.345 -0.847 . . . . 1.72 109.241 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.612 HD11 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -122.48 22.82 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.458 -0.776 . . . . 1.2 109.524 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 153.72 -176.18 31.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.787 -1.725 . . . . 0.66000000000000003 108.787 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 10.5 p -129.04 164.54 23.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -1.154 . . . . 1.1000000000000001 109.688 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.629 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 59.6 m -134.94 136.94 42.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.91000000000000003 109.862 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 53.34 37.81 26.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.838 -0.539 . . . . 1.73 110.168 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.44 -132.94 11.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.371 -1.492 . . . . 1.1499999999999999 109.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.5 mmp_? -105.28 -1.73 0.11 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.312 -1.111 . . . . 1.4199999999999999 113.667 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -74.96 -44.93 0.31 Allowed 'Trans proline' 0 C--N 1.327 -0.601 0 CA-C-N 120.192 1.104 . . . . 0.94999999999999996 110.246 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.629 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 12.1 t -106.22 148.92 10.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.007 -1.058 . . . . 1.24 108.157 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -134.17 165.27 25.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 1.0900000000000001 110.299 -178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.46 ' HB3' HG12 ' A' ' 24' ' ' ILE . 69.3 m -90.06 93.25 9.31 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 0.56000000000000005 108.645 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -95.06 143.27 26.65 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.12 -0.987 . . . . 0.53000000000000003 109.387 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.612 ' HD3' HD11 ' A' ' 24' ' ' ILE . 6.3 ttp180 -121.89 152.04 40.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 1.6399999999999999 108.89 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.573 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.48 -3.73 57.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.432 -0.793 . . . . 1.5600000000000001 109.982 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 117.626 -1.178 . . . . 1.6100000000000001 108.516 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.475 -0.565 . . . . 0.44 109.475 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.21 68.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.072 -1.061 . . . . 0.54000000000000004 110.487 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -54.71 -49.2 71.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.958 -1.319 . . . . 1.1799999999999999 109.808 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.408 ' HB2' HG13 ' A' ' 24' ' ' ILE . 34.8 m120 -114.61 27.7 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 1.05 109.613 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.32 44.08 96.81 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.475 -1.45 . . . . 0.48999999999999999 109.475 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -101.21 159.81 18.64 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.269 -1.532 . . . . 0.40999999999999998 109.269 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.4 145.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.273 -1.133 . . . . 1.6000000000000001 108.824 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.412 ' HB3' HG12 ' A' ' 32' ' ' VAL . 93.3 m -77.29 88.67 3.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.40999999999999998 109.114 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -101.33 122.02 49.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.283 -0.886 . . . . 1.1699999999999999 109.239 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.1 Cg_endo -79.06 173.35 13.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.444 2.096 . . . . 0.53000000000000003 109.718 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.84 -121.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.565 -0.709 . . . . 1.5 109.327 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.28 161.81 14.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.787 -1.196 . . . . 2.7999999999999998 109.772 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.45 152.51 47.12 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.395 -0.816 . . . . 0.56999999999999995 108.819 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.33 165.23 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.474 2.116 . . . . 0.58999999999999997 110.66 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 26.8 m -63.44 155.38 75.35 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.783 -0.573 . . . . 1.26 109.732 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 35.8 Cg_endo -80.31 13.65 21.49 Favored 'Cis proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.438 -1.484 . . . . 0.56000000000000005 111.435 -0.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 ttp 59.19 57.22 3.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 1.77 109.237 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -90.04 89.55 7.75 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.544 -0.91 . . . . 1.5800000000000001 108.544 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.1 124.59 27.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.81999999999999995 109.839 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD12 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -127.57 28.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.45 -0.781 . . . . 0.62 109.232 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -170.23 30.26 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.181 -1.568 . . . . 0.46999999999999997 109.181 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.6 p -140.42 165.43 27.45 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.258 -1.143 . . . . 1.3 109.584 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.5 m -132.62 142.11 48.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -0.903 . . . . 0.63 109.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 54.71 33.98 20.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.814 -0.554 . . . . 1.3999999999999999 110.193 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.441 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -130.66 10.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.451 -1.46 . . . . 0.69999999999999996 109.451 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.738 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -104.19 -2.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.429 -1.042 . . . . 1.7 113.707 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.738 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.54 -47.59 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 120.339 1.157 . . . . 0.60999999999999999 110.159 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 10.9 t -101.47 146.64 9.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.942 -1.132 . . . . 1.1799999999999999 107.942 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 158.72 36.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.918 -1.113 . . . . 0.73999999999999999 110.058 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.2 m -89.98 79.26 6.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.32000000000000001 108.05 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -93.48 145.24 24.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.355 -0.841 . . . . 0.31 109.684 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -114.78 151.99 32.86 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.451 -0.78 . . . . 1.5600000000000001 108.978 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.89 15.71 21.42 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.387 -0.821 . . . . 1.0800000000000001 109.283 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 117.777 -1.106 . . . . 1.05 108.469 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.994 0.426 . . . . 0.59999999999999998 110.554 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.16 30.0 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.619 -1.792 . . . . 1.1699999999999999 108.619 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.98 -36.66 48.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.411 -1.052 . . . . 2.7999999999999998 108.858 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -64.97 -25.99 68.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 1.45 109.307 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.27 56.01 3.12 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.747 -1.741 . . . . 0.95999999999999996 108.747 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -147.01 153.78 25.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.965 -1.654 . . . . 0.46000000000000002 108.965 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.95 141.72 13.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.237 -1.155 . . . . 1.26 109.518 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.8 m -88.3 84.01 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.41999999999999998 109.308 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.523 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 17.0 mt -96.09 136.22 22.24 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.181 -0.949 . . . . 1.2 108.887 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.63 172.27 16.53 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.427 2.085 . . . . 0.62 110.131 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 15' ' ' ILE . 22.9 mm 61.49 -99.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.289 -0.634 . . . . 1.47 109.289 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 170.38 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.598 -1.314 . . . . 1.29 109.085 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.619 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 4.6 m -96.01 134.31 24.02 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.893 . . . . 0.76000000000000001 109.556 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.24 138.82 16.28 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.575 2.184 . . . . 0.88 109.764 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 30.0 m -64.26 155.69 78.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.817 . . . . 1.24 109.198 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -79.58 2.72 35.11 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.494 -1.461 . . . . 0.67000000000000004 111.459 0.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.463 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 26.6 ttm -67.48 113.85 5.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.833 -1.167 . . . . 1.54 109.137 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.71 176.6 5.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 1.25 109.571 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.619 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -82.67 142.72 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 1.0600000000000001 109.241 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.599 HG12 ' HB2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -138.83 33.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 1.2 109.369 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 142.56 -167.82 26.07 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.166 -1.574 . . . . 0.5 109.166 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 9.9 p -131.2 163.91 26.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.203 -1.175 . . . . 1.3700000000000001 109.493 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 m -133.32 140.58 47.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.243 -0.91 . . . . 0.56999999999999995 109.677 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 51.23 41.84 28.27 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.176 0.512 . . . . 0.87 109.934 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 93.55 -134.86 12.3 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.02 -1.632 . . . . 0.60999999999999999 109.02 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.2 mmp_? -105.29 -0.16 0.1 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.215 -1.168 . . . . 1.8100000000000001 113.471 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.7 Cg_endo -74.74 -47.44 0.22 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 120.263 1.13 . . . . 0.68000000000000005 110.337 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.87 156.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.073 -1.017 . . . . 1.03 108.334 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -129.2 163.67 25.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.986 -1.071 . . . . 1.0700000000000001 109.925 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.2 m -90.57 131.99 35.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.357 -0.979 . . . . 0.40000000000000002 108.357 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.7 m -121.33 133.54 55.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.029 -1.044 . . . . 0.47999999999999998 109.663 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.32 146.85 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.727 -0.842 . . . . 1.1299999999999999 108.727 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -23.7 21.33 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.276 -0.89 . . . . 1.27 109.401 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 1.1899999999999999 109.148 -179.911 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.637 -0.505 . . . . 0.72999999999999998 109.637 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.96 -45.03 59.19 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.911 -1.675 . . . . 0.64000000000000001 108.911 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -33.43 75.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -1.074 . . . . 1.8100000000000001 108.93 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.64 -27.88 64.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.33 -0.856 . . . . 1.0700000000000001 109.186 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.76 48.27 5.29 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.26 -1.536 . . . . 0.58999999999999997 109.26 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.01 157.39 27.44 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.159 -1.576 . . . . 0.51000000000000001 109.159 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 m -93.89 150.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -1.12 . . . . 1.3100000000000001 109.416 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.59 ' HB3' HG12 ' A' ' 32' ' ' VAL . 54.2 m -88.54 101.36 13.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.421 -0.8 . . . . 0.57999999999999996 109.392 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.55 HG23 HG13 ' A' ' 15' ' ' ILE . 15.4 mt -100.58 122.31 49.95 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.322 -0.861 . . . . 1.2 109.342 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.502 ' HB3' HG23 ' A' ' 32' ' ' VAL . 36.1 Cg_endo -80.32 31.2 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.827 2.351 . . . . 0.59999999999999998 110.962 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.55 HG13 HG23 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -146.23 -153.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.174 -1.047 . . . . 1.3500000000000001 108.174 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.63 142.84 27.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.035 -1.04 . . . . 2.3100000000000001 108.972 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -63.22 124.18 83.15 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.48999999999999999 109.849 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.87 119.81 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.687 2.258 . . . . 0.88 110.362 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.2 m -65.85 159.88 66.24 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.267 -0.896 . . . . 1.4399999999999999 108.726 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -80.98 8.27 35.9 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 123.614 -1.411 . . . . 0.72999999999999998 111.596 -0.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.669 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 2.0 ttp -60.79 133.99 56.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.925 -1.11 . . . . 1.6599999999999999 108.864 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -101.74 164.91 11.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.5800000000000001 110.039 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.18 151.53 24.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.176 -0.675 . . . . 2.46 109.176 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.613 HG23 ' HD3' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -148.38 44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.613 -0.679 . . . . 1.1799999999999999 109.488 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.25 -174.62 18.33 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.146 -1.581 . . . . 0.48999999999999999 109.146 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.577 HG23 ' HD3' ' A' ' 30' ' ' ARG . 26.4 p -138.16 166.75 23.36 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.291 -1.123 . . . . 1.27 109.415 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 27.0 m -127.03 141.45 51.78 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.155 -0.966 . . . . 0.67000000000000004 109.772 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 56.0 36.65 27.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.877 -0.514 . . . . 1.1899999999999999 110.026 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.34 10.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.92000000000000004 109.043 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -107.98 6.81 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.189 . . . . 1.3500000000000001 113.472 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.2 Cg_endo -76.6 -46.11 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 120.171 1.097 . . . . 0.83999999999999997 109.782 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' A' ' 12' ' ' CYS . 73.2 t -104.63 149.49 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.297 -1.001 . . . . 1.1100000000000001 108.297 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.5 mttp -123.69 154.2 39.74 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.093 -1.005 . . . . 1.1799999999999999 109.83 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.1 m -89.97 136.82 32.81 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.445 -0.946 . . . . 0.5 108.445 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.669 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -135.63 133.72 38.52 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.103 -0.998 . . . . 0.51000000000000001 110.09 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.613 ' HD3' HG23 ' A' ' 24' ' ' ILE . 2.6 ptm180 -145.33 143.03 29.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.185 -1.043 . . . . 0.72999999999999998 108.185 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -33.71 16.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 1.1200000000000001 111.007 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.416 ' OXT' ' HG3' ' A' ' 36' ' ' ARG . 11.3 p-90 . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.018 -1.051 . . . . 1.1599999999999999 109.641 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.158 0.504 . . . . 0.75 109.831 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.89 51.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.506 . . . . 0.64000000000000001 109.336 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.11 -44.2 93.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.309 -1.112 . . . . 3.21 109.468 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.491 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 4.3 m120 -80.27 -25.06 39.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.925 . . . . 1.1799999999999999 109.355 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.18 62.8 2.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.78 -1.728 . . . . 0.57999999999999996 108.78 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -152.37 168.54 31.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.23 -1.548 . . . . 0.47999999999999998 109.23 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 t -91.14 143.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 1.3100000000000001 109.129 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.2 m -86.1 83.98 7.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.305 -0.872 . . . . 0.39000000000000001 109.579 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.511 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 6.7 mt -96.24 128.57 36.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.181 -0.95 . . . . 1.1699999999999999 108.866 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.16 179.07 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.442 2.094 . . . . 0.57999999999999996 110.309 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.6 mt 61.29 -101.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.705 -0.622 . . . . 1.29 109.415 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.36 160.91 40.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.615 -1.303 . . . . 1.6399999999999999 109.374 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.84 131.04 68.43 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.854 . . . . 0.64000000000000001 109.435 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.78 120.15 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.625 2.217 . . . . 0.82999999999999996 109.535 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.1 m -57.32 153.48 26.81 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.822 . . . . 1.4399999999999999 109.334 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.85 10.69 30.11 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.606 -1.414 . . . . 0.84999999999999998 111.626 -0.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.513 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.5 tpp -61.35 118.78 7.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.929 -1.107 . . . . 1.6799999999999999 108.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 1.5 ptp85 -90.03 175.99 6.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 1.22 109.839 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 132.47 52.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.701 -0.851 . . . . 1.7 108.701 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 pt -120.27 -0.08 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 1.21 110.361 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.63 -159.27 31.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.424 -1.471 . . . . 0.56000000000000005 109.424 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.2 p -137.17 165.34 26.34 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.351 -1.088 . . . . 1.27 109.612 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 76.6 m -126.9 148.1 50.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.41999999999999998 109.228 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 55.02 41.56 31.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.045 -0.724 . . . . 0.97999999999999998 109.045 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 -130.9 10.52 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.938 -2.065 . . . . 0.57999999999999996 107.938 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.731 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.6 mtm180 -113.75 10.48 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.186 -1.185 . . . . 3.3300000000000001 113.341 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.7 Cg_endo -77.56 -45.25 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 120.162 1.093 . . . . 0.59999999999999998 109.681 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 46.1 t -98.47 154.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.265 -1.013 . . . . 1.0700000000000001 108.265 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mttp -117.91 157.88 25.89 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 1.76 110.057 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 81.4 m -97.25 104.34 16.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.494 -0.928 . . . . 0.5 108.494 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.513 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 14.7 m -100.05 143.0 30.77 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.131 -0.981 . . . . 0.46000000000000002 109.826 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -143.66 158.69 43.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.519 -0.738 . . . . 1.5 109.205 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -27.96 51.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.335 -0.853 . . . . 1.3 109.429 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 37.0 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.894 -1.05 . . . . 1.48 109.264 179.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 121.383 0.611 . . . . 0.89000000000000001 109.747 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.28 -34.48 69.22 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.217 -1.553 . . . . 1.01 109.217 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -23.93 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -1.17 . . . . 1.77 109.762 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.519 ' HB3' HG13 ' A' ' 24' ' ' ILE . 14.8 m120 -103.51 -11.7 17.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 1.1100000000000001 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.05 32.18 66.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.504 -1.438 . . . . 0.85999999999999999 109.504 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -122.91 164.17 15.99 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.43 -1.468 . . . . 0.56000000000000005 109.43 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.26 154.63 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.41 -1.053 . . . . 1.29 109.275 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.65 93.62 9.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.432 -0.793 . . . . 0.5 109.43 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 17' ' ' CYS . 4.0 mt -102.18 122.58 46.34 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.291 -0.881 . . . . 1.1599999999999999 108.947 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 166.98 23.57 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.64 2.227 . . . . 0.70999999999999996 110.797 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.1 mt 61.42 -94.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.439 -0.578 . . . . 1.3700000000000001 109.439 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.58 165.7 26.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.799 -1.188 . . . . 2.0600000000000001 108.928 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.633 ' HB3' HD11 ' A' ' 13' ' ' ILE . 1.3 m -119.37 163.58 26.16 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.229 -0.92 . . . . 0.5 109.509 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.1 Cg_endo -79.16 170.64 17.39 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.671 2.247 . . . . 0.85999999999999999 109.609 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.63 152.19 93.17 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.453 -0.779 . . . . 1.27 109.248 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 34.1 Cg_endo -79.13 -5.57 38.05 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.19 -1.587 . . . . 0.70999999999999996 111.504 0.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.9 ttm 61.85 65.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 1.9099999999999999 109.648 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -89.91 90.19 8.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.166 -0.959 . . . . 1.8300000000000001 108.506 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.75 117.64 12.52 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.615 -0.678 . . . . 1.3700000000000001 109.828 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -121.24 31.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.881 -0.785 . . . . 0.76000000000000001 108.881 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.35 -167.66 24.66 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.912 -1.675 . . . . 0.5 108.912 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 p -141.09 169.01 18.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.242 -1.152 . . . . 1.1100000000000001 109.517 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 78.5 m -126.28 147.6 49.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.295 -0.878 . . . . 0.54000000000000004 109.285 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 58.62 34.38 23.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.659 -0.497 . . . . 1.3300000000000001 109.659 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 96.73 -134.52 11.83 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.605 -1.798 . . . . 0.70999999999999996 108.605 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.752 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.1 mtp85 -105.02 4.82 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.312 -1.11 . . . . 2.0499999999999998 113.358 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.6 Cg_endo -75.82 -50.28 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 120.137 1.085 . . . . 0.60999999999999999 110.142 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 16.2 t -93.47 147.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.01 -1.056 . . . . 1.0900000000000001 108.757 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -115.34 156.61 25.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.206 -0.934 . . . . 1.3 109.83 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 95.8 m -98.95 92.51 5.55 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.369 -0.832 . . . . 0.52000000000000002 108.897 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -99.51 147.34 25.41 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.147 -0.971 . . . . 0.45000000000000001 109.951 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -130.97 161.12 32.63 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.763 -0.829 . . . . 1.46 108.763 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.483 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -89.79 -18.68 25.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.325 -0.859 . . . . 1.3100000000000001 109.645 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.9 p90 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 117.713 -1.137 . . . . 1.21 108.734 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 25.1 t . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.681 -0.859 . . . . 0.44 108.681 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.43 -24.51 76.7 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.354 -1.098 . . . . 0.73999999999999999 110.354 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -62.21 -48.3 80.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.979 -1.307 . . . . 1.5600000000000001 109.901 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 1.2 110.161 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.62 60.31 3.76 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.349 -1.5 . . . . 0.79000000000000004 109.349 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.66 -166.49 16.45 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.894 -1.682 . . . . 0.44 108.894 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.6 m -96.41 172.51 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -1.209 . . . . 1.3 109.057 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.574 ' HB3' HG13 ' A' ' 32' ' ' VAL . 21.7 m -125.78 111.17 14.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.34999999999999998 109.572 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 15' ' ' ILE . 1.2 mt -98.87 121.85 54.65 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.208 -0.932 . . . . 1.04 108.94 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HB3' HG23 ' A' ' 32' ' ' VAL . 36.4 Cg_endo -79.65 38.26 0.72 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.792 2.328 . . . . 0.56000000000000005 111.494 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -157.31 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.84 -1.162 . . . . 1.29 108.942 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -149.97 173.2 14.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 1.76 108.89 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 t -102.95 110.64 63.93 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.388 -0.82 . . . . 0.46999999999999997 108.954 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.69 135.39 11.49 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.597 2.198 . . . . 1.02 110.294 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m -67.55 159.46 78.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.379 -0.825 . . . . 1.3 108.928 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -79.63 5.29 32.73 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.53 -1.446 . . . . 0.56000000000000005 111.512 0.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.683 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 7.7 tpp -62.74 139.08 58.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.883 -1.136 . . . . 1.9199999999999999 109.119 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -114.03 147.72 38.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.96999999999999997 109.37 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 144.3 50.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 1.1799999999999999 109.284 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.61 37.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 1.24 109.838 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.63 -173.62 21.97 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.605 -1.398 . . . . 0.56000000000000005 109.605 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 41.3 p -126.11 163.13 23.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -1.078 . . . . 1.3200000000000001 109.408 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.615 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 34.1 m -128.0 137.54 52.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.55000000000000004 109.624 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 52.89 43.82 31.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.883 -0.511 . . . . 1.0900000000000001 110.123 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 -132.59 11.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.49 -1.844 . . . . 0.69999999999999996 108.49 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.4 mtm180 -111.54 4.91 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.177 -1.19 . . . . 3.4100000000000001 113.628 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.3 Cg_endo -75.27 -43.51 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.338 1.157 . . . . 0.68999999999999995 109.776 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 49.5 t -107.13 152.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.113 -1.069 . . . . 1.02 108.113 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.1 mttp -124.31 156.74 36.44 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.993 -1.067 . . . . 1.22 110.133 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 71.9 m -90.0 143.59 26.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.933 -1.136 . . . . 0.37 107.933 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.683 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 21.8 m -138.81 138.81 37.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.96 -1.088 . . . . 0.34999999999999998 110.021 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -150.11 162.37 40.56 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.433 -0.792 . . . . 1.23 109.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -33.98 27.0 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.413 -0.805 . . . . 0.91000000000000003 109.23 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 33.6 p90 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 117.789 -1.1 . . . . 1.2 108.851 179.775 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 109.241 -0.651 . . . . 0.46999999999999997 109.241 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.94 175.74 43.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.093 -1.603 . . . . 0.64000000000000001 109.093 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.02 46.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 2.2400000000000002 109.579 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 24' ' ' ILE . 5.5 m-80 -75.27 -25.48 58.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.79000000000000004 109.953 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.81 65.01 0.95 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.506 -1.438 . . . . 0.67000000000000004 109.506 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.418 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . -106.37 -152.97 19.99 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.539 -1.824 . . . . 0.55000000000000004 108.539 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.61 149.39 32.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -1.206 . . . . 1.54 108.882 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.583 ' HB3' HG13 ' A' ' 32' ' ' VAL . 92.2 m -75.0 92.03 2.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.46999999999999997 109.472 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.405 HG21 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mt -102.6 125.43 35.91 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.291 -0.881 . . . . 1.3899999999999999 108.939 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.11 173.57 13.74 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.57 2.18 . . . . 0.65000000000000002 110.258 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 54.21 -119.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.957 -0.757 . . . . 1.75 108.957 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.12 154.94 32.45 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.634 -1.291 . . . . 2.8199999999999998 109.068 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.4 159.72 28.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.318 -0.863 . . . . 0.68999999999999995 109.329 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 167.67 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.679 2.253 . . . . 1.26 110.235 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -60.46 147.23 83.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 1.3700000000000001 109.294 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -79.91 -3.05 39.91 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.55 -1.437 . . . . 0.84999999999999998 111.351 -0.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.2 ttm 62.47 56.22 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 1.51 109.629 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -90.17 87.08 6.72 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.176 -0.953 . . . . 2.7000000000000002 108.53 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 7.3 pt20 -71.87 129.57 38.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 1.72 109.486 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -130.39 38.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.319 -0.863 . . . . 0.60999999999999999 108.697 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.76 -179.82 24.35 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.645 -1.782 . . . . 0.47999999999999998 108.645 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.7 p -132.97 160.76 36.18 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.081 -1.246 . . . . 1.3899999999999999 109.816 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.617 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.7 m -130.03 140.83 50.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.482 -0.761 . . . . 0.63 109.534 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 55.77 37.14 28.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.885 -0.51 . . . . 1.4199999999999999 110.178 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.36 -133.55 11.56 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.487 -1.445 . . . . 0.59999999999999998 109.487 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -103.7 -3.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.8199999999999998 113.71 -179.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.9 Cg_endo -74.85 -43.05 0.45 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.205 1.109 . . . . 0.79000000000000004 110.832 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.6 t -103.81 147.47 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.835 -1.166 . . . . 1.1200000000000001 108.853 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -131.07 156.38 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.011 -1.056 . . . . 1.25 110.022 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 55.8 m -90.09 82.18 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.40999999999999998 108.812 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 73.7 m -91.78 140.99 29.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.133 -0.979 . . . . 0.44 109.843 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.418 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -110.0 152.21 26.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.625 -0.88 . . . . 0.97999999999999998 108.625 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.543 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.09 -7.95 52.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.316 -0.865 . . . . 1.1499999999999999 110.018 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 25.7 p90 . . . . . 0 N--CA 1.487 1.375 0 O-C-N 121.062 -1.024 . . . . 1.3600000000000001 108.719 -179.911 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.59 -0.522 . . . . 0.48999999999999999 109.59 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.28 -49.8 24.66 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.564 . . . . 0.68000000000000005 109.191 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -74.79 -36.11 62.49 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.19 -1.182 . . . . 2.5800000000000001 109.254 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.542 ' HB3' HD11 ' A' ' 24' ' ' ILE . 5.6 m120 -70.45 -30.41 67.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 1.0 109.366 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.46 50.08 6.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.329 -1.509 . . . . 0.48999999999999999 109.329 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.86 -170.69 11.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.347 -1.501 . . . . 0.42999999999999999 109.347 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.3 157.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -1.144 . . . . 1.6000000000000001 109.25 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.2 m -93.23 87.36 5.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.44 109.482 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.438 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 8.3 mt -97.14 131.44 27.56 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 1.1000000000000001 108.92 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 13' ' ' ILE . 34.7 Cg_endo -77.26 172.55 15.82 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.445 2.096 . . . . 0.64000000000000001 110.246 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.9 mm 63.02 -95.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.734 -0.604 . . . . 1.3700000000000001 109.551 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 164.41 35.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.659 -1.275 . . . . 2.1499999999999999 109.368 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.429 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 18.7 m -87.31 132.9 39.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.352 -0.843 . . . . 0.66000000000000003 109.068 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.33 132.56 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.501 2.134 . . . . 0.96999999999999997 109.737 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.6 m -63.12 155.02 75.42 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.837 . . . . 1.4399999999999999 109.132 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.5 7.68 34.39 Favored 'Cis proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.45 -1.479 . . . . 0.77000000000000002 111.621 0.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.452 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 18.6 ttm -63.81 121.49 14.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.777 -1.202 . . . . 1.72 109.145 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -95.54 177.55 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.77000000000000002 109.491 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.429 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.4 tt0 -92.0 147.19 23.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.673 -0.862 . . . . 1.54 108.673 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -145.33 42.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.482 -0.761 . . . . 1.23 109.716 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.74 -166.61 22.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.44 109.472 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 16.5 p -138.98 166.79 23.56 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.325 -1.103 . . . . 1.26 109.176 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.607 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 78.6 m -129.0 140.19 51.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.241 -0.912 . . . . 0.62 109.921 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 55.53 40.84 31.2 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.763 -0.458 . . . . 1.05 109.763 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.58 -130.63 10.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.38 -1.888 . . . . 0.68000000000000005 108.38 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.73 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -111.8 9.58 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.086 -1.243 . . . . 1.8400000000000001 113.386 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.73 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.1 Cg_endo -76.55 -50.52 0.1 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 CA-C-N 120.166 1.095 . . . . 0.69999999999999996 109.766 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.607 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 51.2 t -99.31 155.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.196 -1.039 . . . . 1.27 108.196 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.2 160.0 26.08 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.963 -1.085 . . . . 1.48 109.892 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HB3' HD13 ' A' ' 24' ' ' ILE . 21.7 m -93.54 133.78 36.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.954 -1.128 . . . . 0.39000000000000001 107.954 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 19.5 m -126.04 142.46 51.51 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.088 -1.007 . . . . 0.46999999999999997 109.834 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.576 ' HB2' HG12 ' A' ' 24' ' ' ILE . 4.4 mtp180 -139.03 141.24 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.895 -0.78 . . . . 1.1599999999999999 108.895 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.25 -22.56 60.38 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.337 -0.852 . . . . 0.91000000000000003 109.739 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.6 p90 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 117.788 -1.101 . . . . 0.91000000000000003 108.943 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.4 m . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.244 0.545 . . . . 0.58999999999999997 110.071 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.87 -6.03 89.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.854 -1.298 . . . . 0.64000000000000001 109.854 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -64.18 -60.59 3.02 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.976 -1.308 . . . . 1.01 109.542 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -119.97 13.12 12.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.157 -0.964 . . . . 1.5 110.092 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.31 70.19 1.15 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.635 -1.386 . . . . 0.52000000000000002 109.635 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 24' ' ' ILE . . . -127.02 -156.72 9.25 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.057 -1.617 . . . . 0.40999999999999998 109.057 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -1.152 . . . . 1.6499999999999999 109.432 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.472 ' HB3' HG13 ' A' ' 32' ' ' VAL . 65.7 m -84.33 88.99 7.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.536 -0.727 . . . . 0.48999999999999999 109.329 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -97.85 130.05 29.8 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.11 -0.994 . . . . 1.22 109.307 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -77.65 178.03 8.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.457 2.105 . . . . 0.70999999999999996 110.047 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 mm 59.68 -98.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.717 -0.614 . . . . 1.4399999999999999 109.472 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.94 160.47 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.556 -1.34 . . . . 3.3399999999999999 109.367 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -71.84 146.21 90.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.497 -0.752 . . . . 0.54000000000000004 109.671 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 35.5 Cg_endo -78.53 -165.13 0.31 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.726 2.284 . . . . 0.70999999999999996 110.063 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.427 ' HA ' ' N ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -135.64 140.86 35.1 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.166 -0.959 . . . . 1.3899999999999999 109.588 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.95 109.23 1.39 Allowed 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.183 -1.59 . . . . 0.87 110.53 -1.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.8 ttm -150.8 118.82 6.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.82 -1.175 . . . . 1.7 108.725 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -93.69 178.64 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 2.2000000000000002 109.616 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.2 144.77 25.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.541 -0.725 . . . . 1.0600000000000001 109.195 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.409 HD13 ' HA3' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -142.03 49.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 1.1599999999999999 109.277 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.49 -174.39 17.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.411 -1.475 . . . . 0.51000000000000001 109.411 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 11.4 p -133.19 166.11 23.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.323 -1.104 . . . . 1.25 109.467 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 95.2 m -133.67 136.99 45.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.67000000000000004 109.866 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 56.18 37.59 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 1.1200000000000001 110.144 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.98 -132.8 11.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.934 -1.666 . . . . 0.81999999999999995 108.934 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 20.8 mmm-85 -105.98 1.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.284 -1.127 . . . . 1.96 113.608 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -75.05 -50.85 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.585 0 CA-C-N 120.217 1.113 . . . . 0.89000000000000001 109.865 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 17.2 t -100.12 150.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.035 -1.098 . . . . 1.26 108.035 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 163.33 24.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.01 -1.056 . . . . 0.85999999999999999 109.728 -179.239 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.2 m -92.67 130.45 38.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.293 -1.003 . . . . 0.47999999999999998 108.293 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 35.4 m -125.23 141.82 51.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.062 -1.023 . . . . 0.52000000000000002 109.818 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB2' HG12 ' A' ' 24' ' ' ILE . 10.8 mtp180 -141.05 134.49 29.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.432 -0.792 . . . . 1.6200000000000001 108.932 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.86 -26.12 37.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 1.1799999999999999 109.551 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.8 p90 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 117.796 -1.097 . . . . 1.27 108.822 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.309 -0.626 . . . . 0.67000000000000004 109.309 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.35 -46.58 25.89 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.508 -1.437 . . . . 0.93999999999999995 109.508 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -41.16 99.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -1.118 . . . . 2.4399999999999999 109.651 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -75.65 -25.36 56.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.026 . . . . 0.84999999999999998 109.816 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.21 29.65 12.19 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.631 -1.388 . . . . 0.82999999999999996 109.631 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.641 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -103.81 156.52 17.57 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.613 -1.795 . . . . 0.65000000000000002 108.613 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 158.43 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.193 -1.18 . . . . 1.5700000000000001 109.645 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.627 ' HB3' HG13 ' A' ' 32' ' ' VAL . 96.5 m -79.17 93.18 5.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.521 -0.737 . . . . 0.53000000000000003 109.241 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -101.53 123.74 43.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.357 -0.84 . . . . 1.1599999999999999 109.195 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.49 170.64 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.561 2.174 . . . . 0.75 110.137 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt 56.88 -107.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.659 -0.65 . . . . 1.6299999999999999 109.321 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.58 177.58 5.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.56 -1.338 . . . . 2.2799999999999998 109.067 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 157.98 70.87 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.205 -0.934 . . . . 0.67000000000000004 109.131 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.73 169.97 19.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.643 2.229 . . . . 0.81999999999999995 109.988 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.54 153.4 95.0 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 1.3400000000000001 109.33 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -79.48 4.72 32.47 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.378 -1.509 . . . . 0.72999999999999998 111.177 0.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 ttp 61.0 57.77 2.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 2.1499999999999999 109.805 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -89.93 90.32 8.11 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.195 -0.941 . . . . 1.74 108.591 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 119.41 18.5 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 1.5 109.536 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.641 HD12 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.58 31.59 2.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.455 -0.778 . . . . 0.90000000000000002 109.232 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.8 -177.38 26.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.906 -1.678 . . . . 0.68999999999999995 108.906 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 13.1 p -135.31 161.14 36.24 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.145 -1.209 . . . . 1.25 109.775 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.8 m -126.18 141.93 51.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.248 -0.908 . . . . 0.69999999999999996 109.705 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 56.26 35.12 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.805 -0.56 . . . . 1.3700000000000001 110.12 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.6 -132.42 11.14 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.083 -1.607 . . . . 0.84999999999999998 109.083 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.75 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -105.16 0.71 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 2.0600000000000001 113.685 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.75 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.91 -44.2 0.36 Allowed 'Trans proline' 0 C--N 1.327 -0.602 0 CA-C-N 120.247 1.124 . . . . 0.75 109.925 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.627 HG13 ' HB3' ' A' ' 12' ' ' CYS . 3.6 t -106.21 146.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.129 -1.063 . . . . 1.28 108.129 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -128.03 155.46 44.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.993 -1.067 . . . . 1.3300000000000001 109.937 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.6 m -89.93 81.33 6.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.241 -1.022 . . . . 0.56000000000000005 108.241 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.82 143.33 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.5 109.806 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -103.57 145.44 30.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.598 -0.889 . . . . 1.05 108.598 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.9 19.86 9.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.384 -0.822 . . . . 1.05 109.466 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 108.173 -1.047 . . . . 1.1599999999999999 108.173 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.629 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 25.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.794 -0.447 . . . . 0.83999999999999997 109.794 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.95 -60.94 1.71 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.038 -1.625 . . . . 0.73999999999999999 109.038 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -69.45 89.81 0.51 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -1.07 . . . . 1.79 108.684 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.48 ' C ' HD13 ' A' ' 24' ' ' ILE . 17.3 m120 52.08 63.87 2.07 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.864 -0.791 . . . . 1.9299999999999999 108.864 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' A' ' 5' ' ' CYS . . . -121.23 -62.1 0.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.87 -1.292 . . . . 0.48999999999999999 109.87 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.476 ' HA3' ' HG3' ' A' ' 36' ' ' ARG . . . 99.03 -97.43 1.84 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.212 -1.555 . . . . 0.40000000000000002 109.212 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.41 141.64 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.103 -1.233 . . . . 1.01 109.522 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 58.0 m -82.92 94.45 7.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.40999999999999998 109.206 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 17' ' ' CYS . 5.9 mt -101.7 123.55 43.69 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.174 -0.954 . . . . 1.1399999999999999 109.328 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.5 175.75 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.648 2.232 . . . . 0.57999999999999996 109.912 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.481 HG22 HD11 ' A' ' 15' ' ' ILE . 0.7 OUTLIER 53.75 -120.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.87 -0.789 . . . . 1.8799999999999999 108.87 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -126.18 135.35 51.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.511 -1.368 . . . . 1.51 109.35 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.466 ' HB2' ' HG3' ' A' ' 21' ' ' MET . 3.3 m -75.95 161.88 73.92 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.366 -0.834 . . . . 0.46999999999999997 108.91 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.3 Cg_endo -77.02 160.29 33.56 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.512 2.141 . . . . 0.69999999999999996 110.368 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -61.67 147.76 88.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.616 -0.677 . . . . 1.3899999999999999 109.221 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 35.7 Cg_endo -77.89 -11.98 32.04 Favored 'Cis proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.48 -1.467 . . . . 0.53000000000000003 111.177 -0.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 43.5 ttp 61.68 86.19 0.11 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 1.46 110.286 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.84 89.33 3.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.874 -1.141 . . . . 0.81000000000000005 108.491 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.6 109.89 4.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.70999999999999996 109.226 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 36' ' ' ARG . 9.7 pt -111.01 -3.74 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.397 -0.815 . . . . 1.1000000000000001 109.804 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.06 -171.84 31.78 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.988 -1.645 . . . . 0.42999999999999999 108.988 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -129.55 166.94 18.69 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -1.174 . . . . 1.05 109.414 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 97.3 m -138.74 126.17 21.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.56000000000000005 109.519 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 56.12 39.07 30.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.721 -0.612 . . . . 1.1100000000000001 109.972 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.491 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.62 -136.97 13.16 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.381 -1.487 . . . . 0.68999999999999995 109.381 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 24.4 mmm180 -101.32 -1.84 0.1 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 1.4399999999999999 113.77 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.39 -52.52 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 CA-C-N 120.24 1.121 . . . . 0.58999999999999997 109.698 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -98.19 148.27 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.397 -1.334 . . . . 1.0 107.397 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.71 156.8 45.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.89 -1.131 . . . . 0.46999999999999997 110.282 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.8 m -90.61 97.21 11.05 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.453 -0.943 . . . . 0.40000000000000002 108.453 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.9 m -101.13 142.18 32.94 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.296 -0.878 . . . . 0.41999999999999998 109.364 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' HD12 ' A' ' 24' ' ' ILE . 5.7 ttp85 -144.49 -172.22 3.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.523 -0.917 . . . . 0.73999999999999999 108.523 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.08 49.95 18.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.039 -0.726 . . . . 0.67000000000000004 109.039 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.6 p90 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 118.026 -0.987 . . . . 1.03 109.091 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.909 -0.774 . . . . 1.73 108.909 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.68 157.63 28.18 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.579 2.186 . . . . 1.6100000000000001 110.059 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.413 HD13 ' CZ ' ' A' ' 28' ' ' PHE . 1.1 tp 66.82 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.603 -0.517 . . . . 1.6899999999999999 109.603 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 1.3 m 63.75 -167.62 0.21 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -0.796 . . . . 0.65000000000000002 109.245 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER 69.35 5.0 4.89 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.492 -0.755 . . . . 0.40000000000000002 110.386 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.81 -55.57 3.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.801 -1.72 . . . . 0.41999999999999998 108.801 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.37 93.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.461 -1.023 . . . . 2.4700000000000002 108.778 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -66.99 -39.78 87.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.69999999999999996 108.921 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 59.44 3.25 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.157 -1.577 . . . . 0.37 109.157 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.24 -170.91 15.87 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.101 -1.6 . . . . 0.34000000000000002 109.101 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.02 150.6 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -1.149 . . . . 1.54 109.242 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 5' ' ' CYS . 89.3 m -93.96 94.0 8.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -0.806 . . . . 0.34000000000000002 110.078 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -96.18 128.97 35.01 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.176 -0.952 . . . . 1.1200000000000001 108.846 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.3 Cg_endo -77.76 178.34 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.558 2.172 . . . . 0.46000000000000002 110.57 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.494 HG22 HD12 ' A' ' 15' ' ' ILE . 3.1 mt 61.84 -93.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 1.5600000000000001 109.703 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.18 168.98 21.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.615 -1.303 . . . . 1.7 109.546 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.48 122.95 87.59 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.49 -0.756 . . . . 0.42999999999999999 109.214 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.22 125.28 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.597 2.198 . . . . 0.56999999999999995 109.936 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 26.9 m -68.76 158.97 84.29 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.251 -0.906 . . . . 1.1699999999999999 108.906 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.528 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -81.6 10.78 33.86 Favored 'Cis proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.525 -1.448 . . . . 0.63 111.641 -0.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 20.7 ttm -63.32 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 1.53 109.25 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -107.09 149.87 27.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.818 . . . . 0.85999999999999999 109.22 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.99 142.85 47.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.416 -0.802 . . . . 1.1000000000000001 109.255 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -139.44 39.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.847 . . . . 1.1200000000000001 109.403 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.6 -169.23 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.986 -1.646 . . . . 0.37 108.986 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.9 p -131.43 167.15 19.79 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.234 -1.156 . . . . 1.1599999999999999 109.451 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HA ' ' HB2' ' A' ' 4' ' ' SER . 54.5 m -139.5 140.46 37.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.32000000000000001 109.441 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HB2' HG22 ' A' ' 32' ' ' VAL . 90.9 m-85 55.64 26.92 9.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.562 -0.711 . . . . 1.02 110.05 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.3 -124.35 8.04 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.491 -1.443 . . . . 0.55000000000000004 109.491 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.734 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.0 mmp_? -103.04 -11.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.305 -1.114 . . . . 2.0899999999999999 113.955 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.734 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.1 Cg_endo -72.77 -44.26 0.7 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 CA-C-N 120.061 1.057 . . . . 0.5 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' A' ' 12' ' ' CYS . 2.7 t -106.11 155.87 6.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.994 -1.066 . . . . 1.1200000000000001 108.34 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.8 mttp -134.13 164.45 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 1.53 109.995 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.9 m -90.96 138.04 31.9 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.47 -0.937 . . . . 0.32000000000000001 108.47 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -134.15 133.34 40.89 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.39000000000000001 109.808 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.467 ' HB2' HG12 ' A' ' 24' ' ' ILE . 13.0 ttp180 -150.08 157.65 43.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.93999999999999995 109.102 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -33.46 33.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.361 -0.837 . . . . 0.94999999999999996 109.236 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 37.6 p90 . . . . . 0 N--CA 1.487 1.394 0 O-C-N 121.36 -0.837 . . . . 1.28 108.855 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.623 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.6 -0.518 . . . . 2.8199999999999998 109.6 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.623 ' HD3' ' CB ' ' A' ' 1' ' ' ALA . 34.2 Cg_endo -77.43 83.93 2.06 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.983 1.789 . . . . 2.2999999999999998 110.206 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.59 179.79 7.53 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.296 -0.878 . . . . 2.3500000000000001 108.798 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -57.66 154.42 11.6 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.409 -0.807 . . . . 1.4399999999999999 109.157 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 4' ' ' SER . 4.4 m 73.07 -62.44 0.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.771 -0.581 . . . . 0.76000000000000001 109.568 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.34 -47.29 91.85 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.395 -1.482 . . . . 0.80000000000000004 109.395 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.28 -28.91 69.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.219 -1.165 . . . . 2.29 109.752 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.438 ' HB2' HG13 ' A' ' 24' ' ' ILE . 19.0 m120 -85.12 -13.33 50.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.034 -1.041 . . . . 1.0900000000000001 109.913 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.68 11.22 64.18 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.757 -1.337 . . . . 0.82999999999999996 109.757 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.591 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -96.02 155.62 21.15 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.072 -1.611 . . . . 0.95999999999999996 109.072 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.37 158.92 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -1.086 . . . . 1.5800000000000001 109.176 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 83.2 m -77.76 93.63 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.70999999999999996 109.319 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mt -100.52 123.3 46.64 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.321 -0.862 . . . . 1.3 108.986 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 33.9 Cg_endo -78.62 174.2 12.63 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.504 2.136 . . . . 0.76000000000000001 110.04 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.431 HD12 HG22 ' A' ' 15' ' ' ILE . 0.4 OUTLIER 53.49 -126.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.91 -0.774 . . . . 1.96 108.91 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.77 164.94 11.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.422 -1.424 . . . . 2.0899999999999999 109.065 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -114.11 154.26 46.18 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.284 -0.885 . . . . 0.77000000000000002 109.054 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.8 168.73 23.02 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.719 2.28 . . . . 0.96999999999999997 110.651 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.23 153.93 91.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.677 . . . . 1.5 109.418 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -80.56 10.1 29.9 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.413 -1.494 . . . . 0.65000000000000002 111.344 -0.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttp 59.47 59.37 2.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.917 . . . . 2.2000000000000002 109.341 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -90.02 89.08 7.54 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.391 -0.966 . . . . 1.8100000000000001 108.391 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.19 123.57 24.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 2.1400000000000001 109.815 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.591 HD12 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -128.06 34.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.491 -0.755 . . . . 1.47 109.041 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 179.53 22.96 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.404 -1.479 . . . . 0.80000000000000004 109.404 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.4 p -126.79 165.12 19.91 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -1.115 . . . . 1.21 109.386 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -134.39 131.09 37.81 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.212 -0.93 . . . . 0.70999999999999996 109.628 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 56.36 34.68 24.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.719 -0.613 . . . . 1.28 110.24 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.478 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.27 -133.89 11.71 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.47 -1.452 . . . . 0.81000000000000005 109.47 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -101.73 -2.18 0.1 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.324 -1.104 . . . . 2.5800000000000001 113.888 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.7 Cg_endo -74.56 -45.22 0.33 Allowed 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 120.239 1.121 . . . . 0.58999999999999997 109.821 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.8 t -108.69 149.59 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 1.23 108.093 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.94 -1.1 . . . . 1.1599999999999999 109.653 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 37.1 m -89.97 83.95 6.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.449 -0.945 . . . . 0.71999999999999997 108.449 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.3 m -97.44 141.76 30.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.272 -0.892 . . . . 0.40999999999999998 109.71 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -108.17 151.83 25.39 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.775 -0.824 . . . . 1.6799999999999999 108.775 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 18.78 13.4 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.381 -0.824 . . . . 1.45 109.525 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.486 1.327 0 O-C-N 121.202 -0.936 . . . . 1.96 108.505 179.734 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 108.922 -0.769 . . . . 2.2400000000000002 108.922 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.47 129.54 10.26 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.695 2.263 . . . . 1.6200000000000001 110.405 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.46 17.28 13.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.135 -0.978 . . . . 1.96 109.941 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.42 115.07 29.84 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.874 -1.141 . . . . 1.3799999999999999 109.231 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.7 t -91.09 79.18 5.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 108.487 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.56 -24.51 73.9 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.185 -1.166 . . . . 0.59999999999999998 110.185 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -55.88 -47.33 77.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 1.1299999999999999 109.871 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.553 ' CB ' HG13 ' A' ' 24' ' ' ILE . 13.2 m120 -110.07 6.18 22.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.83999999999999997 110.094 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 66.77 51.44 40.81 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.51 -1.436 . . . . 0.56000000000000005 109.51 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.34 -161.4 9.07 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.985 -1.646 . . . . 0.46000000000000002 108.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.33 140.85 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -1.234 . . . . 1.5600000000000001 109.29 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m -83.05 85.6 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.767 . . . . 0.45000000000000001 109.053 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -98.77 126.65 38.01 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.236 -0.915 . . . . 1.26 109.346 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.5 Cg_endo -79.66 179.46 6.3 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.629 2.219 . . . . 0.70999999999999996 110.081 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt 51.05 -136.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.987 -0.746 . . . . 1.5900000000000001 108.987 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.32 139.55 40.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.726 -1.234 . . . . 1.28 109.326 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 9.6 m -84.66 159.72 57.6 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.226 -0.921 . . . . 0.53000000000000003 109.073 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 35.1 Cg_endo -78.34 168.28 21.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.657 2.238 . . . . 0.63 110.305 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 20' ' ' PRO . 2.6 t -58.39 145.69 74.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.231 -0.655 . . . . 1.48 109.231 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HA ' HG12 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -79.89 -7.09 40.69 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.546 -1.439 . . . . 0.64000000000000001 111.378 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 ttm 63.18 77.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.301 -0.874 . . . . 1.6100000000000001 110.119 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.434 ' HD2' ' CD2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -105.54 93.58 4.74 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.099 -1.001 . . . . 1.0600000000000001 108.867 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.87 121.45 20.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 1.5700000000000001 109.106 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.553 HG13 ' CB ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -124.35 14.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 1.48 110.077 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.06 40.47 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.46000000000000002 109.095 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 35.8 p -115.95 167.65 10.78 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.129 -1.218 . . . . 0.89000000000000001 109.405 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 71.9 m -139.38 129.54 25.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.863 . . . . 0.41999999999999998 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 54.4 43.94 29.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 1.3600000000000001 109.96 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.08 -140.18 14.92 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.068 -1.613 . . . . 0.62 109.068 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -102.67 0.22 0.1 OUTLIER Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.3 -1.117 . . . . 2.0099999999999998 113.676 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.2 Cg_endo -75.57 -46.62 0.2 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-N 120.168 1.096 . . . . 0.76000000000000001 110.058 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.2 t -103.82 155.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.218 -1.03 . . . . 1.1299999999999999 108.218 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -139.4 160.66 39.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 1.0700000000000001 109.593 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 64.6 m -89.97 103.06 15.76 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.371 -0.974 . . . . 0.37 108.371 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.9 m -102.71 153.8 19.78 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 0.42999999999999999 109.853 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.453 ' HB3' ' CE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -135.61 176.24 8.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.236 -1.024 . . . . 1.5700000000000001 108.236 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.77 70.89 1.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.98999999999999999 110.014 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 36' ' ' ARG . 5.7 p90 . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.113 -0.992 . . . . 1.1100000000000001 108.52 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.577 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 108.624 -0.88 . . . . 1.6399999999999999 108.624 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 1' ' ' ALA . 34.5 Cg_endo -77.35 -167.42 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.375 2.05 . . . . 1.51 109.862 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.99 -39.43 63.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.449 -0.782 . . . . 2.0800000000000001 109.346 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.47 105.41 2.61 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.394 -0.816 . . . . 1.79 109.053 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 65.43 33.04 9.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.493 -0.754 . . . . 0.73999999999999999 109.909 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.527 ' HA2' ' HB1' ' A' ' 1' ' ' ALA . . . -68.76 -45.08 66.8 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.2 -1.56 . . . . 0.52000000000000002 109.2 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -63.59 -49.64 72.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.958 . . . . 1.8899999999999999 109.236 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.29 -34.31 76.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.541 -0.724 . . . . 1.4099999999999999 109.399 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.58 32.15 28.33 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.305 -1.518 . . . . 0.67000000000000004 109.305 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.13 178.21 17.71 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.273 -1.531 . . . . 0.52000000000000002 109.273 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.89 135.13 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 1.5800000000000001 109.019 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.598 ' HB3' HG13 ' A' ' 32' ' ' VAL . 51.1 m -79.97 90.03 5.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.411 -0.806 . . . . 0.46999999999999997 109.032 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 17' ' ' CYS . 12.1 mt -104.16 126.14 32.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.309 -0.869 . . . . 1.25 109.404 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.4 Cg_endo -78.65 174.84 11.74 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.66 2.24 . . . . 0.59999999999999998 110.106 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 51.37 -129.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.143 -0.688 . . . . 1.6100000000000001 109.143 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.61 149.64 29.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.536 -1.352 . . . . 1.1299999999999999 109.458 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.503 ' HB3' HD11 ' A' ' 13' ' ' ILE . 3.0 m -101.59 162.84 19.19 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.342 -0.849 . . . . 0.48999999999999999 109.07 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.6 Cg_endo -78.19 167.5 23.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.516 2.144 . . . . 0.78000000000000003 109.999 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.98 152.2 84.14 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.505 -0.747 . . . . 1.27 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.89 -5.67 32.83 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.361 -1.516 . . . . 0.60999999999999999 111.191 -0.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.1 ttm 60.36 58.49 2.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 1.6000000000000001 109.61 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -90.04 93.85 9.55 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.172 -0.955 . . . . 1.3400000000000001 108.89 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.3 112.77 5.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.366 -0.833 . . . . 2.3100000000000001 109.897 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.5 pt -104.14 -1.38 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.827 . . . . 1.0600000000000001 109.49 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.12 -168.34 40.11 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.989 -1.645 . . . . 0.47999999999999998 108.989 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.3 p -122.08 168.61 11.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.274 -1.133 . . . . 1.1200000000000001 109.41 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 81.0 m -138.09 126.37 23.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.54000000000000004 109.589 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 55.84 36.94 28.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.679 -0.638 . . . . 1.1499999999999999 110.072 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.503 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -137.38 13.38 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.677 -1.369 . . . . 0.67000000000000004 109.677 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -99.45 -3.12 0.11 Allowed Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 113.859 1.059 . . . . 1.5900000000000001 113.859 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.6 Cg_endo -74.84 -46.95 0.22 Allowed 'Trans proline' 0 C--N 1.325 -0.688 0 CA-C-N 120.299 1.143 . . . . 0.58999999999999997 110.034 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 12' ' ' CYS . 5.3 t -107.49 150.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.993 -1.114 . . . . 1.03 107.993 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.44 162.65 31.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.87 -1.144 . . . . 1.05 109.865 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 56.3 m -90.4 88.98 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.944 -0.761 . . . . 0.40999999999999998 108.944 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.4 m -91.55 136.01 33.44 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.123 -0.986 . . . . 0.41999999999999998 109.533 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.71 147.51 28.47 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.299 -0.876 . . . . 1.3999999999999999 109.053 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.05 -12.44 50.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.792 . . . . 0.72999999999999998 109.245 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 117.602 -1.19 . . . . 1.28 108.401 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.672 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.418 -0.586 . . . . 4.8899999999999997 109.418 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.672 ' HD3' ' CB ' ' A' ' 1' ' ' ALA . 34.7 Cg_endo -79.6 162.96 24.37 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.495 1.464 . . . . 4.4199999999999999 109.292 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.447 ' HG ' ' CZ ' ' A' ' 28' ' ' PHE . 2.0 mm? -93.93 100.56 12.7 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.255 -0.903 . . . . 2.1099999999999999 108.789 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.07 124.63 20.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.352 -0.843 . . . . 1.3999999999999999 109.944 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 7' ' ' ARG . 34.7 t -85.66 111.89 20.5 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.267 -0.896 . . . . 0.66000000000000003 108.727 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.09 -2.26 77.47 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.267 -0.968 . . . . 0.81000000000000005 111.018 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -58.75 -60.35 3.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.833 -1.392 . . . . 1.9099999999999999 109.637 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB2' ' HB ' ' A' ' 24' ' ' ILE . 22.6 m120 -133.61 35.93 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.158 -0.964 . . . . 1.8300000000000001 109.483 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.19 59.53 9.86 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.454 -1.459 . . . . 0.68999999999999995 109.454 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.587 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -132.83 -167.71 11.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.173 -1.571 . . . . 0.5 109.173 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.03 151.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.197 -1.178 . . . . 1.4199999999999999 109.276 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.477 ' HB3' HG13 ' A' ' 32' ' ' VAL . 67.9 m -91.42 97.97 11.41 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.994 -0.743 . . . . 0.44 108.994 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.561 HG21 ' HD2' ' A' ' 14' ' ' PRO . 3.3 mt -100.28 127.97 31.74 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.394 -0.816 . . . . 1.26 109.02 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.561 ' HD2' HG21 ' A' ' 13' ' ' ILE . 34.2 Cg_endo -76.76 163.51 31.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.422 2.081 . . . . 0.62 110.147 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.9 mm 61.46 -94.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.728 -0.607 . . . . 1.3200000000000001 109.374 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.92 165.24 31.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.759 -1.213 . . . . 1.9199999999999999 109.201 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.55 ' HB3' HD11 ' A' ' 13' ' ' ILE . 2.3 m -109.72 163.69 16.5 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.53000000000000003 109.064 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 33.9 Cg_endo -76.73 160.38 34.48 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.543 2.162 . . . . 0.79000000000000004 110.086 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 24.7 m -64.82 152.49 90.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 1.3799999999999999 109.347 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 34.6 Cg_endo -77.06 -8.27 30.4 Favored 'Cis proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.254 -1.561 . . . . 0.66000000000000003 111.219 0.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.496 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 46.2 ttp 58.89 84.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.419 -0.801 . . . . 2.02 110.501 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER -94.34 96.61 9.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.892 -1.13 . . . . 0.81999999999999995 108.38 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 130.8 46.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.529 -0.732 . . . . 1.74 109.481 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -139.56 34.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.628 -0.67 . . . . 1.1599999999999999 109.38 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.7 -177.77 19.0 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.347 -1.501 . . . . 0.46000000000000002 109.347 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.4 p -132.58 164.49 26.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.238 -1.154 . . . . 1.02 109.084 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 21.9 m -131.85 138.78 48.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.187 -0.945 . . . . 0.54000000000000004 109.607 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.447 ' CZ ' ' HG ' ' A' ' 3' ' ' LEU . 56.1 m-85 57.9 32.26 21.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.894 -0.504 . . . . 1.1399999999999999 109.96 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.46 -128.96 9.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.153 -1.579 . . . . 0.53000000000000003 109.153 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.42 0.82 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -1.145 . . . . 1.73 113.645 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.5 Cg_endo -74.97 -43.88 0.37 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 CA-C-N 120.328 1.153 . . . . 0.63 110.058 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 15.9 t -107.91 147.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.097 -1.075 . . . . 1.1499999999999999 108.097 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.8 mttp -126.58 158.51 36.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 1.4399999999999999 109.926 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 73.7 m -92.48 118.14 30.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.479 -0.934 . . . . 0.38 108.479 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -122.83 138.48 54.63 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.35999999999999999 109.534 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.587 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 6.8 ttm180 -141.81 -171.55 3.37 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.588 -0.893 . . . . 1.29 108.588 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER 52.29 53.64 12.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.604 -0.685 . . . . 1.0800000000000001 109.252 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.563 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.0 p90 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.99 -1.005 . . . . 1.48 108.994 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.62 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.069 -0.345 . . . . 1.6899999999999999 110.069 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.62 ' HD3' ' CB ' ' A' ' 1' ' ' ALA . 36.2 Cg_endo -77.15 122.16 6.07 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.749 1.633 . . . . 1.29 109.978 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.28 84.98 4.45 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.327 -0.858 . . . . 2.8900000000000001 109.362 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m 48.79 41.21 17.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.721 -0.612 . . . . 1.4299999999999999 110.363 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 75.9 m 51.86 49.35 20.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.908 . . . . 0.55000000000000004 109.8 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.94 -25.91 54.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.004 -1.239 . . . . 0.55000000000000004 110.004 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -52.63 -34.85 53.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.292 -1.123 . . . . 0.88 110.185 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.481 ' CB ' HD11 ' A' ' 24' ' ' ILE . 38.3 m-80 -136.94 16.35 3.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.982 -1.074 . . . . 0.67000000000000004 110.351 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.66 62.0 6.8 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.781 -1.328 . . . . 0.46999999999999997 109.781 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.487 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -128.0 -151.26 7.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.331 -1.508 . . . . 0.52000000000000002 109.331 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.02 143.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 1.28 109.248 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 66.3 m -82.65 87.65 6.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.44 -0.787 . . . . 0.46000000000000002 108.993 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 17' ' ' CYS . 3.7 mt -100.06 123.14 48.14 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.211 -0.931 . . . . 1.0900000000000001 109.198 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.2 Cg_endo -79.31 172.14 15.06 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.756 2.304 . . . . 0.71999999999999997 110.378 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.523 HD11 HG22 ' A' ' 15' ' ' ILE . 24.6 mm 58.85 -93.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.367 -0.605 . . . . 1.76 109.367 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 -178.84 5.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.671 -1.268 . . . . 1.9199999999999999 108.804 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.489 ' HB3' HD13 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -131.64 162.39 56.53 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.213 -0.929 . . . . 0.56000000000000005 109.026 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -77.31 163.88 29.62 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.494 2.129 . . . . 0.87 109.813 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.9 150.91 75.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.773 . . . . 1.4399999999999999 109.353 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.597 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.71 -2.1 33.9 Favored 'Cis proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.41 -1.496 . . . . 0.71999999999999997 111.455 0.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.3 ttp 60.84 65.19 1.05 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.143 -0.973 . . . . 1.8700000000000001 109.345 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.04 105.58 17.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.078 -1.014 . . . . 1.48 109.454 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.84 123.26 23.03 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.892 . . . . 1.6399999999999999 109.092 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 34' ' ' CYS . 11.4 pt -123.63 -0.33 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.468 -0.77 . . . . 1.52 110.077 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.52 -171.21 43.1 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.972 -1.651 . . . . 0.56999999999999995 108.972 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.9 p -124.37 164.72 19.06 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.263 -1.139 . . . . 1.25 109.383 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -135.3 132.7 38.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.257 -0.902 . . . . 0.46000000000000002 109.531 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 56.66 34.0 23.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.94999999999999996 110.109 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.87 -134.32 11.83 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.502 -1.439 . . . . 0.54000000000000004 109.502 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -100.38 -4.0 0.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.387 -1.067 . . . . 1.6399999999999999 113.803 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.81 -48.65 0.18 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 CA-C-N 120.23 1.118 . . . . 0.71999999999999997 110.074 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.3 t -101.2 148.98 6.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.021 -1.103 . . . . 1.1000000000000001 108.021 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 18.4 mtmm -128.38 170.35 13.21 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.989 -1.069 . . . . 1.21 109.542 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.56 ' HB3' HG13 ' A' ' 24' ' ' ILE . 46.7 m -100.52 105.12 16.52 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.397 -0.964 . . . . 0.46999999999999997 108.397 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -106.23 146.37 30.39 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.38 109.237 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 3.0 ttp180 -138.67 161.21 37.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.97999999999999998 109.046 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.597 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.54 -24.79 20.52 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.4 -0.813 . . . . 1.1299999999999999 109.271 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 42.9 p90 . . . . . 0 C--N 1.305 -1.355 0 O-C-N 121.314 -0.866 . . . . 1.25 108.71 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.557 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.151 -0.685 . . . . 2.3799999999999999 109.151 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 1' ' ' ALA . 32.6 Cg_endo -76.89 136.7 16.94 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.446 2.097 . . . . 2.1099999999999999 110.863 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 60.1 39.81 19.17 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.306 -0.628 . . . . 2.4399999999999999 109.306 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.57 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -148.11 176.65 10.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.2 -0.937 . . . . 0.80000000000000004 109.458 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -110.89 139.24 46.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.69999999999999996 109.428 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 150.7 16.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.519 -1.433 . . . . 0.60999999999999999 109.519 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -27.06 68.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 2.5600000000000001 109.337 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -68.84 -52.8 26.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -0.839 . . . . 0.68999999999999995 109.235 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.57 ' HA2' ' HB2' ' A' ' 4' ' ' SER . . . 119.67 58.66 0.25 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.329 -1.509 . . . . 0.53000000000000003 109.329 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -98.36 164.83 21.32 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.318 -1.513 . . . . 0.51000000000000001 109.318 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.68 153.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.337 -1.096 . . . . 1.3600000000000001 108.777 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.553 ' HB3' HG13 ' A' ' 32' ' ' VAL . 72.1 m -77.65 87.3 3.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.403 -0.811 . . . . 0.40000000000000002 109.236 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.46 115.81 51.41 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.348 -0.845 . . . . 1.26 109.275 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.576 ' HB3' HG23 ' A' ' 32' ' ' VAL . 35.0 Cg_endo -78.85 172.17 15.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.636 2.224 . . . . 0.62 110.492 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 15' ' ' ILE . 5.0 mm 60.48 -92.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.536 -0.542 . . . . 1.8200000000000001 109.536 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -133.62 176.8 8.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.714 -1.241 . . . . 1.8899999999999999 109.127 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 162.33 57.58 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.19 -0.944 . . . . 0.47999999999999998 109.069 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.99 165.91 25.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.581 2.187 . . . . 0.54000000000000004 109.926 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.36 153.08 87.27 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 1.2 109.394 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -79.65 4.15 34.08 Favored 'Cis proline' 0 C--N 1.309 -1.524 0 C-N-CA 123.372 -1.512 . . . . 0.46999999999999997 111.315 0.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.9 ttp 61.02 56.49 2.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 1.6899999999999999 109.692 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -89.87 89.65 7.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.044 -1.035 . . . . 0.87 108.47 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.21 121.48 19.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.376 -0.827 . . . . 0.81999999999999995 109.451 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.549 HD12 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -129.16 35.18 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.429 -0.794 . . . . 1.02 109.412 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.33 -172.23 26.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.421 -1.472 . . . . 0.44 109.421 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.7 p -141.19 162.11 36.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 1.01 109.261 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 56.8 m -120.23 146.33 46.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.101 -0.999 . . . . 0.40000000000000002 109.818 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' HD2' HG22 ' A' ' 32' ' ' VAL . 21.1 m-85 55.08 41.29 31.84 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.147 0.499 . . . . 1.01 109.838 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.61 -134.89 12.19 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.46 -1.856 . . . . 0.69999999999999996 108.46 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.733 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.2 mmm180 -108.61 9.11 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.208 -1.172 . . . . 1.3200000000000001 113.391 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 36.0 Cg_endo -77.17 -47.12 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 CA-C-N 120.12 1.078 . . . . 0.60999999999999999 110.079 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 14' ' ' PRO . 48.2 t -98.6 148.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.268 -1.012 . . . . 1.1100000000000001 108.268 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -118.68 153.26 34.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.032 -1.042 . . . . 1.0800000000000001 109.965 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 m -94.21 85.19 4.59 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.532 -0.914 . . . . 0.42999999999999999 108.532 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -93.32 136.2 33.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.96 . . . . 0.37 110.083 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -91.92 136.59 33.04 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.366 -0.976 . . . . 1.3200000000000001 108.366 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.63 23.14 4.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.91000000000000003 109.566 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 108.106 -1.072 . . . . 1.03 108.106 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.185 -0.672 . . . . 3.6200000000000001 109.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 33.7 Cg_endo -77.56 106.6 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.5 2.133 . . . . 1.8500000000000001 110.371 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.4 mt -86.6 67.7 9.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.157 -0.965 . . . . 2.1800000000000002 109.416 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.4 43.54 1.15 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.323 -0.86 . . . . 1.3400000000000001 109.298 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.45 44.42 0.95 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.112 -0.993 . . . . 0.59999999999999998 109.352 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.34 -21.88 70.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.816 -1.313 . . . . 0.96999999999999997 109.816 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -42.99 74.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 2.02 109.627 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.406 ' CB ' HG13 ' A' ' 24' ' ' ILE . 86.6 m-20 -108.69 4.66 24.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 1.27 110.017 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.7 41.28 99.85 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.551 -1.42 . . . . 0.65000000000000002 109.551 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -119.25 162.95 13.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.439 -1.464 . . . . 0.46000000000000002 109.439 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.59 154.43 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.351 -1.088 . . . . 1.1899999999999999 109.073 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.458 ' HB3' HG12 ' A' ' 32' ' ' VAL . 97.7 m -96.01 98.27 10.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.186 -0.946 . . . . 0.38 109.422 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.5 HG21 ' HD2' ' A' ' 14' ' ' PRO . 1.6 mt -105.45 127.21 29.02 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.346 -0.846 . . . . 1.1699999999999999 109.087 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.5 ' HD2' HG21 ' A' ' 13' ' ' ILE . 35.3 Cg_endo -78.88 165.65 24.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.567 2.178 . . . . 0.57999999999999996 110.603 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mt 61.89 -92.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.834 -0.541 . . . . 1.77 109.691 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.66 160.04 43.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.579 -1.325 . . . . 2.1299999999999999 108.818 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.477 ' HB2' ' HG3' ' A' ' 21' ' ' MET . 0.8 OUTLIER -110.56 159.04 33.75 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.157 -0.964 . . . . 0.47999999999999998 109.435 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.69 172.1 15.64 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.731 2.287 . . . . 0.68999999999999995 110.199 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 20' ' ' PRO . 3.6 t -58.51 145.52 76.07 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.066 -0.716 . . . . 1.4099999999999999 109.066 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HA ' HG12 ' A' ' 19' ' ' VAL . 36.3 Cg_endo -80.33 -9.77 40.5 Favored 'Cis proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.596 -1.418 . . . . 0.58999999999999997 111.481 -0.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.477 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 33.1 ttp 62.64 63.71 0.97 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 2.1699999999999999 109.347 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -89.88 92.75 9.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.106 -0.996 . . . . 1.05 108.684 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.04 122.2 20.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 1.74 109.559 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.406 HG13 ' CB ' ' A' ' 8' ' ' ASN . 0.1 OUTLIER -126.53 25.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.064 -0.717 . . . . 0.92000000000000004 109.064 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 -171.74 27.47 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.609 -1.796 . . . . 0.48999999999999999 108.609 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.1 p -137.83 168.88 18.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.986 -1.302 . . . . 1.1499999999999999 109.697 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 17.9 m -129.32 142.33 50.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.371 -0.83 . . . . 0.47999999999999998 109.553 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 58.31 34.34 23.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.91 -0.494 . . . . 1.1299999999999999 110.095 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.22 10.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.03 -1.628 . . . . 0.75 109.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.88 5.02 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.166 -1.197 . . . . 2.2200000000000002 113.517 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -76.1 -47.52 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 CA-C-N 120.253 1.126 . . . . 0.68000000000000005 109.969 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 13.0 t -102.19 151.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.134 -0.979 . . . . 1.1699999999999999 108.496 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -124.41 157.17 35.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 1.53 110.218 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 88.7 m -93.59 96.4 9.83 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.729 -0.841 . . . . 0.44 108.729 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.5 m -102.51 149.07 24.77 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.045 -1.034 . . . . 0.39000000000000001 109.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 2.9 ttp180 -136.98 166.44 23.66 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.924 -0.769 . . . . 0.69999999999999996 108.924 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -26.54 18.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.452 -0.78 . . . . 1.01 108.962 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.777 -1.106 . . . . 0.92000000000000004 108.717 179.729 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.267 -0.642 . . . . 4.5199999999999996 109.267 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -77.78 141.55 19.44 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.727 2.284 . . . . 4.0700000000000003 110.189 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 tp -79.27 113.73 17.64 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.0 -0.68 . . . . 3.4500000000000002 109.289 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.511 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -57.3 110.45 0.85 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.984 -0.747 . . . . 1.48 108.984 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 4.0 m 66.72 35.37 5.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.592 -0.692 . . . . 0.93000000000000005 109.279 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.37 -42.21 96.13 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.749 -1.341 . . . . 0.63 109.749 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.7 mmm180 -65.08 -32.84 74.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.122 -1.222 . . . . 2.21 108.934 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.525 ' CB ' HG13 ' A' ' 24' ' ' ILE . 2.6 m120 -81.17 -25.22 36.98 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.416 -0.803 . . . . 1.1899999999999999 109.129 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.33 37.24 11.19 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.574 -1.41 . . . . 0.68000000000000005 109.574 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' HA3' HD13 ' A' ' 24' ' ' ILE . . . -138.83 -160.48 8.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.178 -1.569 . . . . 0.66000000000000003 109.178 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.57 157.48 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.228 -1.16 . . . . 1.54 109.138 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 4' ' ' SER . 56.0 m -87.11 92.14 8.95 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.358 -0.839 . . . . 0.81999999999999995 109.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 17' ' ' CYS . 8.3 mt -101.38 123.65 43.84 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.344 -0.847 . . . . 1.3500000000000001 109.31 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.21 172.11 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.792 2.328 . . . . 0.80000000000000004 110.274 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.4 mm 54.92 -116.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.947 -0.76 . . . . 1.28 108.947 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.31 161.36 19.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.592 -1.317 . . . . 1.71 109.241 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HB3' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.44 165.14 13.39 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.391 -0.818 . . . . 0.69999999999999996 109.228 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.03 164.03 27.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.666 2.244 . . . . 0.91000000000000003 110.021 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.75 147.82 77.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 109.195 -0.669 . . . . 1.6699999999999999 109.195 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.573 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.5 Cg_endo -80.61 -2.97 42.93 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.457 -1.476 . . . . 0.73999999999999999 111.18 -0.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.9 ttm 63.26 59.08 1.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 1.6499999999999999 109.849 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -90.36 104.24 16.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.16 -0.963 . . . . 1.25 108.869 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 122.71 23.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.345 -0.847 . . . . 1.72 109.241 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.612 HD11 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -122.48 22.82 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.458 -0.776 . . . . 1.2 109.524 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 153.72 -176.18 31.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.787 -1.725 . . . . 0.66000000000000003 108.787 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 10.5 p -129.04 164.54 23.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -1.154 . . . . 1.1000000000000001 109.688 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.629 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 59.6 m -134.94 136.94 42.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.91000000000000003 109.862 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 53.34 37.81 26.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.838 -0.539 . . . . 1.73 110.168 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.44 -132.94 11.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.371 -1.492 . . . . 1.1499999999999999 109.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.5 mmp_? -105.28 -1.73 0.11 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.312 -1.111 . . . . 1.4199999999999999 113.667 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -74.96 -44.93 0.31 Allowed 'Trans proline' 0 C--N 1.327 -0.601 0 CA-C-N 120.192 1.104 . . . . 0.94999999999999996 110.246 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.629 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 12.1 t -106.22 148.92 10.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.007 -1.058 . . . . 1.24 108.157 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -134.17 165.27 25.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 1.0900000000000001 110.299 -178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.46 ' HB3' HG12 ' A' ' 24' ' ' ILE . 69.3 m -90.06 93.25 9.31 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 0.56000000000000005 108.645 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.0 m -95.06 143.27 26.65 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.12 -0.987 . . . . 0.53000000000000003 109.387 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.612 ' HD3' HD11 ' A' ' 24' ' ' ILE . 6.3 ttp180 -121.89 152.04 40.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 1.6399999999999999 108.89 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.573 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.48 -3.73 57.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.432 -0.793 . . . . 1.5600000000000001 109.982 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 117.626 -1.178 . . . . 1.6100000000000001 108.516 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.633 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.651 -0.499 . . . . 1.8600000000000001 109.651 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 1' ' ' ALA . 36.2 Cg_endo -78.94 171.95 15.71 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.935 1.757 . . . . 1.3700000000000001 110.06 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.445 HD21 ' HA2' ' A' ' 25' ' ' GLY . 1.7 tp -122.35 168.11 12.46 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.806 -0.812 . . . . 1.6100000000000001 108.806 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -71.08 104.74 3.12 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.281 -0.887 . . . . 0.90000000000000002 109.61 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -39.41 81.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.44 109.475 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.21 68.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.072 -1.061 . . . . 0.54000000000000004 110.487 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.603 ' HB2' ' HB2' ' A' ' 4' ' ' SER . 10.4 ttm105 -54.71 -49.2 71.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.958 -1.319 . . . . 1.1799999999999999 109.808 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.408 ' HB2' HG13 ' A' ' 24' ' ' ILE . 34.8 m120 -114.61 27.7 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 1.05 109.613 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.32 44.08 96.81 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.475 -1.45 . . . . 0.48999999999999999 109.475 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -101.21 159.81 18.64 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.269 -1.532 . . . . 0.40999999999999998 109.269 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.4 145.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.273 -1.133 . . . . 1.6000000000000001 108.824 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.412 ' HB3' HG12 ' A' ' 32' ' ' VAL . 93.3 m -77.29 88.67 3.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.40999999999999998 109.114 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.8 mt -101.33 122.02 49.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.283 -0.886 . . . . 1.1699999999999999 109.239 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.1 Cg_endo -79.06 173.35 13.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.444 2.096 . . . . 0.53000000000000003 109.718 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.84 -121.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.565 -0.709 . . . . 1.5 109.327 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.28 161.81 14.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.787 -1.196 . . . . 2.7999999999999998 109.772 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.45 152.51 47.12 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.395 -0.816 . . . . 0.56999999999999995 108.819 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.33 165.23 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.474 2.116 . . . . 0.58999999999999997 110.66 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 26.8 m -63.44 155.38 75.35 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.783 -0.573 . . . . 1.26 109.732 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 35.8 Cg_endo -80.31 13.65 21.49 Favored 'Cis proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.438 -1.484 . . . . 0.56000000000000005 111.435 -0.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 ttp 59.19 57.22 3.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 1.77 109.237 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -90.04 89.55 7.75 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.544 -0.91 . . . . 1.5800000000000001 108.544 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.1 124.59 27.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.81999999999999995 109.839 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD12 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -127.57 28.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.45 -0.781 . . . . 0.62 109.232 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.445 ' HA2' HD21 ' A' ' 3' ' ' LEU . . . 150.29 -170.23 30.26 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.181 -1.568 . . . . 0.46999999999999997 109.181 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.6 p -140.42 165.43 27.45 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.258 -1.143 . . . . 1.3 109.584 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.5 m -132.62 142.11 48.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -0.903 . . . . 0.63 109.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 54.71 33.98 20.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.814 -0.554 . . . . 1.3999999999999999 110.193 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.441 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -130.66 10.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.451 -1.46 . . . . 0.69999999999999996 109.451 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.738 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -104.19 -2.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.429 -1.042 . . . . 1.7 113.707 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.738 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.54 -47.59 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 120.339 1.157 . . . . 0.60999999999999999 110.159 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 10.9 t -101.47 146.64 9.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.942 -1.132 . . . . 1.1799999999999999 107.942 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 158.72 36.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.918 -1.113 . . . . 0.73999999999999999 110.058 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.2 m -89.98 79.26 6.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.32000000000000001 108.05 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -93.48 145.24 24.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.355 -0.841 . . . . 0.31 109.684 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -114.78 151.99 32.86 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.451 -0.78 . . . . 1.5600000000000001 108.978 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.89 15.71 21.42 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.387 -0.821 . . . . 1.0800000000000001 109.283 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 117.777 -1.106 . . . . 1.05 108.469 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.966 -0.753 . . . . 3.75 108.966 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.87 83.26 2.14 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.487 2.125 . . . . 3.1200000000000001 109.803 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 56.71 40.65 29.08 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.167 -0.679 . . . . 2.0 109.167 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.52 152.98 50.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.387 -0.821 . . . . 1.2 108.958 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.4 40.18 1.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.88 . . . . 0.59999999999999998 110.554 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.16 30.0 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.619 -1.792 . . . . 1.1699999999999999 108.619 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.98 -36.66 48.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.411 -1.052 . . . . 2.7999999999999998 108.858 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -64.97 -25.99 68.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 1.45 109.307 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.27 56.01 3.12 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.747 -1.741 . . . . 0.95999999999999996 108.747 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -147.01 153.78 25.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.965 -1.654 . . . . 0.46000000000000002 108.965 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.95 141.72 13.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.237 -1.155 . . . . 1.26 109.518 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 87.8 m -88.3 84.01 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.41999999999999998 109.308 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.523 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 17.0 mt -96.09 136.22 22.24 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.181 -0.949 . . . . 1.2 108.887 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.63 172.27 16.53 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.427 2.085 . . . . 0.62 110.131 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.476 HD13 HG22 ' A' ' 15' ' ' ILE . 22.9 mm 61.49 -99.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.289 -0.634 . . . . 1.47 109.289 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 170.38 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.598 -1.314 . . . . 1.29 109.085 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.619 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 4.6 m -96.01 134.31 24.02 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.893 . . . . 0.76000000000000001 109.556 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.24 138.82 16.28 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.575 2.184 . . . . 0.88 109.764 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 30.0 m -64.26 155.69 78.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.817 . . . . 1.24 109.198 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -79.58 2.72 35.11 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.494 -1.461 . . . . 0.67000000000000004 111.459 0.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.463 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 26.6 ttm -67.48 113.85 5.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.833 -1.167 . . . . 1.54 109.137 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.71 176.6 5.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 1.25 109.571 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.619 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -82.67 142.72 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 1.0600000000000001 109.241 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.599 HG12 ' HB2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -138.83 33.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 1.2 109.369 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 142.56 -167.82 26.07 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.166 -1.574 . . . . 0.5 109.166 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 9.9 p -131.2 163.91 26.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.203 -1.175 . . . . 1.3700000000000001 109.493 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 m -133.32 140.58 47.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.243 -0.91 . . . . 0.56999999999999995 109.677 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 51.23 41.84 28.27 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.176 0.512 . . . . 0.87 109.934 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 93.55 -134.86 12.3 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.02 -1.632 . . . . 0.60999999999999999 109.02 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.2 mmp_? -105.29 -0.16 0.1 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.215 -1.168 . . . . 1.8100000000000001 113.471 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.7 Cg_endo -74.74 -47.44 0.22 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 120.263 1.13 . . . . 0.68000000000000005 110.337 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.1 t -100.87 156.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.073 -1.017 . . . . 1.03 108.334 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -129.2 163.67 25.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.986 -1.071 . . . . 1.0700000000000001 109.925 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.2 m -90.57 131.99 35.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.357 -0.979 . . . . 0.40000000000000002 108.357 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.523 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.7 m -121.33 133.54 55.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.029 -1.044 . . . . 0.47999999999999998 109.663 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.599 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.32 146.85 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.727 -0.842 . . . . 1.1299999999999999 108.727 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -23.7 21.33 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.276 -0.89 . . . . 1.27 109.401 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 1.1899999999999999 109.148 -179.911 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.504 -0.554 . . . . 2.4700000000000002 109.504 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -77.93 110.81 2.98 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.578 2.185 . . . . 3.0 110.739 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.2 mt 54.35 70.77 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.838 -0.539 . . . . 1.8999999999999999 110.048 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.54 103.19 0.64 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.317 -0.994 . . . . 2.0 108.317 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.46 23.53 12.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.534 -0.729 . . . . 0.72999999999999998 109.637 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.96 -45.03 59.19 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.911 -1.675 . . . . 0.64000000000000001 108.911 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -33.43 75.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -1.074 . . . . 1.8100000000000001 108.93 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.64 -27.88 64.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.33 -0.856 . . . . 1.0700000000000001 109.186 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.76 48.27 5.29 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.26 -1.536 . . . . 0.58999999999999997 109.26 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.01 157.39 27.44 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.159 -1.576 . . . . 0.51000000000000001 109.159 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 m -93.89 150.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -1.12 . . . . 1.3100000000000001 109.416 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.59 ' HB3' HG12 ' A' ' 32' ' ' VAL . 54.2 m -88.54 101.36 13.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.421 -0.8 . . . . 0.57999999999999996 109.392 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.55 HG23 HG13 ' A' ' 15' ' ' ILE . 15.4 mt -100.58 122.31 49.95 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.322 -0.861 . . . . 1.2 109.342 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.502 ' HB3' HG23 ' A' ' 32' ' ' VAL . 36.1 Cg_endo -80.32 31.2 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.827 2.351 . . . . 0.59999999999999998 110.962 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 HG13 HG23 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -146.23 -153.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.174 -1.047 . . . . 1.3500000000000001 108.174 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.63 142.84 27.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.035 -1.04 . . . . 2.3100000000000001 108.972 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -63.22 124.18 83.15 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.48999999999999999 109.849 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.87 119.81 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.687 2.258 . . . . 0.88 110.362 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.2 m -65.85 159.88 66.24 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.267 -0.896 . . . . 1.4399999999999999 108.726 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -80.98 8.27 35.9 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 123.614 -1.411 . . . . 0.72999999999999998 111.596 -0.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.669 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 2.0 ttp -60.79 133.99 56.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.925 -1.11 . . . . 1.6599999999999999 108.864 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -101.74 164.91 11.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.5800000000000001 110.039 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.18 151.53 24.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.176 -0.675 . . . . 2.46 109.176 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.613 HG23 ' HD3' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -148.38 44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.613 -0.679 . . . . 1.1799999999999999 109.488 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.25 -174.62 18.33 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.146 -1.581 . . . . 0.48999999999999999 109.146 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.577 HG23 ' HD3' ' A' ' 30' ' ' ARG . 26.4 p -138.16 166.75 23.36 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.291 -1.123 . . . . 1.27 109.415 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 27.0 m -127.03 141.45 51.78 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.155 -0.966 . . . . 0.67000000000000004 109.772 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 56.0 36.65 27.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.877 -0.514 . . . . 1.1899999999999999 110.026 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.34 10.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.92000000000000004 109.043 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -107.98 6.81 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.189 . . . . 1.3500000000000001 113.472 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.2 Cg_endo -76.6 -46.11 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 120.171 1.097 . . . . 0.83999999999999997 109.782 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' A' ' 12' ' ' CYS . 73.2 t -104.63 149.49 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.297 -1.001 . . . . 1.1100000000000001 108.297 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.5 mttp -123.69 154.2 39.74 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.093 -1.005 . . . . 1.1799999999999999 109.83 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.1 m -89.97 136.82 32.81 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.445 -0.946 . . . . 0.5 108.445 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.669 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -135.63 133.72 38.52 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.103 -0.998 . . . . 0.51000000000000001 110.09 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.613 ' HD3' HG23 ' A' ' 24' ' ' ILE . 2.6 ptm180 -145.33 143.03 29.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.185 -1.043 . . . . 0.72999999999999998 108.185 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -33.71 16.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 1.1200000000000001 111.007 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.416 ' OXT' ' HG3' ' A' ' 36' ' ' ARG . 11.3 p-90 . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.018 -1.051 . . . . 1.1599999999999999 109.641 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.543 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.824 -0.435 . . . . 1.5700000000000001 109.824 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 1' ' ' ALA . 35.0 Cg_endo -77.5 179.49 6.46 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.93 1.753 . . . . 0.83999999999999997 110.07 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.5 mt -70.23 -64.55 0.87 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 1.5700000000000001 108.81 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.55 161.19 14.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.608 -0.886 . . . . 1.0 108.608 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -104.75 45.6 0.95 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.107 -0.996 . . . . 0.75 109.831 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.89 51.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.506 . . . . 0.64000000000000001 109.336 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.11 -44.2 93.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.309 -1.112 . . . . 3.21 109.468 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.491 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 4.3 m120 -80.27 -25.06 39.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.925 . . . . 1.1799999999999999 109.355 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.18 62.8 2.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.78 -1.728 . . . . 0.57999999999999996 108.78 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -152.37 168.54 31.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.23 -1.548 . . . . 0.47999999999999998 109.23 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 t -91.14 143.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 1.3100000000000001 109.129 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.2 m -86.1 83.98 7.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.305 -0.872 . . . . 0.39000000000000001 109.579 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.511 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 6.7 mt -96.24 128.57 36.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.181 -0.95 . . . . 1.1699999999999999 108.866 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.16 179.07 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.442 2.094 . . . . 0.57999999999999996 110.309 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.6 mt 61.29 -101.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.705 -0.622 . . . . 1.29 109.415 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.36 160.91 40.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.615 -1.303 . . . . 1.6399999999999999 109.374 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.84 131.04 68.43 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.854 . . . . 0.64000000000000001 109.435 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.78 120.15 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.625 2.217 . . . . 0.82999999999999996 109.535 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.1 m -57.32 153.48 26.81 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.822 . . . . 1.4399999999999999 109.334 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.85 10.69 30.11 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.606 -1.414 . . . . 0.84999999999999998 111.626 -0.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.513 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.5 tpp -61.35 118.78 7.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.929 -1.107 . . . . 1.6799999999999999 108.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 1.5 ptp85 -90.03 175.99 6.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 1.22 109.839 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 132.47 52.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.701 -0.851 . . . . 1.7 108.701 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 pt -120.27 -0.08 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 1.21 110.361 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.63 -159.27 31.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.424 -1.471 . . . . 0.56000000000000005 109.424 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.2 p -137.17 165.34 26.34 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.351 -1.088 . . . . 1.27 109.612 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 76.6 m -126.9 148.1 50.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.41999999999999998 109.228 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 55.02 41.56 31.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.045 -0.724 . . . . 0.97999999999999998 109.045 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 -130.9 10.52 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.938 -2.065 . . . . 0.57999999999999996 107.938 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.731 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.6 mtm180 -113.75 10.48 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.186 -1.185 . . . . 3.3300000000000001 113.341 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.7 Cg_endo -77.56 -45.25 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 120.162 1.093 . . . . 0.59999999999999998 109.681 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 46.1 t -98.47 154.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.265 -1.013 . . . . 1.0700000000000001 108.265 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mttp -117.91 157.88 25.89 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 1.76 110.057 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 81.4 m -97.25 104.34 16.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.494 -0.928 . . . . 0.5 108.494 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.513 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 14.7 m -100.05 143.0 30.77 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.131 -0.981 . . . . 0.46000000000000002 109.826 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -143.66 158.69 43.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.519 -0.738 . . . . 1.5 109.205 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -27.96 51.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.335 -0.853 . . . . 1.3 109.429 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 37.0 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.894 -1.05 . . . . 1.48 109.264 179.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.081 -0.711 . . . . 1.9199999999999999 109.081 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -81.23 153.56 18.69 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.592 2.194 . . . . 1.7 110.704 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.2 mt 54.56 41.77 31.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.925 -0.484 . . . . 1.73 110.77 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.02 168.16 16.2 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.873 -1.142 . . . . 1.55 108.799 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 49.18 1.04 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.108 -0.995 . . . . 0.89000000000000001 109.747 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.28 -34.48 69.22 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.217 -1.553 . . . . 1.01 109.217 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -23.93 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -1.17 . . . . 1.77 109.762 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' HB3' HG13 ' A' ' 24' ' ' ILE . 14.8 m120 -103.51 -11.7 17.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 1.1100000000000001 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.05 32.18 66.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.504 -1.438 . . . . 0.85999999999999999 109.504 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -122.91 164.17 15.99 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.43 -1.468 . . . . 0.56000000000000005 109.43 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.26 154.63 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.41 -1.053 . . . . 1.29 109.275 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.65 93.62 9.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.432 -0.793 . . . . 0.5 109.43 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 17' ' ' CYS . 4.0 mt -102.18 122.58 46.34 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.291 -0.881 . . . . 1.1599999999999999 108.947 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 166.98 23.57 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.64 2.227 . . . . 0.70999999999999996 110.797 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.1 mt 61.42 -94.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.439 -0.578 . . . . 1.3700000000000001 109.439 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.58 165.7 26.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.799 -1.188 . . . . 2.0600000000000001 108.928 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.633 ' HB3' HD11 ' A' ' 13' ' ' ILE . 1.3 m -119.37 163.58 26.16 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.229 -0.92 . . . . 0.5 109.509 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.1 Cg_endo -79.16 170.64 17.39 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.671 2.247 . . . . 0.85999999999999999 109.609 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.63 152.19 93.17 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.453 -0.779 . . . . 1.27 109.248 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 34.1 Cg_endo -79.13 -5.57 38.05 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.19 -1.587 . . . . 0.70999999999999996 111.504 0.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.9 ttm 61.85 65.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 1.9099999999999999 109.648 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -89.91 90.19 8.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.166 -0.959 . . . . 1.8300000000000001 108.506 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.75 117.64 12.52 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.615 -0.678 . . . . 1.3700000000000001 109.828 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -121.24 31.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.881 -0.785 . . . . 0.76000000000000001 108.881 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.35 -167.66 24.66 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.912 -1.675 . . . . 0.5 108.912 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 p -141.09 169.01 18.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.242 -1.152 . . . . 1.1100000000000001 109.517 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 78.5 m -126.28 147.6 49.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.295 -0.878 . . . . 0.54000000000000004 109.285 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 58.62 34.38 23.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.659 -0.497 . . . . 1.3300000000000001 109.659 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 96.73 -134.52 11.83 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.605 -1.798 . . . . 0.70999999999999996 108.605 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.752 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.1 mtp85 -105.02 4.82 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.312 -1.11 . . . . 2.0499999999999998 113.358 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.6 Cg_endo -75.82 -50.28 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 120.137 1.085 . . . . 0.60999999999999999 110.142 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 16.2 t -93.47 147.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.01 -1.056 . . . . 1.0900000000000001 108.757 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -115.34 156.61 25.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.206 -0.934 . . . . 1.3 109.83 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 95.8 m -98.95 92.51 5.55 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.369 -0.832 . . . . 0.52000000000000002 108.897 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -99.51 147.34 25.41 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.147 -0.971 . . . . 0.45000000000000001 109.951 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -130.97 161.12 32.63 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.763 -0.829 . . . . 1.46 108.763 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.483 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -89.79 -18.68 25.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.325 -0.859 . . . . 1.3100000000000001 109.645 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.9 p90 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 117.713 -1.137 . . . . 1.21 108.734 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.617 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.597 -0.519 . . . . 1.5800000000000001 109.597 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.617 ' HD3' ' CB ' ' A' ' 1' ' ' ALA . 34.6 Cg_endo -77.33 161.42 31.87 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.888 1.726 . . . . 1.1000000000000001 109.774 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.2 mt -113.72 49.03 1.01 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.3 -0.875 . . . . 1.6100000000000001 109.188 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.63 119.19 31.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.375 -0.828 . . . . 1.22 109.638 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 25.1 t -87.47 83.67 7.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.244 -0.91 . . . . 0.44 108.681 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.43 -24.51 76.7 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.354 -1.098 . . . . 0.73999999999999999 110.354 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -62.21 -48.3 80.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.979 -1.307 . . . . 1.5600000000000001 109.901 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 1.2 110.161 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.62 60.31 3.76 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.349 -1.5 . . . . 0.79000000000000004 109.349 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.66 -166.49 16.45 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.894 -1.682 . . . . 0.44 108.894 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.6 m -96.41 172.51 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -1.209 . . . . 1.3 109.057 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.574 ' HB3' HG13 ' A' ' 32' ' ' VAL . 21.7 m -125.78 111.17 14.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.34999999999999998 109.572 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 15' ' ' ILE . 1.2 mt -98.87 121.85 54.65 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.208 -0.932 . . . . 1.04 108.94 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HB3' HG23 ' A' ' 32' ' ' VAL . 36.4 Cg_endo -79.65 38.26 0.72 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.792 2.328 . . . . 0.56000000000000005 111.494 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -157.31 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.84 -1.162 . . . . 1.29 108.942 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -149.97 173.2 14.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 1.76 108.89 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 t -102.95 110.64 63.93 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.388 -0.82 . . . . 0.46999999999999997 108.954 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.69 135.39 11.49 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.597 2.198 . . . . 1.02 110.294 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m -67.55 159.46 78.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.379 -0.825 . . . . 1.3 108.928 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -79.63 5.29 32.73 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.53 -1.446 . . . . 0.56000000000000005 111.512 0.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.683 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 7.7 tpp -62.74 139.08 58.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.883 -1.136 . . . . 1.9199999999999999 109.119 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -114.03 147.72 38.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.96999999999999997 109.37 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 144.3 50.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 1.1799999999999999 109.284 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -138.61 37.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 1.24 109.838 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.63 -173.62 21.97 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.605 -1.398 . . . . 0.56000000000000005 109.605 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 41.3 p -126.11 163.13 23.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -1.078 . . . . 1.3200000000000001 109.408 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.615 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 34.1 m -128.0 137.54 52.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.55000000000000004 109.624 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 52.89 43.82 31.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.883 -0.511 . . . . 1.0900000000000001 110.123 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 -132.59 11.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.49 -1.844 . . . . 0.69999999999999996 108.49 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.4 mtm180 -111.54 4.91 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.177 -1.19 . . . . 3.4100000000000001 113.628 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.3 Cg_endo -75.27 -43.51 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.338 1.157 . . . . 0.68999999999999995 109.776 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 49.5 t -107.13 152.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.113 -1.069 . . . . 1.02 108.113 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.1 mttp -124.31 156.74 36.44 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.993 -1.067 . . . . 1.22 110.133 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 71.9 m -90.0 143.59 26.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.933 -1.136 . . . . 0.37 107.933 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.683 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 21.8 m -138.81 138.81 37.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.96 -1.088 . . . . 0.34999999999999998 110.021 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -150.11 162.37 40.56 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.433 -0.792 . . . . 1.23 109.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -33.98 27.0 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.413 -0.805 . . . . 0.91000000000000003 109.23 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 33.6 p90 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 117.789 -1.1 . . . . 1.2 108.851 179.775 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.161 -0.681 . . . . 3.8900000000000001 109.161 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.47 128.94 9.09 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.614 2.209 . . . . 2.8399999999999999 110.584 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 tp -96.31 166.92 11.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -0.817 . . . . 2.6000000000000001 108.874 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.35 117.11 4.83 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.556 -0.715 . . . . 1.48 109.245 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 p -128.05 162.4 26.95 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.211 -0.93 . . . . 0.46999999999999997 109.241 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.94 175.74 43.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.093 -1.603 . . . . 0.64000000000000001 109.093 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.02 46.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 2.2400000000000002 109.579 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 24' ' ' ILE . 5.5 m-80 -75.27 -25.48 58.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.79000000000000004 109.953 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.81 65.01 0.95 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.506 -1.438 . . . . 0.67000000000000004 109.506 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . -106.37 -152.97 19.99 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.539 -1.824 . . . . 0.55000000000000004 108.539 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.61 149.39 32.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -1.206 . . . . 1.54 108.882 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.583 ' HB3' HG13 ' A' ' 32' ' ' VAL . 92.2 m -75.0 92.03 2.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.46999999999999997 109.472 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 HG21 ' HD2' ' A' ' 14' ' ' PRO . 2.3 mt -102.6 125.43 35.91 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.291 -0.881 . . . . 1.3899999999999999 108.939 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.11 173.57 13.74 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.57 2.18 . . . . 0.65000000000000002 110.258 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 54.21 -119.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.957 -0.757 . . . . 1.75 108.957 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.12 154.94 32.45 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.634 -1.291 . . . . 2.8199999999999998 109.068 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.4 159.72 28.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.318 -0.863 . . . . 0.68999999999999995 109.329 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 167.67 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.679 2.253 . . . . 1.26 110.235 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -60.46 147.23 83.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 1.3700000000000001 109.294 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -79.91 -3.05 39.91 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.55 -1.437 . . . . 0.84999999999999998 111.351 -0.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.2 ttm 62.47 56.22 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 1.51 109.629 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -90.17 87.08 6.72 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.176 -0.953 . . . . 2.7000000000000002 108.53 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 7.3 pt20 -71.87 129.57 38.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 1.72 109.486 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -130.39 38.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.319 -0.863 . . . . 0.60999999999999999 108.697 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.76 -179.82 24.35 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.645 -1.782 . . . . 0.47999999999999998 108.645 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.7 p -132.97 160.76 36.18 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.081 -1.246 . . . . 1.3899999999999999 109.816 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.617 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.7 m -130.03 140.83 50.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.482 -0.761 . . . . 0.63 109.534 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 55.77 37.14 28.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.885 -0.51 . . . . 1.4199999999999999 110.178 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.36 -133.55 11.56 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.487 -1.445 . . . . 0.59999999999999998 109.487 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -103.7 -3.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.8199999999999998 113.71 -179.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.9 Cg_endo -74.85 -43.05 0.45 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.205 1.109 . . . . 0.79000000000000004 110.832 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.6 t -103.81 147.47 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.835 -1.166 . . . . 1.1200000000000001 108.853 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -131.07 156.38 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.011 -1.056 . . . . 1.25 110.022 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 55.8 m -90.09 82.18 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.40999999999999998 108.812 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 73.7 m -91.78 140.99 29.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.133 -0.979 . . . . 0.44 109.843 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.418 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -110.0 152.21 26.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.625 -0.88 . . . . 0.97999999999999998 108.625 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.543 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.09 -7.95 52.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.316 -0.865 . . . . 1.1499999999999999 110.018 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 25.7 p90 . . . . . 0 N--CA 1.487 1.375 0 O-C-N 121.062 -1.024 . . . . 1.3600000000000001 108.719 -179.911 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.927 -0.768 . . . . 3.2999999999999998 108.927 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -77.29 87.71 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.683 2.255 . . . . 3.5600000000000001 109.877 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 78.7 mt -75.96 135.46 40.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.435 -0.791 . . . . 2.3900000000000001 110.117 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.72 177.65 10.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.31 -0.996 . . . . 1.3200000000000001 108.31 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -104.7 37.51 2.12 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.005 -1.06 . . . . 0.48999999999999999 109.59 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.28 -49.8 24.66 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.564 . . . . 0.68000000000000005 109.191 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -74.79 -36.11 62.49 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.19 -1.182 . . . . 2.5800000000000001 109.254 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.542 ' HB3' HD11 ' A' ' 24' ' ' ILE . 5.6 m120 -70.45 -30.41 67.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 1.0 109.366 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.46 50.08 6.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.329 -1.509 . . . . 0.48999999999999999 109.329 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.86 -170.69 11.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.347 -1.501 . . . . 0.42999999999999999 109.347 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.3 157.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -1.144 . . . . 1.6000000000000001 109.25 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.2 m -93.23 87.36 5.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.44 109.482 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.438 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 8.3 mt -97.14 131.44 27.56 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 1.1000000000000001 108.92 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 13' ' ' ILE . 34.7 Cg_endo -77.26 172.55 15.82 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.445 2.096 . . . . 0.64000000000000001 110.246 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.9 mm 63.02 -95.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.734 -0.604 . . . . 1.3700000000000001 109.551 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 164.41 35.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.659 -1.275 . . . . 2.1499999999999999 109.368 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.429 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 18.7 m -87.31 132.9 39.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.352 -0.843 . . . . 0.66000000000000003 109.068 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.33 132.56 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.501 2.134 . . . . 0.96999999999999997 109.737 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.6 m -63.12 155.02 75.42 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.837 . . . . 1.4399999999999999 109.132 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.5 7.68 34.39 Favored 'Cis proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.45 -1.479 . . . . 0.77000000000000002 111.621 0.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.452 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 18.6 ttm -63.81 121.49 14.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.777 -1.202 . . . . 1.72 109.145 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -95.54 177.55 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.77000000000000002 109.491 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.429 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.4 tt0 -92.0 147.19 23.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.673 -0.862 . . . . 1.54 108.673 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.594 HD13 ' HB3' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -145.33 42.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.482 -0.761 . . . . 1.23 109.716 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.74 -166.61 22.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.44 109.472 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 16.5 p -138.98 166.79 23.56 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.325 -1.103 . . . . 1.26 109.176 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.607 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 78.6 m -129.0 140.19 51.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.241 -0.912 . . . . 0.62 109.921 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 55.53 40.84 31.2 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.763 -0.458 . . . . 1.05 109.763 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.58 -130.63 10.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.38 -1.888 . . . . 0.68000000000000005 108.38 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.73 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -111.8 9.58 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.086 -1.243 . . . . 1.8400000000000001 113.386 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.73 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.1 Cg_endo -76.55 -50.52 0.1 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 CA-C-N 120.166 1.095 . . . . 0.69999999999999996 109.766 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.607 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 51.2 t -99.31 155.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.196 -1.039 . . . . 1.27 108.196 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.2 160.0 26.08 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.963 -1.085 . . . . 1.48 109.892 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HB3' HD13 ' A' ' 24' ' ' ILE . 21.7 m -93.54 133.78 36.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.954 -1.128 . . . . 0.39000000000000001 107.954 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 19.5 m -126.04 142.46 51.51 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.088 -1.007 . . . . 0.46999999999999997 109.834 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.576 ' HB2' HG12 ' A' ' 24' ' ' ILE . 4.4 mtp180 -139.03 141.24 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.895 -0.78 . . . . 1.1599999999999999 108.895 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.25 -22.56 60.38 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.337 -0.852 . . . . 0.91000000000000003 109.739 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.6 p90 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 117.788 -1.101 . . . . 0.91000000000000003 108.943 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.811 -0.811 . . . . 1.6599999999999999 108.811 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.28 171.85 17.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.574 2.183 . . . . 1.47 110.113 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 70.69 132.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.317 -0.623 . . . . 1.6699999999999999 109.317 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.42 85.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.285 -0.885 . . . . 1.3899999999999999 109.695 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.4 m 55.22 41.26 31.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.452 -0.78 . . . . 0.58999999999999997 110.071 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.87 -6.03 89.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.854 -1.298 . . . . 0.64000000000000001 109.854 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -64.18 -60.59 3.02 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.976 -1.308 . . . . 1.01 109.542 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -119.97 13.12 12.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.157 -0.964 . . . . 1.5 110.092 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.31 70.19 1.15 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.635 -1.386 . . . . 0.52000000000000002 109.635 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 24' ' ' ILE . . . -127.02 -156.72 9.25 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.057 -1.617 . . . . 0.40999999999999998 109.057 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -1.152 . . . . 1.6499999999999999 109.432 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.472 ' HB3' HG13 ' A' ' 32' ' ' VAL . 65.7 m -84.33 88.99 7.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.536 -0.727 . . . . 0.48999999999999999 109.329 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -97.85 130.05 29.8 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.11 -0.994 . . . . 1.22 109.307 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -77.65 178.03 8.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.457 2.105 . . . . 0.70999999999999996 110.047 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 mm 59.68 -98.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.717 -0.614 . . . . 1.4399999999999999 109.472 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.94 160.47 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.556 -1.34 . . . . 3.3399999999999999 109.367 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -71.84 146.21 90.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.497 -0.752 . . . . 0.54000000000000004 109.671 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 35.5 Cg_endo -78.53 -165.13 0.31 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.726 2.284 . . . . 0.70999999999999996 110.063 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.427 ' HA ' ' N ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -135.64 140.86 35.1 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.166 -0.959 . . . . 1.3899999999999999 109.588 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.95 109.23 1.39 Allowed 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.183 -1.59 . . . . 0.87 110.53 -1.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.8 ttm -150.8 118.82 6.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.82 -1.175 . . . . 1.7 108.725 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -93.69 178.64 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 2.2000000000000002 109.616 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.2 144.77 25.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.541 -0.725 . . . . 1.0600000000000001 109.195 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.409 HD13 ' HA3' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -142.03 49.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 1.1599999999999999 109.277 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.49 -174.39 17.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.411 -1.475 . . . . 0.51000000000000001 109.411 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 11.4 p -133.19 166.11 23.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.323 -1.104 . . . . 1.25 109.467 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 95.2 m -133.67 136.99 45.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.67000000000000004 109.866 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 56.18 37.59 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 1.1200000000000001 110.144 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.98 -132.8 11.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.934 -1.666 . . . . 0.81999999999999995 108.934 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 20.8 mmm-85 -105.98 1.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.284 -1.127 . . . . 1.96 113.608 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -75.05 -50.85 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.585 0 CA-C-N 120.217 1.113 . . . . 0.89000000000000001 109.865 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 17.2 t -100.12 150.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.035 -1.098 . . . . 1.26 108.035 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 163.33 24.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.01 -1.056 . . . . 0.85999999999999999 109.728 -179.239 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.2 m -92.67 130.45 38.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.293 -1.003 . . . . 0.47999999999999998 108.293 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 35.4 m -125.23 141.82 51.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.062 -1.023 . . . . 0.52000000000000002 109.818 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB2' HG12 ' A' ' 24' ' ' ILE . 10.8 mtp180 -141.05 134.49 29.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.432 -0.792 . . . . 1.6200000000000001 108.932 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.86 -26.12 37.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 1.1799999999999999 109.551 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.8 p90 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 117.796 -1.097 . . . . 1.27 108.822 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.633 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.37 -0.604 . . . . 4.5700000000000003 109.37 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 1' ' ' ALA . 36.3 Cg_endo -77.59 82.36 2.42 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.657 1.571 . . . . 3.5899999999999999 110.369 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.5 mt -80.86 -61.86 1.84 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.618 -0.882 . . . . 2.6299999999999999 108.618 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p 57.46 -171.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.626 0.727 . . . . 1.05 110.494 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.07 -26.33 11.18 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.447 -0.783 . . . . 0.67000000000000004 109.309 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.35 -46.58 25.89 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.508 -1.437 . . . . 0.93999999999999995 109.508 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -41.16 99.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -1.118 . . . . 2.4399999999999999 109.651 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -75.65 -25.36 56.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.026 . . . . 0.84999999999999998 109.816 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.21 29.65 12.19 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.631 -1.388 . . . . 0.82999999999999996 109.631 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.641 ' HA3' HD12 ' A' ' 24' ' ' ILE . . . -103.81 156.52 17.57 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.613 -1.795 . . . . 0.65000000000000002 108.613 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 158.43 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.193 -1.18 . . . . 1.5700000000000001 109.645 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.627 ' HB3' HG13 ' A' ' 32' ' ' VAL . 96.5 m -79.17 93.18 5.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.521 -0.737 . . . . 0.53000000000000003 109.241 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mt -101.53 123.74 43.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.357 -0.84 . . . . 1.1599999999999999 109.195 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.49 170.64 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.561 2.174 . . . . 0.75 110.137 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt 56.88 -107.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.659 -0.65 . . . . 1.6299999999999999 109.321 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.58 177.58 5.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.56 -1.338 . . . . 2.2799999999999998 109.067 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 157.98 70.87 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.205 -0.934 . . . . 0.67000000000000004 109.131 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.73 169.97 19.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.643 2.229 . . . . 0.81999999999999995 109.988 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.54 153.4 95.0 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 1.3400000000000001 109.33 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -79.48 4.72 32.47 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.378 -1.509 . . . . 0.72999999999999998 111.177 0.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 ttp 61.0 57.77 2.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 2.1499999999999999 109.805 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -89.93 90.32 8.11 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.195 -0.941 . . . . 1.74 108.591 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 119.41 18.5 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 1.5 109.536 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.641 HD12 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.58 31.59 2.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.455 -0.778 . . . . 0.90000000000000002 109.232 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.8 -177.38 26.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.906 -1.678 . . . . 0.68999999999999995 108.906 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 13.1 p -135.31 161.14 36.24 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.145 -1.209 . . . . 1.25 109.775 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.8 m -126.18 141.93 51.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.248 -0.908 . . . . 0.69999999999999996 109.705 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 56.26 35.12 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.805 -0.56 . . . . 1.3700000000000001 110.12 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.6 -132.42 11.14 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.083 -1.607 . . . . 0.84999999999999998 109.083 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.75 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -105.16 0.71 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 2.0600000000000001 113.685 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.75 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.91 -44.2 0.36 Allowed 'Trans proline' 0 C--N 1.327 -0.602 0 CA-C-N 120.247 1.124 . . . . 0.75 109.925 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.627 HG13 ' HB3' ' A' ' 12' ' ' CYS . 3.6 t -106.21 146.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.129 -1.063 . . . . 1.28 108.129 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -128.03 155.46 44.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.993 -1.067 . . . . 1.3300000000000001 109.937 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.6 m -89.93 81.33 6.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.241 -1.022 . . . . 0.56000000000000005 108.241 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.82 143.33 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.5 109.806 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -103.57 145.44 30.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.598 -0.889 . . . . 1.05 108.598 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.9 19.86 9.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.384 -0.822 . . . . 1.05 109.466 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 108.173 -1.047 . . . . 1.1599999999999999 108.173 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.067 -0.716 . . . . 4.0999999999999996 109.067 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 1' ' ' ALA . 30.9 Cg_endo -75.47 133.55 16.03 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.407 2.071 . . . . 3.0299999999999998 110.641 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 3' ' ' LEU . 60.0 mt -76.53 116.0 16.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.476 -0.765 . . . . 2.9100000000000001 109.675 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.14 124.34 20.58 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.301 -1.0 . . . . 1.55 108.301 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.629 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 25.8 m 59.23 28.1 17.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.53 -0.731 . . . . 0.83999999999999997 109.794 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.95 -60.94 1.71 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.038 -1.625 . . . . 0.73999999999999999 109.038 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -69.45 89.81 0.51 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -1.07 . . . . 1.79 108.684 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.48 ' C ' HD13 ' A' ' 24' ' ' ILE . 17.3 m120 52.08 63.87 2.07 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.864 -0.791 . . . . 1.9299999999999999 108.864 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' A' ' 5' ' ' CYS . . . -121.23 -62.1 0.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.87 -1.292 . . . . 0.48999999999999999 109.87 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.476 ' HA3' ' HG3' ' A' ' 36' ' ' ARG . . . 99.03 -97.43 1.84 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.212 -1.555 . . . . 0.40000000000000002 109.212 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.41 141.64 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.103 -1.233 . . . . 1.01 109.522 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 58.0 m -82.92 94.45 7.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.40999999999999998 109.206 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 17' ' ' CYS . 5.9 mt -101.7 123.55 43.69 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.174 -0.954 . . . . 1.1399999999999999 109.328 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.5 175.75 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.648 2.232 . . . . 0.57999999999999996 109.912 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.481 HG22 HD11 ' A' ' 15' ' ' ILE . 0.7 OUTLIER 53.75 -120.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.87 -0.789 . . . . 1.8799999999999999 108.87 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -126.18 135.35 51.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.511 -1.368 . . . . 1.51 109.35 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.466 ' HB2' ' HG3' ' A' ' 21' ' ' MET . 3.3 m -75.95 161.88 73.92 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.366 -0.834 . . . . 0.46999999999999997 108.91 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.3 Cg_endo -77.02 160.29 33.56 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.512 2.141 . . . . 0.69999999999999996 110.368 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -61.67 147.76 88.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.616 -0.677 . . . . 1.3899999999999999 109.221 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 35.7 Cg_endo -77.89 -11.98 32.04 Favored 'Cis proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.48 -1.467 . . . . 0.53000000000000003 111.177 -0.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 43.5 ttp 61.68 86.19 0.11 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 1.46 110.286 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.84 89.33 3.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.874 -1.141 . . . . 0.81000000000000005 108.491 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.6 109.89 4.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.70999999999999996 109.226 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 36' ' ' ARG . 9.7 pt -111.01 -3.74 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.397 -0.815 . . . . 1.1000000000000001 109.804 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.06 -171.84 31.78 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.988 -1.645 . . . . 0.42999999999999999 108.988 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.1 p -129.55 166.94 18.69 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -1.174 . . . . 1.05 109.414 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 97.3 m -138.74 126.17 21.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.56000000000000005 109.519 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 56.12 39.07 30.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.721 -0.612 . . . . 1.1100000000000001 109.972 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.62 -136.97 13.16 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.381 -1.487 . . . . 0.68999999999999995 109.381 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 24.4 mmm180 -101.32 -1.84 0.1 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 1.4399999999999999 113.77 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.39 -52.52 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 CA-C-N 120.24 1.121 . . . . 0.58999999999999997 109.698 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -98.19 148.27 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.397 -1.334 . . . . 1.0 107.397 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.71 156.8 45.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.89 -1.131 . . . . 0.46999999999999997 110.282 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.8 m -90.61 97.21 11.05 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.453 -0.943 . . . . 0.40000000000000002 108.453 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.9 m -101.13 142.18 32.94 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.296 -0.878 . . . . 0.41999999999999998 109.364 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HB2' HD12 ' A' ' 24' ' ' ILE . 5.7 ttp85 -144.49 -172.22 3.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.523 -0.917 . . . . 0.73999999999999999 108.523 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.08 49.95 18.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.039 -0.726 . . . . 0.67000000000000004 109.039 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.65 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.6 p90 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 118.026 -0.987 . . . . 1.03 109.091 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 120.791 0.329 . . . . 0.4 110.386 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.81 -55.57 3.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.801 -1.72 . . . . 0.39 108.801 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.37 93.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.461 -1.023 . . . . 2.08 108.778 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB3' HD12 ' A' ' 24' ' ' ILE . 7.6 m120 -66.99 -39.78 87.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.66 108.921 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 59.44 3.25 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.157 -1.577 . . . . 0.37 109.157 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -147.24 -170.91 15.87 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.101 -1.6 . . . . 0.29 109.101 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.02 150.6 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -1.149 . . . . 0.94 109.242 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 5' ' ' CYS . 89.3 m -93.96 94.0 8.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -0.806 . . . . 0.29 110.078 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -96.18 128.97 35.01 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.176 -0.952 . . . . 0.38 108.846 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.3 Cg_endo -77.76 178.34 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.558 2.172 . . . . 0.39 110.57 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mt 61.84 -93.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 1.03 109.703 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.18 168.98 21.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.615 -1.303 . . . . 1.38 109.546 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.48 122.95 87.59 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.49 -0.756 . . . . 0.38 109.214 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.22 125.28 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.597 2.198 . . . . 0.48 109.936 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 26.9 m -68.76 158.97 84.29 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.251 -0.906 . . . . 0.62 108.906 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.504 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -81.6 10.78 33.86 Favored 'Cis proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.525 -1.448 . . . . 0.54 111.641 -0.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.429 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 20.7 ttm -63.32 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 1.02 109.25 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -107.09 149.87 27.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.818 . . . . 0.69 109.22 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.99 142.85 47.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.416 -0.802 . . . . 0.9 109.255 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.614 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -139.44 39.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.847 . . . . 0.5 109.403 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.6 -169.23 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.986 -1.646 . . . . 0.33 108.986 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.9 p -131.43 167.15 19.79 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.234 -1.156 . . . . 0.46 109.451 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 m -139.5 140.46 37.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.28 109.441 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 55.64 26.92 9.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.562 -0.711 . . . . 0.81 110.05 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.3 -124.35 8.04 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.491 -1.443 . . . . 0.47 109.491 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.734 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.0 mmp_? -103.04 -11.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.305 -1.114 . . . . 1.41 113.955 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.734 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.1 Cg_endo -72.77 -44.26 0.7 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 CA-C-N 120.061 1.057 . . . . 0.43 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.7 t -106.11 155.87 6.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.994 -1.066 . . . . 0.32 108.34 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.8 mttp -134.13 164.45 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.88 109.995 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.9 m -90.96 138.04 31.9 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.47 -0.937 . . . . 0.32 108.47 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -134.15 133.34 40.89 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.39 109.808 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.479 ' HB2' HG12 ' A' ' 24' ' ' ILE . 13.0 ttp180 -150.08 157.65 43.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.75 109.102 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -33.46 33.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.361 -0.837 . . . . 0.67 109.236 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 37.6 p90 . . . . . 0 N--CA 1.487 1.394 0 O-C-N 121.36 -0.837 . . . . 1.11 108.855 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.508 ' N ' HD21 ' A' ' 8' ' ' ASN . 4.4 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.568 -0.53 . . . . 0.67 109.568 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.34 -47.29 91.85 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.395 -1.482 . . . . 0.74 109.395 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.28 -28.91 69.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.219 -1.165 . . . . 1.92 109.752 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.508 HD21 ' N ' ' A' ' 5' ' ' CYS . 32.2 m-80 -85.12 -13.33 50.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.034 -1.041 . . . . 0.94 109.913 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.68 11.22 64.18 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.757 -1.337 . . . . 0.65 109.757 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.799 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -96.02 155.62 21.15 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.072 -1.611 . . . . 0.96 109.072 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.37 158.92 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -1.086 . . . . 1.01 109.176 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.454 ' HB3' HG11 ' A' ' 32' ' ' VAL . 83.2 m -77.76 93.63 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.7 109.319 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 35' ' ' CYS . 1.4 mt -100.52 123.3 46.64 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.321 -0.862 . . . . 0.61 108.986 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 33.9 Cg_endo -78.62 174.2 12.63 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.504 2.136 . . . . 0.68 110.04 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 53.49 -126.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.91 -0.774 . . . . 1.43 108.91 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.77 164.94 11.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.422 -1.424 . . . . 1.71 109.065 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -114.11 154.26 46.18 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.284 -0.885 . . . . 0.71 109.054 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.8 168.73 23.02 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.719 2.28 . . . . 0.85 110.651 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.23 153.93 91.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.677 . . . . 0.88 109.418 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -80.56 10.1 29.9 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.413 -1.494 . . . . 0.65 111.344 -0.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttp 59.47 59.37 2.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.917 . . . . 1.64 109.341 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 2.9 tpp180 -90.02 89.08 7.54 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.391 -0.966 . . . . 1.24 108.391 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.19 123.57 24.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 1.69 109.815 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.799 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -128.06 34.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.491 -0.755 . . . . 1.1 109.041 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 179.53 22.96 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.404 -1.479 . . . . 0.71 109.404 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.4 p -126.79 165.12 19.91 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -1.115 . . . . 0.83 109.386 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.644 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -134.39 131.09 37.81 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.212 -0.93 . . . . 0.63 109.628 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 56.36 34.68 24.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.719 -0.613 . . . . 1.08 110.24 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.507 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.27 -133.89 11.71 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.47 -1.452 . . . . 0.72 109.47 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -101.73 -2.18 0.1 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.324 -1.104 . . . . 2.21 113.888 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.7 Cg_endo -74.56 -45.22 0.33 Allowed 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 120.239 1.121 . . . . 0.5 109.821 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.8 t -108.69 149.59 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.51 108.093 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.94 -1.1 . . . . 0.64 109.653 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 37.1 m -89.97 83.95 6.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.449 -0.945 . . . . 0.72 108.449 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.3 m -97.44 141.76 30.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.272 -0.892 . . . . 0.39 109.71 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 4.6 ttp180 -108.17 151.83 25.39 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.775 -0.824 . . . . 1.32 108.775 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 18.78 13.4 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.381 -0.824 . . . . 1.28 109.525 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.486 1.327 0 O-C-N 121.202 -0.936 . . . . 1.78 108.505 179.734 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.487 -0.931 . . . . 0.44 108.487 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.56 -24.51 73.9 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.185 -1.166 . . . . 0.54 110.185 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -55.88 -47.33 77.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.88 109.871 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.571 ' CB ' HG13 ' A' ' 24' ' ' ILE . 13.2 m120 -110.07 6.18 22.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.72 110.094 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . 66.77 51.44 40.81 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.51 -1.436 . . . . 0.49 109.51 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.34 -161.4 9.07 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.985 -1.646 . . . . 0.41 108.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.33 140.85 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -1.234 . . . . 0.92 109.29 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m -83.05 85.6 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.767 . . . . 0.45 109.053 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -98.77 126.65 38.01 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.236 -0.915 . . . . 0.64 109.346 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.5 Cg_endo -79.66 179.46 6.3 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.629 2.219 . . . . 0.61 110.081 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt 51.05 -136.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.987 -0.746 . . . . 0.88 108.987 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.32 139.55 40.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.726 -1.234 . . . . 1.07 109.326 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 9.6 m -84.66 159.72 57.6 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.226 -0.921 . . . . 0.52 109.073 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 35.1 Cg_endo -78.34 168.28 21.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.657 2.238 . . . . 0.53 110.305 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.608 HG13 ' HA ' ' A' ' 20' ' ' PRO . 2.6 t -58.39 145.69 74.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.231 -0.655 . . . . 0.83 109.231 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HA ' HG13 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -79.89 -7.09 40.69 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.546 -1.439 . . . . 0.57 111.378 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 ttm 63.18 77.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.301 -0.874 . . . . 1.1 110.119 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HD2' ' CD2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -105.54 93.58 4.74 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.099 -1.001 . . . . 0.76 108.867 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.87 121.45 20.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 1.23 109.106 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.571 HG13 ' CB ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -124.35 14.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.69 110.077 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.06 40.47 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.35 109.095 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 35.8 p -115.95 167.65 10.78 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.129 -1.218 . . . . 0.46 109.405 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 71.9 m -139.38 129.54 25.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.863 . . . . 0.39 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HD2' HG21 ' A' ' 32' ' ' VAL . 14.5 m-85 54.4 43.94 29.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 1.04 109.96 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.511 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.08 -140.18 14.92 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.068 -1.613 . . . . 0.56 109.068 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -102.67 0.22 0.1 OUTLIER Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.3 -1.117 . . . . 1.73 113.676 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.2 Cg_endo -75.57 -46.62 0.2 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-N 120.168 1.096 . . . . 0.65 110.058 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.2 t -103.82 155.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.218 -1.03 . . . . 0.41 108.218 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -139.4 160.66 39.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.69 109.593 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 64.6 m -89.97 103.06 15.76 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.371 -0.974 . . . . 0.37 108.371 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.9 m -102.71 153.8 19.78 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 0.43 109.853 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB3' ' CE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -135.61 176.24 8.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.236 -1.024 . . . . 1.24 108.236 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.403 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -140.77 70.89 1.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.74 110.014 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.463 ' CE3' ' HB3' ' A' ' 36' ' ' ARG . 5.7 p90 . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.113 -0.992 . . . . 0.93 108.52 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 121.06 0.457 . . . . 0.66 109.909 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.76 -45.08 66.8 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.2 -1.56 . . . . 0.52 109.2 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -63.59 -49.64 72.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.958 . . . . 1.56 109.236 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.29 -34.31 76.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.541 -0.724 . . . . 1.23 109.399 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.58 32.15 28.33 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.305 -1.518 . . . . 0.62 109.305 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -115.13 178.21 17.71 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.273 -1.531 . . . . 0.51 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.89 135.13 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.93 109.019 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.1 m -79.97 90.03 5.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.411 -0.806 . . . . 0.45 109.032 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 35' ' ' CYS . 12.1 mt -104.16 126.14 32.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.309 -0.869 . . . . 0.58 109.404 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.4 Cg_endo -78.65 174.84 11.74 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.66 2.24 . . . . 0.51 110.106 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 51.37 -129.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.143 -0.688 . . . . 1.09 109.143 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.61 149.64 29.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.536 -1.352 . . . . 1.0 109.458 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 3.0 m -101.59 162.84 19.19 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.342 -0.849 . . . . 0.4 109.07 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.6 Cg_endo -78.19 167.5 23.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.516 2.144 . . . . 0.65 109.999 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.98 152.2 84.14 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.505 -0.747 . . . . 0.62 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.89 -5.67 32.83 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.361 -1.516 . . . . 0.53 111.191 -0.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.1 ttm 60.36 58.49 2.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.98 109.61 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -90.04 93.85 9.55 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.172 -0.955 . . . . 1.08 108.89 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.3 112.77 5.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.366 -0.833 . . . . 1.72 109.897 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.574 HD11 ' HA3' ' A' ' 10' ' ' GLY . 3.5 pt -104.14 -1.38 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.827 . . . . 0.6 109.49 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.12 -168.34 40.11 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.989 -1.645 . . . . 0.39 108.989 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.3 p -122.08 168.61 11.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.274 -1.133 . . . . 0.56 109.41 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 81.0 m -138.09 126.37 23.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.46 109.589 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 55.84 36.94 28.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.679 -0.638 . . . . 0.93 110.072 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.532 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -137.38 13.38 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.677 -1.369 . . . . 0.6 109.677 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -99.45 -3.12 0.11 Allowed Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 113.859 1.059 . . . . 1.37 113.859 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.6 Cg_endo -74.84 -46.95 0.22 Allowed 'Trans proline' 0 C--N 1.325 -0.688 0 CA-C-N 120.299 1.143 . . . . 0.5 110.034 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 5.3 t -107.49 150.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.993 -1.114 . . . . 0.37 107.993 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -134.44 162.65 31.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.87 -1.144 . . . . 0.72 109.865 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 56.3 m -90.4 88.98 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.944 -0.761 . . . . 0.35 108.944 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HB2' HD12 ' A' ' 13' ' ' ILE . 95.4 m -91.55 136.01 33.44 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.123 -0.986 . . . . 0.37 109.533 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -105.71 147.51 28.47 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.299 -0.876 . . . . 1.08 109.053 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -86.05 -12.44 50.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.792 . . . . 0.62 109.245 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 117.602 -1.19 . . . . 1.11 108.401 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 7' ' ' ARG . 34.7 t . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 108.727 -0.842 . . . . 0.5 108.727 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.09 -2.26 77.47 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.267 -0.968 . . . . 0.81 111.018 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.451 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -58.75 -60.35 3.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.833 -1.392 . . . . 1.66 109.637 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.483 ' HB2' HD13 ' A' ' 24' ' ' ILE . 22.6 m120 -133.61 35.93 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.158 -0.964 . . . . 1.26 109.483 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.19 59.53 9.86 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.454 -1.459 . . . . 0.69 109.454 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.627 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -132.83 -167.71 11.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.173 -1.571 . . . . 0.48 109.173 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.03 151.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.197 -1.178 . . . . 0.79 109.276 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' HB3' HG11 ' A' ' 32' ' ' VAL . 67.9 m -91.42 97.97 11.41 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.994 -0.743 . . . . 0.42 108.994 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 17' ' ' CYS . 3.3 mt -100.28 127.97 31.74 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.394 -0.816 . . . . 0.6 109.02 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.2 Cg_endo -76.76 163.51 31.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.422 2.081 . . . . 0.55 110.147 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.9 mm 61.46 -94.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.728 -0.607 . . . . 0.73 109.374 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.92 165.24 31.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.759 -1.213 . . . . 1.46 109.201 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.599 ' HB3' HD12 ' A' ' 13' ' ' ILE . 2.3 m -109.72 163.69 16.5 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.49 109.064 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 33.9 Cg_endo -76.73 160.38 34.48 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.543 2.162 . . . . 0.69 110.086 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 24.7 m -64.82 152.49 90.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.77 109.347 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.587 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 34.6 Cg_endo -77.06 -8.27 30.4 Favored 'Cis proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.254 -1.561 . . . . 0.58 111.219 0.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 46.2 ttp 58.89 84.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.419 -0.801 . . . . 1.37 110.501 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER -94.34 96.61 9.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.892 -1.13 . . . . 0.73 108.38 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 130.8 46.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.529 -0.732 . . . . 1.44 109.481 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.543 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -139.56 34.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.628 -0.67 . . . . 0.49 109.38 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.7 -177.77 19.0 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.347 -1.501 . . . . 0.36 109.347 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.4 p -132.58 164.49 26.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.238 -1.154 . . . . 0.58 109.084 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 21.9 m -131.85 138.78 48.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.187 -0.945 . . . . 0.41 109.607 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 57.9 32.26 21.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.894 -0.504 . . . . 0.88 109.96 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.45 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.46 -128.96 9.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.153 -1.579 . . . . 0.48 109.153 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.42 0.82 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -1.145 . . . . 1.36 113.645 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.5 Cg_endo -74.97 -43.88 0.37 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 CA-C-N 120.328 1.153 . . . . 0.54 110.058 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 15.9 t -107.91 147.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.097 -1.075 . . . . 0.43 108.097 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.8 mttp -126.58 158.51 36.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.82 109.926 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 73.7 m -92.48 118.14 30.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.479 -0.934 . . . . 0.38 108.479 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -122.83 138.48 54.63 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.35 109.534 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 6.8 ttm180 -141.81 -171.55 3.37 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.588 -0.893 . . . . 1.02 108.588 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER 52.29 53.64 12.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.604 -0.685 . . . . 0.63 109.252 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.587 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.0 p90 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.99 -1.005 . . . . 1.26 108.994 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 75.9 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.8 -0.444 . . . . 0.44 109.8 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.94 -25.91 54.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.004 -1.239 . . . . 0.47 110.004 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HD2' ' HA3' ' A' ' 25' ' ' GLY . 4.3 ptp180 -52.63 -34.85 53.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.292 -1.123 . . . . 0.76 110.185 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB2' HD12 ' A' ' 24' ' ' ILE . 38.3 m-80 -136.94 16.35 3.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.982 -1.074 . . . . 0.66 110.351 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.66 62.0 6.8 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.781 -1.328 . . . . 0.47 109.781 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -128.0 -151.26 7.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.331 -1.508 . . . . 0.43 109.331 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.02 143.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.75 109.248 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.428 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.3 m -82.65 87.65 6.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.44 -0.787 . . . . 0.42 108.993 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 17' ' ' CYS . 3.7 mt -100.06 123.14 48.14 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.211 -0.931 . . . . 0.46 109.198 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.2 Cg_endo -79.31 172.14 15.06 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.756 2.304 . . . . 0.61 110.378 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mm 58.85 -93.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.367 -0.605 . . . . 1.07 109.367 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 -178.84 5.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.671 -1.268 . . . . 1.58 108.804 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.543 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -131.64 162.39 56.53 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.213 -0.929 . . . . 0.56 109.026 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -77.31 163.88 29.62 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.494 2.129 . . . . 0.77 109.813 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.9 150.91 75.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.773 . . . . 0.91 109.353 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.624 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.71 -2.1 33.9 Favored 'Cis proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.41 -1.496 . . . . 0.62 111.455 0.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.3 ttp 60.84 65.19 1.05 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.143 -0.973 . . . . 1.35 109.345 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.04 105.58 17.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.078 -1.014 . . . . 1.17 109.454 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.84 123.26 23.03 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.892 . . . . 1.28 109.092 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.705 HD11 ' HA3' ' A' ' 10' ' ' GLY . 11.4 pt -123.63 -0.33 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.468 -0.77 . . . . 0.91 110.077 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 34' ' ' CYS . . . 169.52 -171.21 43.1 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.972 -1.651 . . . . 0.46 108.972 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.9 p -124.37 164.72 19.06 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.263 -1.139 . . . . 0.61 109.383 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -135.3 132.7 38.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.257 -0.902 . . . . 0.39 109.531 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 56.66 34.0 23.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.77 110.109 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.508 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.87 -134.32 11.83 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.502 -1.439 . . . . 0.49 109.502 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -100.38 -4.0 0.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.387 -1.067 . . . . 1.38 113.803 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.81 -48.65 0.18 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 CA-C-N 120.23 1.118 . . . . 0.62 110.074 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.3 t -101.2 148.98 6.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.021 -1.103 . . . . 0.44 108.021 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 18.4 mtmm -128.38 170.35 13.21 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.989 -1.069 . . . . 0.67 109.542 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.609 ' HB3' HG13 ' A' ' 24' ' ' ILE . 46.7 m -100.52 105.12 16.52 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.397 -0.964 . . . . 0.47 108.397 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -106.23 146.37 30.39 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.38 109.237 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HD3' HD13 ' A' ' 24' ' ' ILE . 3.0 ttp180 -138.67 161.21 37.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.84 109.046 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.624 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.54 -24.79 20.52 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.4 -0.813 . . . . 0.81 109.271 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 42.9 p90 . . . . . 0 C--N 1.305 -1.355 0 O-C-N 121.314 -0.866 . . . . 1.1 108.71 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.428 -0.582 . . . . 0.46 109.428 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 150.7 16.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.519 -1.433 . . . . 0.52 109.519 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -27.06 68.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 2.01 109.337 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -68.84 -52.8 26.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -0.839 . . . . 0.69 109.235 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.67 58.66 0.25 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.329 -1.509 . . . . 0.49 109.329 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -98.36 164.83 21.32 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.318 -1.513 . . . . 0.44 109.318 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.68 153.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.337 -1.096 . . . . 0.76 108.777 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.471 ' HB3' HG11 ' A' ' 32' ' ' VAL . 72.1 m -77.65 87.3 3.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.403 -0.811 . . . . 0.39 109.236 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.614 HD12 ' HB3' ' A' ' 17' ' ' CYS . 4.6 mt -111.46 115.81 51.41 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.348 -0.845 . . . . 0.5 109.275 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.709 ' HB3' HG22 ' A' ' 32' ' ' VAL . 35.0 Cg_endo -78.85 172.17 15.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.636 2.224 . . . . 0.52 110.492 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.0 mm 60.48 -92.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.536 -0.542 . . . . 1.22 109.536 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -133.62 176.8 8.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.714 -1.241 . . . . 1.62 109.127 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.614 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -135.79 162.33 57.58 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.19 -0.944 . . . . 0.39 109.069 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.99 165.91 25.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.581 2.187 . . . . 0.46 109.926 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.36 153.08 87.27 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.55 109.394 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -79.65 4.15 34.08 Favored 'Cis proline' 0 C--N 1.309 -1.524 0 C-N-CA 123.372 -1.512 . . . . 0.41 111.315 0.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.9 ttp 61.02 56.49 2.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 1.09 109.692 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -89.87 89.65 7.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.044 -1.035 . . . . 0.72 108.47 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.21 121.48 19.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.376 -0.827 . . . . 0.68 109.451 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.479 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -129.16 35.18 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.429 -0.794 . . . . 0.56 109.412 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.33 -172.23 26.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.421 -1.472 . . . . 0.37 109.421 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.7 p -141.19 162.11 36.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 0.41 109.261 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 56.8 m -120.23 146.33 46.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.101 -0.999 . . . . 0.39 109.818 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 55.08 41.29 31.84 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.147 0.499 . . . . 0.79 109.838 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.61 -134.89 12.19 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.46 -1.856 . . . . 0.59 108.46 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.733 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.2 mmm180 -108.61 9.11 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.208 -1.172 . . . . 1.16 113.391 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 36.0 Cg_endo -77.17 -47.12 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 CA-C-N 120.12 1.078 . . . . 0.51 110.079 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 14' ' ' PRO . 48.2 t -98.6 148.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.38 108.268 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -118.68 153.26 34.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.032 -1.042 . . . . 0.61 109.965 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 m -94.21 85.19 4.59 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.532 -0.914 . . . . 0.35 108.532 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -93.32 136.2 33.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.96 . . . . 0.36 110.083 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -91.92 136.59 33.04 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.366 -0.976 . . . . 1.13 108.366 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.63 23.14 4.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.84 109.566 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.91 108.106 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 109.352 -0.611 . . . . 0.48 109.352 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.34 -21.88 70.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.816 -1.313 . . . . 0.97 109.816 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -42.99 74.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 1.73 109.627 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.41 ' CB ' HG13 ' A' ' 24' ' ' ILE . 86.6 m-20 -108.69 4.66 24.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 1.08 110.017 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.7 41.28 99.85 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.551 -1.42 . . . . 0.57 109.551 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -119.25 162.95 13.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.439 -1.464 . . . . 0.45 109.439 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.59 154.43 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.351 -1.088 . . . . 0.51 109.073 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.572 ' HB3' HG11 ' A' ' 32' ' ' VAL . 97.7 m -96.01 98.27 10.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.186 -0.946 . . . . 0.38 109.422 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.802 HD12 ' HB3' ' A' ' 17' ' ' CYS . 1.6 mt -105.45 127.21 29.02 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.346 -0.846 . . . . 0.5 109.087 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.88 165.65 24.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.567 2.178 . . . . 0.51 110.603 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mt 61.89 -92.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.834 -0.541 . . . . 1.23 109.691 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.66 160.04 43.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.579 -1.325 . . . . 1.83 108.818 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.802 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -110.56 159.04 33.75 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.157 -0.964 . . . . 0.39 109.435 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.69 172.1 15.64 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.731 2.287 . . . . 0.59 110.199 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 20' ' ' PRO . 3.6 t -58.51 145.52 76.07 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.066 -0.716 . . . . 0.77 109.066 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.646 ' HA ' HG13 ' A' ' 19' ' ' VAL . 36.3 Cg_endo -80.33 -9.77 40.5 Favored 'Cis proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.596 -1.418 . . . . 0.51 111.481 -0.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 33.1 ttp 62.64 63.71 0.97 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 1.49 109.347 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -89.88 92.75 9.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.106 -0.996 . . . . 0.87 108.684 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.04 122.2 20.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 1.39 109.559 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -126.53 25.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.064 -0.717 . . . . 0.65 109.064 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 -171.74 27.47 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.609 -1.796 . . . . 0.36 108.609 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.1 p -137.83 168.88 18.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.986 -1.302 . . . . 0.51 109.697 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 17.9 m -129.32 142.33 50.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.371 -0.83 . . . . 0.42 109.553 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 58.31 34.34 23.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.91 -0.494 . . . . 0.88 110.095 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.465 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.22 10.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.03 -1.628 . . . . 0.67 109.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.88 5.02 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.166 -1.197 . . . . 1.73 113.517 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -76.1 -47.52 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 CA-C-N 120.253 1.126 . . . . 0.58 109.969 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 12' ' ' CYS . 13.0 t -102.19 151.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.134 -0.979 . . . . 0.46 108.496 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -124.41 157.17 35.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.91 110.218 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 88.7 m -93.59 96.4 9.83 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.729 -0.841 . . . . 0.44 108.729 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.5 m -102.51 149.07 24.77 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.045 -1.034 . . . . 0.39 109.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.582 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 2.9 ttp180 -136.98 166.44 23.66 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.924 -0.769 . . . . 0.6 108.924 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -26.54 18.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.452 -0.78 . . . . 0.64 108.962 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.777 -1.106 . . . . 0.81 108.717 179.729 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 4.0 m . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.279 -0.637 . . . . 0.75 109.279 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.37 -42.21 96.13 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.749 -1.341 . . . . 0.59 109.749 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.7 mmm180 -65.08 -32.84 74.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.122 -1.222 . . . . 1.88 108.934 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.535 ' CB ' HG13 ' A' ' 24' ' ' ILE . 2.6 m120 -81.17 -25.22 36.98 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.416 -0.803 . . . . 1.06 109.129 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.33 37.24 11.19 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.574 -1.41 . . . . 0.68 109.574 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -138.83 -160.48 8.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.178 -1.569 . . . . 0.56 109.178 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.57 157.48 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.228 -1.16 . . . . 1.1 109.138 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 56.0 m -87.11 92.14 8.95 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.358 -0.839 . . . . 0.81 109.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 17' ' ' CYS . 8.3 mt -101.38 123.65 43.84 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.344 -0.847 . . . . 0.69 109.31 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.607 ' HB3' HG22 ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.21 172.11 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.792 2.328 . . . . 0.68 110.274 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.4 mm 54.92 -116.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.947 -0.76 . . . . 0.73 108.947 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.31 161.36 19.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.592 -1.317 . . . . 1.45 109.241 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.44 165.14 13.39 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.391 -0.818 . . . . 0.62 109.228 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.03 164.03 27.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.666 2.244 . . . . 0.81 110.021 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -59.75 147.82 77.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 109.195 -0.669 . . . . 1.16 109.195 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.5 Cg_endo -80.61 -2.97 42.93 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.457 -1.476 . . . . 0.74 111.18 -0.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.9 ttm 63.26 59.08 1.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 1.12 109.849 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -90.36 104.24 16.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.16 -0.963 . . . . 1.04 108.869 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 122.71 23.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.345 -0.847 . . . . 1.32 109.241 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.627 HD12 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -122.48 22.82 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.458 -0.776 . . . . 0.76 109.524 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 153.72 -176.18 31.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.787 -1.725 . . . . 0.6 108.787 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 10.5 p -129.04 164.54 23.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -1.154 . . . . 0.96 109.688 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.656 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 59.6 m -134.94 136.94 42.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.83 109.862 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 53.34 37.81 26.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.838 -0.539 . . . . 1.44 110.168 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.44 -132.94 11.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.371 -1.492 . . . . 1.06 109.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.5 mmp_? -105.28 -1.73 0.11 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.312 -1.111 . . . . 1.21 113.667 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -74.96 -44.93 0.31 Allowed 'Trans proline' 0 C--N 1.327 -0.601 0 CA-C-N 120.192 1.104 . . . . 0.84 110.246 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 12.1 t -106.22 148.92 10.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.62 108.157 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -134.17 165.27 25.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.71 110.299 -178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HB3' HG12 ' A' ' 24' ' ' ILE . 69.3 m -90.06 93.25 9.31 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 0.56 108.645 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 13' ' ' ILE . 4.0 m -95.06 143.27 26.65 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.12 -0.987 . . . . 0.51 109.387 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HD3' HD12 ' A' ' 24' ' ' ILE . 6.3 ttp180 -121.89 152.04 40.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 1.31 108.89 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.616 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.48 -3.73 57.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.432 -0.793 . . . . 1.46 109.982 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 117.626 -1.178 . . . . 1.48 108.516 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.475 -0.565 . . . . 0.37 109.475 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.21 68.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.072 -1.061 . . . . 0.54 110.487 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -54.71 -49.2 71.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.958 -1.319 . . . . 0.85 109.808 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -114.61 27.7 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.87 109.613 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.32 44.08 96.81 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.475 -1.45 . . . . 0.49 109.475 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.633 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -101.21 159.81 18.64 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.269 -1.532 . . . . 0.35 109.269 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.4 145.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.273 -1.133 . . . . 0.91 108.824 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' HB3' HG11 ' A' ' 32' ' ' VAL . 93.3 m -77.29 88.67 3.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.41 109.114 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 35' ' ' CYS . 4.8 mt -101.33 122.02 49.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.283 -0.886 . . . . 0.48 109.239 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.1 Cg_endo -79.06 173.35 13.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.444 2.096 . . . . 0.44 109.718 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.84 -121.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.565 -0.709 . . . . 0.93 109.327 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.28 161.81 14.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.787 -1.196 . . . . 2.22 109.772 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.45 152.51 47.12 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.395 -0.816 . . . . 0.43 108.819 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.33 165.23 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.474 2.116 . . . . 0.5 110.66 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.44 155.38 75.35 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.783 -0.573 . . . . 0.58 109.732 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.31 13.65 21.49 Favored 'Cis proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.438 -1.484 . . . . 0.49 111.435 -0.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 ttp 59.19 57.22 3.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 1.25 109.237 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -90.04 89.55 7.75 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.544 -0.91 . . . . 0.93 108.544 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.1 124.59 27.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.62 109.839 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.633 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -127.57 28.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.45 -0.781 . . . . 0.42 109.232 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -170.23 30.26 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.181 -1.568 . . . . 0.39 109.181 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.6 p -140.42 165.43 27.45 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.258 -1.143 . . . . 0.6 109.584 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.628 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.5 m -132.62 142.11 48.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -0.903 . . . . 0.48 109.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 54.71 33.98 20.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.814 -0.554 . . . . 1.08 110.193 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.468 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -130.66 10.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.451 -1.46 . . . . 0.62 109.451 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.738 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -104.19 -2.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.429 -1.042 . . . . 1.21 113.707 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.738 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.54 -47.59 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 120.339 1.157 . . . . 0.51 110.159 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.628 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 10.9 t -101.47 146.64 9.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.942 -1.132 . . . . 0.45 107.942 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 158.72 36.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.918 -1.113 . . . . 0.5 110.058 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.2 m -89.98 79.26 6.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.29 108.05 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.502 ' HB2' HD12 ' A' ' 13' ' ' ILE . 3.9 m -93.48 145.24 24.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.355 -0.841 . . . . 0.31 109.684 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -114.78 151.99 32.86 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.451 -0.78 . . . . 1.22 108.978 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.89 15.71 21.42 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.387 -0.821 . . . . 0.74 109.283 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 117.777 -1.106 . . . . 0.91 108.469 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.994 0.426 . . . . 0.5 110.554 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.16 30.0 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.619 -1.792 . . . . 1.17 108.619 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.98 -36.66 48.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.411 -1.052 . . . . 2.39 108.858 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -64.97 -25.99 68.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 1.3 109.307 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.27 56.01 3.12 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.747 -1.741 . . . . 0.96 108.747 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -147.01 153.78 25.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.965 -1.654 . . . . 0.39 108.965 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.95 141.72 13.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.237 -1.155 . . . . 0.6 109.518 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.405 ' HB3' HG11 ' A' ' 32' ' ' VAL . 87.8 m -88.3 84.01 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.37 109.308 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 17.0 mt -96.09 136.22 22.24 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.181 -0.949 . . . . 0.48 108.887 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 33.9 Cg_endo -76.63 172.27 16.53 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.427 2.085 . . . . 0.51 110.131 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.9 mm 61.49 -99.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 170.38 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.598 -1.314 . . . . 1.12 109.085 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.623 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 4.6 m -96.01 134.31 24.02 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.893 . . . . 0.54 109.556 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.24 138.82 16.28 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.575 2.184 . . . . 0.73 109.764 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.26 155.69 78.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.817 . . . . 0.65 109.198 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.58 2.72 35.11 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.494 -1.461 . . . . 0.58 111.459 0.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.461 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 26.6 ttm -67.48 113.85 5.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.833 -1.167 . . . . 0.97 109.137 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.71 176.6 5.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.99 109.571 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.623 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -82.67 142.72 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.86 109.241 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.611 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -138.83 33.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.55 109.369 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 142.56 -167.82 26.07 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.166 -1.574 . . . . 0.42 109.166 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 9.9 p -131.2 163.91 26.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.203 -1.175 . . . . 0.63 109.493 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 m -133.32 140.58 47.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.243 -0.91 . . . . 0.45 109.677 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.481 ' HD2' HG21 ' A' ' 32' ' ' VAL . 18.0 m-85 51.23 41.84 28.27 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.176 0.512 . . . . 0.68 109.934 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 93.55 -134.86 12.3 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.02 -1.632 . . . . 0.55 109.02 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.2 mmp_? -105.29 -0.16 0.1 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.215 -1.168 . . . . 1.48 113.471 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.7 Cg_endo -74.74 -47.44 0.22 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 120.263 1.13 . . . . 0.58 110.337 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.481 HG21 ' HD2' ' A' ' 28' ' ' PHE . 18.1 t -100.87 156.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.073 -1.017 . . . . 0.48 108.334 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -129.2 163.67 25.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.986 -1.071 . . . . 0.7 109.925 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HB3' HG13 ' A' ' 24' ' ' ILE . 52.2 m -90.57 131.99 35.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.357 -0.979 . . . . 0.39 108.357 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.7 m -121.33 133.54 55.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.029 -1.044 . . . . 0.46 109.663 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.608 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.32 146.85 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.727 -0.842 . . . . 0.83 108.727 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -23.7 21.33 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.276 -0.89 . . . . 0.88 109.401 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 1.07 109.148 -179.911 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.637 -0.505 . . . . 0.6 109.637 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.96 -45.03 59.19 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.911 -1.675 . . . . 0.64 108.911 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -33.43 75.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -1.074 . . . . 1.52 108.93 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.64 -27.88 64.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.33 -0.856 . . . . 0.94 109.186 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.76 48.27 5.29 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.26 -1.536 . . . . 0.53 109.26 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.715 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -154.01 157.39 27.44 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.159 -1.576 . . . . 0.51 109.159 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 m -93.89 150.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -1.12 . . . . 0.74 109.416 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.706 ' HB3' HG11 ' A' ' 32' ' ' VAL . 54.2 m -88.54 101.36 13.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.421 -0.8 . . . . 0.58 109.392 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.59 HG22 HG13 ' A' ' 15' ' ' ILE . 15.4 mt -100.58 122.31 49.95 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.322 -0.861 . . . . 0.51 109.342 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.508 ' HB3' HG22 ' A' ' 32' ' ' VAL . 36.1 Cg_endo -80.32 31.2 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.827 2.351 . . . . 0.54 110.962 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.59 HG13 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -146.23 -153.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.174 -1.047 . . . . 0.75 108.174 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.63 142.84 27.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.035 -1.04 . . . . 1.7 108.972 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -63.22 124.18 83.15 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.48 109.849 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.87 119.81 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.687 2.258 . . . . 0.73 110.362 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.2 m -65.85 159.88 66.24 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.267 -0.896 . . . . 0.81 108.726 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -80.98 8.27 35.9 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 123.614 -1.411 . . . . 0.64 111.596 -0.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.671 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 2.0 ttp -60.79 133.99 56.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.925 -1.11 . . . . 1.13 108.864 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -101.74 164.91 11.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.17 110.039 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.18 151.53 24.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.176 -0.675 . . . . 2.12 109.176 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.715 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -148.38 44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.613 -0.679 . . . . 0.55 109.488 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.25 -174.62 18.33 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.146 -1.581 . . . . 0.41 109.146 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 26.4 p -138.16 166.75 23.36 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.291 -1.123 . . . . 0.69 109.415 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 27.0 m -127.03 141.45 51.78 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.155 -0.966 . . . . 0.54 109.772 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 56.0 36.65 27.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.877 -0.514 . . . . 0.96 110.026 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.34 10.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.81 109.043 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -107.98 6.81 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.189 . . . . 1.2 113.472 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.2 Cg_endo -76.6 -46.11 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 120.171 1.097 . . . . 0.72 109.782 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 12' ' ' CYS . 73.2 t -104.63 149.49 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.297 -1.001 . . . . 0.42 108.297 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.5 mttp -123.69 154.2 39.74 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.093 -1.005 . . . . 0.64 109.83 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.1 m -89.97 136.82 32.81 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.445 -0.946 . . . . 0.5 108.445 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.671 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -135.63 133.72 38.52 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.103 -0.998 . . . . 0.47 110.09 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.684 ' CD ' HG21 ' A' ' 24' ' ' ILE . 2.6 ptm180 -145.33 143.03 29.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.185 -1.043 . . . . 0.61 108.185 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -33.71 16.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.89 111.007 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.413 ' OXT' ' HG3' ' A' ' 36' ' ' ARG . 11.3 p-90 . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.018 -1.051 . . . . 0.98 109.641 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.158 0.504 . . . . 0.69 109.831 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.89 51.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.506 . . . . 0.59 109.336 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.11 -44.2 93.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.309 -1.112 . . . . 2.71 109.468 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.506 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 4.3 m120 -80.27 -25.06 39.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.925 . . . . 1.18 109.355 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.18 62.8 2.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.78 -1.728 . . . . 0.58 108.78 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -152.37 168.54 31.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.23 -1.548 . . . . 0.42 109.23 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 t -91.14 143.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.65 109.129 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HB3' HG11 ' A' ' 32' ' ' VAL . 92.2 m -86.1 83.98 7.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.305 -0.872 . . . . 0.34 109.579 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 6.7 mt -96.24 128.57 36.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.181 -0.95 . . . . 0.5 108.866 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.16 179.07 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.442 2.094 . . . . 0.49 110.309 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.6 mt 61.29 -101.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.705 -0.622 . . . . 0.77 109.415 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.36 160.91 40.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.615 -1.303 . . . . 1.36 109.374 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.84 131.04 68.43 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.854 . . . . 0.49 109.435 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.78 120.15 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.625 2.217 . . . . 0.7 109.535 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.1 m -57.32 153.48 26.81 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.822 . . . . 0.82 109.334 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.85 10.69 30.11 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.606 -1.414 . . . . 0.73 111.626 -0.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.5 tpp -61.35 118.78 7.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.929 -1.107 . . . . 1.08 108.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 1.5 ptp85 -90.03 175.99 6.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.95 109.839 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 132.47 52.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.701 -0.851 . . . . 1.34 108.701 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.525 HD11 ' HA3' ' A' ' 10' ' ' GLY . 8.2 pt -120.27 -0.08 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.74 110.361 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.63 -159.27 31.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.424 -1.471 . . . . 0.4 109.424 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.2 p -137.17 165.34 26.34 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.351 -1.088 . . . . 0.55 109.612 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 76.6 m -126.9 148.1 50.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.38 109.228 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 55.02 41.56 31.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.045 -0.724 . . . . 0.74 109.045 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 -130.9 10.52 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.938 -2.065 . . . . 0.51 107.938 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.731 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.6 mtm180 -113.75 10.48 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.186 -1.185 . . . . 2.6 113.341 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.7 Cg_endo -77.56 -45.25 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 120.162 1.093 . . . . 0.5 109.681 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 46.1 t -98.47 154.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.265 -1.013 . . . . 0.36 108.265 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mttp -117.91 157.88 25.89 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 1.11 110.057 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 81.4 m -97.25 104.34 16.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.494 -0.928 . . . . 0.5 108.494 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.566 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 14.7 m -100.05 143.0 30.77 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.131 -0.981 . . . . 0.44 109.826 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.502 ' HB2' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -143.66 158.69 43.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.519 -0.738 . . . . 0.92 109.205 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -27.96 51.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.335 -0.853 . . . . 0.93 109.429 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.422 ' CE2' ' HD2' ' A' ' 36' ' ' ARG . 37.0 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.894 -1.05 . . . . 1.31 109.264 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 121.383 0.611 . . . . 0.66 109.747 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.28 -34.48 69.22 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.217 -1.553 . . . . 1.01 109.217 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -64.1 -23.93 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -1.17 . . . . 1.47 109.762 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.555 ' HB3' HG13 ' A' ' 24' ' ' ILE . 14.8 m120 -103.51 -11.7 17.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.99 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.05 32.18 66.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.504 -1.438 . . . . 0.82 109.504 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -122.91 164.17 15.99 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.43 -1.468 . . . . 0.48 109.43 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.26 154.63 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.41 -1.053 . . . . 0.65 109.275 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.551 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.2 m -91.65 93.62 9.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.432 -0.793 . . . . 0.5 109.43 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.591 HD12 ' HB3' ' A' ' 17' ' ' CYS . 4.0 mt -102.18 122.58 46.34 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.291 -0.881 . . . . 0.48 108.947 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 166.98 23.57 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.64 2.227 . . . . 0.59 110.797 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.1 mt 61.42 -94.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.439 -0.578 . . . . 0.85 109.439 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.58 165.7 26.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.799 -1.188 . . . . 1.72 108.928 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.3 m -119.37 163.58 26.16 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.229 -0.92 . . . . 0.46 109.509 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.1 Cg_endo -79.16 170.64 17.39 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.671 2.247 . . . . 0.73 109.609 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.63 152.19 93.17 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.453 -0.779 . . . . 0.65 109.248 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 34.1 Cg_endo -79.13 -5.57 38.05 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.19 -1.587 . . . . 0.63 111.504 0.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.9 ttm 61.85 65.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 1.27 109.648 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -89.91 90.19 8.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.166 -0.959 . . . . 1.46 108.506 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.75 117.64 12.52 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.615 -0.678 . . . . 1.08 109.828 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.557 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.24 31.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.881 -0.785 . . . . 0.59 108.881 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.35 -167.66 24.66 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.912 -1.675 . . . . 0.43 108.912 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 p -141.09 169.01 18.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.242 -1.152 . . . . 0.52 109.517 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 78.5 m -126.28 147.6 49.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.295 -0.878 . . . . 0.52 109.285 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 58.62 34.38 23.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.659 -0.497 . . . . 1.06 109.659 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.505 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 96.73 -134.52 11.83 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.605 -1.798 . . . . 0.64 108.605 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.752 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.1 mtp85 -105.02 4.82 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.312 -1.11 . . . . 1.67 113.358 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.6 Cg_endo -75.82 -50.28 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 120.137 1.085 . . . . 0.52 110.142 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 12' ' ' CYS . 16.2 t -93.47 147.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.01 -1.056 . . . . 0.42 108.757 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -115.34 156.61 25.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.206 -0.934 . . . . 0.62 109.83 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 95.8 m -98.95 92.51 5.55 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.369 -0.832 . . . . 0.45 108.897 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -99.51 147.34 25.41 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.147 -0.971 . . . . 0.42 109.951 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 7.1 ttp180 -130.97 161.12 32.63 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.763 -0.829 . . . . 1.07 108.763 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -89.79 -18.68 25.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.325 -0.859 . . . . 0.95 109.645 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.9 p90 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 117.713 -1.137 . . . . 1.02 108.734 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 25.1 t . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.681 -0.859 . . . . 0.4 108.681 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.43 -24.51 76.7 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.354 -1.098 . . . . 0.74 110.354 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -62.21 -48.3 80.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.979 -1.307 . . . . 1.36 109.901 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 24' ' ' ILE . 17.9 m120 -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 1.08 110.161 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.62 60.31 3.76 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.349 -1.5 . . . . 0.79 109.349 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.66 -166.49 16.45 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.894 -1.682 . . . . 0.37 108.894 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.6 m -96.41 172.51 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -1.209 . . . . 0.68 109.057 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.487 ' HB3' HG11 ' A' ' 32' ' ' VAL . 21.7 m -125.78 111.17 14.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.35 109.572 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.711 HG22 HG13 ' A' ' 15' ' ' ILE . 1.2 mt -98.87 121.85 54.65 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.208 -0.932 . . . . 0.36 108.94 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 32' ' ' VAL . 36.4 Cg_endo -79.65 38.26 0.72 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.792 2.328 . . . . 0.49 111.494 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.711 HG13 HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -157.31 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.84 -1.162 . . . . 0.58 108.942 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -149.97 173.2 14.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 1.49 108.89 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 t -102.95 110.64 63.93 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.388 -0.82 . . . . 0.47 108.954 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.69 135.39 11.49 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.597 2.198 . . . . 0.85 110.294 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m -67.55 159.46 78.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.379 -0.825 . . . . 0.65 108.928 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -79.63 5.29 32.73 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.53 -1.446 . . . . 0.48 111.512 0.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.724 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 7.7 tpp -62.74 139.08 58.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.883 -1.136 . . . . 1.45 109.119 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -114.03 147.72 38.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.74 109.37 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 144.3 50.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.97 109.284 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -138.61 37.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.58 109.838 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.63 -173.62 21.97 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.605 -1.398 . . . . 0.44 109.605 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 41.3 p -126.11 163.13 23.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -1.078 . . . . 0.74 109.408 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.651 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 34.1 m -128.0 137.54 52.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.37 109.624 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 52.89 43.82 31.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.883 -0.511 . . . . 0.84 110.123 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.62 -132.59 11.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.49 -1.844 . . . . 0.63 108.49 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.4 mtm180 -111.54 4.91 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.177 -1.19 . . . . 2.91 113.628 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.3 Cg_endo -75.27 -43.51 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.338 1.157 . . . . 0.58 109.776 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 49.5 t -107.13 152.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.113 -1.069 . . . . 0.33 108.113 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.1 mttp -124.31 156.74 36.44 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.993 -1.067 . . . . 0.64 110.133 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 71.9 m -90.0 143.59 26.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.933 -1.136 . . . . 0.32 107.933 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 21.8 m -138.81 138.81 37.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.96 -1.088 . . . . 0.35 110.021 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -150.11 162.37 40.56 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.433 -0.792 . . . . 0.98 109.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -33.98 27.0 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.413 -0.805 . . . . 0.58 109.23 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 33.6 p90 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 117.789 -1.1 . . . . 1.01 108.851 179.775 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 109.241 -0.651 . . . . 0.43 109.241 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.94 175.74 43.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.093 -1.603 . . . . 0.64 109.093 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.02 46.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 1.93 109.579 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 24' ' ' ILE . 5.5 m-80 -75.27 -25.48 58.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.79 109.953 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.81 65.01 0.95 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.506 -1.438 . . . . 0.56 109.506 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . -106.37 -152.97 19.99 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.539 -1.824 . . . . 0.51 108.539 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.61 149.39 32.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -1.206 . . . . 0.93 108.882 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.2 m -75.0 92.03 2.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.47 109.472 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 17' ' ' CYS . 2.3 mt -102.6 125.43 35.91 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.291 -0.881 . . . . 0.59 108.939 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.11 173.57 13.74 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.57 2.18 . . . . 0.6 110.258 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 54.21 -119.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.957 -0.757 . . . . 1.24 108.957 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.12 154.94 32.45 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.634 -1.291 . . . . 2.44 109.068 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.558 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.8 m -101.4 159.72 28.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.318 -0.863 . . . . 0.62 109.329 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 167.67 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.679 2.253 . . . . 1.06 110.235 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -60.46 147.23 83.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.81 109.294 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.583 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -79.91 -3.05 39.91 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.55 -1.437 . . . . 0.72 111.351 -0.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.2 ttm 62.47 56.22 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 1.05 109.629 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -90.17 87.08 6.72 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.176 -0.953 . . . . 2.26 108.53 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 7.3 pt20 -71.87 129.57 38.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 1.34 109.486 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -130.39 38.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.319 -0.863 . . . . 0.44 108.697 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.76 -179.82 24.35 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.645 -1.782 . . . . 0.39 108.645 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.7 p -132.97 160.76 36.18 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.081 -1.246 . . . . 0.65 109.816 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.7 m -130.03 140.83 50.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.482 -0.761 . . . . 0.46 109.534 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 55.77 37.14 28.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.885 -0.51 . . . . 1.12 110.178 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.36 -133.55 11.56 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.487 -1.445 . . . . 0.52 109.487 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -103.7 -3.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.26 113.71 -179.187 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.9 Cg_endo -74.85 -43.05 0.45 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.205 1.109 . . . . 0.69 110.832 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.6 t -103.81 147.47 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.835 -1.166 . . . . 0.57 108.853 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -131.07 156.38 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.011 -1.056 . . . . 0.69 110.022 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 55.8 m -90.09 82.18 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.41 108.812 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 73.7 m -91.78 140.99 29.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.133 -0.979 . . . . 0.44 109.843 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -110.0 152.21 26.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.625 -0.88 . . . . 0.83 108.625 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.583 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.09 -7.95 52.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.316 -0.865 . . . . 0.86 110.018 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 25.7 p90 . . . . . 0 N--CA 1.487 1.375 0 O-C-N 121.062 -1.024 . . . . 1.19 108.719 -179.911 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.59 -0.522 . . . . 0.42 109.59 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.28 -49.8 24.66 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.564 . . . . 0.67 109.191 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -74.79 -36.11 62.49 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.19 -1.182 . . . . 2.29 109.254 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.45 -30.41 67.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.8 109.366 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.46 50.08 6.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.329 -1.509 . . . . 0.48 109.329 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -136.86 -170.69 11.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.347 -1.501 . . . . 0.43 109.347 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.3 157.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -1.144 . . . . 0.87 109.25 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.489 ' HB3' HG11 ' A' ' 32' ' ' VAL . 59.2 m -93.23 87.36 5.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.43 109.482 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.441 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 8.3 mt -97.14 131.44 27.56 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.46 108.92 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.26 172.55 15.82 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.445 2.096 . . . . 0.54 110.246 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.9 mm 63.02 -95.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.734 -0.604 . . . . 0.74 109.551 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 164.41 35.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.659 -1.275 . . . . 1.71 109.368 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 18.7 m -87.31 132.9 39.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.352 -0.843 . . . . 0.5 109.068 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 34.9 Cg_endo -78.33 132.56 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.501 2.134 . . . . 0.81 109.737 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.6 m -63.12 155.02 75.42 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.837 . . . . 0.75 109.132 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.5 7.68 34.39 Favored 'Cis proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.45 -1.479 . . . . 0.66 111.621 0.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 18.6 ttm -63.81 121.49 14.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.777 -1.202 . . . . 1.17 109.145 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -95.54 177.55 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.68 109.491 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.4 tt0 -92.0 147.19 23.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.673 -0.862 . . . . 1.25 108.673 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.643 HD13 ' HD3' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -145.33 42.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.482 -0.761 . . . . 0.55 109.716 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.74 -166.61 22.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.38 109.472 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 16.5 p -138.98 166.79 23.56 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.325 -1.103 . . . . 0.56 109.176 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 78.6 m -129.0 140.19 51.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.241 -0.912 . . . . 0.48 109.921 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 55.53 40.84 31.2 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.763 -0.458 . . . . 0.83 109.763 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.58 -130.63 10.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.38 -1.888 . . . . 0.62 108.38 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.73 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -111.8 9.58 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.086 -1.243 . . . . 1.54 113.386 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.73 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.1 Cg_endo -76.55 -50.52 0.1 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 CA-C-N 120.166 1.095 . . . . 0.62 109.766 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 51.2 t -99.31 155.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.196 -1.039 . . . . 0.47 108.196 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.2 160.0 26.08 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.963 -1.085 . . . . 0.87 109.892 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 m -93.54 133.78 36.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.954 -1.128 . . . . 0.39 107.954 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.456 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 19.5 m -126.04 142.46 51.51 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.088 -1.007 . . . . 0.43 109.834 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.643 ' HD3' HD13 ' A' ' 24' ' ' ILE . 4.4 mtp180 -139.03 141.24 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.895 -0.78 . . . . 0.88 108.895 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.25 -22.56 60.38 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.337 -0.852 . . . . 0.61 109.739 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.6 p90 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 117.788 -1.101 . . . . 0.79 108.943 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 93.4 m . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.244 0.545 . . . . 0.42 110.071 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.87 -6.03 89.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.854 -1.298 . . . . 0.64 109.854 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -64.18 -60.59 3.02 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.976 -1.308 . . . . 0.8 109.542 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.493 ' HB2' HD13 ' A' ' 24' ' ' ILE . 30.6 m120 -119.97 13.12 12.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.157 -0.964 . . . . 1.36 110.092 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.31 70.19 1.15 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.635 -1.386 . . . . 0.52 109.635 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -127.02 -156.72 9.25 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.057 -1.617 . . . . 0.35 109.057 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -1.152 . . . . 0.98 109.432 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 65.7 m -84.33 88.99 7.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.536 -0.727 . . . . 0.49 109.329 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -97.85 130.05 29.8 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.11 -0.994 . . . . 0.52 109.307 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -77.65 178.03 8.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.457 2.105 . . . . 0.6 110.047 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.411 HG22 ' HG2' ' A' ' 16' ' ' ARG . 23.5 mm 59.68 -98.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.717 -0.614 . . . . 0.83 109.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.411 ' HG2' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -148.94 160.47 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.556 -1.34 . . . . 2.6 109.367 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -71.84 146.21 90.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.497 -0.752 . . . . 0.52 109.671 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 35.5 Cg_endo -78.53 -165.13 0.31 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.726 2.284 . . . . 0.58 110.063 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.44 ' HA ' ' N ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -135.64 140.86 35.1 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.166 -0.959 . . . . 0.77 109.588 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.95 109.23 1.39 Allowed 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.183 -1.59 . . . . 0.75 110.53 -1.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.476 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.8 ttm -150.8 118.82 6.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.82 -1.175 . . . . 1.01 108.725 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -93.69 178.64 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 1.69 109.616 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.2 144.77 25.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.541 -0.725 . . . . 0.85 109.195 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.634 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -142.03 49.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.56 109.277 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.49 -174.39 17.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.411 -1.475 . . . . 0.42 109.411 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 11.4 p -133.19 166.11 23.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.323 -1.104 . . . . 0.64 109.467 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 95.2 m -133.67 136.99 45.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.54 109.866 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 56.18 37.59 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.89 110.144 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.98 -132.8 11.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.934 -1.666 . . . . 0.77 108.934 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 20.8 mmm-85 -105.98 1.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.284 -1.127 . . . . 1.57 113.608 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -75.05 -50.85 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.585 0 CA-C-N 120.217 1.113 . . . . 0.76 109.865 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 17.2 t -100.12 150.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.035 -1.098 . . . . 0.54 108.035 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 163.33 24.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.01 -1.056 . . . . 0.62 109.728 -179.239 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.2 m -92.67 130.45 38.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.293 -1.003 . . . . 0.48 108.293 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 35.4 m -125.23 141.82 51.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.062 -1.023 . . . . 0.41 109.818 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.427 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.8 mtp180 -141.05 134.49 29.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.432 -0.792 . . . . 1.29 108.932 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.86 -26.12 37.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.88 109.551 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.8 p90 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 117.796 -1.097 . . . . 1.06 108.822 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.309 -0.626 . . . . 0.67 109.309 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.35 -46.58 25.89 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.508 -1.437 . . . . 0.79 109.508 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -41.16 99.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -1.118 . . . . 1.88 109.651 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -75.65 -25.36 56.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.026 . . . . 0.84 109.816 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.21 29.65 12.19 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.631 -1.388 . . . . 0.73 109.631 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -103.81 156.52 17.57 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.613 -1.795 . . . . 0.65 108.613 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 158.43 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.193 -1.18 . . . . 0.9 109.645 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.5 m -79.17 93.18 5.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.521 -0.737 . . . . 0.52 109.241 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 17' ' ' CYS . 1.3 mt -101.53 123.74 43.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.357 -0.84 . . . . 0.47 109.195 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.49 170.64 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.561 2.174 . . . . 0.64 110.137 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt 56.88 -107.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.659 -0.65 . . . . 1.1 109.321 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.58 177.58 5.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.56 -1.338 . . . . 1.86 109.067 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.646 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -127.31 157.98 70.87 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.205 -0.934 . . . . 0.59 109.131 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.73 169.97 19.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.643 2.229 . . . . 0.71 109.988 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.54 153.4 95.0 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.81 109.33 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -79.48 4.72 32.47 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.378 -1.509 . . . . 0.67 111.177 0.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 ttp 61.0 57.77 2.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 1.46 109.805 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -89.93 90.32 8.11 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.195 -0.941 . . . . 1.23 108.591 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 119.41 18.5 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 1.23 109.536 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.714 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.58 31.59 2.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.455 -0.778 . . . . 0.78 109.232 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.8 -177.38 26.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.906 -1.678 . . . . 0.6 108.906 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 13.1 p -135.31 161.14 36.24 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.145 -1.209 . . . . 0.65 109.775 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.8 m -126.18 141.93 51.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.248 -0.908 . . . . 0.55 109.705 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 56.26 35.12 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.805 -0.56 . . . . 1.11 110.12 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.6 -132.42 11.14 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.083 -1.607 . . . . 0.76 109.083 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.75 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -105.16 0.71 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 1.7 113.685 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.75 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.91 -44.2 0.36 Allowed 'Trans proline' 0 C--N 1.327 -0.602 0 CA-C-N 120.247 1.124 . . . . 0.65 109.925 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -106.21 146.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.129 -1.063 . . . . 0.58 108.129 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -128.03 155.46 44.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.993 -1.067 . . . . 0.74 109.937 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.6 m -89.93 81.33 6.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.241 -1.022 . . . . 0.56 108.241 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.82 143.33 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.5 109.806 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -103.57 145.44 30.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.598 -0.889 . . . . 0.91 108.598 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.9 19.86 9.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.384 -0.822 . . . . 0.85 109.466 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 108.173 -1.047 . . . . 1.02 108.173 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 25.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.794 -0.447 . . . . 0.54 109.794 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.95 -60.94 1.71 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.038 -1.625 . . . . 0.74 109.038 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -69.45 89.81 0.51 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -1.07 . . . . 1.55 108.684 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.08 63.87 2.07 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.864 -0.791 . . . . 1.41 108.864 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 5' ' ' CYS . . . -121.23 -62.1 0.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.87 -1.292 . . . . 0.38 109.87 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 36' ' ' ARG . . . 99.03 -97.43 1.84 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.212 -1.555 . . . . 0.4 109.212 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.41 141.64 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.103 -1.233 . . . . 0.47 109.522 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 58.0 m -82.92 94.45 7.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.41 109.206 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.43 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.9 mt -101.7 123.55 43.69 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.174 -0.954 . . . . 0.53 109.328 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.5 175.75 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.648 2.232 . . . . 0.51 109.912 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 53.75 -120.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.87 -0.789 . . . . 1.18 108.87 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -126.18 135.35 51.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.511 -1.368 . . . . 1.24 109.35 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 3.3 m -75.95 161.88 73.92 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.366 -0.834 . . . . 0.42 108.91 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.3 Cg_endo -77.02 160.29 33.56 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.512 2.141 . . . . 0.59 110.368 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -61.67 147.76 88.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.616 -0.677 . . . . 0.85 109.221 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.676 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 35.7 Cg_endo -77.89 -11.98 32.04 Favored 'Cis proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.48 -1.467 . . . . 0.46 111.177 -0.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.448 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 43.5 ttp 61.68 86.19 0.11 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 0.94 110.286 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.84 89.33 3.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.874 -1.141 . . . . 0.7 108.491 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.6 109.89 4.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.59 109.226 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.01 -3.74 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.397 -0.815 . . . . 0.5 109.804 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.06 -171.84 31.78 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.988 -1.645 . . . . 0.38 108.988 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 17.1 p -129.55 166.94 18.69 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -1.174 . . . . 0.51 109.414 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 97.3 m -138.74 126.17 21.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.46 109.519 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 56.12 39.07 30.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.721 -0.612 . . . . 0.88 109.972 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.52 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.62 -136.97 13.16 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.381 -1.487 . . . . 0.62 109.381 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 24.4 mmm180 -101.32 -1.84 0.1 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 1.08 113.77 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.39 -52.52 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 CA-C-N 120.24 1.121 . . . . 0.51 109.698 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -98.19 148.27 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.397 -1.334 . . . . 0.46 107.397 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HD3' ' C ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.71 156.8 45.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.89 -1.131 . . . . 0.36 110.282 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.8 m -90.61 97.21 11.05 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.453 -0.943 . . . . 0.4 108.453 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.9 m -101.13 142.18 32.94 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.296 -0.878 . . . . 0.37 109.364 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.501 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 5.7 ttp85 -144.49 -172.22 3.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.523 -0.917 . . . . 0.62 108.523 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.08 49.95 18.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.039 -0.726 . . . . 0.47 109.039 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.676 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.6 p90 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 118.026 -0.987 . . . . 0.88 109.091 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.909 -0.774 . . . . 1.24 108.909 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.499 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 35.3 Cg_endo -78.68 157.63 28.18 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.579 2.186 . . . . 1.35 110.059 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.436 HD12 ' CZ ' ' A' ' 28' ' ' PHE . 1.1 tp 66.82 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.603 -0.517 . . . . 1.15 109.603 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.579 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 1.3 m 63.75 -167.62 0.21 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -0.796 . . . . 0.55 109.245 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER 69.35 5.0 4.89 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.492 -0.755 . . . . 0.4 110.386 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.81 -55.57 3.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.801 -1.72 . . . . 0.39 108.801 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.37 93.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.461 -1.023 . . . . 2.08 108.778 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB3' HD12 ' A' ' 24' ' ' ILE . 7.6 m120 -66.99 -39.78 87.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.66 108.921 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 59.44 3.25 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.157 -1.577 . . . . 0.37 109.157 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -147.24 -170.91 15.87 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.101 -1.6 . . . . 0.29 109.101 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.02 150.6 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -1.149 . . . . 0.94 109.242 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 5' ' ' CYS . 89.3 m -93.96 94.0 8.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -0.806 . . . . 0.29 110.078 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -96.18 128.97 35.01 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.176 -0.952 . . . . 0.38 108.846 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.3 Cg_endo -77.76 178.34 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.558 2.172 . . . . 0.39 110.57 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mt 61.84 -93.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 1.03 109.703 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.18 168.98 21.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.615 -1.303 . . . . 1.38 109.546 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.48 122.95 87.59 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.49 -0.756 . . . . 0.38 109.214 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.22 125.28 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.597 2.198 . . . . 0.48 109.936 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 26.9 m -68.76 158.97 84.29 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.251 -0.906 . . . . 0.62 108.906 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.504 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -81.6 10.78 33.86 Favored 'Cis proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.525 -1.448 . . . . 0.54 111.641 -0.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.429 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 20.7 ttm -63.32 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 1.02 109.25 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -107.09 149.87 27.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.818 . . . . 0.69 109.22 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.99 142.85 47.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.416 -0.802 . . . . 0.9 109.255 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.614 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -139.44 39.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.847 . . . . 0.5 109.403 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.6 -169.23 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.986 -1.646 . . . . 0.33 108.986 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.9 p -131.43 167.15 19.79 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.234 -1.156 . . . . 0.46 109.451 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 4' ' ' SER . 54.5 m -139.5 140.46 37.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.28 109.441 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.436 ' CZ ' HD12 ' A' ' 3' ' ' LEU . 90.9 m-85 55.64 26.92 9.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.562 -0.711 . . . . 0.81 110.05 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.3 -124.35 8.04 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.491 -1.443 . . . . 0.47 109.491 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.734 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.0 mmp_? -103.04 -11.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.305 -1.114 . . . . 1.41 113.955 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.734 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.1 Cg_endo -72.77 -44.26 0.7 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 CA-C-N 120.061 1.057 . . . . 0.43 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.7 t -106.11 155.87 6.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.994 -1.066 . . . . 0.32 108.34 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.8 mttp -134.13 164.45 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.88 109.995 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.9 m -90.96 138.04 31.9 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.47 -0.937 . . . . 0.32 108.47 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -134.15 133.34 40.89 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.39 109.808 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.479 ' HB2' HG12 ' A' ' 24' ' ' ILE . 13.0 ttp180 -150.08 157.65 43.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.75 109.102 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -33.46 33.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.361 -0.837 . . . . 0.67 109.236 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 37.6 p90 . . . . . 0 N--CA 1.487 1.394 0 O-C-N 121.36 -0.837 . . . . 1.11 108.855 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.03 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.6 -0.518 . . . . 2.55 109.6 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 1.03 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 34.2 Cg_endo -77.43 83.93 2.06 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.983 1.789 . . . . 2.07 110.206 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.59 179.79 7.53 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.296 -0.878 . . . . 1.91 108.798 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -57.66 154.42 11.6 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.409 -0.807 . . . . 1.15 109.157 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 4' ' ' SER . 4.4 m 73.07 -62.44 0.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.771 -0.581 . . . . 0.67 109.568 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.34 -47.29 91.85 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.395 -1.482 . . . . 0.74 109.395 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.28 -28.91 69.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.219 -1.165 . . . . 1.92 109.752 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB2' HG13 ' A' ' 24' ' ' ILE . 19.0 m120 -85.12 -13.33 50.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.034 -1.041 . . . . 0.94 109.913 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.68 11.22 64.18 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.757 -1.337 . . . . 0.65 109.757 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.799 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -96.02 155.62 21.15 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.072 -1.611 . . . . 0.96 109.072 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.37 158.92 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -1.086 . . . . 1.01 109.176 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.454 ' HB3' HG11 ' A' ' 32' ' ' VAL . 83.2 m -77.76 93.63 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.7 109.319 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 35' ' ' CYS . 1.4 mt -100.52 123.3 46.64 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.321 -0.862 . . . . 0.61 108.986 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 33.9 Cg_endo -78.62 174.2 12.63 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.504 2.136 . . . . 0.68 110.04 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 53.49 -126.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.91 -0.774 . . . . 1.43 108.91 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.77 164.94 11.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.422 -1.424 . . . . 1.71 109.065 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -114.11 154.26 46.18 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.284 -0.885 . . . . 0.71 109.054 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.8 168.73 23.02 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.719 2.28 . . . . 0.85 110.651 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.23 153.93 91.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.677 . . . . 0.88 109.418 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -80.56 10.1 29.9 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.413 -1.494 . . . . 0.65 111.344 -0.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttp 59.47 59.37 2.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.917 . . . . 1.64 109.341 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 2.9 tpp180 -90.02 89.08 7.54 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.391 -0.966 . . . . 1.24 108.391 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.19 123.57 24.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 1.69 109.815 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.799 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -128.06 34.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.491 -0.755 . . . . 1.1 109.041 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 179.53 22.96 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.404 -1.479 . . . . 0.71 109.404 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.4 p -126.79 165.12 19.91 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -1.115 . . . . 0.83 109.386 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.644 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -134.39 131.09 37.81 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.212 -0.93 . . . . 0.63 109.628 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 56.36 34.68 24.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.719 -0.613 . . . . 1.08 110.24 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.507 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.27 -133.89 11.71 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.47 -1.452 . . . . 0.72 109.47 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -101.73 -2.18 0.1 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.324 -1.104 . . . . 2.21 113.888 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.7 Cg_endo -74.56 -45.22 0.33 Allowed 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 120.239 1.121 . . . . 0.5 109.821 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.8 t -108.69 149.59 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.51 108.093 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.94 -1.1 . . . . 0.64 109.653 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 37.1 m -89.97 83.95 6.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.449 -0.945 . . . . 0.72 108.449 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.3 m -97.44 141.76 30.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.272 -0.892 . . . . 0.39 109.71 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 4.6 ttp180 -108.17 151.83 25.39 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.775 -0.824 . . . . 1.32 108.775 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 18.78 13.4 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.381 -0.824 . . . . 1.28 109.525 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.486 1.327 0 O-C-N 121.202 -0.936 . . . . 1.78 108.505 179.734 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 108.922 -0.769 . . . . 1.85 108.922 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 34.2 Cg_endo -77.47 129.54 10.26 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.695 2.263 . . . . 1.4 110.405 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 12' ' ' CYS . 1.4 mp -94.46 17.28 13.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.135 -0.978 . . . . 1.45 109.941 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.42 115.07 29.84 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.874 -1.141 . . . . 0.92 109.231 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.7 t -91.09 79.18 5.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.209 -0.932 . . . . 0.44 108.487 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.56 -24.51 73.9 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.185 -1.166 . . . . 0.54 110.185 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -55.88 -47.33 77.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.88 109.871 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.571 ' CB ' HG13 ' A' ' 24' ' ' ILE . 13.2 m120 -110.07 6.18 22.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.72 110.094 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . 66.77 51.44 40.81 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.51 -1.436 . . . . 0.49 109.51 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.34 -161.4 9.07 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.985 -1.646 . . . . 0.41 108.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.33 140.85 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -1.234 . . . . 0.92 109.29 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 58.0 m -83.05 85.6 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.767 . . . . 0.45 109.053 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -98.77 126.65 38.01 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.236 -0.915 . . . . 0.64 109.346 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.5 Cg_endo -79.66 179.46 6.3 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.629 2.219 . . . . 0.61 110.081 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt 51.05 -136.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.987 -0.746 . . . . 0.88 108.987 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.32 139.55 40.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.726 -1.234 . . . . 1.07 109.326 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 9.6 m -84.66 159.72 57.6 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.226 -0.921 . . . . 0.52 109.073 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 35.1 Cg_endo -78.34 168.28 21.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.657 2.238 . . . . 0.53 110.305 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.608 HG13 ' HA ' ' A' ' 20' ' ' PRO . 2.6 t -58.39 145.69 74.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.231 -0.655 . . . . 0.83 109.231 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HA ' HG13 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -79.89 -7.09 40.69 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.546 -1.439 . . . . 0.57 111.378 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 ttm 63.18 77.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.301 -0.874 . . . . 1.1 110.119 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HD2' ' CD2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -105.54 93.58 4.74 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.099 -1.001 . . . . 0.76 108.867 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.87 121.45 20.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 1.23 109.106 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.571 HG13 ' CB ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -124.35 14.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.69 110.077 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.06 40.47 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.35 109.095 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 35.8 p -115.95 167.65 10.78 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.129 -1.218 . . . . 0.46 109.405 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 71.9 m -139.38 129.54 25.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.863 . . . . 0.39 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HD2' HG21 ' A' ' 32' ' ' VAL . 14.5 m-85 54.4 43.94 29.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 1.04 109.96 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.511 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.08 -140.18 14.92 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.068 -1.613 . . . . 0.56 109.068 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -102.67 0.22 0.1 OUTLIER Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.3 -1.117 . . . . 1.73 113.676 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.2 Cg_endo -75.57 -46.62 0.2 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-N 120.168 1.096 . . . . 0.65 110.058 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.2 t -103.82 155.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.218 -1.03 . . . . 0.41 108.218 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -139.4 160.66 39.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.69 109.593 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 64.6 m -89.97 103.06 15.76 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.371 -0.974 . . . . 0.37 108.371 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.9 m -102.71 153.8 19.78 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 0.43 109.853 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB3' ' CE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -135.61 176.24 8.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.236 -1.024 . . . . 1.24 108.236 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.403 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -140.77 70.89 1.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.74 110.014 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.463 ' CE3' ' HB3' ' A' ' 36' ' ' ARG . 5.7 p90 . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.113 -0.992 . . . . 0.93 108.52 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 108.624 -0.88 . . . . 1.22 108.624 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 34.5 Cg_endo -77.35 -167.42 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.375 2.05 . . . . 1.28 109.862 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.99 -39.43 63.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.449 -0.782 . . . . 1.73 109.346 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.402 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -69.47 105.41 2.61 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.394 -0.816 . . . . 1.29 109.053 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 65.43 33.04 9.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.493 -0.754 . . . . 0.66 109.909 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 1' ' ' ALA . . . -68.76 -45.08 66.8 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.2 -1.56 . . . . 0.52 109.2 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -63.59 -49.64 72.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.958 . . . . 1.56 109.236 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.29 -34.31 76.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.541 -0.724 . . . . 1.23 109.399 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.58 32.15 28.33 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.305 -1.518 . . . . 0.62 109.305 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -115.13 178.21 17.71 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.273 -1.531 . . . . 0.51 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.89 135.13 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.93 109.019 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 4' ' ' SER . 51.1 m -79.97 90.03 5.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.411 -0.806 . . . . 0.45 109.032 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 35' ' ' CYS . 12.1 mt -104.16 126.14 32.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.309 -0.869 . . . . 0.58 109.404 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.4 Cg_endo -78.65 174.84 11.74 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.66 2.24 . . . . 0.51 110.106 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 51.37 -129.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.143 -0.688 . . . . 1.09 109.143 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.61 149.64 29.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.536 -1.352 . . . . 1.0 109.458 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 3.0 m -101.59 162.84 19.19 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.342 -0.849 . . . . 0.4 109.07 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.6 Cg_endo -78.19 167.5 23.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.516 2.144 . . . . 0.65 109.999 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.98 152.2 84.14 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.505 -0.747 . . . . 0.62 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.89 -5.67 32.83 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.361 -1.516 . . . . 0.53 111.191 -0.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.1 ttm 60.36 58.49 2.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.98 109.61 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -90.04 93.85 9.55 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.172 -0.955 . . . . 1.08 108.89 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.3 112.77 5.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.366 -0.833 . . . . 1.72 109.897 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.574 HD11 ' HA3' ' A' ' 10' ' ' GLY . 3.5 pt -104.14 -1.38 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.827 . . . . 0.6 109.49 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.12 -168.34 40.11 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.989 -1.645 . . . . 0.39 108.989 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.3 p -122.08 168.61 11.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.274 -1.133 . . . . 0.56 109.41 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 81.0 m -138.09 126.37 23.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.46 109.589 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 55.84 36.94 28.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.679 -0.638 . . . . 0.93 110.072 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.532 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -137.38 13.38 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.677 -1.369 . . . . 0.6 109.677 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -99.45 -3.12 0.11 Allowed Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 113.859 1.059 . . . . 1.37 113.859 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.6 Cg_endo -74.84 -46.95 0.22 Allowed 'Trans proline' 0 C--N 1.325 -0.688 0 CA-C-N 120.299 1.143 . . . . 0.5 110.034 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 5.3 t -107.49 150.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.993 -1.114 . . . . 0.37 107.993 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -134.44 162.65 31.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.87 -1.144 . . . . 0.72 109.865 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 56.3 m -90.4 88.98 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.944 -0.761 . . . . 0.35 108.944 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HB2' HD12 ' A' ' 13' ' ' ILE . 95.4 m -91.55 136.01 33.44 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.123 -0.986 . . . . 0.37 109.533 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -105.71 147.51 28.47 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.299 -0.876 . . . . 1.08 109.053 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -86.05 -12.44 50.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.792 . . . . 0.62 109.245 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 117.602 -1.19 . . . . 1.11 108.401 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.024 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.418 -0.586 . . . . 4.45 109.418 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 1.024 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 34.7 Cg_endo -79.6 162.96 24.37 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.495 1.464 . . . . 3.75 109.292 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.456 ' HG ' ' CZ ' ' A' ' 28' ' ' PHE . 2.0 mm? -93.93 100.56 12.7 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.255 -0.903 . . . . 1.61 108.789 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.07 124.63 20.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.352 -0.843 . . . . 1.13 109.944 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 7' ' ' ARG . 34.7 t -85.66 111.89 20.5 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.267 -0.896 . . . . 0.5 108.727 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.09 -2.26 77.47 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.267 -0.968 . . . . 0.81 111.018 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.451 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -58.75 -60.35 3.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.833 -1.392 . . . . 1.66 109.637 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.483 ' HB2' HD13 ' A' ' 24' ' ' ILE . 22.6 m120 -133.61 35.93 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.158 -0.964 . . . . 1.26 109.483 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.19 59.53 9.86 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.454 -1.459 . . . . 0.69 109.454 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.627 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -132.83 -167.71 11.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.173 -1.571 . . . . 0.48 109.173 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.03 151.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.197 -1.178 . . . . 0.79 109.276 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' HB3' HG11 ' A' ' 32' ' ' VAL . 67.9 m -91.42 97.97 11.41 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.994 -0.743 . . . . 0.42 108.994 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 17' ' ' CYS . 3.3 mt -100.28 127.97 31.74 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.394 -0.816 . . . . 0.6 109.02 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.2 Cg_endo -76.76 163.51 31.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.422 2.081 . . . . 0.55 110.147 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.9 mm 61.46 -94.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.728 -0.607 . . . . 0.73 109.374 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.92 165.24 31.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.759 -1.213 . . . . 1.46 109.201 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.599 ' HB3' HD12 ' A' ' 13' ' ' ILE . 2.3 m -109.72 163.69 16.5 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.49 109.064 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 33.9 Cg_endo -76.73 160.38 34.48 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.543 2.162 . . . . 0.69 110.086 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 24.7 m -64.82 152.49 90.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.77 109.347 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.587 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 34.6 Cg_endo -77.06 -8.27 30.4 Favored 'Cis proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.254 -1.561 . . . . 0.58 111.219 0.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 46.2 ttp 58.89 84.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.419 -0.801 . . . . 1.37 110.501 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER -94.34 96.61 9.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.892 -1.13 . . . . 0.73 108.38 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 130.8 46.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.529 -0.732 . . . . 1.44 109.481 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.543 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -139.56 34.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.628 -0.67 . . . . 0.49 109.38 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.7 -177.77 19.0 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.347 -1.501 . . . . 0.36 109.347 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.4 p -132.58 164.49 26.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.238 -1.154 . . . . 0.58 109.084 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 21.9 m -131.85 138.78 48.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.187 -0.945 . . . . 0.41 109.607 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CZ ' ' HG ' ' A' ' 3' ' ' LEU . 56.1 m-85 57.9 32.26 21.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.894 -0.504 . . . . 0.88 109.96 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.45 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.46 -128.96 9.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.153 -1.579 . . . . 0.48 109.153 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.42 0.82 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -1.145 . . . . 1.36 113.645 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.5 Cg_endo -74.97 -43.88 0.37 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 CA-C-N 120.328 1.153 . . . . 0.54 110.058 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 15.9 t -107.91 147.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.097 -1.075 . . . . 0.43 108.097 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.8 mttp -126.58 158.51 36.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.82 109.926 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 73.7 m -92.48 118.14 30.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.479 -0.934 . . . . 0.38 108.479 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -122.83 138.48 54.63 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.35 109.534 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 6.8 ttm180 -141.81 -171.55 3.37 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.588 -0.893 . . . . 1.02 108.588 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER 52.29 53.64 12.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.604 -0.685 . . . . 0.63 109.252 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.587 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.0 p90 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.99 -1.005 . . . . 1.26 108.994 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.027 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.069 -0.345 . . . . 1.43 110.069 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 1.027 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 36.2 Cg_endo -77.15 122.16 6.07 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.749 1.633 . . . . 1.16 109.978 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.28 84.98 4.45 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.327 -0.858 . . . . 2.57 109.362 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m 48.79 41.21 17.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.721 -0.612 . . . . 1.29 110.363 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 75.9 m 51.86 49.35 20.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.908 . . . . 0.44 109.8 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.94 -25.91 54.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.004 -1.239 . . . . 0.47 110.004 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HD2' ' HA3' ' A' ' 25' ' ' GLY . 4.3 ptp180 -52.63 -34.85 53.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.292 -1.123 . . . . 0.76 110.185 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB2' HD12 ' A' ' 24' ' ' ILE . 38.3 m-80 -136.94 16.35 3.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.982 -1.074 . . . . 0.66 110.351 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.66 62.0 6.8 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.781 -1.328 . . . . 0.47 109.781 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -128.0 -151.26 7.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.331 -1.508 . . . . 0.43 109.331 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.02 143.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.75 109.248 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.428 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.3 m -82.65 87.65 6.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.44 -0.787 . . . . 0.42 108.993 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 17' ' ' CYS . 3.7 mt -100.06 123.14 48.14 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.211 -0.931 . . . . 0.46 109.198 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.2 Cg_endo -79.31 172.14 15.06 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.756 2.304 . . . . 0.61 110.378 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mm 58.85 -93.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.367 -0.605 . . . . 1.07 109.367 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 -178.84 5.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.671 -1.268 . . . . 1.58 108.804 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.543 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -131.64 162.39 56.53 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.213 -0.929 . . . . 0.56 109.026 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -77.31 163.88 29.62 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.494 2.129 . . . . 0.77 109.813 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.9 150.91 75.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.773 . . . . 0.91 109.353 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.624 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.71 -2.1 33.9 Favored 'Cis proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.41 -1.496 . . . . 0.62 111.455 0.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.3 ttp 60.84 65.19 1.05 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.143 -0.973 . . . . 1.35 109.345 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.04 105.58 17.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.078 -1.014 . . . . 1.17 109.454 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.84 123.26 23.03 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.892 . . . . 1.28 109.092 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.705 HD11 ' HA3' ' A' ' 10' ' ' GLY . 11.4 pt -123.63 -0.33 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.468 -0.77 . . . . 0.91 110.077 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 34' ' ' CYS . . . 169.52 -171.21 43.1 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.972 -1.651 . . . . 0.46 108.972 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.9 p -124.37 164.72 19.06 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.263 -1.139 . . . . 0.61 109.383 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -135.3 132.7 38.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.257 -0.902 . . . . 0.39 109.531 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 56.66 34.0 23.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.77 110.109 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.508 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.87 -134.32 11.83 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.502 -1.439 . . . . 0.49 109.502 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -100.38 -4.0 0.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.387 -1.067 . . . . 1.38 113.803 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.81 -48.65 0.18 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 CA-C-N 120.23 1.118 . . . . 0.62 110.074 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.3 t -101.2 148.98 6.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.021 -1.103 . . . . 0.44 108.021 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 18.4 mtmm -128.38 170.35 13.21 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.989 -1.069 . . . . 0.67 109.542 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.609 ' HB3' HG13 ' A' ' 24' ' ' ILE . 46.7 m -100.52 105.12 16.52 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.397 -0.964 . . . . 0.47 108.397 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -106.23 146.37 30.39 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.38 109.237 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HD3' HD13 ' A' ' 24' ' ' ILE . 3.0 ttp180 -138.67 161.21 37.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.84 109.046 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.624 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.54 -24.79 20.52 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.4 -0.813 . . . . 0.81 109.271 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 42.9 p90 . . . . . 0 C--N 1.305 -1.355 0 O-C-N 121.314 -0.866 . . . . 1.1 108.71 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.151 -0.685 . . . . 2.01 109.151 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 32.6 Cg_endo -76.89 136.7 16.94 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.446 2.097 . . . . 1.78 110.863 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.9 OUTLIER 60.1 39.81 19.17 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.306 -0.628 . . . . 1.98 109.306 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.594 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -148.11 176.65 10.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.2 -0.937 . . . . 0.68 109.458 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -110.89 139.24 46.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.46 109.428 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 150.7 16.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.519 -1.433 . . . . 0.52 109.519 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -27.06 68.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 2.01 109.337 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -68.84 -52.8 26.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -0.839 . . . . 0.69 109.235 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.594 ' HA2' ' HB2' ' A' ' 4' ' ' SER . . . 119.67 58.66 0.25 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.329 -1.509 . . . . 0.49 109.329 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -98.36 164.83 21.32 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.318 -1.513 . . . . 0.44 109.318 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.68 153.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.337 -1.096 . . . . 0.76 108.777 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.471 ' HB3' HG11 ' A' ' 32' ' ' VAL . 72.1 m -77.65 87.3 3.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.403 -0.811 . . . . 0.39 109.236 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.614 HD12 ' HB3' ' A' ' 17' ' ' CYS . 4.6 mt -111.46 115.81 51.41 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.348 -0.845 . . . . 0.5 109.275 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.709 ' HB3' HG22 ' A' ' 32' ' ' VAL . 35.0 Cg_endo -78.85 172.17 15.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.636 2.224 . . . . 0.52 110.492 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.0 mm 60.48 -92.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.536 -0.542 . . . . 1.22 109.536 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -133.62 176.8 8.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.714 -1.241 . . . . 1.62 109.127 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.614 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -135.79 162.33 57.58 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.19 -0.944 . . . . 0.39 109.069 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.99 165.91 25.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.581 2.187 . . . . 0.46 109.926 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.36 153.08 87.27 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.55 109.394 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -79.65 4.15 34.08 Favored 'Cis proline' 0 C--N 1.309 -1.524 0 C-N-CA 123.372 -1.512 . . . . 0.41 111.315 0.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.9 ttp 61.02 56.49 2.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 1.09 109.692 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -89.87 89.65 7.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.044 -1.035 . . . . 0.72 108.47 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.21 121.48 19.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.376 -0.827 . . . . 0.68 109.451 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.479 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -129.16 35.18 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.429 -0.794 . . . . 0.56 109.412 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.33 -172.23 26.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.421 -1.472 . . . . 0.37 109.421 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.7 p -141.19 162.11 36.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 0.41 109.261 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 56.8 m -120.23 146.33 46.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.101 -0.999 . . . . 0.39 109.818 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 55.08 41.29 31.84 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.147 0.499 . . . . 0.79 109.838 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.61 -134.89 12.19 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.46 -1.856 . . . . 0.59 108.46 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.733 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.2 mmm180 -108.61 9.11 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.208 -1.172 . . . . 1.16 113.391 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 36.0 Cg_endo -77.17 -47.12 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 CA-C-N 120.12 1.078 . . . . 0.51 110.079 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 14' ' ' PRO . 48.2 t -98.6 148.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.38 108.268 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -118.68 153.26 34.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.032 -1.042 . . . . 0.61 109.965 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 m -94.21 85.19 4.59 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.532 -0.914 . . . . 0.35 108.532 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -93.32 136.2 33.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.96 . . . . 0.36 110.083 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -91.92 136.59 33.04 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.366 -0.976 . . . . 1.13 108.366 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.63 23.14 4.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.84 109.566 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.91 108.106 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.185 -0.672 . . . . 3.13 109.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 33.7 Cg_endo -77.56 106.6 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.5 2.133 . . . . 1.59 110.371 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 11' ' ' VAL . 96.4 mt -86.6 67.7 9.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.157 -0.965 . . . . 1.68 109.416 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.4 43.54 1.15 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.323 -0.86 . . . . 1.11 109.298 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.45 44.42 0.95 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.112 -0.993 . . . . 0.48 109.352 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.34 -21.88 70.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.816 -1.313 . . . . 0.97 109.816 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -42.99 74.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 1.73 109.627 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.41 ' CB ' HG13 ' A' ' 24' ' ' ILE . 86.6 m-20 -108.69 4.66 24.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 1.08 110.017 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.7 41.28 99.85 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.551 -1.42 . . . . 0.57 109.551 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -119.25 162.95 13.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.439 -1.464 . . . . 0.45 109.439 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 3' ' ' LEU . 35.9 m -95.59 154.43 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.351 -1.088 . . . . 0.51 109.073 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.572 ' HB3' HG11 ' A' ' 32' ' ' VAL . 97.7 m -96.01 98.27 10.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.186 -0.946 . . . . 0.38 109.422 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.802 HD12 ' HB3' ' A' ' 17' ' ' CYS . 1.6 mt -105.45 127.21 29.02 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.346 -0.846 . . . . 0.5 109.087 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.88 165.65 24.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.567 2.178 . . . . 0.51 110.603 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mt 61.89 -92.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.834 -0.541 . . . . 1.23 109.691 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.66 160.04 43.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.579 -1.325 . . . . 1.83 108.818 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.802 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -110.56 159.04 33.75 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.157 -0.964 . . . . 0.39 109.435 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.69 172.1 15.64 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.731 2.287 . . . . 0.59 110.199 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 20' ' ' PRO . 3.6 t -58.51 145.52 76.07 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.066 -0.716 . . . . 0.77 109.066 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.646 ' HA ' HG13 ' A' ' 19' ' ' VAL . 36.3 Cg_endo -80.33 -9.77 40.5 Favored 'Cis proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.596 -1.418 . . . . 0.51 111.481 -0.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 33.1 ttp 62.64 63.71 0.97 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 1.49 109.347 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -89.88 92.75 9.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.106 -0.996 . . . . 0.87 108.684 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.04 122.2 20.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 1.39 109.559 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -126.53 25.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.064 -0.717 . . . . 0.65 109.064 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 -171.74 27.47 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.609 -1.796 . . . . 0.36 108.609 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.1 p -137.83 168.88 18.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.986 -1.302 . . . . 0.51 109.697 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 17.9 m -129.32 142.33 50.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.371 -0.83 . . . . 0.42 109.553 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 58.31 34.34 23.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.91 -0.494 . . . . 0.88 110.095 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.465 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.22 10.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.03 -1.628 . . . . 0.67 109.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.88 5.02 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.166 -1.197 . . . . 1.73 113.517 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -76.1 -47.52 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 CA-C-N 120.253 1.126 . . . . 0.58 109.969 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 12' ' ' CYS . 13.0 t -102.19 151.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.134 -0.979 . . . . 0.46 108.496 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -124.41 157.17 35.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.91 110.218 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 88.7 m -93.59 96.4 9.83 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.729 -0.841 . . . . 0.44 108.729 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.5 m -102.51 149.07 24.77 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.045 -1.034 . . . . 0.39 109.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.582 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 2.9 ttp180 -136.98 166.44 23.66 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.924 -0.769 . . . . 0.6 108.924 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -26.54 18.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.452 -0.78 . . . . 0.64 108.962 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.777 -1.106 . . . . 0.81 108.717 179.729 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.267 -0.642 . . . . 4.22 109.267 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -77.78 141.55 19.44 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.727 2.284 . . . . 3.47 110.189 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 3' ' ' LEU . 2.2 tp -79.27 113.73 17.64 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.0 -0.68 . . . . 3.07 109.289 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.527 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -57.3 110.45 0.85 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.984 -0.747 . . . . 1.14 108.984 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 4.0 m 66.72 35.37 5.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.592 -0.692 . . . . 0.75 109.279 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.37 -42.21 96.13 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.749 -1.341 . . . . 0.59 109.749 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.7 mmm180 -65.08 -32.84 74.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.122 -1.222 . . . . 1.88 108.934 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.535 ' CB ' HG13 ' A' ' 24' ' ' ILE . 2.6 m120 -81.17 -25.22 36.98 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.416 -0.803 . . . . 1.06 109.129 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.33 37.24 11.19 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.574 -1.41 . . . . 0.68 109.574 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -138.83 -160.48 8.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.178 -1.569 . . . . 0.56 109.178 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.57 157.48 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.228 -1.16 . . . . 1.1 109.138 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 4' ' ' SER . 56.0 m -87.11 92.14 8.95 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.358 -0.839 . . . . 0.81 109.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 17' ' ' CYS . 8.3 mt -101.38 123.65 43.84 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.344 -0.847 . . . . 0.69 109.31 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.607 ' HB3' HG22 ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.21 172.11 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.792 2.328 . . . . 0.68 110.274 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.4 mm 54.92 -116.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.947 -0.76 . . . . 0.73 108.947 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.31 161.36 19.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.592 -1.317 . . . . 1.45 109.241 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.44 165.14 13.39 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.391 -0.818 . . . . 0.62 109.228 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.03 164.03 27.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.666 2.244 . . . . 0.81 110.021 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -59.75 147.82 77.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 109.195 -0.669 . . . . 1.16 109.195 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.5 Cg_endo -80.61 -2.97 42.93 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.457 -1.476 . . . . 0.74 111.18 -0.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.9 ttm 63.26 59.08 1.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 1.12 109.849 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -90.36 104.24 16.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.16 -0.963 . . . . 1.04 108.869 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 122.71 23.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.345 -0.847 . . . . 1.32 109.241 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.627 HD12 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -122.48 22.82 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.458 -0.776 . . . . 0.76 109.524 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 153.72 -176.18 31.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.787 -1.725 . . . . 0.6 108.787 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 10.5 p -129.04 164.54 23.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -1.154 . . . . 0.96 109.688 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.656 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 59.6 m -134.94 136.94 42.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.83 109.862 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 53.34 37.81 26.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.838 -0.539 . . . . 1.44 110.168 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.44 -132.94 11.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.371 -1.492 . . . . 1.06 109.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.5 mmp_? -105.28 -1.73 0.11 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.312 -1.111 . . . . 1.21 113.667 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -74.96 -44.93 0.31 Allowed 'Trans proline' 0 C--N 1.327 -0.601 0 CA-C-N 120.192 1.104 . . . . 0.84 110.246 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 12.1 t -106.22 148.92 10.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.62 108.157 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -134.17 165.27 25.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.71 110.299 -178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HB3' HG12 ' A' ' 24' ' ' ILE . 69.3 m -90.06 93.25 9.31 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 0.56 108.645 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 13' ' ' ILE . 4.0 m -95.06 143.27 26.65 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.12 -0.987 . . . . 0.51 109.387 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HD3' HD12 ' A' ' 24' ' ' ILE . 6.3 ttp180 -121.89 152.04 40.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 1.31 108.89 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.616 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.48 -3.73 57.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.432 -0.793 . . . . 1.46 109.982 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 117.626 -1.178 . . . . 1.48 108.516 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.031 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.651 -0.499 . . . . 1.57 109.651 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 1.031 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 36.2 Cg_endo -78.94 171.95 15.71 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.935 1.757 . . . . 1.22 110.06 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tp -122.35 168.11 12.46 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.806 -0.812 . . . . 1.08 108.806 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -71.08 104.74 3.12 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.281 -0.887 . . . . 0.72 109.61 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -39.41 81.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.37 109.475 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.21 68.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.072 -1.061 . . . . 0.54 110.487 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HB2' ' HB2' ' A' ' 4' ' ' SER . 10.4 ttm105 -54.71 -49.2 71.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.958 -1.319 . . . . 0.85 109.808 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -114.61 27.7 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.87 109.613 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.32 44.08 96.81 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.475 -1.45 . . . . 0.49 109.475 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.633 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -101.21 159.81 18.64 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.269 -1.532 . . . . 0.35 109.269 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.4 145.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.273 -1.133 . . . . 0.91 108.824 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.482 ' HB3' HG11 ' A' ' 32' ' ' VAL . 93.3 m -77.29 88.67 3.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.41 109.114 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 35' ' ' CYS . 4.8 mt -101.33 122.02 49.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.283 -0.886 . . . . 0.48 109.239 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.1 Cg_endo -79.06 173.35 13.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.444 2.096 . . . . 0.44 109.718 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.84 -121.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.565 -0.709 . . . . 0.93 109.327 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.28 161.81 14.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.787 -1.196 . . . . 2.22 109.772 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.45 152.51 47.12 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.395 -0.816 . . . . 0.43 108.819 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.33 165.23 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.474 2.116 . . . . 0.5 110.66 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.44 155.38 75.35 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.783 -0.573 . . . . 0.58 109.732 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.31 13.65 21.49 Favored 'Cis proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.438 -1.484 . . . . 0.49 111.435 -0.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 ttp 59.19 57.22 3.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 1.25 109.237 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -90.04 89.55 7.75 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.544 -0.91 . . . . 0.93 108.544 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.1 124.59 27.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.62 109.839 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.633 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -127.57 28.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.45 -0.781 . . . . 0.42 109.232 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -170.23 30.26 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.181 -1.568 . . . . 0.39 109.181 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.6 p -140.42 165.43 27.45 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.258 -1.143 . . . . 0.6 109.584 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.628 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.5 m -132.62 142.11 48.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -0.903 . . . . 0.48 109.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 54.71 33.98 20.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.814 -0.554 . . . . 1.08 110.193 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.468 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -130.66 10.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.451 -1.46 . . . . 0.62 109.451 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.738 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -104.19 -2.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.429 -1.042 . . . . 1.21 113.707 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.738 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.54 -47.59 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 120.339 1.157 . . . . 0.51 110.159 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.628 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 10.9 t -101.47 146.64 9.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.942 -1.132 . . . . 0.45 107.942 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 158.72 36.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.918 -1.113 . . . . 0.5 110.058 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.2 m -89.98 79.26 6.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.29 108.05 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.502 ' HB2' HD12 ' A' ' 13' ' ' ILE . 3.9 m -93.48 145.24 24.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.355 -0.841 . . . . 0.31 109.684 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -114.78 151.99 32.86 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.451 -0.78 . . . . 1.22 108.978 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.89 15.71 21.42 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.387 -0.821 . . . . 0.74 109.283 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 117.777 -1.106 . . . . 0.91 108.469 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.966 -0.753 . . . . 3.29 108.966 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.87 83.26 2.14 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.487 2.125 . . . . 2.63 109.803 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.486 ' HA ' HD13 ' A' ' 3' ' ' LEU . 3.7 mm? 56.71 40.65 29.08 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.167 -0.679 . . . . 1.51 109.167 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.52 152.98 50.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.387 -0.821 . . . . 1.11 108.958 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.4 40.18 1.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.88 . . . . 0.5 110.554 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.16 30.0 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.619 -1.792 . . . . 1.17 108.619 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.98 -36.66 48.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.411 -1.052 . . . . 2.39 108.858 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -64.97 -25.99 68.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 1.3 109.307 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.27 56.01 3.12 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.747 -1.741 . . . . 0.96 108.747 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -147.01 153.78 25.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.965 -1.654 . . . . 0.39 108.965 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.95 141.72 13.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.237 -1.155 . . . . 0.6 109.518 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.405 ' HB3' HG11 ' A' ' 32' ' ' VAL . 87.8 m -88.3 84.01 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.37 109.308 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 17.0 mt -96.09 136.22 22.24 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.181 -0.949 . . . . 0.48 108.887 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 33.9 Cg_endo -76.63 172.27 16.53 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.427 2.085 . . . . 0.51 110.131 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.9 mm 61.49 -99.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 170.38 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.598 -1.314 . . . . 1.12 109.085 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.623 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 4.6 m -96.01 134.31 24.02 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.893 . . . . 0.54 109.556 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.24 138.82 16.28 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.575 2.184 . . . . 0.73 109.764 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.26 155.69 78.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.817 . . . . 0.65 109.198 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.58 2.72 35.11 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.494 -1.461 . . . . 0.58 111.459 0.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.461 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 26.6 ttm -67.48 113.85 5.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.833 -1.167 . . . . 0.97 109.137 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.71 176.6 5.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.99 109.571 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.623 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -82.67 142.72 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.86 109.241 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.611 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -138.83 33.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.55 109.369 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 142.56 -167.82 26.07 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.166 -1.574 . . . . 0.42 109.166 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 9.9 p -131.2 163.91 26.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.203 -1.175 . . . . 0.63 109.493 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 m -133.32 140.58 47.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.243 -0.91 . . . . 0.45 109.677 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.481 ' HD2' HG21 ' A' ' 32' ' ' VAL . 18.0 m-85 51.23 41.84 28.27 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.176 0.512 . . . . 0.68 109.934 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 93.55 -134.86 12.3 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.02 -1.632 . . . . 0.55 109.02 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.2 mmp_? -105.29 -0.16 0.1 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.215 -1.168 . . . . 1.48 113.471 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.7 Cg_endo -74.74 -47.44 0.22 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 120.263 1.13 . . . . 0.58 110.337 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.481 HG21 ' HD2' ' A' ' 28' ' ' PHE . 18.1 t -100.87 156.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.073 -1.017 . . . . 0.48 108.334 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -129.2 163.67 25.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.986 -1.071 . . . . 0.7 109.925 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HB3' HG13 ' A' ' 24' ' ' ILE . 52.2 m -90.57 131.99 35.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.357 -0.979 . . . . 0.39 108.357 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.7 m -121.33 133.54 55.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.029 -1.044 . . . . 0.46 109.663 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.608 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.32 146.85 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.727 -0.842 . . . . 0.83 108.727 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -23.7 21.33 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.276 -0.89 . . . . 0.88 109.401 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 1.07 109.148 -179.911 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.504 -0.554 . . . . 1.93 109.504 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -77.93 110.81 2.98 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.578 2.185 . . . . 2.45 110.739 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.2 mt 54.35 70.77 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.838 -0.539 . . . . 1.39 110.048 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.54 103.19 0.64 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.317 -0.994 . . . . 1.62 108.317 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.46 23.53 12.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.534 -0.729 . . . . 0.6 109.637 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.96 -45.03 59.19 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.911 -1.675 . . . . 0.64 108.911 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -33.43 75.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -1.074 . . . . 1.52 108.93 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.64 -27.88 64.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.33 -0.856 . . . . 0.94 109.186 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.76 48.27 5.29 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.26 -1.536 . . . . 0.53 109.26 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.715 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -154.01 157.39 27.44 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.159 -1.576 . . . . 0.51 109.159 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 m -93.89 150.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -1.12 . . . . 0.74 109.416 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.706 ' HB3' HG11 ' A' ' 32' ' ' VAL . 54.2 m -88.54 101.36 13.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.421 -0.8 . . . . 0.58 109.392 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.59 HG22 HG13 ' A' ' 15' ' ' ILE . 15.4 mt -100.58 122.31 49.95 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.322 -0.861 . . . . 0.51 109.342 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.508 ' HB3' HG22 ' A' ' 32' ' ' VAL . 36.1 Cg_endo -80.32 31.2 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.827 2.351 . . . . 0.54 110.962 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.59 HG13 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -146.23 -153.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.174 -1.047 . . . . 0.75 108.174 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.63 142.84 27.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.035 -1.04 . . . . 1.7 108.972 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -63.22 124.18 83.15 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.48 109.849 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.87 119.81 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.687 2.258 . . . . 0.73 110.362 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.2 m -65.85 159.88 66.24 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.267 -0.896 . . . . 0.81 108.726 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -80.98 8.27 35.9 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 123.614 -1.411 . . . . 0.64 111.596 -0.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.671 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 2.0 ttp -60.79 133.99 56.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.925 -1.11 . . . . 1.13 108.864 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -101.74 164.91 11.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.17 110.039 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.18 151.53 24.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.176 -0.675 . . . . 2.12 109.176 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.715 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -148.38 44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.613 -0.679 . . . . 0.55 109.488 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.25 -174.62 18.33 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.146 -1.581 . . . . 0.41 109.146 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 26.4 p -138.16 166.75 23.36 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.291 -1.123 . . . . 0.69 109.415 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 27.0 m -127.03 141.45 51.78 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.155 -0.966 . . . . 0.54 109.772 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 56.0 36.65 27.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.877 -0.514 . . . . 0.96 110.026 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.34 10.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.81 109.043 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -107.98 6.81 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.189 . . . . 1.2 113.472 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.2 Cg_endo -76.6 -46.11 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 120.171 1.097 . . . . 0.72 109.782 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 12' ' ' CYS . 73.2 t -104.63 149.49 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.297 -1.001 . . . . 0.42 108.297 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.5 mttp -123.69 154.2 39.74 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.093 -1.005 . . . . 0.64 109.83 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.1 m -89.97 136.82 32.81 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.445 -0.946 . . . . 0.5 108.445 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.671 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -135.63 133.72 38.52 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.103 -0.998 . . . . 0.47 110.09 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.684 ' CD ' HG21 ' A' ' 24' ' ' ILE . 2.6 ptm180 -145.33 143.03 29.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.185 -1.043 . . . . 0.61 108.185 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -33.71 16.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.89 111.007 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.413 ' OXT' ' HG3' ' A' ' 36' ' ' ARG . 11.3 p-90 . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.018 -1.051 . . . . 0.98 109.641 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.958 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.824 -0.435 . . . . 1.04 109.824 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.958 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 35.0 Cg_endo -77.5 179.49 6.46 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.93 1.753 . . . . 0.72 110.07 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.5 mt -70.23 -64.55 0.87 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 1.06 108.81 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.55 161.19 14.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.608 -0.886 . . . . 0.66 108.608 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -104.75 45.6 0.95 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.107 -0.996 . . . . 0.69 109.831 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.89 51.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.506 . . . . 0.59 109.336 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.11 -44.2 93.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.309 -1.112 . . . . 2.71 109.468 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.506 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 4.3 m120 -80.27 -25.06 39.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.925 . . . . 1.18 109.355 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.18 62.8 2.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.78 -1.728 . . . . 0.58 108.78 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -152.37 168.54 31.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.23 -1.548 . . . . 0.42 109.23 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 t -91.14 143.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.65 109.129 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HB3' HG11 ' A' ' 32' ' ' VAL . 92.2 m -86.1 83.98 7.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.305 -0.872 . . . . 0.34 109.579 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 6.7 mt -96.24 128.57 36.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.181 -0.95 . . . . 0.5 108.866 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.16 179.07 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.442 2.094 . . . . 0.49 110.309 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.6 mt 61.29 -101.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.705 -0.622 . . . . 0.77 109.415 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.36 160.91 40.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.615 -1.303 . . . . 1.36 109.374 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.84 131.04 68.43 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.854 . . . . 0.49 109.435 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.78 120.15 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.625 2.217 . . . . 0.7 109.535 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.1 m -57.32 153.48 26.81 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.822 . . . . 0.82 109.334 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.85 10.69 30.11 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.606 -1.414 . . . . 0.73 111.626 -0.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.5 tpp -61.35 118.78 7.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.929 -1.107 . . . . 1.08 108.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 1.5 ptp85 -90.03 175.99 6.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.95 109.839 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 132.47 52.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.701 -0.851 . . . . 1.34 108.701 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.525 HD11 ' HA3' ' A' ' 10' ' ' GLY . 8.2 pt -120.27 -0.08 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.74 110.361 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.63 -159.27 31.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.424 -1.471 . . . . 0.4 109.424 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.2 p -137.17 165.34 26.34 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.351 -1.088 . . . . 0.55 109.612 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 76.6 m -126.9 148.1 50.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.38 109.228 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 55.02 41.56 31.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.045 -0.724 . . . . 0.74 109.045 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 -130.9 10.52 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.938 -2.065 . . . . 0.51 107.938 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.731 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.6 mtm180 -113.75 10.48 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.186 -1.185 . . . . 2.6 113.341 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.7 Cg_endo -77.56 -45.25 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 120.162 1.093 . . . . 0.5 109.681 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 46.1 t -98.47 154.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.265 -1.013 . . . . 0.36 108.265 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mttp -117.91 157.88 25.89 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 1.11 110.057 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 81.4 m -97.25 104.34 16.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.494 -0.928 . . . . 0.5 108.494 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 14.7 m -100.05 143.0 30.77 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.131 -0.981 . . . . 0.44 109.826 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.502 ' HB2' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -143.66 158.69 43.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.519 -0.738 . . . . 0.92 109.205 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -27.96 51.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.335 -0.853 . . . . 0.93 109.429 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.422 ' CE2' ' HD2' ' A' ' 36' ' ' ARG . 37.0 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.894 -1.05 . . . . 1.31 109.264 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.081 -0.711 . . . . 1.53 109.081 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 36.1 Cg_endo -81.23 153.56 18.69 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.592 2.194 . . . . 1.42 110.704 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.2 mt 54.56 41.77 31.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.925 -0.484 . . . . 1.2 110.77 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.02 168.16 16.2 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.873 -1.142 . . . . 1.18 108.799 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 49.18 1.04 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.108 -0.995 . . . . 0.66 109.747 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.28 -34.48 69.22 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.217 -1.553 . . . . 1.01 109.217 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -64.1 -23.93 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -1.17 . . . . 1.47 109.762 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.555 ' HB3' HG13 ' A' ' 24' ' ' ILE . 14.8 m120 -103.51 -11.7 17.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.99 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.05 32.18 66.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.504 -1.438 . . . . 0.82 109.504 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -122.91 164.17 15.99 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.43 -1.468 . . . . 0.48 109.43 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.26 154.63 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.41 -1.053 . . . . 0.65 109.275 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.551 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.2 m -91.65 93.62 9.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.432 -0.793 . . . . 0.5 109.43 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.591 HD12 ' HB3' ' A' ' 17' ' ' CYS . 4.0 mt -102.18 122.58 46.34 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.291 -0.881 . . . . 0.48 108.947 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 166.98 23.57 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.64 2.227 . . . . 0.59 110.797 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.1 mt 61.42 -94.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.439 -0.578 . . . . 0.85 109.439 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.58 165.7 26.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.799 -1.188 . . . . 1.72 108.928 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.3 m -119.37 163.58 26.16 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.229 -0.92 . . . . 0.46 109.509 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.1 Cg_endo -79.16 170.64 17.39 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.671 2.247 . . . . 0.73 109.609 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.63 152.19 93.17 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.453 -0.779 . . . . 0.65 109.248 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 34.1 Cg_endo -79.13 -5.57 38.05 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.19 -1.587 . . . . 0.63 111.504 0.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.9 ttm 61.85 65.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 1.27 109.648 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -89.91 90.19 8.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.166 -0.959 . . . . 1.46 108.506 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.75 117.64 12.52 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.615 -0.678 . . . . 1.08 109.828 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.557 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.24 31.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.881 -0.785 . . . . 0.59 108.881 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.35 -167.66 24.66 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.912 -1.675 . . . . 0.43 108.912 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 p -141.09 169.01 18.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.242 -1.152 . . . . 0.52 109.517 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 78.5 m -126.28 147.6 49.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.295 -0.878 . . . . 0.52 109.285 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 58.62 34.38 23.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.659 -0.497 . . . . 1.06 109.659 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.505 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 96.73 -134.52 11.83 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.605 -1.798 . . . . 0.64 108.605 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.752 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.1 mtp85 -105.02 4.82 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.312 -1.11 . . . . 1.67 113.358 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.6 Cg_endo -75.82 -50.28 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 120.137 1.085 . . . . 0.52 110.142 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 12' ' ' CYS . 16.2 t -93.47 147.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.01 -1.056 . . . . 0.42 108.757 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -115.34 156.61 25.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.206 -0.934 . . . . 0.62 109.83 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 95.8 m -98.95 92.51 5.55 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.369 -0.832 . . . . 0.45 108.897 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -99.51 147.34 25.41 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.147 -0.971 . . . . 0.42 109.951 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 7.1 ttp180 -130.97 161.12 32.63 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.763 -0.829 . . . . 1.07 108.763 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -89.79 -18.68 25.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.325 -0.859 . . . . 0.95 109.645 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.9 p90 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 117.713 -1.137 . . . . 1.02 108.734 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.074 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.597 -0.519 . . . . 1.35 109.597 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 1.074 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 34.6 Cg_endo -77.33 161.42 31.87 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.888 1.726 . . . . 0.96 109.774 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.2 mt -113.72 49.03 1.01 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.3 -0.875 . . . . 1.11 109.188 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.63 119.19 31.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.375 -0.828 . . . . 0.81 109.638 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 25.1 t -87.47 83.67 7.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.244 -0.91 . . . . 0.4 108.681 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.43 -24.51 76.7 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.354 -1.098 . . . . 0.74 110.354 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -62.21 -48.3 80.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.979 -1.307 . . . . 1.36 109.901 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 24' ' ' ILE . 17.9 m120 -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 1.08 110.161 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.62 60.31 3.76 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.349 -1.5 . . . . 0.79 109.349 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.66 -166.49 16.45 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.894 -1.682 . . . . 0.37 108.894 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.6 m -96.41 172.51 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -1.209 . . . . 0.68 109.057 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.487 ' HB3' HG11 ' A' ' 32' ' ' VAL . 21.7 m -125.78 111.17 14.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.35 109.572 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.711 HG22 HG13 ' A' ' 15' ' ' ILE . 1.2 mt -98.87 121.85 54.65 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.208 -0.932 . . . . 0.36 108.94 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 32' ' ' VAL . 36.4 Cg_endo -79.65 38.26 0.72 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.792 2.328 . . . . 0.49 111.494 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.711 HG13 HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -157.31 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.84 -1.162 . . . . 0.58 108.942 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -149.97 173.2 14.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 1.49 108.89 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 t -102.95 110.64 63.93 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.388 -0.82 . . . . 0.47 108.954 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.69 135.39 11.49 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.597 2.198 . . . . 0.85 110.294 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m -67.55 159.46 78.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.379 -0.825 . . . . 0.65 108.928 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -79.63 5.29 32.73 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.53 -1.446 . . . . 0.48 111.512 0.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.724 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 7.7 tpp -62.74 139.08 58.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.883 -1.136 . . . . 1.45 109.119 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -114.03 147.72 38.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.74 109.37 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 144.3 50.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.97 109.284 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -138.61 37.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.58 109.838 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.63 -173.62 21.97 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.605 -1.398 . . . . 0.44 109.605 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 41.3 p -126.11 163.13 23.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -1.078 . . . . 0.74 109.408 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.651 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 34.1 m -128.0 137.54 52.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.37 109.624 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 52.89 43.82 31.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.883 -0.511 . . . . 0.84 110.123 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.62 -132.59 11.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.49 -1.844 . . . . 0.63 108.49 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.4 mtm180 -111.54 4.91 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.177 -1.19 . . . . 2.91 113.628 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.3 Cg_endo -75.27 -43.51 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.338 1.157 . . . . 0.58 109.776 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 49.5 t -107.13 152.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.113 -1.069 . . . . 0.33 108.113 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.1 mttp -124.31 156.74 36.44 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.993 -1.067 . . . . 0.64 110.133 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 71.9 m -90.0 143.59 26.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.933 -1.136 . . . . 0.32 107.933 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 21.8 m -138.81 138.81 37.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.96 -1.088 . . . . 0.35 110.021 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -150.11 162.37 40.56 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.433 -0.792 . . . . 0.98 109.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -33.98 27.0 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.413 -0.805 . . . . 0.58 109.23 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 33.6 p90 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 117.789 -1.1 . . . . 1.01 108.851 179.775 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.161 -0.681 . . . . 3.28 109.161 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.505 ' HB2' HG12 ' A' ' 11' ' ' VAL . 34.5 Cg_endo -78.47 128.94 9.09 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.614 2.209 . . . . 2.46 110.584 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 tp -96.31 166.92 11.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -0.817 . . . . 2.2 108.874 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.35 117.11 4.83 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.556 -0.715 . . . . 1.11 109.245 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 p -128.05 162.4 26.95 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.211 -0.93 . . . . 0.43 109.241 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.94 175.74 43.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.093 -1.603 . . . . 0.64 109.093 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.02 46.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 1.93 109.579 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 24' ' ' ILE . 5.5 m-80 -75.27 -25.48 58.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.79 109.953 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.81 65.01 0.95 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.506 -1.438 . . . . 0.56 109.506 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . -106.37 -152.97 19.99 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.539 -1.824 . . . . 0.51 108.539 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.505 HG12 ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -127.61 149.39 32.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -1.206 . . . . 0.93 108.882 179.508 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.2 m -75.0 92.03 2.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.47 109.472 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 17' ' ' CYS . 2.3 mt -102.6 125.43 35.91 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.291 -0.881 . . . . 0.59 108.939 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.11 173.57 13.74 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.57 2.18 . . . . 0.6 110.258 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 54.21 -119.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.957 -0.757 . . . . 1.24 108.957 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.12 154.94 32.45 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.634 -1.291 . . . . 2.44 109.068 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.558 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.8 m -101.4 159.72 28.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.318 -0.863 . . . . 0.62 109.329 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 167.67 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.679 2.253 . . . . 1.06 110.235 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -60.46 147.23 83.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.81 109.294 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.583 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -79.91 -3.05 39.91 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.55 -1.437 . . . . 0.72 111.351 -0.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.2 ttm 62.47 56.22 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 1.05 109.629 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -90.17 87.08 6.72 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.176 -0.953 . . . . 2.26 108.53 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 7.3 pt20 -71.87 129.57 38.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 1.34 109.486 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -130.39 38.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.319 -0.863 . . . . 0.44 108.697 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.76 -179.82 24.35 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.645 -1.782 . . . . 0.39 108.645 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.7 p -132.97 160.76 36.18 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.081 -1.246 . . . . 0.65 109.816 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.7 m -130.03 140.83 50.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.482 -0.761 . . . . 0.46 109.534 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 55.77 37.14 28.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.885 -0.51 . . . . 1.12 110.178 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.36 -133.55 11.56 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.487 -1.445 . . . . 0.52 109.487 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -103.7 -3.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.26 113.71 -179.187 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.9 Cg_endo -74.85 -43.05 0.45 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.205 1.109 . . . . 0.69 110.832 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.6 t -103.81 147.47 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.835 -1.166 . . . . 0.57 108.853 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -131.07 156.38 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.011 -1.056 . . . . 0.69 110.022 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 55.8 m -90.09 82.18 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.41 108.812 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 73.7 m -91.78 140.99 29.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.133 -0.979 . . . . 0.44 109.843 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -110.0 152.21 26.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.625 -0.88 . . . . 0.83 108.625 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.583 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.09 -7.95 52.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.316 -0.865 . . . . 0.86 110.018 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 25.7 p90 . . . . . 0 N--CA 1.487 1.375 0 O-C-N 121.062 -1.024 . . . . 1.19 108.719 -179.911 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.424 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.927 -0.768 . . . . 3.04 108.927 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 33.7 Cg_endo -77.29 87.71 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.683 2.255 . . . . 3.07 109.877 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 78.7 mt -75.96 135.46 40.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.435 -0.791 . . . . 1.83 110.117 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.72 177.65 10.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.31 -0.996 . . . . 1.08 108.31 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -104.7 37.51 2.12 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.005 -1.06 . . . . 0.42 109.59 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.28 -49.8 24.66 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.564 . . . . 0.67 109.191 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -74.79 -36.11 62.49 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.19 -1.182 . . . . 2.29 109.254 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.45 -30.41 67.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.8 109.366 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.46 50.08 6.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.329 -1.509 . . . . 0.48 109.329 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -136.86 -170.69 11.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.347 -1.501 . . . . 0.43 109.347 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.3 157.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -1.144 . . . . 0.87 109.25 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.489 ' HB3' HG11 ' A' ' 32' ' ' VAL . 59.2 m -93.23 87.36 5.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.43 109.482 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.441 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 8.3 mt -97.14 131.44 27.56 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.46 108.92 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.26 172.55 15.82 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.445 2.096 . . . . 0.54 110.246 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.9 mm 63.02 -95.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.734 -0.604 . . . . 0.74 109.551 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 164.41 35.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.659 -1.275 . . . . 1.71 109.368 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 18.7 m -87.31 132.9 39.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.352 -0.843 . . . . 0.5 109.068 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 34.9 Cg_endo -78.33 132.56 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.501 2.134 . . . . 0.81 109.737 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.6 m -63.12 155.02 75.42 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.837 . . . . 0.75 109.132 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.5 7.68 34.39 Favored 'Cis proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.45 -1.479 . . . . 0.66 111.621 0.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 18.6 ttm -63.81 121.49 14.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.777 -1.202 . . . . 1.17 109.145 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -95.54 177.55 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.68 109.491 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.4 tt0 -92.0 147.19 23.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.673 -0.862 . . . . 1.25 108.673 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.643 HD13 ' HD3' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -145.33 42.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.482 -0.761 . . . . 0.55 109.716 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.74 -166.61 22.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.38 109.472 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 16.5 p -138.98 166.79 23.56 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.325 -1.103 . . . . 0.56 109.176 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 78.6 m -129.0 140.19 51.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.241 -0.912 . . . . 0.48 109.921 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 55.53 40.84 31.2 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.763 -0.458 . . . . 0.83 109.763 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.58 -130.63 10.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.38 -1.888 . . . . 0.62 108.38 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.73 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -111.8 9.58 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.086 -1.243 . . . . 1.54 113.386 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.73 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.1 Cg_endo -76.55 -50.52 0.1 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 CA-C-N 120.166 1.095 . . . . 0.62 109.766 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 51.2 t -99.31 155.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.196 -1.039 . . . . 0.47 108.196 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.2 160.0 26.08 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.963 -1.085 . . . . 0.87 109.892 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 m -93.54 133.78 36.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.954 -1.128 . . . . 0.39 107.954 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.456 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 19.5 m -126.04 142.46 51.51 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.088 -1.007 . . . . 0.43 109.834 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.643 ' HD3' HD13 ' A' ' 24' ' ' ILE . 4.4 mtp180 -139.03 141.24 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.895 -0.78 . . . . 0.88 108.895 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.25 -22.56 60.38 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.337 -0.852 . . . . 0.61 109.739 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.6 p90 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 117.788 -1.101 . . . . 0.79 108.943 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.811 -0.811 . . . . 1.36 108.811 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 34.2 Cg_endo -77.28 171.85 17.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.574 2.183 . . . . 1.32 110.113 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 70.69 132.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.317 -0.623 . . . . 1.17 109.317 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.42 85.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.285 -0.885 . . . . 1.12 109.695 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 93.4 m 55.22 41.26 31.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.452 -0.78 . . . . 0.42 110.071 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.87 -6.03 89.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.854 -1.298 . . . . 0.64 109.854 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -64.18 -60.59 3.02 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.976 -1.308 . . . . 0.8 109.542 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.493 ' HB2' HD13 ' A' ' 24' ' ' ILE . 30.6 m120 -119.97 13.12 12.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.157 -0.964 . . . . 1.36 110.092 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.31 70.19 1.15 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.635 -1.386 . . . . 0.52 109.635 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -127.02 -156.72 9.25 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.057 -1.617 . . . . 0.35 109.057 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -1.152 . . . . 0.98 109.432 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 65.7 m -84.33 88.99 7.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.536 -0.727 . . . . 0.49 109.329 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -97.85 130.05 29.8 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.11 -0.994 . . . . 0.52 109.307 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -77.65 178.03 8.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.457 2.105 . . . . 0.6 110.047 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.411 HG22 ' HG2' ' A' ' 16' ' ' ARG . 23.5 mm 59.68 -98.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.717 -0.614 . . . . 0.83 109.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.411 ' HG2' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -148.94 160.47 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.556 -1.34 . . . . 2.6 109.367 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -71.84 146.21 90.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.497 -0.752 . . . . 0.52 109.671 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 35.5 Cg_endo -78.53 -165.13 0.31 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.726 2.284 . . . . 0.58 110.063 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.44 ' HA ' ' N ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -135.64 140.86 35.1 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.166 -0.959 . . . . 0.77 109.588 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.95 109.23 1.39 Allowed 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.183 -1.59 . . . . 0.75 110.53 -1.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.476 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.8 ttm -150.8 118.82 6.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.82 -1.175 . . . . 1.01 108.725 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -93.69 178.64 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 1.69 109.616 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.2 144.77 25.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.541 -0.725 . . . . 0.85 109.195 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.634 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -142.03 49.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.56 109.277 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.49 -174.39 17.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.411 -1.475 . . . . 0.42 109.411 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 11.4 p -133.19 166.11 23.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.323 -1.104 . . . . 0.64 109.467 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 95.2 m -133.67 136.99 45.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.54 109.866 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 56.18 37.59 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.89 110.144 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.98 -132.8 11.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.934 -1.666 . . . . 0.77 108.934 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 20.8 mmm-85 -105.98 1.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.284 -1.127 . . . . 1.57 113.608 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -75.05 -50.85 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.585 0 CA-C-N 120.217 1.113 . . . . 0.76 109.865 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 17.2 t -100.12 150.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.035 -1.098 . . . . 0.54 108.035 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 163.33 24.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.01 -1.056 . . . . 0.62 109.728 -179.239 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.2 m -92.67 130.45 38.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.293 -1.003 . . . . 0.48 108.293 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 35.4 m -125.23 141.82 51.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.062 -1.023 . . . . 0.41 109.818 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.427 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.8 mtp180 -141.05 134.49 29.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.432 -0.792 . . . . 1.29 108.932 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.86 -26.12 37.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.88 109.551 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.8 p90 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 117.796 -1.097 . . . . 1.06 108.822 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.051 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.37 -0.604 . . . . 3.98 109.37 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 1.051 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 36.3 Cg_endo -77.59 82.36 2.42 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.657 1.571 . . . . 3.1 110.369 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 3' ' ' LEU . 91.5 mt -80.86 -61.86 1.84 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.618 -0.882 . . . . 2.22 108.618 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p 57.46 -171.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.626 0.727 . . . . 0.83 110.494 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.07 -26.33 11.18 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.447 -0.783 . . . . 0.67 109.309 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.35 -46.58 25.89 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.508 -1.437 . . . . 0.79 109.508 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -41.16 99.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -1.118 . . . . 1.88 109.651 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -75.65 -25.36 56.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.026 . . . . 0.84 109.816 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.21 29.65 12.19 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.631 -1.388 . . . . 0.73 109.631 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -103.81 156.52 17.57 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.613 -1.795 . . . . 0.65 108.613 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 158.43 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.193 -1.18 . . . . 0.9 109.645 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.5 m -79.17 93.18 5.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.521 -0.737 . . . . 0.52 109.241 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 17' ' ' CYS . 1.3 mt -101.53 123.74 43.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.357 -0.84 . . . . 0.47 109.195 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.49 170.64 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.561 2.174 . . . . 0.64 110.137 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt 56.88 -107.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.659 -0.65 . . . . 1.1 109.321 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.58 177.58 5.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.56 -1.338 . . . . 1.86 109.067 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.646 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -127.31 157.98 70.87 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.205 -0.934 . . . . 0.59 109.131 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.73 169.97 19.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.643 2.229 . . . . 0.71 109.988 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.54 153.4 95.0 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.81 109.33 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -79.48 4.72 32.47 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.378 -1.509 . . . . 0.67 111.177 0.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 ttp 61.0 57.77 2.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 1.46 109.805 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -89.93 90.32 8.11 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.195 -0.941 . . . . 1.23 108.591 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 119.41 18.5 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 1.23 109.536 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.714 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.58 31.59 2.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.455 -0.778 . . . . 0.78 109.232 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.8 -177.38 26.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.906 -1.678 . . . . 0.6 108.906 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 13.1 p -135.31 161.14 36.24 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.145 -1.209 . . . . 0.65 109.775 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.8 m -126.18 141.93 51.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.248 -0.908 . . . . 0.55 109.705 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 56.26 35.12 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.805 -0.56 . . . . 1.11 110.12 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.6 -132.42 11.14 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.083 -1.607 . . . . 0.76 109.083 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.75 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -105.16 0.71 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 1.7 113.685 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.75 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.91 -44.2 0.36 Allowed 'Trans proline' 0 C--N 1.327 -0.602 0 CA-C-N 120.247 1.124 . . . . 0.65 109.925 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -106.21 146.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.129 -1.063 . . . . 0.58 108.129 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -128.03 155.46 44.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.993 -1.067 . . . . 0.74 109.937 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.6 m -89.93 81.33 6.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.241 -1.022 . . . . 0.56 108.241 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.82 143.33 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.5 109.806 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -103.57 145.44 30.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.598 -0.889 . . . . 0.91 108.598 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.9 19.86 9.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.384 -0.822 . . . . 0.85 109.466 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 108.173 -1.047 . . . . 1.02 108.173 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.067 -0.716 . . . . 3.79 109.067 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 30.9 Cg_endo -75.47 133.55 16.03 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.407 2.071 . . . . 2.53 110.641 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.0 mt -76.53 116.0 16.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.476 -0.765 . . . . 2.54 109.675 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.14 124.34 20.58 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.301 -1.0 . . . . 1.34 108.301 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 25.8 m 59.23 28.1 17.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.53 -0.731 . . . . 0.54 109.794 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.95 -60.94 1.71 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.038 -1.625 . . . . 0.74 109.038 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -69.45 89.81 0.51 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -1.07 . . . . 1.55 108.684 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.08 63.87 2.07 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.864 -0.791 . . . . 1.41 108.864 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 5' ' ' CYS . . . -121.23 -62.1 0.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.87 -1.292 . . . . 0.38 109.87 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 36' ' ' ARG . . . 99.03 -97.43 1.84 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.212 -1.555 . . . . 0.4 109.212 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.41 141.64 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.103 -1.233 . . . . 0.47 109.522 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 58.0 m -82.92 94.45 7.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.41 109.206 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.43 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.9 mt -101.7 123.55 43.69 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.174 -0.954 . . . . 0.53 109.328 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.5 175.75 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.648 2.232 . . . . 0.51 109.912 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 53.75 -120.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.87 -0.789 . . . . 1.18 108.87 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -126.18 135.35 51.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.511 -1.368 . . . . 1.24 109.35 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 3.3 m -75.95 161.88 73.92 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.366 -0.834 . . . . 0.42 108.91 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.3 Cg_endo -77.02 160.29 33.56 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.512 2.141 . . . . 0.59 110.368 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -61.67 147.76 88.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.616 -0.677 . . . . 0.85 109.221 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.676 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 35.7 Cg_endo -77.89 -11.98 32.04 Favored 'Cis proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.48 -1.467 . . . . 0.46 111.177 -0.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.448 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 43.5 ttp 61.68 86.19 0.11 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 0.94 110.286 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.84 89.33 3.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.874 -1.141 . . . . 0.7 108.491 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.6 109.89 4.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.59 109.226 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.01 -3.74 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.397 -0.815 . . . . 0.5 109.804 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.06 -171.84 31.78 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.988 -1.645 . . . . 0.38 108.988 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 17.1 p -129.55 166.94 18.69 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -1.174 . . . . 0.51 109.414 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 97.3 m -138.74 126.17 21.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.46 109.519 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 56.12 39.07 30.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.721 -0.612 . . . . 0.88 109.972 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.52 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.62 -136.97 13.16 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.381 -1.487 . . . . 0.62 109.381 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 24.4 mmm180 -101.32 -1.84 0.1 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 1.08 113.77 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.39 -52.52 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 CA-C-N 120.24 1.121 . . . . 0.51 109.698 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -98.19 148.27 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.397 -1.334 . . . . 0.46 107.397 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HD3' ' C ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.71 156.8 45.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.89 -1.131 . . . . 0.36 110.282 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.8 m -90.61 97.21 11.05 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.453 -0.943 . . . . 0.4 108.453 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.9 m -101.13 142.18 32.94 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.296 -0.878 . . . . 0.37 109.364 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.501 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 5.7 ttp85 -144.49 -172.22 3.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.523 -0.917 . . . . 0.62 108.523 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.08 49.95 18.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.039 -0.726 . . . . 0.47 109.039 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.676 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.6 p90 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 118.026 -0.987 . . . . 0.88 109.091 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 120.791 0.329 . . . . 0.40000000000000002 110.386 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.81 -55.57 3.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.801 -1.72 . . . . 0.39000000000000001 108.801 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.37 93.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.461 -1.023 . . . . 2.0800000000000001 108.778 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB3' HD12 ' A' ' 24' ' ' ILE . 7.6 m120 -66.99 -39.78 87.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.66000000000000003 108.921 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 59.44 3.25 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.157 -1.577 . . . . 0.37 109.157 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -147.24 -170.91 15.87 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.101 -1.6 . . . . 0.28999999999999998 109.101 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.02 150.6 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -1.149 . . . . 0.93999999999999995 109.242 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 5' ' ' CYS . 89.3 m -93.96 94.0 8.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -0.806 . . . . 0.28999999999999998 110.078 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -96.18 128.97 35.01 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.176 -0.952 . . . . 0.38 108.846 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.3 Cg_endo -77.76 178.34 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.558 2.172 . . . . 0.39000000000000001 110.57 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mt 61.84 -93.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 1.03 109.703 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.18 168.98 21.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.615 -1.303 . . . . 1.3799999999999999 109.546 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.48 122.95 87.59 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.49 -0.756 . . . . 0.38 109.214 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.22 125.28 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.597 2.198 . . . . 0.47999999999999998 109.936 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 26.9 m -68.76 158.97 84.29 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.251 -0.906 . . . . 0.62 108.906 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.504 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -81.6 10.78 33.86 Favored 'Cis proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.525 -1.448 . . . . 0.54000000000000004 111.641 -0.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.429 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 20.7 ttm -63.32 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 1.02 109.25 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -107.09 149.87 27.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.818 . . . . 0.68999999999999995 109.22 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.99 142.85 47.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.416 -0.802 . . . . 0.90000000000000002 109.255 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.614 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -139.44 39.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.847 . . . . 0.5 109.403 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.6 -169.23 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.986 -1.646 . . . . 0.33000000000000002 108.986 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.9 p -131.43 167.15 19.79 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.234 -1.156 . . . . 0.46000000000000002 109.451 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 54.5 m -139.5 140.46 37.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.28000000000000003 109.441 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 55.64 26.92 9.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.562 -0.711 . . . . 0.81000000000000005 110.05 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.3 -124.35 8.04 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.491 -1.443 . . . . 0.46999999999999997 109.491 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.734 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.0 mmp_? -103.04 -11.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.305 -1.114 . . . . 1.4099999999999999 113.955 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.734 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.1 Cg_endo -72.77 -44.26 0.7 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 CA-C-N 120.061 1.057 . . . . 0.42999999999999999 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.7 t -106.11 155.87 6.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.994 -1.066 . . . . 0.32000000000000001 108.34 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.8 mttp -134.13 164.45 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.88 109.995 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.9 m -90.96 138.04 31.9 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.47 -0.937 . . . . 0.32000000000000001 108.47 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -134.15 133.34 40.89 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.39000000000000001 109.808 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.479 ' HB2' HG12 ' A' ' 24' ' ' ILE . 13.0 ttp180 -150.08 157.65 43.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.75 109.102 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -33.46 33.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.361 -0.837 . . . . 0.67000000000000004 109.236 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 37.6 p90 . . . . . 0 N--CA 1.487 1.394 0 O-C-N 121.36 -0.837 . . . . 1.1100000000000001 108.855 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.568 -0.53 . . . . 0.67000000000000004 109.568 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.34 -47.29 91.85 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.395 -1.482 . . . . 0.73999999999999999 109.395 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.28 -28.91 69.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.219 -1.165 . . . . 1.9199999999999999 109.752 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB2' HG13 ' A' ' 24' ' ' ILE . 19.0 m120 -85.12 -13.33 50.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.034 -1.041 . . . . 0.93999999999999995 109.913 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.68 11.22 64.18 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.757 -1.337 . . . . 0.65000000000000002 109.757 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.799 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -96.02 155.62 21.15 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.072 -1.611 . . . . 0.95999999999999996 109.072 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.37 158.92 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -1.086 . . . . 1.01 109.176 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.454 ' HB3' HG11 ' A' ' 32' ' ' VAL . 83.2 m -77.76 93.63 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.69999999999999996 109.319 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 35' ' ' CYS . 1.4 mt -100.52 123.3 46.64 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.321 -0.862 . . . . 0.60999999999999999 108.986 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 33.9 Cg_endo -78.62 174.2 12.63 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.504 2.136 . . . . 0.68000000000000005 110.04 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 53.49 -126.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.91 -0.774 . . . . 1.4299999999999999 108.91 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.77 164.94 11.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.422 -1.424 . . . . 1.71 109.065 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -114.11 154.26 46.18 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.284 -0.885 . . . . 0.70999999999999996 109.054 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.8 168.73 23.02 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.719 2.28 . . . . 0.84999999999999998 110.651 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.23 153.93 91.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.677 . . . . 0.88 109.418 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -80.56 10.1 29.9 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.413 -1.494 . . . . 0.65000000000000002 111.344 -0.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttp 59.47 59.37 2.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.917 . . . . 1.6399999999999999 109.341 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 2.9 tpp180 -90.02 89.08 7.54 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.391 -0.966 . . . . 1.24 108.391 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.19 123.57 24.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 1.6899999999999999 109.815 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.799 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -128.06 34.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.491 -0.755 . . . . 1.1000000000000001 109.041 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 179.53 22.96 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.404 -1.479 . . . . 0.70999999999999996 109.404 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.4 p -126.79 165.12 19.91 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -1.115 . . . . 0.82999999999999996 109.386 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.644 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -134.39 131.09 37.81 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.212 -0.93 . . . . 0.63 109.628 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 56.36 34.68 24.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.719 -0.613 . . . . 1.0800000000000001 110.24 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.507 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.27 -133.89 11.71 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.47 -1.452 . . . . 0.71999999999999997 109.47 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -101.73 -2.18 0.1 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.324 -1.104 . . . . 2.21 113.888 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.7 Cg_endo -74.56 -45.22 0.33 Allowed 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 120.239 1.121 . . . . 0.5 109.821 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.8 t -108.69 149.59 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.51000000000000001 108.093 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.94 -1.1 . . . . 0.64000000000000001 109.653 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 37.1 m -89.97 83.95 6.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.449 -0.945 . . . . 0.71999999999999997 108.449 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.3 m -97.44 141.76 30.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.272 -0.892 . . . . 0.39000000000000001 109.71 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 4.6 ttp180 -108.17 151.83 25.39 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.775 -0.824 . . . . 1.3200000000000001 108.775 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 18.78 13.4 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.381 -0.824 . . . . 1.28 109.525 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.486 1.327 0 O-C-N 121.202 -0.936 . . . . 1.78 108.505 179.734 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 108.487 -0.931 . . . . 0.44 108.487 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.56 -24.51 73.9 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.185 -1.166 . . . . 0.54000000000000004 110.185 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -55.88 -47.33 77.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.88 109.871 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.571 ' CB ' HG13 ' A' ' 24' ' ' ILE . 13.2 m120 -110.07 6.18 22.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.71999999999999997 110.094 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . 66.77 51.44 40.81 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.51 -1.436 . . . . 0.48999999999999999 109.51 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.34 -161.4 9.07 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.985 -1.646 . . . . 0.40999999999999998 108.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.33 140.85 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -1.234 . . . . 0.92000000000000004 109.29 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 58.0 m -83.05 85.6 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.767 . . . . 0.45000000000000001 109.053 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -98.77 126.65 38.01 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.236 -0.915 . . . . 0.64000000000000001 109.346 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.5 Cg_endo -79.66 179.46 6.3 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.629 2.219 . . . . 0.60999999999999999 110.081 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt 51.05 -136.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.987 -0.746 . . . . 0.88 108.987 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.32 139.55 40.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.726 -1.234 . . . . 1.0700000000000001 109.326 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 9.6 m -84.66 159.72 57.6 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.226 -0.921 . . . . 0.52000000000000002 109.073 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 35.1 Cg_endo -78.34 168.28 21.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.657 2.238 . . . . 0.53000000000000003 110.305 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.608 HG13 ' HA ' ' A' ' 20' ' ' PRO . 2.6 t -58.39 145.69 74.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.231 -0.655 . . . . 0.82999999999999996 109.231 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HA ' HG13 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -79.89 -7.09 40.69 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.546 -1.439 . . . . 0.56999999999999995 111.378 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 ttm 63.18 77.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.301 -0.874 . . . . 1.1000000000000001 110.119 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HD2' ' CD2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -105.54 93.58 4.74 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.099 -1.001 . . . . 0.76000000000000001 108.867 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.87 121.45 20.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 1.23 109.106 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.571 HG13 ' CB ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -124.35 14.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.68999999999999995 110.077 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.06 40.47 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.34999999999999998 109.095 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 35.8 p -115.95 167.65 10.78 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.129 -1.218 . . . . 0.46000000000000002 109.405 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 71.9 m -139.38 129.54 25.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.863 . . . . 0.39000000000000001 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HD2' HG21 ' A' ' 32' ' ' VAL . 14.5 m-85 54.4 43.94 29.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 1.04 109.96 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.511 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.08 -140.18 14.92 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.068 -1.613 . . . . 0.56000000000000005 109.068 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -102.67 0.22 0.1 OUTLIER Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.3 -1.117 . . . . 1.73 113.676 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.2 Cg_endo -75.57 -46.62 0.2 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-N 120.168 1.096 . . . . 0.65000000000000002 110.058 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.2 t -103.82 155.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.218 -1.03 . . . . 0.40999999999999998 108.218 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -139.4 160.66 39.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.68999999999999995 109.593 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 64.6 m -89.97 103.06 15.76 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.371 -0.974 . . . . 0.37 108.371 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.9 m -102.71 153.8 19.78 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 0.42999999999999999 109.853 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB3' ' CE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -135.61 176.24 8.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.236 -1.024 . . . . 1.24 108.236 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.403 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -140.77 70.89 1.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.73999999999999999 110.014 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.463 ' CE3' ' HB3' ' A' ' 36' ' ' ARG . 5.7 p90 . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.113 -0.992 . . . . 0.93000000000000005 108.52 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 121.06 0.457 . . . . 0.66000000000000003 109.909 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.76 -45.08 66.8 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.2 -1.56 . . . . 0.52000000000000002 109.2 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -63.59 -49.64 72.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.958 . . . . 1.5600000000000001 109.236 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.29 -34.31 76.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.541 -0.724 . . . . 1.23 109.399 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.58 32.15 28.33 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.305 -1.518 . . . . 0.62 109.305 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -115.13 178.21 17.71 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.273 -1.531 . . . . 0.51000000000000001 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.89 135.13 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.93000000000000005 109.019 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 51.1 m -79.97 90.03 5.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.411 -0.806 . . . . 0.45000000000000001 109.032 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 35' ' ' CYS . 12.1 mt -104.16 126.14 32.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.309 -0.869 . . . . 0.57999999999999996 109.404 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.4 Cg_endo -78.65 174.84 11.74 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.66 2.24 . . . . 0.51000000000000001 110.106 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 51.37 -129.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.143 -0.688 . . . . 1.0900000000000001 109.143 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.61 149.64 29.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.536 -1.352 . . . . 1.0 109.458 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 3.0 m -101.59 162.84 19.19 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.342 -0.849 . . . . 0.40000000000000002 109.07 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.6 Cg_endo -78.19 167.5 23.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.516 2.144 . . . . 0.65000000000000002 109.999 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.98 152.2 84.14 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.505 -0.747 . . . . 0.62 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.89 -5.67 32.83 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.361 -1.516 . . . . 0.53000000000000003 111.191 -0.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.1 ttm 60.36 58.49 2.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.97999999999999998 109.61 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -90.04 93.85 9.55 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.172 -0.955 . . . . 1.0800000000000001 108.89 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.3 112.77 5.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.366 -0.833 . . . . 1.72 109.897 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.574 HD11 ' HA3' ' A' ' 10' ' ' GLY . 3.5 pt -104.14 -1.38 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.827 . . . . 0.59999999999999998 109.49 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.12 -168.34 40.11 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.989 -1.645 . . . . 0.39000000000000001 108.989 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.3 p -122.08 168.61 11.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.274 -1.133 . . . . 0.56000000000000005 109.41 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 81.0 m -138.09 126.37 23.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.46000000000000002 109.589 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 55.84 36.94 28.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.679 -0.638 . . . . 0.93000000000000005 110.072 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.532 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -137.38 13.38 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.677 -1.369 . . . . 0.59999999999999998 109.677 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -99.45 -3.12 0.11 Allowed Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 113.859 1.059 . . . . 1.3700000000000001 113.859 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.6 Cg_endo -74.84 -46.95 0.22 Allowed 'Trans proline' 0 C--N 1.325 -0.688 0 CA-C-N 120.299 1.143 . . . . 0.5 110.034 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 5.3 t -107.49 150.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.993 -1.114 . . . . 0.37 107.993 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -134.44 162.65 31.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.87 -1.144 . . . . 0.71999999999999997 109.865 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 56.3 m -90.4 88.98 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.944 -0.761 . . . . 0.34999999999999998 108.944 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HB2' HD12 ' A' ' 13' ' ' ILE . 95.4 m -91.55 136.01 33.44 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.123 -0.986 . . . . 0.37 109.533 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -105.71 147.51 28.47 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.299 -0.876 . . . . 1.0800000000000001 109.053 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -86.05 -12.44 50.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.792 . . . . 0.62 109.245 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 117.602 -1.19 . . . . 1.1100000000000001 108.401 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 7' ' ' ARG . 34.7 t . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 108.727 -0.842 . . . . 0.5 108.727 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.09 -2.26 77.47 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.267 -0.968 . . . . 0.81000000000000005 111.018 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.451 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -58.75 -60.35 3.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.833 -1.392 . . . . 1.6599999999999999 109.637 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.483 ' HB2' HD13 ' A' ' 24' ' ' ILE . 22.6 m120 -133.61 35.93 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.158 -0.964 . . . . 1.26 109.483 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.19 59.53 9.86 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.454 -1.459 . . . . 0.68999999999999995 109.454 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.627 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -132.83 -167.71 11.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.173 -1.571 . . . . 0.47999999999999998 109.173 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.03 151.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.197 -1.178 . . . . 0.79000000000000004 109.276 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' HB3' HG11 ' A' ' 32' ' ' VAL . 67.9 m -91.42 97.97 11.41 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.994 -0.743 . . . . 0.41999999999999998 108.994 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 17' ' ' CYS . 3.3 mt -100.28 127.97 31.74 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.394 -0.816 . . . . 0.59999999999999998 109.02 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.2 Cg_endo -76.76 163.51 31.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.422 2.081 . . . . 0.55000000000000004 110.147 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.9 mm 61.46 -94.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.728 -0.607 . . . . 0.72999999999999998 109.374 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.92 165.24 31.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.759 -1.213 . . . . 1.46 109.201 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.599 ' HB3' HD12 ' A' ' 13' ' ' ILE . 2.3 m -109.72 163.69 16.5 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.48999999999999999 109.064 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 33.9 Cg_endo -76.73 160.38 34.48 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.543 2.162 . . . . 0.68999999999999995 110.086 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 24.7 m -64.82 152.49 90.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.77000000000000002 109.347 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.587 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 34.6 Cg_endo -77.06 -8.27 30.4 Favored 'Cis proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.254 -1.561 . . . . 0.57999999999999996 111.219 0.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 46.2 ttp 58.89 84.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.419 -0.801 . . . . 1.3700000000000001 110.501 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER -94.34 96.61 9.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.892 -1.13 . . . . 0.72999999999999998 108.38 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 130.8 46.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.529 -0.732 . . . . 1.4399999999999999 109.481 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.543 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -139.56 34.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.628 -0.67 . . . . 0.48999999999999999 109.38 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.7 -177.77 19.0 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.347 -1.501 . . . . 0.35999999999999999 109.347 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.4 p -132.58 164.49 26.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.238 -1.154 . . . . 0.57999999999999996 109.084 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 21.9 m -131.85 138.78 48.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.187 -0.945 . . . . 0.40999999999999998 109.607 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 57.9 32.26 21.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.894 -0.504 . . . . 0.88 109.96 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.45 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.46 -128.96 9.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.153 -1.579 . . . . 0.47999999999999998 109.153 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.42 0.82 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -1.145 . . . . 1.3600000000000001 113.645 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.5 Cg_endo -74.97 -43.88 0.37 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 CA-C-N 120.328 1.153 . . . . 0.54000000000000004 110.058 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 15.9 t -107.91 147.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.097 -1.075 . . . . 0.42999999999999999 108.097 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.8 mttp -126.58 158.51 36.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.81999999999999995 109.926 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 73.7 m -92.48 118.14 30.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.479 -0.934 . . . . 0.38 108.479 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -122.83 138.48 54.63 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.34999999999999998 109.534 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 6.8 ttm180 -141.81 -171.55 3.37 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.588 -0.893 . . . . 1.02 108.588 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER 52.29 53.64 12.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.604 -0.685 . . . . 0.63 109.252 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.587 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.0 p90 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.99 -1.005 . . . . 1.26 108.994 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 75.9 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.8 -0.444 . . . . 0.44 109.8 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.94 -25.91 54.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.004 -1.239 . . . . 0.46999999999999997 110.004 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HD2' ' HA3' ' A' ' 25' ' ' GLY . 4.3 ptp180 -52.63 -34.85 53.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.292 -1.123 . . . . 0.76000000000000001 110.185 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB2' HD12 ' A' ' 24' ' ' ILE . 38.3 m-80 -136.94 16.35 3.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.982 -1.074 . . . . 0.66000000000000003 110.351 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.66 62.0 6.8 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.781 -1.328 . . . . 0.46999999999999997 109.781 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -128.0 -151.26 7.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.331 -1.508 . . . . 0.42999999999999999 109.331 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.02 143.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.75 109.248 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.428 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.3 m -82.65 87.65 6.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.44 -0.787 . . . . 0.41999999999999998 108.993 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 17' ' ' CYS . 3.7 mt -100.06 123.14 48.14 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.211 -0.931 . . . . 0.46000000000000002 109.198 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.2 Cg_endo -79.31 172.14 15.06 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.756 2.304 . . . . 0.60999999999999999 110.378 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mm 58.85 -93.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.367 -0.605 . . . . 1.0700000000000001 109.367 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 -178.84 5.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.671 -1.268 . . . . 1.5800000000000001 108.804 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.543 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -131.64 162.39 56.53 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.213 -0.929 . . . . 0.56000000000000005 109.026 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -77.31 163.88 29.62 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.494 2.129 . . . . 0.77000000000000002 109.813 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.9 150.91 75.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.773 . . . . 0.91000000000000003 109.353 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.624 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.71 -2.1 33.9 Favored 'Cis proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.41 -1.496 . . . . 0.62 111.455 0.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.3 ttp 60.84 65.19 1.05 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.143 -0.973 . . . . 1.3500000000000001 109.345 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.04 105.58 17.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.078 -1.014 . . . . 1.1699999999999999 109.454 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.84 123.26 23.03 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.892 . . . . 1.28 109.092 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.705 HD11 ' HA3' ' A' ' 10' ' ' GLY . 11.4 pt -123.63 -0.33 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.468 -0.77 . . . . 0.91000000000000003 110.077 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 34' ' ' CYS . . . 169.52 -171.21 43.1 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.972 -1.651 . . . . 0.46000000000000002 108.972 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.9 p -124.37 164.72 19.06 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.263 -1.139 . . . . 0.60999999999999999 109.383 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -135.3 132.7 38.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.257 -0.902 . . . . 0.39000000000000001 109.531 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 56.66 34.0 23.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.77000000000000002 110.109 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.508 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.87 -134.32 11.83 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.502 -1.439 . . . . 0.48999999999999999 109.502 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -100.38 -4.0 0.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.387 -1.067 . . . . 1.3799999999999999 113.803 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.81 -48.65 0.18 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 CA-C-N 120.23 1.118 . . . . 0.62 110.074 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.3 t -101.2 148.98 6.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.021 -1.103 . . . . 0.44 108.021 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 18.4 mtmm -128.38 170.35 13.21 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.989 -1.069 . . . . 0.67000000000000004 109.542 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.609 ' HB3' HG13 ' A' ' 24' ' ' ILE . 46.7 m -100.52 105.12 16.52 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.397 -0.964 . . . . 0.46999999999999997 108.397 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -106.23 146.37 30.39 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.38 109.237 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HD3' HD13 ' A' ' 24' ' ' ILE . 3.0 ttp180 -138.67 161.21 37.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.83999999999999997 109.046 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.624 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.54 -24.79 20.52 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.4 -0.813 . . . . 0.81000000000000005 109.271 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 42.9 p90 . . . . . 0 C--N 1.305 -1.355 0 O-C-N 121.314 -0.866 . . . . 1.1000000000000001 108.71 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.428 -0.582 . . . . 0.46000000000000002 109.428 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 150.7 16.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.519 -1.433 . . . . 0.52000000000000002 109.519 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -27.06 68.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 2.0099999999999998 109.337 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -68.84 -52.8 26.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -0.839 . . . . 0.68999999999999995 109.235 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 119.67 58.66 0.25 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.329 -1.509 . . . . 0.48999999999999999 109.329 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -98.36 164.83 21.32 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.318 -1.513 . . . . 0.44 109.318 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.68 153.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.337 -1.096 . . . . 0.76000000000000001 108.777 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.471 ' HB3' HG11 ' A' ' 32' ' ' VAL . 72.1 m -77.65 87.3 3.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.403 -0.811 . . . . 0.39000000000000001 109.236 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.614 HD12 ' HB3' ' A' ' 17' ' ' CYS . 4.6 mt -111.46 115.81 51.41 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.348 -0.845 . . . . 0.5 109.275 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.709 ' HB3' HG22 ' A' ' 32' ' ' VAL . 35.0 Cg_endo -78.85 172.17 15.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.636 2.224 . . . . 0.52000000000000002 110.492 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.0 mm 60.48 -92.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.536 -0.542 . . . . 1.22 109.536 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -133.62 176.8 8.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.714 -1.241 . . . . 1.6200000000000001 109.127 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.614 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -135.79 162.33 57.58 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.19 -0.944 . . . . 0.39000000000000001 109.069 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.99 165.91 25.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.581 2.187 . . . . 0.46000000000000002 109.926 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.36 153.08 87.27 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.55000000000000004 109.394 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -79.65 4.15 34.08 Favored 'Cis proline' 0 C--N 1.309 -1.524 0 C-N-CA 123.372 -1.512 . . . . 0.40999999999999998 111.315 0.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.9 ttp 61.02 56.49 2.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 1.0900000000000001 109.692 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -89.87 89.65 7.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.044 -1.035 . . . . 0.71999999999999997 108.47 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.21 121.48 19.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.376 -0.827 . . . . 0.68000000000000005 109.451 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.479 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -129.16 35.18 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.429 -0.794 . . . . 0.56000000000000005 109.412 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.33 -172.23 26.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.421 -1.472 . . . . 0.37 109.421 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.7 p -141.19 162.11 36.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 0.40999999999999998 109.261 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 56.8 m -120.23 146.33 46.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.101 -0.999 . . . . 0.39000000000000001 109.818 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 55.08 41.29 31.84 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.147 0.499 . . . . 0.79000000000000004 109.838 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.61 -134.89 12.19 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.46 -1.856 . . . . 0.58999999999999997 108.46 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.733 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.2 mmm180 -108.61 9.11 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.208 -1.172 . . . . 1.1599999999999999 113.391 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 36.0 Cg_endo -77.17 -47.12 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 CA-C-N 120.12 1.078 . . . . 0.51000000000000001 110.079 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 14' ' ' PRO . 48.2 t -98.6 148.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.38 108.268 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -118.68 153.26 34.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.032 -1.042 . . . . 0.60999999999999999 109.965 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 m -94.21 85.19 4.59 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.532 -0.914 . . . . 0.34999999999999998 108.532 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -93.32 136.2 33.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.96 . . . . 0.35999999999999999 110.083 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -91.92 136.59 33.04 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.366 -0.976 . . . . 1.1299999999999999 108.366 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.63 23.14 4.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.83999999999999997 109.566 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.91000000000000003 108.106 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 109.352 -0.611 . . . . 0.47999999999999998 109.352 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.34 -21.88 70.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.816 -1.313 . . . . 0.96999999999999997 109.816 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -42.99 74.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 1.73 109.627 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.41 ' CB ' HG13 ' A' ' 24' ' ' ILE . 86.6 m-20 -108.69 4.66 24.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 1.0800000000000001 110.017 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.7 41.28 99.85 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.551 -1.42 . . . . 0.56999999999999995 109.551 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -119.25 162.95 13.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.439 -1.464 . . . . 0.45000000000000001 109.439 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.59 154.43 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.351 -1.088 . . . . 0.51000000000000001 109.073 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.572 ' HB3' HG11 ' A' ' 32' ' ' VAL . 97.7 m -96.01 98.27 10.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.186 -0.946 . . . . 0.38 109.422 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.802 HD12 ' HB3' ' A' ' 17' ' ' CYS . 1.6 mt -105.45 127.21 29.02 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.346 -0.846 . . . . 0.5 109.087 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.88 165.65 24.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.567 2.178 . . . . 0.51000000000000001 110.603 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mt 61.89 -92.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.834 -0.541 . . . . 1.23 109.691 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.66 160.04 43.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.579 -1.325 . . . . 1.8300000000000001 108.818 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.802 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -110.56 159.04 33.75 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.157 -0.964 . . . . 0.39000000000000001 109.435 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.69 172.1 15.64 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.731 2.287 . . . . 0.58999999999999997 110.199 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 20' ' ' PRO . 3.6 t -58.51 145.52 76.07 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.066 -0.716 . . . . 0.77000000000000002 109.066 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.646 ' HA ' HG13 ' A' ' 19' ' ' VAL . 36.3 Cg_endo -80.33 -9.77 40.5 Favored 'Cis proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.596 -1.418 . . . . 0.51000000000000001 111.481 -0.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 33.1 ttp 62.64 63.71 0.97 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 1.49 109.347 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -89.88 92.75 9.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.106 -0.996 . . . . 0.87 108.684 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.04 122.2 20.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 1.3899999999999999 109.559 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -126.53 25.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.064 -0.717 . . . . 0.65000000000000002 109.064 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 -171.74 27.47 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.609 -1.796 . . . . 0.35999999999999999 108.609 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.1 p -137.83 168.88 18.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.986 -1.302 . . . . 0.51000000000000001 109.697 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 17.9 m -129.32 142.33 50.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.371 -0.83 . . . . 0.41999999999999998 109.553 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 58.31 34.34 23.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.91 -0.494 . . . . 0.88 110.095 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.465 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.22 10.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.03 -1.628 . . . . 0.67000000000000004 109.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.88 5.02 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.166 -1.197 . . . . 1.73 113.517 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -76.1 -47.52 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 CA-C-N 120.253 1.126 . . . . 0.57999999999999996 109.969 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 12' ' ' CYS . 13.0 t -102.19 151.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.134 -0.979 . . . . 0.46000000000000002 108.496 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -124.41 157.17 35.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.91000000000000003 110.218 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 88.7 m -93.59 96.4 9.83 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.729 -0.841 . . . . 0.44 108.729 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.5 m -102.51 149.07 24.77 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.045 -1.034 . . . . 0.39000000000000001 109.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.582 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 2.9 ttp180 -136.98 166.44 23.66 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.924 -0.769 . . . . 0.59999999999999998 108.924 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -26.54 18.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.452 -0.78 . . . . 0.64000000000000001 108.962 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.777 -1.106 . . . . 0.81000000000000005 108.717 179.729 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 4.0 m . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.279 -0.637 . . . . 0.75 109.279 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.37 -42.21 96.13 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.749 -1.341 . . . . 0.58999999999999997 109.749 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.7 mmm180 -65.08 -32.84 74.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.122 -1.222 . . . . 1.8799999999999999 108.934 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.535 ' CB ' HG13 ' A' ' 24' ' ' ILE . 2.6 m120 -81.17 -25.22 36.98 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.416 -0.803 . . . . 1.0600000000000001 109.129 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.33 37.24 11.19 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.574 -1.41 . . . . 0.68000000000000005 109.574 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -138.83 -160.48 8.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.178 -1.569 . . . . 0.56000000000000005 109.178 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.57 157.48 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.228 -1.16 . . . . 1.1000000000000001 109.138 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 56.0 m -87.11 92.14 8.95 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.358 -0.839 . . . . 0.81000000000000005 109.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 17' ' ' CYS . 8.3 mt -101.38 123.65 43.84 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.344 -0.847 . . . . 0.68999999999999995 109.31 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.607 ' HB3' HG22 ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.21 172.11 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.792 2.328 . . . . 0.68000000000000005 110.274 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.4 mm 54.92 -116.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.947 -0.76 . . . . 0.72999999999999998 108.947 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.31 161.36 19.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.592 -1.317 . . . . 1.45 109.241 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.44 165.14 13.39 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.391 -0.818 . . . . 0.62 109.228 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.03 164.03 27.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.666 2.244 . . . . 0.81000000000000005 110.021 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -59.75 147.82 77.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 109.195 -0.669 . . . . 1.1599999999999999 109.195 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.5 Cg_endo -80.61 -2.97 42.93 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.457 -1.476 . . . . 0.73999999999999999 111.18 -0.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.9 ttm 63.26 59.08 1.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 1.1200000000000001 109.849 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -90.36 104.24 16.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.16 -0.963 . . . . 1.04 108.869 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 122.71 23.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.345 -0.847 . . . . 1.3200000000000001 109.241 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.627 HD12 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -122.48 22.82 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.458 -0.776 . . . . 0.76000000000000001 109.524 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 153.72 -176.18 31.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.787 -1.725 . . . . 0.59999999999999998 108.787 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 10.5 p -129.04 164.54 23.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -1.154 . . . . 0.95999999999999996 109.688 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.656 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 59.6 m -134.94 136.94 42.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.82999999999999996 109.862 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 53.34 37.81 26.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.838 -0.539 . . . . 1.4399999999999999 110.168 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.44 -132.94 11.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.371 -1.492 . . . . 1.0600000000000001 109.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.5 mmp_? -105.28 -1.73 0.11 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.312 -1.111 . . . . 1.21 113.667 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -74.96 -44.93 0.31 Allowed 'Trans proline' 0 C--N 1.327 -0.601 0 CA-C-N 120.192 1.104 . . . . 0.83999999999999997 110.246 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 12.1 t -106.22 148.92 10.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.62 108.157 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -134.17 165.27 25.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.70999999999999996 110.299 -178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HB3' HG12 ' A' ' 24' ' ' ILE . 69.3 m -90.06 93.25 9.31 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 0.56000000000000005 108.645 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 13' ' ' ILE . 4.0 m -95.06 143.27 26.65 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.12 -0.987 . . . . 0.51000000000000001 109.387 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HD3' HD12 ' A' ' 24' ' ' ILE . 6.3 ttp180 -121.89 152.04 40.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 1.3100000000000001 108.89 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.616 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.48 -3.73 57.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.432 -0.793 . . . . 1.46 109.982 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 117.626 -1.178 . . . . 1.48 108.516 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.475 -0.565 . . . . 0.37 109.475 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.21 68.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.072 -1.061 . . . . 0.54000000000000004 110.487 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.4 ttm105 -54.71 -49.2 71.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.958 -1.319 . . . . 0.84999999999999998 109.808 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -114.61 27.7 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.87 109.613 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.32 44.08 96.81 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.475 -1.45 . . . . 0.48999999999999999 109.475 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.633 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -101.21 159.81 18.64 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.269 -1.532 . . . . 0.34999999999999998 109.269 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.4 145.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.273 -1.133 . . . . 0.91000000000000003 108.824 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.482 ' HB3' HG11 ' A' ' 32' ' ' VAL . 93.3 m -77.29 88.67 3.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.40999999999999998 109.114 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 35' ' ' CYS . 4.8 mt -101.33 122.02 49.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.283 -0.886 . . . . 0.47999999999999998 109.239 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.1 Cg_endo -79.06 173.35 13.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.444 2.096 . . . . 0.44 109.718 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.84 -121.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.565 -0.709 . . . . 0.93000000000000005 109.327 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.28 161.81 14.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.787 -1.196 . . . . 2.2200000000000002 109.772 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.45 152.51 47.12 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.395 -0.816 . . . . 0.42999999999999999 108.819 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.33 165.23 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.474 2.116 . . . . 0.5 110.66 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.44 155.38 75.35 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.783 -0.573 . . . . 0.57999999999999996 109.732 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.31 13.65 21.49 Favored 'Cis proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.438 -1.484 . . . . 0.48999999999999999 111.435 -0.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 ttp 59.19 57.22 3.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 1.25 109.237 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -90.04 89.55 7.75 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.544 -0.91 . . . . 0.93000000000000005 108.544 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.1 124.59 27.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.62 109.839 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.633 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -127.57 28.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.45 -0.781 . . . . 0.41999999999999998 109.232 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -170.23 30.26 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.181 -1.568 . . . . 0.39000000000000001 109.181 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.6 p -140.42 165.43 27.45 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.258 -1.143 . . . . 0.59999999999999998 109.584 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.628 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.5 m -132.62 142.11 48.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -0.903 . . . . 0.47999999999999998 109.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 54.71 33.98 20.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.814 -0.554 . . . . 1.0800000000000001 110.193 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.468 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -130.66 10.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.451 -1.46 . . . . 0.62 109.451 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.738 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -104.19 -2.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.429 -1.042 . . . . 1.21 113.707 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.738 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.54 -47.59 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 120.339 1.157 . . . . 0.51000000000000001 110.159 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.628 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 10.9 t -101.47 146.64 9.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.942 -1.132 . . . . 0.45000000000000001 107.942 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 158.72 36.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.918 -1.113 . . . . 0.5 110.058 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.2 m -89.98 79.26 6.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.28999999999999998 108.05 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.502 ' HB2' HD12 ' A' ' 13' ' ' ILE . 3.9 m -93.48 145.24 24.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.355 -0.841 . . . . 0.31 109.684 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -114.78 151.99 32.86 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.451 -0.78 . . . . 1.22 108.978 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.89 15.71 21.42 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.387 -0.821 . . . . 0.73999999999999999 109.283 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 117.777 -1.106 . . . . 0.91000000000000003 108.469 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.994 0.426 . . . . 0.5 110.554 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.16 30.0 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.619 -1.792 . . . . 1.1699999999999999 108.619 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.98 -36.66 48.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.411 -1.052 . . . . 2.3900000000000001 108.858 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -64.97 -25.99 68.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 1.3 109.307 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.27 56.01 3.12 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.747 -1.741 . . . . 0.95999999999999996 108.747 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -147.01 153.78 25.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.965 -1.654 . . . . 0.39000000000000001 108.965 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.95 141.72 13.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.237 -1.155 . . . . 0.59999999999999998 109.518 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.405 ' HB3' HG11 ' A' ' 32' ' ' VAL . 87.8 m -88.3 84.01 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.37 109.308 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 17.0 mt -96.09 136.22 22.24 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.181 -0.949 . . . . 0.47999999999999998 108.887 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 33.9 Cg_endo -76.63 172.27 16.53 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.427 2.085 . . . . 0.51000000000000001 110.131 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.9 mm 61.49 -99.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 170.38 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.598 -1.314 . . . . 1.1200000000000001 109.085 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.623 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 4.6 m -96.01 134.31 24.02 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.893 . . . . 0.54000000000000004 109.556 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.24 138.82 16.28 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.575 2.184 . . . . 0.72999999999999998 109.764 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.26 155.69 78.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.817 . . . . 0.65000000000000002 109.198 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.58 2.72 35.11 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.494 -1.461 . . . . 0.57999999999999996 111.459 0.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.461 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 26.6 ttm -67.48 113.85 5.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.833 -1.167 . . . . 0.96999999999999997 109.137 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.71 176.6 5.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.98999999999999999 109.571 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.623 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -82.67 142.72 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.85999999999999999 109.241 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.611 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -138.83 33.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.55000000000000004 109.369 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 142.56 -167.82 26.07 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.166 -1.574 . . . . 0.41999999999999998 109.166 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 9.9 p -131.2 163.91 26.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.203 -1.175 . . . . 0.63 109.493 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 m -133.32 140.58 47.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.243 -0.91 . . . . 0.45000000000000001 109.677 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.481 ' HD2' HG21 ' A' ' 32' ' ' VAL . 18.0 m-85 51.23 41.84 28.27 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.176 0.512 . . . . 0.68000000000000005 109.934 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 93.55 -134.86 12.3 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.02 -1.632 . . . . 0.55000000000000004 109.02 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.2 mmp_? -105.29 -0.16 0.1 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.215 -1.168 . . . . 1.48 113.471 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.7 Cg_endo -74.74 -47.44 0.22 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 120.263 1.13 . . . . 0.57999999999999996 110.337 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.481 HG21 ' HD2' ' A' ' 28' ' ' PHE . 18.1 t -100.87 156.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.073 -1.017 . . . . 0.47999999999999998 108.334 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -129.2 163.67 25.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.986 -1.071 . . . . 0.69999999999999996 109.925 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HB3' HG13 ' A' ' 24' ' ' ILE . 52.2 m -90.57 131.99 35.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.357 -0.979 . . . . 0.39000000000000001 108.357 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.7 m -121.33 133.54 55.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.029 -1.044 . . . . 0.46000000000000002 109.663 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.608 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.32 146.85 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.727 -0.842 . . . . 0.82999999999999996 108.727 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -23.7 21.33 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.276 -0.89 . . . . 0.88 109.401 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 1.0700000000000001 109.148 -179.911 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.637 -0.505 . . . . 0.59999999999999998 109.637 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.96 -45.03 59.19 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.911 -1.675 . . . . 0.64000000000000001 108.911 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -33.43 75.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -1.074 . . . . 1.52 108.93 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.64 -27.88 64.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.33 -0.856 . . . . 0.93999999999999995 109.186 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.76 48.27 5.29 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.26 -1.536 . . . . 0.53000000000000003 109.26 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.715 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -154.01 157.39 27.44 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.159 -1.576 . . . . 0.51000000000000001 109.159 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 m -93.89 150.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -1.12 . . . . 0.73999999999999999 109.416 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.706 ' HB3' HG11 ' A' ' 32' ' ' VAL . 54.2 m -88.54 101.36 13.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.421 -0.8 . . . . 0.57999999999999996 109.392 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.59 HG22 HG13 ' A' ' 15' ' ' ILE . 15.4 mt -100.58 122.31 49.95 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.322 -0.861 . . . . 0.51000000000000001 109.342 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.508 ' HB3' HG22 ' A' ' 32' ' ' VAL . 36.1 Cg_endo -80.32 31.2 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.827 2.351 . . . . 0.54000000000000004 110.962 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.59 HG13 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -146.23 -153.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.174 -1.047 . . . . 0.75 108.174 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.63 142.84 27.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.035 -1.04 . . . . 1.7 108.972 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -63.22 124.18 83.15 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.47999999999999998 109.849 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.87 119.81 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.687 2.258 . . . . 0.72999999999999998 110.362 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.2 m -65.85 159.88 66.24 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.267 -0.896 . . . . 0.81000000000000005 108.726 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -80.98 8.27 35.9 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 123.614 -1.411 . . . . 0.64000000000000001 111.596 -0.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.671 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 2.0 ttp -60.79 133.99 56.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.925 -1.11 . . . . 1.1299999999999999 108.864 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -101.74 164.91 11.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.1699999999999999 110.039 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.18 151.53 24.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.176 -0.675 . . . . 2.1200000000000001 109.176 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.715 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -148.38 44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.613 -0.679 . . . . 0.55000000000000004 109.488 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.25 -174.62 18.33 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.146 -1.581 . . . . 0.40999999999999998 109.146 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 26.4 p -138.16 166.75 23.36 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.291 -1.123 . . . . 0.68999999999999995 109.415 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 27.0 m -127.03 141.45 51.78 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.155 -0.966 . . . . 0.54000000000000004 109.772 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 56.0 36.65 27.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.877 -0.514 . . . . 0.95999999999999996 110.026 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.34 10.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.81000000000000005 109.043 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -107.98 6.81 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.189 . . . . 1.2 113.472 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.2 Cg_endo -76.6 -46.11 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 120.171 1.097 . . . . 0.71999999999999997 109.782 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 12' ' ' CYS . 73.2 t -104.63 149.49 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.297 -1.001 . . . . 0.41999999999999998 108.297 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.5 mttp -123.69 154.2 39.74 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.093 -1.005 . . . . 0.64000000000000001 109.83 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.1 m -89.97 136.82 32.81 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.445 -0.946 . . . . 0.5 108.445 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.671 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -135.63 133.72 38.52 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.103 -0.998 . . . . 0.46999999999999997 110.09 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.684 ' CD ' HG21 ' A' ' 24' ' ' ILE . 2.6 ptm180 -145.33 143.03 29.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.185 -1.043 . . . . 0.60999999999999999 108.185 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -33.71 16.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.89000000000000001 111.007 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.413 ' OXT' ' HG3' ' A' ' 36' ' ' ARG . 11.3 p-90 . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.018 -1.051 . . . . 0.97999999999999998 109.641 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.158 0.504 . . . . 0.68999999999999995 109.831 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.89 51.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.506 . . . . 0.58999999999999997 109.336 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.11 -44.2 93.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.309 -1.112 . . . . 2.71 109.468 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.506 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 4.3 m120 -80.27 -25.06 39.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.925 . . . . 1.1799999999999999 109.355 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.18 62.8 2.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.78 -1.728 . . . . 0.57999999999999996 108.78 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -152.37 168.54 31.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.23 -1.548 . . . . 0.41999999999999998 109.23 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 t -91.14 143.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.65000000000000002 109.129 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HB3' HG11 ' A' ' 32' ' ' VAL . 92.2 m -86.1 83.98 7.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.305 -0.872 . . . . 0.34000000000000002 109.579 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 6.7 mt -96.24 128.57 36.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.181 -0.95 . . . . 0.5 108.866 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.16 179.07 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.442 2.094 . . . . 0.48999999999999999 110.309 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.6 mt 61.29 -101.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.705 -0.622 . . . . 0.77000000000000002 109.415 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.36 160.91 40.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.615 -1.303 . . . . 1.3600000000000001 109.374 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.84 131.04 68.43 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.854 . . . . 0.48999999999999999 109.435 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.78 120.15 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.625 2.217 . . . . 0.69999999999999996 109.535 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.1 m -57.32 153.48 26.81 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.822 . . . . 0.81999999999999995 109.334 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.85 10.69 30.11 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.606 -1.414 . . . . 0.72999999999999998 111.626 -0.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.5 tpp -61.35 118.78 7.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.929 -1.107 . . . . 1.0800000000000001 108.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 1.5 ptp85 -90.03 175.99 6.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.94999999999999996 109.839 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 132.47 52.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.701 -0.851 . . . . 1.3400000000000001 108.701 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.525 HD11 ' HA3' ' A' ' 10' ' ' GLY . 8.2 pt -120.27 -0.08 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.73999999999999999 110.361 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.63 -159.27 31.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.424 -1.471 . . . . 0.40000000000000002 109.424 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.2 p -137.17 165.34 26.34 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.351 -1.088 . . . . 0.55000000000000004 109.612 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 76.6 m -126.9 148.1 50.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.38 109.228 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 55.02 41.56 31.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.045 -0.724 . . . . 0.73999999999999999 109.045 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 -130.9 10.52 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.938 -2.065 . . . . 0.51000000000000001 107.938 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.731 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.6 mtm180 -113.75 10.48 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.186 -1.185 . . . . 2.6000000000000001 113.341 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.7 Cg_endo -77.56 -45.25 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 120.162 1.093 . . . . 0.5 109.681 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 46.1 t -98.47 154.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.265 -1.013 . . . . 0.35999999999999999 108.265 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mttp -117.91 157.88 25.89 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 1.1100000000000001 110.057 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 81.4 m -97.25 104.34 16.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.494 -0.928 . . . . 0.5 108.494 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.566 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 14.7 m -100.05 143.0 30.77 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.131 -0.981 . . . . 0.44 109.826 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.502 ' HB2' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -143.66 158.69 43.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.519 -0.738 . . . . 0.92000000000000004 109.205 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -27.96 51.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.335 -0.853 . . . . 0.93000000000000005 109.429 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.422 ' CE2' ' HD2' ' A' ' 36' ' ' ARG . 37.0 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.894 -1.05 . . . . 1.3100000000000001 109.264 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 121.383 0.611 . . . . 0.66000000000000003 109.747 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.28 -34.48 69.22 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.217 -1.553 . . . . 1.01 109.217 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -64.1 -23.93 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -1.17 . . . . 1.47 109.762 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.555 ' HB3' HG13 ' A' ' 24' ' ' ILE . 14.8 m120 -103.51 -11.7 17.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.98999999999999999 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.05 32.18 66.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.504 -1.438 . . . . 0.81999999999999995 109.504 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -122.91 164.17 15.99 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.43 -1.468 . . . . 0.47999999999999998 109.43 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.26 154.63 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.41 -1.053 . . . . 0.65000000000000002 109.275 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.551 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.2 m -91.65 93.62 9.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.432 -0.793 . . . . 0.5 109.43 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.591 HD12 ' HB3' ' A' ' 17' ' ' CYS . 4.0 mt -102.18 122.58 46.34 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.291 -0.881 . . . . 0.47999999999999998 108.947 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 166.98 23.57 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.64 2.227 . . . . 0.58999999999999997 110.797 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.1 mt 61.42 -94.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.439 -0.578 . . . . 0.84999999999999998 109.439 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.58 165.7 26.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.799 -1.188 . . . . 1.72 108.928 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.3 m -119.37 163.58 26.16 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.229 -0.92 . . . . 0.46000000000000002 109.509 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.1 Cg_endo -79.16 170.64 17.39 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.671 2.247 . . . . 0.72999999999999998 109.609 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.63 152.19 93.17 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.453 -0.779 . . . . 0.65000000000000002 109.248 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 34.1 Cg_endo -79.13 -5.57 38.05 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.19 -1.587 . . . . 0.63 111.504 0.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.9 ttm 61.85 65.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 1.27 109.648 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -89.91 90.19 8.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.166 -0.959 . . . . 1.46 108.506 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.75 117.64 12.52 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.615 -0.678 . . . . 1.0800000000000001 109.828 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.557 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.24 31.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.881 -0.785 . . . . 0.58999999999999997 108.881 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.35 -167.66 24.66 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.912 -1.675 . . . . 0.42999999999999999 108.912 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 p -141.09 169.01 18.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.242 -1.152 . . . . 0.52000000000000002 109.517 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 78.5 m -126.28 147.6 49.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.295 -0.878 . . . . 0.52000000000000002 109.285 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 58.62 34.38 23.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.659 -0.497 . . . . 1.0600000000000001 109.659 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.505 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 96.73 -134.52 11.83 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.605 -1.798 . . . . 0.64000000000000001 108.605 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.752 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.1 mtp85 -105.02 4.82 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.312 -1.11 . . . . 1.6699999999999999 113.358 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.6 Cg_endo -75.82 -50.28 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 120.137 1.085 . . . . 0.52000000000000002 110.142 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 12' ' ' CYS . 16.2 t -93.47 147.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.01 -1.056 . . . . 0.41999999999999998 108.757 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -115.34 156.61 25.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.206 -0.934 . . . . 0.62 109.83 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 95.8 m -98.95 92.51 5.55 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.369 -0.832 . . . . 0.45000000000000001 108.897 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -99.51 147.34 25.41 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.147 -0.971 . . . . 0.41999999999999998 109.951 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 7.1 ttp180 -130.97 161.12 32.63 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.763 -0.829 . . . . 1.0700000000000001 108.763 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -89.79 -18.68 25.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.325 -0.859 . . . . 0.94999999999999996 109.645 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.9 p90 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 117.713 -1.137 . . . . 1.02 108.734 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 25.1 t . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.681 -0.859 . . . . 0.40000000000000002 108.681 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.43 -24.51 76.7 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.354 -1.098 . . . . 0.73999999999999999 110.354 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -62.21 -48.3 80.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.979 -1.307 . . . . 1.3600000000000001 109.901 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 24' ' ' ILE . 17.9 m120 -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 1.0800000000000001 110.161 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.62 60.31 3.76 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.349 -1.5 . . . . 0.79000000000000004 109.349 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.66 -166.49 16.45 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.894 -1.682 . . . . 0.37 108.894 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.6 m -96.41 172.51 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -1.209 . . . . 0.68000000000000005 109.057 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.487 ' HB3' HG11 ' A' ' 32' ' ' VAL . 21.7 m -125.78 111.17 14.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.34999999999999998 109.572 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.711 HG22 HG13 ' A' ' 15' ' ' ILE . 1.2 mt -98.87 121.85 54.65 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.208 -0.932 . . . . 0.35999999999999999 108.94 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 32' ' ' VAL . 36.4 Cg_endo -79.65 38.26 0.72 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.792 2.328 . . . . 0.48999999999999999 111.494 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.711 HG13 HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -157.31 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.84 -1.162 . . . . 0.57999999999999996 108.942 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -149.97 173.2 14.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 1.49 108.89 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 t -102.95 110.64 63.93 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.388 -0.82 . . . . 0.46999999999999997 108.954 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.69 135.39 11.49 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.597 2.198 . . . . 0.84999999999999998 110.294 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m -67.55 159.46 78.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.379 -0.825 . . . . 0.65000000000000002 108.928 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -79.63 5.29 32.73 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.53 -1.446 . . . . 0.47999999999999998 111.512 0.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.724 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 7.7 tpp -62.74 139.08 58.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.883 -1.136 . . . . 1.45 109.119 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -114.03 147.72 38.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.73999999999999999 109.37 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 144.3 50.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.96999999999999997 109.284 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -138.61 37.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.57999999999999996 109.838 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.63 -173.62 21.97 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.605 -1.398 . . . . 0.44 109.605 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 41.3 p -126.11 163.13 23.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -1.078 . . . . 0.73999999999999999 109.408 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.651 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 34.1 m -128.0 137.54 52.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.37 109.624 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 52.89 43.82 31.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.883 -0.511 . . . . 0.83999999999999997 110.123 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.62 -132.59 11.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.49 -1.844 . . . . 0.63 108.49 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.4 mtm180 -111.54 4.91 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.177 -1.19 . . . . 2.9100000000000001 113.628 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.3 Cg_endo -75.27 -43.51 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.338 1.157 . . . . 0.57999999999999996 109.776 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 49.5 t -107.13 152.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.113 -1.069 . . . . 0.33000000000000002 108.113 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.1 mttp -124.31 156.74 36.44 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.993 -1.067 . . . . 0.64000000000000001 110.133 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 71.9 m -90.0 143.59 26.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.933 -1.136 . . . . 0.32000000000000001 107.933 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 21.8 m -138.81 138.81 37.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.96 -1.088 . . . . 0.34999999999999998 110.021 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -150.11 162.37 40.56 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.433 -0.792 . . . . 0.97999999999999998 109.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -33.98 27.0 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.413 -0.805 . . . . 0.57999999999999996 109.23 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 33.6 p90 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 117.789 -1.1 . . . . 1.01 108.851 179.775 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 109.241 -0.651 . . . . 0.42999999999999999 109.241 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.94 175.74 43.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.093 -1.603 . . . . 0.64000000000000001 109.093 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.02 46.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 1.9299999999999999 109.579 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 24' ' ' ILE . 5.5 m-80 -75.27 -25.48 58.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.79000000000000004 109.953 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.81 65.01 0.95 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.506 -1.438 . . . . 0.56000000000000005 109.506 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . -106.37 -152.97 19.99 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.539 -1.824 . . . . 0.51000000000000001 108.539 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.61 149.39 32.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -1.206 . . . . 0.93000000000000005 108.882 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.2 m -75.0 92.03 2.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.46999999999999997 109.472 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 17' ' ' CYS . 2.3 mt -102.6 125.43 35.91 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.291 -0.881 . . . . 0.58999999999999997 108.939 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.11 173.57 13.74 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.57 2.18 . . . . 0.59999999999999998 110.258 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 54.21 -119.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.957 -0.757 . . . . 1.24 108.957 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.12 154.94 32.45 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.634 -1.291 . . . . 2.4399999999999999 109.068 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.558 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.8 m -101.4 159.72 28.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.318 -0.863 . . . . 0.62 109.329 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 167.67 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.679 2.253 . . . . 1.0600000000000001 110.235 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -60.46 147.23 83.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.81000000000000005 109.294 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.583 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -79.91 -3.05 39.91 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.55 -1.437 . . . . 0.71999999999999997 111.351 -0.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.2 ttm 62.47 56.22 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 1.05 109.629 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -90.17 87.08 6.72 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.176 -0.953 . . . . 2.2599999999999998 108.53 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 7.3 pt20 -71.87 129.57 38.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 1.3400000000000001 109.486 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -130.39 38.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.319 -0.863 . . . . 0.44 108.697 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.76 -179.82 24.35 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.645 -1.782 . . . . 0.39000000000000001 108.645 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.7 p -132.97 160.76 36.18 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.081 -1.246 . . . . 0.65000000000000002 109.816 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.7 m -130.03 140.83 50.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.482 -0.761 . . . . 0.46000000000000002 109.534 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 55.77 37.14 28.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.885 -0.51 . . . . 1.1200000000000001 110.178 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.36 -133.55 11.56 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.487 -1.445 . . . . 0.52000000000000002 109.487 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -103.7 -3.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.2599999999999998 113.71 -179.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.9 Cg_endo -74.85 -43.05 0.45 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.205 1.109 . . . . 0.68999999999999995 110.832 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.6 t -103.81 147.47 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.835 -1.166 . . . . 0.56999999999999995 108.853 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -131.07 156.38 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.011 -1.056 . . . . 0.68999999999999995 110.022 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 55.8 m -90.09 82.18 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.40999999999999998 108.812 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 73.7 m -91.78 140.99 29.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.133 -0.979 . . . . 0.44 109.843 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -110.0 152.21 26.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.625 -0.88 . . . . 0.82999999999999996 108.625 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.583 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.09 -7.95 52.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.316 -0.865 . . . . 0.85999999999999999 110.018 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 25.7 p90 . . . . . 0 N--CA 1.487 1.375 0 O-C-N 121.062 -1.024 . . . . 1.1899999999999999 108.719 -179.911 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.59 -0.522 . . . . 0.41999999999999998 109.59 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.28 -49.8 24.66 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.564 . . . . 0.67000000000000004 109.191 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -74.79 -36.11 62.49 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.19 -1.182 . . . . 2.29 109.254 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.45 -30.41 67.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.80000000000000004 109.366 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.46 50.08 6.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.329 -1.509 . . . . 0.47999999999999998 109.329 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -136.86 -170.69 11.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.347 -1.501 . . . . 0.42999999999999999 109.347 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.3 157.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -1.144 . . . . 0.87 109.25 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.489 ' HB3' HG11 ' A' ' 32' ' ' VAL . 59.2 m -93.23 87.36 5.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.42999999999999999 109.482 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.441 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 8.3 mt -97.14 131.44 27.56 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.46000000000000002 108.92 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.26 172.55 15.82 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.445 2.096 . . . . 0.54000000000000004 110.246 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.9 mm 63.02 -95.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.734 -0.604 . . . . 0.73999999999999999 109.551 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 164.41 35.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.659 -1.275 . . . . 1.71 109.368 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 18.7 m -87.31 132.9 39.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.352 -0.843 . . . . 0.5 109.068 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 34.9 Cg_endo -78.33 132.56 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.501 2.134 . . . . 0.81000000000000005 109.737 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.6 m -63.12 155.02 75.42 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.837 . . . . 0.75 109.132 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.5 7.68 34.39 Favored 'Cis proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.45 -1.479 . . . . 0.66000000000000003 111.621 0.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 18.6 ttm -63.81 121.49 14.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.777 -1.202 . . . . 1.1699999999999999 109.145 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -95.54 177.55 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.68000000000000005 109.491 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.4 tt0 -92.0 147.19 23.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.673 -0.862 . . . . 1.25 108.673 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.643 HD13 ' HD3' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -145.33 42.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.482 -0.761 . . . . 0.55000000000000004 109.716 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.74 -166.61 22.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.38 109.472 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 16.5 p -138.98 166.79 23.56 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.325 -1.103 . . . . 0.56000000000000005 109.176 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 78.6 m -129.0 140.19 51.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.241 -0.912 . . . . 0.47999999999999998 109.921 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 55.53 40.84 31.2 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.763 -0.458 . . . . 0.82999999999999996 109.763 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.58 -130.63 10.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.38 -1.888 . . . . 0.62 108.38 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.73 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -111.8 9.58 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.086 -1.243 . . . . 1.54 113.386 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.73 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.1 Cg_endo -76.55 -50.52 0.1 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 CA-C-N 120.166 1.095 . . . . 0.62 109.766 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 51.2 t -99.31 155.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.196 -1.039 . . . . 0.46999999999999997 108.196 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.2 160.0 26.08 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.963 -1.085 . . . . 0.87 109.892 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 m -93.54 133.78 36.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.954 -1.128 . . . . 0.39000000000000001 107.954 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.456 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 19.5 m -126.04 142.46 51.51 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.088 -1.007 . . . . 0.42999999999999999 109.834 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.643 ' HD3' HD13 ' A' ' 24' ' ' ILE . 4.4 mtp180 -139.03 141.24 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.895 -0.78 . . . . 0.88 108.895 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.25 -22.56 60.38 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.337 -0.852 . . . . 0.60999999999999999 109.739 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.6 p90 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 117.788 -1.101 . . . . 0.79000000000000004 108.943 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 93.4 m . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.244 0.545 . . . . 0.41999999999999998 110.071 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.87 -6.03 89.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.854 -1.298 . . . . 0.64000000000000001 109.854 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -64.18 -60.59 3.02 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.976 -1.308 . . . . 0.80000000000000004 109.542 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.493 ' HB2' HD13 ' A' ' 24' ' ' ILE . 30.6 m120 -119.97 13.12 12.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.157 -0.964 . . . . 1.3600000000000001 110.092 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.31 70.19 1.15 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.635 -1.386 . . . . 0.52000000000000002 109.635 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -127.02 -156.72 9.25 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.057 -1.617 . . . . 0.34999999999999998 109.057 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -1.152 . . . . 0.97999999999999998 109.432 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 65.7 m -84.33 88.99 7.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.536 -0.727 . . . . 0.48999999999999999 109.329 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -97.85 130.05 29.8 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.11 -0.994 . . . . 0.52000000000000002 109.307 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -77.65 178.03 8.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.457 2.105 . . . . 0.59999999999999998 110.047 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.411 HG22 ' HG2' ' A' ' 16' ' ' ARG . 23.5 mm 59.68 -98.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.717 -0.614 . . . . 0.82999999999999996 109.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.411 ' HG2' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -148.94 160.47 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.556 -1.34 . . . . 2.6000000000000001 109.367 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -71.84 146.21 90.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.497 -0.752 . . . . 0.52000000000000002 109.671 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 35.5 Cg_endo -78.53 -165.13 0.31 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.726 2.284 . . . . 0.57999999999999996 110.063 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.44 ' HA ' ' N ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -135.64 140.86 35.1 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.166 -0.959 . . . . 0.77000000000000002 109.588 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.95 109.23 1.39 Allowed 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.183 -1.59 . . . . 0.75 110.53 -1.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.476 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.8 ttm -150.8 118.82 6.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.82 -1.175 . . . . 1.01 108.725 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -93.69 178.64 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 1.6899999999999999 109.616 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.2 144.77 25.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.541 -0.725 . . . . 0.84999999999999998 109.195 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.634 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -142.03 49.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.56000000000000005 109.277 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.49 -174.39 17.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.411 -1.475 . . . . 0.41999999999999998 109.411 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 11.4 p -133.19 166.11 23.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.323 -1.104 . . . . 0.64000000000000001 109.467 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 95.2 m -133.67 136.99 45.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.54000000000000004 109.866 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 56.18 37.59 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.89000000000000001 110.144 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.472 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.98 -132.8 11.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.934 -1.666 . . . . 0.77000000000000002 108.934 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 20.8 mmm-85 -105.98 1.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.284 -1.127 . . . . 1.5700000000000001 113.608 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -75.05 -50.85 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.585 0 CA-C-N 120.217 1.113 . . . . 0.76000000000000001 109.865 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 17.2 t -100.12 150.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.035 -1.098 . . . . 0.54000000000000004 108.035 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 163.33 24.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.01 -1.056 . . . . 0.62 109.728 -179.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.2 m -92.67 130.45 38.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.293 -1.003 . . . . 0.47999999999999998 108.293 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 35.4 m -125.23 141.82 51.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.062 -1.023 . . . . 0.40999999999999998 109.818 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.427 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.8 mtp180 -141.05 134.49 29.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.432 -0.792 . . . . 1.29 108.932 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.86 -26.12 37.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.88 109.551 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.8 p90 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 117.796 -1.097 . . . . 1.0600000000000001 108.822 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.309 -0.626 . . . . 0.67000000000000004 109.309 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.35 -46.58 25.89 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.508 -1.437 . . . . 0.79000000000000004 109.508 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -41.16 99.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -1.118 . . . . 1.8799999999999999 109.651 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -75.65 -25.36 56.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.026 . . . . 0.83999999999999997 109.816 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.21 29.65 12.19 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.631 -1.388 . . . . 0.72999999999999998 109.631 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -103.81 156.52 17.57 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.613 -1.795 . . . . 0.65000000000000002 108.613 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 158.43 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.193 -1.18 . . . . 0.90000000000000002 109.645 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.5 m -79.17 93.18 5.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.521 -0.737 . . . . 0.52000000000000002 109.241 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 17' ' ' CYS . 1.3 mt -101.53 123.74 43.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.357 -0.84 . . . . 0.46999999999999997 109.195 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.49 170.64 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.561 2.174 . . . . 0.64000000000000001 110.137 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt 56.88 -107.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.659 -0.65 . . . . 1.1000000000000001 109.321 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.58 177.58 5.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.56 -1.338 . . . . 1.8600000000000001 109.067 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.646 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -127.31 157.98 70.87 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.205 -0.934 . . . . 0.58999999999999997 109.131 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.73 169.97 19.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.643 2.229 . . . . 0.70999999999999996 109.988 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.54 153.4 95.0 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.81000000000000005 109.33 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -79.48 4.72 32.47 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.378 -1.509 . . . . 0.67000000000000004 111.177 0.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 ttp 61.0 57.77 2.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 1.46 109.805 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -89.93 90.32 8.11 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.195 -0.941 . . . . 1.23 108.591 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 119.41 18.5 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 1.23 109.536 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.714 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.58 31.59 2.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.455 -0.778 . . . . 0.78000000000000003 109.232 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.8 -177.38 26.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.906 -1.678 . . . . 0.59999999999999998 108.906 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 13.1 p -135.31 161.14 36.24 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.145 -1.209 . . . . 0.65000000000000002 109.775 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.8 m -126.18 141.93 51.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.248 -0.908 . . . . 0.55000000000000004 109.705 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 56.26 35.12 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.805 -0.56 . . . . 1.1100000000000001 110.12 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.6 -132.42 11.14 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.083 -1.607 . . . . 0.76000000000000001 109.083 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.75 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -105.16 0.71 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 1.7 113.685 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.75 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.91 -44.2 0.36 Allowed 'Trans proline' 0 C--N 1.327 -0.602 0 CA-C-N 120.247 1.124 . . . . 0.65000000000000002 109.925 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -106.21 146.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.129 -1.063 . . . . 0.57999999999999996 108.129 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -128.03 155.46 44.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.993 -1.067 . . . . 0.73999999999999999 109.937 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.6 m -89.93 81.33 6.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.241 -1.022 . . . . 0.56000000000000005 108.241 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.82 143.33 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.5 109.806 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -103.57 145.44 30.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.598 -0.889 . . . . 0.91000000000000003 108.598 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.9 19.86 9.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.384 -0.822 . . . . 0.84999999999999998 109.466 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 108.173 -1.047 . . . . 1.02 108.173 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 25.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.794 -0.447 . . . . 0.54000000000000004 109.794 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.95 -60.94 1.71 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.038 -1.625 . . . . 0.73999999999999999 109.038 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -69.45 89.81 0.51 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -1.07 . . . . 1.55 108.684 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.08 63.87 2.07 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.864 -0.791 . . . . 1.4099999999999999 108.864 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 5' ' ' CYS . . . -121.23 -62.1 0.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.87 -1.292 . . . . 0.38 109.87 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 36' ' ' ARG . . . 99.03 -97.43 1.84 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.212 -1.555 . . . . 0.40000000000000002 109.212 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.41 141.64 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.103 -1.233 . . . . 0.46999999999999997 109.522 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 58.0 m -82.92 94.45 7.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.40999999999999998 109.206 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.43 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.9 mt -101.7 123.55 43.69 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.174 -0.954 . . . . 0.53000000000000003 109.328 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.5 175.75 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.648 2.232 . . . . 0.51000000000000001 109.912 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 53.75 -120.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.87 -0.789 . . . . 1.1799999999999999 108.87 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -126.18 135.35 51.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.511 -1.368 . . . . 1.24 109.35 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 3.3 m -75.95 161.88 73.92 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.366 -0.834 . . . . 0.41999999999999998 108.91 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.3 Cg_endo -77.02 160.29 33.56 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.512 2.141 . . . . 0.58999999999999997 110.368 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -61.67 147.76 88.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.616 -0.677 . . . . 0.84999999999999998 109.221 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.676 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 35.7 Cg_endo -77.89 -11.98 32.04 Favored 'Cis proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.48 -1.467 . . . . 0.46000000000000002 111.177 -0.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.448 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 43.5 ttp 61.68 86.19 0.11 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 0.93999999999999995 110.286 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.84 89.33 3.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.874 -1.141 . . . . 0.69999999999999996 108.491 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.6 109.89 4.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.58999999999999997 109.226 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.01 -3.74 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.397 -0.815 . . . . 0.5 109.804 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.06 -171.84 31.78 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.988 -1.645 . . . . 0.38 108.988 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 17.1 p -129.55 166.94 18.69 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -1.174 . . . . 0.51000000000000001 109.414 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 97.3 m -138.74 126.17 21.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.46000000000000002 109.519 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 56.12 39.07 30.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.721 -0.612 . . . . 0.88 109.972 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.52 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.62 -136.97 13.16 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.381 -1.487 . . . . 0.62 109.381 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 24.4 mmm180 -101.32 -1.84 0.1 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 1.0800000000000001 113.77 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.39 -52.52 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 CA-C-N 120.24 1.121 . . . . 0.51000000000000001 109.698 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -98.19 148.27 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.397 -1.334 . . . . 0.46000000000000002 107.397 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HD3' ' C ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.71 156.8 45.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.89 -1.131 . . . . 0.35999999999999999 110.282 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.8 m -90.61 97.21 11.05 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.453 -0.943 . . . . 0.40000000000000002 108.453 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.9 m -101.13 142.18 32.94 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.296 -0.878 . . . . 0.37 109.364 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.501 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 5.7 ttp85 -144.49 -172.22 3.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.523 -0.917 . . . . 0.62 108.523 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.08 49.95 18.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.039 -0.726 . . . . 0.46999999999999997 109.039 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.676 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.6 p90 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 118.026 -0.987 . . . . 0.88 109.091 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.909 -0.774 . . . . 1.24 108.909 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.499 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 35.3 Cg_endo -78.68 157.63 28.18 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.579 2.186 . . . . 1.3500000000000001 110.059 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.436 HD12 ' CZ ' ' A' ' 28' ' ' PHE . 1.1 tp 66.82 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.603 -0.517 . . . . 1.1499999999999999 109.603 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.579 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 1.3 m 63.75 -167.62 0.21 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -0.796 . . . . 0.55000000000000004 109.245 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER 69.35 5.0 4.89 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.492 -0.755 . . . . 0.40000000000000002 110.386 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.81 -55.57 3.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.801 -1.72 . . . . 0.39000000000000001 108.801 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.37 93.67 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.461 -1.023 . . . . 2.0800000000000001 108.778 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' HB3' HD12 ' A' ' 24' ' ' ILE . 7.6 m120 -66.99 -39.78 87.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.66000000000000003 108.921 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.62 59.44 3.25 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.157 -1.577 . . . . 0.37 109.157 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.614 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -147.24 -170.91 15.87 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.101 -1.6 . . . . 0.28999999999999998 109.101 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -101.02 150.6 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -1.149 . . . . 0.93999999999999995 109.242 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 5' ' ' CYS . 89.3 m -93.96 94.0 8.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.41 -0.806 . . . . 0.28999999999999998 110.078 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.1 mt -96.18 128.97 35.01 Favored Pre-proline 0 C--N 1.303 -1.442 0 O-C-N 121.176 -0.952 . . . . 0.38 108.846 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.3 Cg_endo -77.76 178.34 7.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.558 2.172 . . . . 0.39000000000000001 110.57 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 mt 61.84 -93.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.784 -0.572 . . . . 1.03 109.703 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.18 168.98 21.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.615 -1.303 . . . . 1.3799999999999999 109.546 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -76.48 122.95 87.59 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.49 -0.756 . . . . 0.38 109.214 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -79.22 125.28 6.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.597 2.198 . . . . 0.47999999999999998 109.936 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 26.9 m -68.76 158.97 84.29 Favored Pre-proline 0 C--N 1.302 -1.486 0 O-C-N 121.251 -0.906 . . . . 0.62 108.906 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.504 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -81.6 10.78 33.86 Favored 'Cis proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.525 -1.448 . . . . 0.54000000000000004 111.641 -0.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.429 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 20.7 ttm -63.32 141.1 58.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.798 -1.189 . . . . 1.02 109.25 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 ttp85 -107.09 149.87 27.16 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.818 . . . . 0.68999999999999995 109.22 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.99 142.85 47.76 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.416 -0.802 . . . . 0.90000000000000002 109.255 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.614 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -139.44 39.89 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.847 . . . . 0.5 109.403 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.6 -169.23 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.986 -1.646 . . . . 0.33000000000000002 108.986 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.9 p -131.43 167.15 19.79 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.234 -1.156 . . . . 0.46000000000000002 109.451 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 4' ' ' SER . 54.5 m -139.5 140.46 37.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.296 -0.877 . . . . 0.28000000000000003 109.441 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.436 ' CZ ' HD12 ' A' ' 3' ' ' LEU . 90.9 m-85 55.64 26.92 9.81 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.562 -0.711 . . . . 0.81000000000000005 110.05 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.3 -124.35 8.04 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.491 -1.443 . . . . 0.46999999999999997 109.491 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.734 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.0 mmp_? -103.04 -11.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.305 -1.114 . . . . 1.4099999999999999 113.955 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.734 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.1 Cg_endo -72.77 -44.26 0.7 Allowed 'Trans proline' 0 C--N 1.325 -0.669 0 CA-C-N 120.061 1.057 . . . . 0.42999999999999999 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 2.7 t -106.11 155.87 6.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.994 -1.066 . . . . 0.32000000000000001 108.34 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.8 mttp -134.13 164.45 27.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.885 -1.134 . . . . 0.88 109.995 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 21.9 m -90.96 138.04 31.9 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.47 -0.937 . . . . 0.32000000000000001 108.47 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -134.15 133.34 40.89 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.046 -1.034 . . . . 0.39000000000000001 109.808 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.479 ' HB2' HG12 ' A' ' 24' ' ' ILE . 13.0 ttp180 -150.08 157.65 43.34 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.334 -0.854 . . . . 0.75 109.102 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.13 -33.46 33.2 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.361 -0.837 . . . . 0.67000000000000004 109.236 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 37.6 p90 . . . . . 0 N--CA 1.487 1.394 0 O-C-N 121.36 -0.837 . . . . 1.1100000000000001 108.855 179.885 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.03 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.6 -0.518 . . . . 2.5499999999999998 109.6 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 1.03 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 34.2 Cg_endo -77.43 83.93 2.06 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 121.983 1.789 . . . . 2.0699999999999998 110.206 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.59 179.79 7.53 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.296 -0.878 . . . . 1.9099999999999999 108.798 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -57.66 154.42 11.6 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.409 -0.807 . . . . 1.1499999999999999 109.157 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 4' ' ' SER . 4.4 m 73.07 -62.44 0.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.771 -0.581 . . . . 0.67000000000000004 109.568 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.34 -47.29 91.85 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.395 -1.482 . . . . 0.73999999999999999 109.395 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -65.28 -28.91 69.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.219 -1.165 . . . . 1.9199999999999999 109.752 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB2' HG13 ' A' ' 24' ' ' ILE . 19.0 m120 -85.12 -13.33 50.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.034 -1.041 . . . . 0.93999999999999995 109.913 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.68 11.22 64.18 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.757 -1.337 . . . . 0.65000000000000002 109.757 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.799 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -96.02 155.62 21.15 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.072 -1.611 . . . . 0.95999999999999996 109.072 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.37 158.92 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -1.086 . . . . 1.01 109.176 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.454 ' HB3' HG11 ' A' ' 32' ' ' VAL . 83.2 m -77.76 93.63 4.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.69999999999999996 109.319 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' A' ' 35' ' ' CYS . 1.4 mt -100.52 123.3 46.64 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.321 -0.862 . . . . 0.60999999999999999 108.986 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 33.9 Cg_endo -78.62 174.2 12.63 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.504 2.136 . . . . 0.68000000000000005 110.04 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 53.49 -126.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.91 -0.774 . . . . 1.4299999999999999 108.91 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.77 164.94 11.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.422 -1.424 . . . . 1.71 109.065 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.6 m -114.11 154.26 46.18 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.284 -0.885 . . . . 0.70999999999999996 109.054 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.8 168.73 23.02 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.719 2.28 . . . . 0.84999999999999998 110.651 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.6 m -66.23 153.93 91.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.616 -0.677 . . . . 0.88 109.418 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -80.56 10.1 29.9 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.413 -1.494 . . . . 0.65000000000000002 111.344 -0.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ttp 59.47 59.37 2.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.917 . . . . 1.6399999999999999 109.341 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . 2.9 tpp180 -90.02 89.08 7.54 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.391 -0.966 . . . . 1.24 108.391 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.19 123.57 24.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 1.6899999999999999 109.815 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.799 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -128.06 34.45 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.491 -0.755 . . . . 1.1000000000000001 109.041 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 179.53 22.96 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.404 -1.479 . . . . 0.70999999999999996 109.404 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.4 p -126.79 165.12 19.91 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -1.115 . . . . 0.82999999999999996 109.386 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.644 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -134.39 131.09 37.81 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.212 -0.93 . . . . 0.63 109.628 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 56.36 34.68 24.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.719 -0.613 . . . . 1.0800000000000001 110.24 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.507 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.27 -133.89 11.71 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.47 -1.452 . . . . 0.71999999999999997 109.47 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -101.73 -2.18 0.1 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.324 -1.104 . . . . 2.21 113.888 -179.186 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.7 Cg_endo -74.56 -45.22 0.33 Allowed 'Trans proline' 0 C--N 1.325 -0.698 0 CA-C-N 120.239 1.121 . . . . 0.5 109.821 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.8 t -108.69 149.59 11.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.093 -1.077 . . . . 0.51000000000000001 108.093 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.0 OUTLIER -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.94 -1.1 . . . . 0.64000000000000001 109.653 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 37.1 m -89.97 83.95 6.16 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.449 -0.945 . . . . 0.71999999999999997 108.449 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HB2' HD12 ' A' ' 13' ' ' ILE . 5.3 m -97.44 141.76 30.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.272 -0.892 . . . . 0.39000000000000001 109.71 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 4.6 ttp180 -108.17 151.83 25.39 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.775 -0.824 . . . . 1.3200000000000001 108.775 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 18.78 13.4 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.381 -0.824 . . . . 1.28 109.525 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.486 1.327 0 O-C-N 121.202 -0.936 . . . . 1.78 108.505 179.734 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.431 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 108.922 -0.769 . . . . 1.8500000000000001 108.922 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 34.2 Cg_endo -77.47 129.54 10.26 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.695 2.263 . . . . 1.3999999999999999 110.405 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 12' ' ' CYS . 1.4 mp -94.46 17.28 13.34 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.135 -0.978 . . . . 1.45 109.941 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.42 115.07 29.84 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.874 -1.141 . . . . 0.92000000000000004 109.231 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.7 t -91.09 79.18 5.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.209 -0.932 . . . . 0.44 108.487 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.56 -24.51 73.9 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.185 -1.166 . . . . 0.54000000000000004 110.185 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -55.88 -47.33 77.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -1.174 . . . . 0.88 109.871 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.571 ' CB ' HG13 ' A' ' 24' ' ' ILE . 13.2 m120 -110.07 6.18 22.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.938 . . . . 0.71999999999999997 110.094 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . 66.77 51.44 40.81 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.51 -1.436 . . . . 0.48999999999999999 109.51 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.34 -161.4 9.07 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.985 -1.646 . . . . 0.40999999999999998 108.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.33 140.85 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.102 -1.234 . . . . 0.92000000000000004 109.29 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.408 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 58.0 m -83.05 85.6 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.767 . . . . 0.45000000000000001 109.053 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -98.77 126.65 38.01 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.236 -0.915 . . . . 0.64000000000000001 109.346 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.5 Cg_endo -79.66 179.46 6.3 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.629 2.219 . . . . 0.60999999999999999 110.081 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt 51.05 -136.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.987 -0.746 . . . . 0.88 108.987 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.32 139.55 40.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.726 -1.234 . . . . 1.0700000000000001 109.326 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 9.6 m -84.66 159.72 57.6 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.226 -0.921 . . . . 0.52000000000000002 109.073 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 35.1 Cg_endo -78.34 168.28 21.82 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.657 2.238 . . . . 0.53000000000000003 110.305 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.608 HG13 ' HA ' ' A' ' 20' ' ' PRO . 2.6 t -58.39 145.69 74.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.231 -0.655 . . . . 0.82999999999999996 109.231 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HA ' HG13 ' A' ' 19' ' ' VAL . 35.7 Cg_endo -79.89 -7.09 40.69 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.546 -1.439 . . . . 0.56999999999999995 111.378 -0.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 ttm 63.18 77.04 0.34 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.301 -0.874 . . . . 1.1000000000000001 110.119 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HD2' ' CD2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -105.54 93.58 4.74 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.099 -1.001 . . . . 0.76000000000000001 108.867 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.87 121.45 20.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.241 -0.912 . . . . 1.23 109.106 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.571 HG13 ' CB ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -124.35 14.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.68999999999999995 110.077 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 168.27 179.06 40.47 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.095 -1.602 . . . . 0.34999999999999998 109.095 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 35.8 p -115.95 167.65 10.78 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.129 -1.218 . . . . 0.46000000000000002 109.405 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 71.9 m -139.38 129.54 25.25 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.32 -0.863 . . . . 0.39000000000000001 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.417 ' HD2' HG21 ' A' ' 32' ' ' VAL . 14.5 m-85 54.4 43.94 29.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.695 -0.628 . . . . 1.04 109.96 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.511 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.08 -140.18 14.92 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.068 -1.613 . . . . 0.56000000000000005 109.068 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -102.67 0.22 0.1 OUTLIER Pre-proline 0 N--CA 1.487 1.403 0 O-C-N 121.3 -1.117 . . . . 1.73 113.676 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.2 Cg_endo -75.57 -46.62 0.2 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-N 120.168 1.096 . . . . 0.65000000000000002 110.058 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.2 t -103.82 155.13 5.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.218 -1.03 . . . . 0.40999999999999998 108.218 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -139.4 160.66 39.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.68999999999999995 109.593 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 64.6 m -89.97 103.06 15.76 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.371 -0.974 . . . . 0.37 108.371 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.9 m -102.71 153.8 19.78 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.143 -0.973 . . . . 0.42999999999999999 109.853 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB3' ' CE3' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -135.61 176.24 8.86 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.236 -1.024 . . . . 1.24 108.236 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.403 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -140.77 70.89 1.36 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.27 -0.894 . . . . 0.73999999999999999 110.014 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.463 ' CE3' ' HB3' ' A' ' 36' ' ' ARG . 5.7 p90 . . . . . 0 N--CA 1.488 1.446 0 O-C-N 121.113 -0.992 . . . . 0.93000000000000005 108.52 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 108.624 -0.88 . . . . 1.22 108.624 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 34.5 Cg_endo -77.35 -167.42 0.47 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 C-N-CA 122.375 2.05 . . . . 1.28 109.862 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.99 -39.43 63.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.449 -0.782 . . . . 1.73 109.346 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.402 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -69.47 105.41 2.61 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.394 -0.816 . . . . 1.29 109.053 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 65.43 33.04 9.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.493 -0.754 . . . . 0.66000000000000003 109.909 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 1' ' ' ALA . . . -68.76 -45.08 66.8 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.2 -1.56 . . . . 0.52000000000000002 109.2 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -63.59 -49.64 72.57 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.958 . . . . 1.5600000000000001 109.236 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.29 -34.31 76.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.541 -0.724 . . . . 1.23 109.399 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.58 32.15 28.33 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.305 -1.518 . . . . 0.62 109.305 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.574 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -115.13 178.21 17.71 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.273 -1.531 . . . . 0.51000000000000001 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.89 135.13 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.363 -1.081 . . . . 0.93000000000000005 109.019 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 4' ' ' SER . 51.1 m -79.97 90.03 5.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.411 -0.806 . . . . 0.45000000000000001 109.032 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 35' ' ' CYS . 12.1 mt -104.16 126.14 32.46 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.309 -0.869 . . . . 0.57999999999999996 109.404 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.4 Cg_endo -78.65 174.84 11.74 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.66 2.24 . . . . 0.51000000000000001 110.106 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 51.37 -129.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 109.143 -0.688 . . . . 1.0900000000000001 109.143 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.61 149.64 29.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.536 -1.352 . . . . 1.0 109.458 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 3.0 m -101.59 162.84 19.19 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.342 -0.849 . . . . 0.40000000000000002 109.07 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.6 Cg_endo -78.19 167.5 23.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.516 2.144 . . . . 0.65000000000000002 109.999 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.5 m -62.98 152.2 84.14 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.505 -0.747 . . . . 0.62 109.298 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.89 -5.67 32.83 Favored 'Cis proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.361 -1.516 . . . . 0.53000000000000003 111.191 -0.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.1 ttm 60.36 58.49 2.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.887 . . . . 0.97999999999999998 109.61 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -90.04 93.85 9.55 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.172 -0.955 . . . . 1.0800000000000001 108.89 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.3 112.77 5.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.366 -0.833 . . . . 1.72 109.897 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.574 HD11 ' HA3' ' A' ' 10' ' ' GLY . 3.5 pt -104.14 -1.38 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.827 . . . . 0.59999999999999998 109.49 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.12 -168.34 40.11 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.989 -1.645 . . . . 0.39000000000000001 108.989 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 12.3 p -122.08 168.61 11.75 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.274 -1.133 . . . . 0.56000000000000005 109.41 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 81.0 m -138.09 126.37 23.09 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.272 -0.892 . . . . 0.46000000000000002 109.589 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 55.84 36.94 28.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.679 -0.638 . . . . 0.93000000000000005 110.072 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.532 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -137.38 13.38 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.677 -1.369 . . . . 0.59999999999999998 109.677 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -99.45 -3.12 0.11 Allowed Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 113.859 1.059 . . . . 1.3700000000000001 113.859 -179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.6 Cg_endo -74.84 -46.95 0.22 Allowed 'Trans proline' 0 C--N 1.325 -0.688 0 CA-C-N 120.299 1.143 . . . . 0.5 110.034 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 5.3 t -107.49 150.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 107.993 -1.114 . . . . 0.37 107.993 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.7 OUTLIER -134.44 162.65 31.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.87 -1.144 . . . . 0.71999999999999997 109.865 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 56.3 m -90.4 88.98 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.944 -0.761 . . . . 0.34999999999999998 108.944 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HB2' HD12 ' A' ' 13' ' ' ILE . 95.4 m -91.55 136.01 33.44 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.123 -0.986 . . . . 0.37 109.533 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -105.71 147.51 28.47 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.299 -0.876 . . . . 1.0800000000000001 109.053 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.405 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -86.05 -12.44 50.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.792 . . . . 0.62 109.245 179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 117.602 -1.19 . . . . 1.1100000000000001 108.401 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.024 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.418 -0.586 . . . . 4.4500000000000002 109.418 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 1.024 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 34.7 Cg_endo -79.6 162.96 24.37 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.495 1.464 . . . . 3.75 109.292 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.456 ' HG ' ' CZ ' ' A' ' 28' ' ' PHE . 2.0 mm? -93.93 100.56 12.7 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.255 -0.903 . . . . 1.6100000000000001 108.789 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.07 124.63 20.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.352 -0.843 . . . . 1.1299999999999999 109.944 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 7' ' ' ARG . 34.7 t -85.66 111.89 20.5 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.267 -0.896 . . . . 0.5 108.727 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.09 -2.26 77.47 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 120.267 -0.968 . . . . 0.81000000000000005 111.018 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.451 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -58.75 -60.35 3.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.833 -1.392 . . . . 1.6599999999999999 109.637 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.483 ' HB2' HD13 ' A' ' 24' ' ' ILE . 22.6 m120 -133.61 35.93 3.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.158 -0.964 . . . . 1.26 109.483 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 61.19 59.53 9.86 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.454 -1.459 . . . . 0.68999999999999995 109.454 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.627 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -132.83 -167.71 11.8 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.173 -1.571 . . . . 0.47999999999999998 109.173 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.03 151.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.197 -1.178 . . . . 0.79000000000000004 109.276 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' HB3' HG11 ' A' ' 32' ' ' VAL . 67.9 m -91.42 97.97 11.41 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.994 -0.743 . . . . 0.41999999999999998 108.994 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 17' ' ' CYS . 3.3 mt -100.28 127.97 31.74 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.394 -0.816 . . . . 0.59999999999999998 109.02 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 34.2 Cg_endo -76.76 163.51 31.37 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.422 2.081 . . . . 0.55000000000000004 110.147 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.9 mm 61.46 -94.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.728 -0.607 . . . . 0.72999999999999998 109.374 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.92 165.24 31.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.759 -1.213 . . . . 1.46 109.201 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.599 ' HB3' HD12 ' A' ' 13' ' ' ILE . 2.3 m -109.72 163.69 16.5 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.369 -0.832 . . . . 0.48999999999999999 109.064 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 33.9 Cg_endo -76.73 160.38 34.48 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.543 2.162 . . . . 0.68999999999999995 110.086 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' C ' ' A' ' 20' ' ' PRO . 24.7 m -64.82 152.49 90.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.519 -0.738 . . . . 0.77000000000000002 109.347 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.587 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 34.6 Cg_endo -77.06 -8.27 30.4 Favored 'Cis proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.254 -1.561 . . . . 0.57999999999999996 111.219 0.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.481 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 46.2 ttp 58.89 84.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.419 -0.801 . . . . 1.3700000000000001 110.501 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 0.0 OUTLIER -94.34 96.61 9.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.892 -1.13 . . . . 0.72999999999999998 108.38 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 130.8 46.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.529 -0.732 . . . . 1.4399999999999999 109.481 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.543 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -139.56 34.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.628 -0.67 . . . . 0.48999999999999999 109.38 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.7 -177.77 19.0 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.347 -1.501 . . . . 0.35999999999999999 109.347 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.4 p -132.58 164.49 26.55 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.238 -1.154 . . . . 0.57999999999999996 109.084 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 21.9 m -131.85 138.78 48.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.187 -0.945 . . . . 0.40999999999999998 109.607 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CZ ' ' HG ' ' A' ' 3' ' ' LEU . 56.1 m-85 57.9 32.26 21.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.894 -0.504 . . . . 0.88 109.96 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.45 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.46 -128.96 9.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.153 -1.579 . . . . 0.47999999999999998 109.153 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.749 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.42 0.82 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.254 -1.145 . . . . 1.3600000000000001 113.645 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.749 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.5 Cg_endo -74.97 -43.88 0.37 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 CA-C-N 120.328 1.153 . . . . 0.54000000000000004 110.058 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 15.9 t -107.91 147.26 13.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.097 -1.075 . . . . 0.42999999999999999 108.097 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.8 mttp -126.58 158.51 36.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.81999999999999995 109.926 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.607 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 73.7 m -92.48 118.14 30.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.479 -0.934 . . . . 0.38 108.479 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -122.83 138.48 54.63 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.116 -0.99 . . . . 0.34999999999999998 109.534 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 6.8 ttm180 -141.81 -171.55 3.37 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.588 -0.893 . . . . 1.02 108.588 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER 52.29 53.64 12.06 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.604 -0.685 . . . . 0.63 109.252 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.587 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.0 p90 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.99 -1.005 . . . . 1.26 108.994 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.027 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.069 -0.345 . . . . 1.4299999999999999 110.069 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 1.027 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 36.2 Cg_endo -77.15 122.16 6.07 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.749 1.633 . . . . 1.1599999999999999 109.978 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.28 84.98 4.45 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.327 -0.858 . . . . 2.5699999999999998 109.362 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m 48.79 41.21 17.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.721 -0.612 . . . . 1.29 110.363 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 75.9 m 51.86 49.35 20.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.908 . . . . 0.44 109.8 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.94 -25.91 54.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.004 -1.239 . . . . 0.46999999999999997 110.004 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HD2' ' HA3' ' A' ' 25' ' ' GLY . 4.3 ptp180 -52.63 -34.85 53.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.292 -1.123 . . . . 0.76000000000000001 110.185 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.677 ' HB2' HD12 ' A' ' 24' ' ' ILE . 38.3 m-80 -136.94 16.35 3.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.982 -1.074 . . . . 0.66000000000000003 110.351 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 55.66 62.0 6.8 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.781 -1.328 . . . . 0.46999999999999997 109.781 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -128.0 -151.26 7.53 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.331 -1.508 . . . . 0.42999999999999999 109.331 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.02 143.89 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.191 -1.182 . . . . 0.75 109.248 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.428 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.3 m -82.65 87.65 6.72 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.44 -0.787 . . . . 0.41999999999999998 108.993 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 17' ' ' CYS . 3.7 mt -100.06 123.14 48.14 Favored Pre-proline 0 C--N 1.303 -1.435 0 O-C-N 121.211 -0.931 . . . . 0.46000000000000002 109.198 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.2 Cg_endo -79.31 172.14 15.06 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.756 2.304 . . . . 0.60999999999999999 110.378 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.6 mm 58.85 -93.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 109.367 -0.605 . . . . 1.0700000000000001 109.367 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 -178.84 5.99 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.671 -1.268 . . . . 1.5800000000000001 108.804 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.543 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -131.64 162.39 56.53 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.213 -0.929 . . . . 0.56000000000000005 109.026 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -77.31 163.88 29.62 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.494 2.129 . . . . 0.77000000000000002 109.813 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.9 m -60.9 150.91 75.91 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.773 . . . . 0.91000000000000003 109.353 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.624 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.71 -2.1 33.9 Favored 'Cis proline' 0 C--N 1.307 -1.651 0 C-N-CA 123.41 -1.496 . . . . 0.62 111.455 0.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 38.3 ttp 60.84 65.19 1.05 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.143 -0.973 . . . . 1.3500000000000001 109.345 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.04 105.58 17.9 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.078 -1.014 . . . . 1.1699999999999999 109.454 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.84 123.26 23.03 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.892 . . . . 1.28 109.092 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.705 HD11 ' HA3' ' A' ' 10' ' ' GLY . 11.4 pt -123.63 -0.33 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.468 -0.77 . . . . 0.91000000000000003 110.077 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.417 ' N ' ' HB2' ' A' ' 34' ' ' CYS . . . 169.52 -171.21 43.1 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.972 -1.651 . . . . 0.46000000000000002 108.972 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.9 p -124.37 164.72 19.06 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.263 -1.139 . . . . 0.60999999999999999 109.383 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 70.9 m -135.3 132.7 38.03 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.257 -0.902 . . . . 0.39000000000000001 109.531 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 56.66 34.0 23.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.691 -0.631 . . . . 0.77000000000000002 110.109 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.508 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.87 -134.32 11.83 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.502 -1.439 . . . . 0.48999999999999999 109.502 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -100.38 -4.0 0.11 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.387 -1.067 . . . . 1.3799999999999999 113.803 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.81 -48.65 0.18 Allowed 'Trans proline' 0 C--N 1.326 -0.643 0 CA-C-N 120.23 1.118 . . . . 0.62 110.074 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.3 t -101.2 148.98 6.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.021 -1.103 . . . . 0.44 108.021 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 18.4 mtmm -128.38 170.35 13.21 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.989 -1.069 . . . . 0.67000000000000004 109.542 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.609 ' HB3' HG13 ' A' ' 24' ' ' ILE . 46.7 m -100.52 105.12 16.52 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.397 -0.964 . . . . 0.46999999999999997 108.397 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -106.23 146.37 30.39 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.201 -0.937 . . . . 0.38 109.237 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.592 ' HD3' HD13 ' A' ' 24' ' ' ILE . 3.0 ttp180 -138.67 161.21 37.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.295 -0.878 . . . . 0.83999999999999997 109.046 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.624 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.54 -24.79 20.52 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.4 -0.813 . . . . 0.81000000000000005 109.271 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 42.9 p90 . . . . . 0 C--N 1.305 -1.355 0 O-C-N 121.314 -0.866 . . . . 1.1000000000000001 108.71 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.151 -0.685 . . . . 2.0099999999999998 109.151 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 32.6 Cg_endo -76.89 136.7 16.94 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.446 2.097 . . . . 1.78 110.863 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 3' ' ' LEU . 0.9 OUTLIER 60.1 39.81 19.17 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.306 -0.628 . . . . 1.98 109.306 -179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.594 ' HB2' ' HA2' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -148.11 176.65 10.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.2 -0.937 . . . . 0.68000000000000005 109.458 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 t -110.89 139.24 46.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.46000000000000002 109.428 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 150.7 16.12 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.519 -1.433 . . . . 0.52000000000000002 109.519 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -27.06 68.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -1.113 . . . . 2.0099999999999998 109.337 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -68.84 -52.8 26.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.357 -0.839 . . . . 0.68999999999999995 109.235 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.594 ' HA2' ' HB2' ' A' ' 4' ' ' SER . . . 119.67 58.66 0.25 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.329 -1.509 . . . . 0.48999999999999999 109.329 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -98.36 164.83 21.32 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.318 -1.513 . . . . 0.44 109.318 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.68 153.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.337 -1.096 . . . . 0.76000000000000001 108.777 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.471 ' HB3' HG11 ' A' ' 32' ' ' VAL . 72.1 m -77.65 87.3 3.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.403 -0.811 . . . . 0.39000000000000001 109.236 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.614 HD12 ' HB3' ' A' ' 17' ' ' CYS . 4.6 mt -111.46 115.81 51.41 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.348 -0.845 . . . . 0.5 109.275 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.709 ' HB3' HG22 ' A' ' 32' ' ' VAL . 35.0 Cg_endo -78.85 172.17 15.43 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.636 2.224 . . . . 0.52000000000000002 110.492 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.0 mm 60.48 -92.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.536 -0.542 . . . . 1.22 109.536 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -133.62 176.8 8.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.714 -1.241 . . . . 1.6200000000000001 109.127 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.614 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -135.79 162.33 57.58 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.19 -0.944 . . . . 0.39000000000000001 109.069 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.99 165.91 25.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.581 2.187 . . . . 0.46000000000000002 109.926 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -64.36 153.08 87.27 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.494 -0.754 . . . . 0.55000000000000004 109.394 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -79.65 4.15 34.08 Favored 'Cis proline' 0 C--N 1.309 -1.524 0 C-N-CA 123.372 -1.512 . . . . 0.40999999999999998 111.315 0.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 9.9 ttp 61.02 56.49 2.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.284 -0.885 . . . . 1.0900000000000001 109.692 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -89.87 89.65 7.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.044 -1.035 . . . . 0.71999999999999997 108.47 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -72.21 121.48 19.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.376 -0.827 . . . . 0.68000000000000005 109.451 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.479 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -129.16 35.18 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.429 -0.794 . . . . 0.56000000000000005 109.412 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.33 -172.23 26.97 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.421 -1.472 . . . . 0.37 109.421 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.7 p -141.19 162.11 36.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 0.40999999999999998 109.261 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 56.8 m -120.23 146.33 46.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.101 -0.999 . . . . 0.39000000000000001 109.818 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 55.08 41.29 31.84 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.147 0.499 . . . . 0.79000000000000004 109.838 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.61 -134.89 12.19 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.46 -1.856 . . . . 0.58999999999999997 108.46 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.733 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 9.2 mmm180 -108.61 9.11 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.208 -1.172 . . . . 1.1599999999999999 113.391 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.733 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 36.0 Cg_endo -77.17 -47.12 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 CA-C-N 120.12 1.078 . . . . 0.51000000000000001 110.079 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.709 HG22 ' HB3' ' A' ' 14' ' ' PRO . 48.2 t -98.6 148.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.38 108.268 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -118.68 153.26 34.63 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.032 -1.042 . . . . 0.60999999999999999 109.965 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 38.2 m -94.21 85.19 4.59 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.532 -0.914 . . . . 0.34999999999999998 108.532 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 m -93.32 136.2 33.81 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.163 -0.96 . . . . 0.35999999999999999 110.083 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -91.92 136.59 33.04 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.366 -0.976 . . . . 1.1299999999999999 108.366 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.63 23.14 4.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.268 -0.895 . . . . 0.83999999999999997 109.566 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 . . . . . 0 C--N 1.305 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.91000000000000003 108.106 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.185 -0.672 . . . . 3.1299999999999999 109.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 33.7 Cg_endo -77.56 106.6 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.5 2.133 . . . . 1.5900000000000001 110.371 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 11' ' ' VAL . 96.4 mt -86.6 67.7 9.95 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.157 -0.965 . . . . 1.6799999999999999 109.416 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.4 43.54 1.15 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.323 -0.86 . . . . 1.1100000000000001 109.298 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.45 44.42 0.95 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.112 -0.993 . . . . 0.47999999999999998 109.352 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.34 -21.88 70.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.816 -1.313 . . . . 0.96999999999999997 109.816 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.32 -42.99 74.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 1.73 109.627 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.41 ' CB ' HG13 ' A' ' 24' ' ' ILE . 86.6 m-20 -108.69 4.66 24.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 1.0800000000000001 110.017 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 62.7 41.28 99.85 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.551 -1.42 . . . . 0.56999999999999995 109.551 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA2' ' HG3' ' A' ' 36' ' ' ARG . . . -119.25 162.95 13.48 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.439 -1.464 . . . . 0.45000000000000001 109.439 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 3' ' ' LEU . 35.9 m -95.59 154.43 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.351 -1.088 . . . . 0.51000000000000001 109.073 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.572 ' HB3' HG11 ' A' ' 32' ' ' VAL . 97.7 m -96.01 98.27 10.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.186 -0.946 . . . . 0.38 109.422 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.802 HD12 ' HB3' ' A' ' 17' ' ' CYS . 1.6 mt -105.45 127.21 29.02 Favored Pre-proline 0 N--CA 1.486 1.348 0 O-C-N 121.346 -0.846 . . . . 0.5 109.087 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.88 165.65 24.16 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.567 2.178 . . . . 0.51000000000000001 110.603 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mt 61.89 -92.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.834 -0.541 . . . . 1.23 109.691 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -147.66 160.04 43.12 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.579 -1.325 . . . . 1.8300000000000001 108.818 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.802 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -110.56 159.04 33.75 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.157 -0.964 . . . . 0.39000000000000001 109.435 -179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.69 172.1 15.64 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.731 2.287 . . . . 0.58999999999999997 110.199 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 20' ' ' PRO . 3.6 t -58.51 145.52 76.07 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 109.066 -0.716 . . . . 0.77000000000000002 109.066 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.646 ' HA ' HG13 ' A' ' 19' ' ' VAL . 36.3 Cg_endo -80.33 -9.77 40.5 Favored 'Cis proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.596 -1.418 . . . . 0.51000000000000001 111.481 -0.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 33.1 ttp 62.64 63.71 0.97 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 1.49 109.347 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -89.88 92.75 9.15 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.106 -0.996 . . . . 0.87 108.684 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.04 122.2 20.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 1.3899999999999999 109.559 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.417 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -126.53 25.34 2.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.064 -0.717 . . . . 0.65000000000000002 109.064 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 146.78 -171.74 27.47 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.609 -1.796 . . . . 0.35999999999999999 108.609 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 14.1 p -137.83 168.88 18.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.986 -1.302 . . . . 0.51000000000000001 109.697 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 17.9 m -129.32 142.33 50.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.371 -0.83 . . . . 0.41999999999999998 109.553 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 58.31 34.34 23.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.91 -0.494 . . . . 0.88 110.095 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.465 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.22 10.58 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 109.03 -1.628 . . . . 0.67000000000000004 109.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -106.88 5.02 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.166 -1.197 . . . . 1.73 113.517 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -76.1 -47.52 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 CA-C-N 120.253 1.126 . . . . 0.57999999999999996 109.969 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 12' ' ' CYS . 13.0 t -102.19 151.33 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.134 -0.979 . . . . 0.46000000000000002 108.496 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -124.41 157.17 35.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.91000000000000003 110.218 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 88.7 m -93.59 96.4 9.83 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.729 -0.841 . . . . 0.44 108.729 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.5 m -102.51 149.07 24.77 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.045 -1.034 . . . . 0.39000000000000001 109.751 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.582 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 2.9 ttp180 -136.98 166.44 23.66 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.924 -0.769 . . . . 0.59999999999999998 108.924 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -26.54 18.96 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.452 -0.78 . . . . 0.64000000000000001 108.962 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.777 -1.106 . . . . 0.81000000000000005 108.717 179.729 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.267 -0.642 . . . . 4.2199999999999998 109.267 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -77.78 141.55 19.44 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.727 2.284 . . . . 3.4700000000000002 110.189 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 3' ' ' LEU . 2.2 tp -79.27 113.73 17.64 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.0 -0.68 . . . . 3.0699999999999998 109.289 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.527 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -57.3 110.45 0.85 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.984 -0.747 . . . . 1.1399999999999999 108.984 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 4.0 m 66.72 35.37 5.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.592 -0.692 . . . . 0.75 109.279 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.37 -42.21 96.13 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.749 -1.341 . . . . 0.58999999999999997 109.749 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.7 mmm180 -65.08 -32.84 74.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.122 -1.222 . . . . 1.8799999999999999 108.934 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.535 ' CB ' HG13 ' A' ' 24' ' ' ILE . 2.6 m120 -81.17 -25.22 36.98 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.416 -0.803 . . . . 1.0600000000000001 109.129 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.33 37.24 11.19 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.574 -1.41 . . . . 0.68000000000000005 109.574 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.417 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -138.83 -160.48 8.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.178 -1.569 . . . . 0.56000000000000005 109.178 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.57 157.48 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.228 -1.16 . . . . 1.1000000000000001 109.138 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 4' ' ' SER . 56.0 m -87.11 92.14 8.95 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.358 -0.839 . . . . 0.81000000000000005 109.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 17' ' ' CYS . 8.3 mt -101.38 123.65 43.84 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.344 -0.847 . . . . 0.68999999999999995 109.31 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.607 ' HB3' HG22 ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.21 172.11 15.95 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.792 2.328 . . . . 0.68000000000000005 110.274 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.4 mm 54.92 -116.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.947 -0.76 . . . . 0.72999999999999998 108.947 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.31 161.36 19.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.592 -1.317 . . . . 1.45 109.241 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -111.44 165.14 13.39 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.391 -0.818 . . . . 0.62 109.228 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.03 164.03 27.66 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.666 2.244 . . . . 0.81000000000000005 110.021 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -59.75 147.82 77.37 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 109.195 -0.669 . . . . 1.1599999999999999 109.195 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 35.5 Cg_endo -80.61 -2.97 42.93 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.457 -1.476 . . . . 0.73999999999999999 111.18 -0.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.9 ttm 63.26 59.08 1.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.328 -0.857 . . . . 1.1200000000000001 109.849 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -90.36 104.24 16.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.16 -0.963 . . . . 1.04 108.869 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 122.71 23.07 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.345 -0.847 . . . . 1.3200000000000001 109.241 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.627 HD12 ' HD3' ' A' ' 36' ' ' ARG . 0.1 OUTLIER -122.48 22.82 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.458 -0.776 . . . . 0.76000000000000001 109.524 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 153.72 -176.18 31.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.787 -1.725 . . . . 0.59999999999999998 108.787 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 10.5 p -129.04 164.54 23.01 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.238 -1.154 . . . . 0.95999999999999996 109.688 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.656 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 59.6 m -134.94 136.94 42.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.82999999999999996 109.862 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 53.34 37.81 26.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.838 -0.539 . . . . 1.4399999999999999 110.168 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.44 -132.94 11.3 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.371 -1.492 . . . . 1.0600000000000001 109.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.5 mmp_? -105.28 -1.73 0.11 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.312 -1.111 . . . . 1.21 113.667 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.3 Cg_endo -74.96 -44.93 0.31 Allowed 'Trans proline' 0 C--N 1.327 -0.601 0 CA-C-N 120.192 1.104 . . . . 0.83999999999999997 110.246 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 12.1 t -106.22 148.92 10.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.007 -1.058 . . . . 0.62 108.157 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.5 OUTLIER -134.17 165.27 25.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.70999999999999996 110.299 -178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' HB3' HG12 ' A' ' 24' ' ' ILE . 69.3 m -90.06 93.25 9.31 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.645 -0.872 . . . . 0.56000000000000005 108.645 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.507 ' HB2' HD12 ' A' ' 13' ' ' ILE . 4.0 m -95.06 143.27 26.65 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.12 -0.987 . . . . 0.51000000000000001 109.387 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.627 ' HD3' HD12 ' A' ' 24' ' ' ILE . 6.3 ttp180 -121.89 152.04 40.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 1.3100000000000001 108.89 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.616 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.48 -3.73 57.44 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.432 -0.793 . . . . 1.46 109.982 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 117.626 -1.178 . . . . 1.48 108.516 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.031 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.651 -0.499 . . . . 1.5700000000000001 109.651 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 1.031 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 36.2 Cg_endo -78.94 171.95 15.71 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.935 1.757 . . . . 1.22 110.06 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 tp -122.35 168.11 12.46 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.806 -0.812 . . . . 1.0800000000000001 108.806 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.599 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -71.08 104.74 3.12 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.281 -0.887 . . . . 0.71999999999999997 109.61 -179.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -39.41 81.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.37 109.475 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.69 -11.21 68.7 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 120.072 -1.061 . . . . 0.54000000000000004 110.487 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HB2' ' HB2' ' A' ' 4' ' ' SER . 10.4 ttm105 -54.71 -49.2 71.3 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.958 -1.319 . . . . 0.84999999999999998 109.808 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -114.61 27.7 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.87 109.613 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 59.32 44.08 96.81 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.475 -1.45 . . . . 0.48999999999999999 109.475 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.633 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -101.21 159.81 18.64 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.269 -1.532 . . . . 0.34999999999999998 109.269 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.4 145.08 18.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.273 -1.133 . . . . 0.91000000000000003 108.824 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.482 ' HB3' HG11 ' A' ' 32' ' ' VAL . 93.3 m -77.29 88.67 3.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.404 -0.81 . . . . 0.40999999999999998 109.114 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 35' ' ' CYS . 4.8 mt -101.33 122.02 49.66 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.283 -0.886 . . . . 0.47999999999999998 109.239 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 36.1 Cg_endo -79.06 173.35 13.57 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.444 2.096 . . . . 0.44 109.718 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.84 -121.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.565 -0.709 . . . . 0.93000000000000005 109.327 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.28 161.81 14.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.787 -1.196 . . . . 2.2200000000000002 109.772 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.45 152.51 47.12 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.395 -0.816 . . . . 0.42999999999999999 108.819 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.33 165.23 32.31 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.474 2.116 . . . . 0.5 110.66 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -63.44 155.38 75.35 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.783 -0.573 . . . . 0.57999999999999996 109.732 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.31 13.65 21.49 Favored 'Cis proline' 0 C--N 1.31 -1.495 0 C-N-CA 123.438 -1.484 . . . . 0.48999999999999999 111.435 -0.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.5 ttp 59.19 57.22 3.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.217 -0.927 . . . . 1.25 109.237 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -90.04 89.55 7.75 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.544 -0.91 . . . . 0.93000000000000005 108.544 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.1 124.59 27.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.248 -0.908 . . . . 0.62 109.839 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.633 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -127.57 28.91 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.45 -0.781 . . . . 0.41999999999999998 109.232 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -170.23 30.26 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.181 -1.568 . . . . 0.39000000000000001 109.181 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.6 p -140.42 165.43 27.45 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.258 -1.143 . . . . 0.59999999999999998 109.584 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.628 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.5 m -132.62 142.11 48.97 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.256 -0.903 . . . . 0.47999999999999998 109.507 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 54.71 33.98 20.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.814 -0.554 . . . . 1.0800000000000001 110.193 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.468 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.66 -130.66 10.37 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.451 -1.46 . . . . 0.62 109.451 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.738 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -104.19 -2.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.429 -1.042 . . . . 1.21 113.707 -179.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.738 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -74.54 -47.59 0.22 Allowed 'Trans proline' 0 C--N 1.326 -0.615 0 CA-C-N 120.339 1.157 . . . . 0.51000000000000001 110.159 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.628 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 10.9 t -101.47 146.64 9.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.942 -1.132 . . . . 0.45000000000000001 107.942 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 158.72 36.79 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.918 -1.113 . . . . 0.5 110.058 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.2 m -89.98 79.26 6.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.05 -1.093 . . . . 0.28999999999999998 108.05 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.502 ' HB2' HD12 ' A' ' 13' ' ' ILE . 3.9 m -93.48 145.24 24.65 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.355 -0.841 . . . . 0.31 109.684 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -114.78 151.99 32.86 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.451 -0.78 . . . . 1.22 108.978 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.89 15.71 21.42 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.387 -0.821 . . . . 0.73999999999999999 109.283 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 117.777 -1.106 . . . . 0.91000000000000003 108.469 179.821 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.966 -0.753 . . . . 3.29 108.966 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.87 83.26 2.14 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.487 2.125 . . . . 2.6299999999999999 109.803 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.486 ' HA ' HD13 ' A' ' 3' ' ' LEU . 3.7 mm? 56.71 40.65 29.08 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.167 -0.679 . . . . 1.51 109.167 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.52 152.98 50.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.387 -0.821 . . . . 1.1100000000000001 108.958 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.4 40.18 1.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.88 . . . . 0.5 110.554 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.39 -47.16 30.0 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.619 -1.792 . . . . 1.1699999999999999 108.619 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.98 -36.66 48.71 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.411 -1.052 . . . . 2.3900000000000001 108.858 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -64.97 -25.99 68.11 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 1.3 109.307 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.27 56.01 3.12 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.747 -1.741 . . . . 0.95999999999999996 108.747 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.611 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -147.01 153.78 25.57 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.965 -1.654 . . . . 0.39000000000000001 108.965 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.95 141.72 13.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.237 -1.155 . . . . 0.59999999999999998 109.518 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.405 ' HB3' HG11 ' A' ' 32' ' ' VAL . 87.8 m -88.3 84.01 6.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.38 -0.825 . . . . 0.37 109.308 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 17.0 mt -96.09 136.22 22.24 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.181 -0.949 . . . . 0.47999999999999998 108.887 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 13' ' ' ILE . 33.9 Cg_endo -76.63 172.27 16.53 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.427 2.085 . . . . 0.51000000000000001 110.131 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.9 mm 61.49 -99.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.48 170.38 18.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.598 -1.314 . . . . 1.1200000000000001 109.085 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.623 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 4.6 m -96.01 134.31 24.02 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.893 . . . . 0.54000000000000004 109.556 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.24 138.82 16.28 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.575 2.184 . . . . 0.72999999999999998 109.764 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.26 155.69 78.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.817 . . . . 0.65000000000000002 109.198 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.58 2.72 35.11 Favored 'Cis proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.494 -1.461 . . . . 0.57999999999999996 111.459 0.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.461 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 26.6 ttm -67.48 113.85 5.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.833 -1.167 . . . . 0.96999999999999997 109.137 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.71 176.6 5.76 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.98999999999999999 109.571 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.623 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -82.67 142.72 31.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.549 -0.719 . . . . 0.85999999999999999 109.241 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.611 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -138.83 33.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.441 -0.787 . . . . 0.55000000000000004 109.369 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 142.56 -167.82 26.07 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.166 -1.574 . . . . 0.41999999999999998 109.166 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 9.9 p -131.2 163.91 26.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.203 -1.175 . . . . 0.63 109.493 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 m -133.32 140.58 47.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.243 -0.91 . . . . 0.45000000000000001 109.677 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.481 ' HD2' HG21 ' A' ' 32' ' ' VAL . 18.0 m-85 51.23 41.84 28.27 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.176 0.512 . . . . 0.68000000000000005 109.934 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 93.55 -134.86 12.3 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.02 -1.632 . . . . 0.55000000000000004 109.02 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.743 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.2 mmp_? -105.29 -0.16 0.1 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.215 -1.168 . . . . 1.48 113.471 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.743 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.7 Cg_endo -74.74 -47.44 0.22 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 CA-C-N 120.263 1.13 . . . . 0.57999999999999996 110.337 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.481 HG21 ' HD2' ' A' ' 28' ' ' PHE . 18.1 t -100.87 156.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.073 -1.017 . . . . 0.47999999999999998 108.334 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -129.2 163.67 25.09 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.986 -1.071 . . . . 0.69999999999999996 109.925 -179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HB3' HG13 ' A' ' 24' ' ' ILE . 52.2 m -90.57 131.99 35.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.357 -0.979 . . . . 0.39000000000000001 108.357 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 13' ' ' ILE . 38.7 m -121.33 133.54 55.12 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.029 -1.044 . . . . 0.46000000000000002 109.663 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.608 ' HB2' HG12 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.32 146.85 28.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.727 -0.842 . . . . 0.82999999999999996 108.727 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.09 -23.7 21.33 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.276 -0.89 . . . . 0.88 109.401 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 17.9 p-90 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 1.0700000000000001 109.148 -179.911 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.504 -0.554 . . . . 1.9299999999999999 109.504 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -77.93 110.81 2.98 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.578 2.185 . . . . 2.4500000000000002 110.739 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.2 mt 54.35 70.77 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.838 -0.539 . . . . 1.3899999999999999 110.048 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.54 103.19 0.64 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.317 -0.994 . . . . 1.6200000000000001 108.317 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.46 23.53 12.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.534 -0.729 . . . . 0.59999999999999998 109.637 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.96 -45.03 59.19 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.911 -1.675 . . . . 0.64000000000000001 108.911 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -33.43 75.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -1.074 . . . . 1.52 108.93 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.64 -27.88 64.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.33 -0.856 . . . . 0.93999999999999995 109.186 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.76 48.27 5.29 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.26 -1.536 . . . . 0.53000000000000003 109.26 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.715 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -154.01 157.39 27.44 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.159 -1.576 . . . . 0.51000000000000001 109.159 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.3 m -93.89 150.37 4.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.297 -1.12 . . . . 0.73999999999999999 109.416 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.706 ' HB3' HG11 ' A' ' 32' ' ' VAL . 54.2 m -88.54 101.36 13.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.421 -0.8 . . . . 0.57999999999999996 109.392 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.59 HG22 HG13 ' A' ' 15' ' ' ILE . 15.4 mt -100.58 122.31 49.95 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.322 -0.861 . . . . 0.51000000000000001 109.342 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.508 ' HB3' HG22 ' A' ' 32' ' ' VAL . 36.1 Cg_endo -80.32 31.2 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.827 2.351 . . . . 0.54000000000000004 110.962 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.59 HG13 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -146.23 -153.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.174 -1.047 . . . . 0.75 108.174 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.63 142.84 27.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.035 -1.04 . . . . 1.7 108.972 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 t -63.22 124.18 83.15 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.484 -0.76 . . . . 0.47999999999999998 109.849 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.87 119.81 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.687 2.258 . . . . 0.72999999999999998 110.362 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.2 m -65.85 159.88 66.24 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.267 -0.896 . . . . 0.81000000000000005 108.726 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.8 Cg_endo -80.98 8.27 35.9 Favored 'Cis proline' 0 C--N 1.307 -1.653 0 C-N-CA 123.614 -1.411 . . . . 0.64000000000000001 111.596 -0.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.671 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 2.0 ttp -60.79 133.99 56.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.925 -1.11 . . . . 1.1299999999999999 108.864 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -101.74 164.91 11.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.971 . . . . 1.1699999999999999 110.039 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.18 151.53 24.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.176 -0.675 . . . . 2.1200000000000001 109.176 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.715 HD11 ' HA3' ' A' ' 10' ' ' GLY . 1.0 OUTLIER -148.38 44.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.613 -0.679 . . . . 0.55000000000000004 109.488 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.25 -174.62 18.33 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.146 -1.581 . . . . 0.40999999999999998 109.146 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 26.4 p -138.16 166.75 23.36 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.291 -1.123 . . . . 0.68999999999999995 109.415 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 27.0 m -127.03 141.45 51.78 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.155 -0.966 . . . . 0.54000000000000004 109.772 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 56.0 36.65 27.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.877 -0.514 . . . . 0.95999999999999996 110.026 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.457 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.86 -131.34 10.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.043 -1.623 . . . . 0.81000000000000005 109.043 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -107.98 6.81 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.178 -1.189 . . . . 1.2 113.472 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.2 Cg_endo -76.6 -46.11 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 120.171 1.097 . . . . 0.71999999999999997 109.782 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 12' ' ' CYS . 73.2 t -104.63 149.49 8.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.297 -1.001 . . . . 0.41999999999999998 108.297 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.5 mttp -123.69 154.2 39.74 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.093 -1.005 . . . . 0.64000000000000001 109.83 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.1 m -89.97 136.82 32.81 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.445 -0.946 . . . . 0.5 108.445 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.671 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 30.8 m -135.63 133.72 38.52 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.103 -0.998 . . . . 0.46999999999999997 110.09 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.684 ' CD ' HG21 ' A' ' 24' ' ' ILE . 2.6 ptm180 -145.33 143.03 29.94 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.185 -1.043 . . . . 0.60999999999999999 108.185 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -33.71 16.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.123 -0.985 . . . . 0.89000000000000001 111.007 -178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.413 ' OXT' ' HG3' ' A' ' 36' ' ' ARG . 11.3 p-90 . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.018 -1.051 . . . . 0.97999999999999998 109.641 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.958 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.824 -0.435 . . . . 1.04 109.824 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.958 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 35.0 Cg_endo -77.5 179.49 6.46 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.93 1.753 . . . . 0.71999999999999997 110.07 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.5 mt -70.23 -64.55 0.87 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 1.0600000000000001 108.81 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.55 161.19 14.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.608 -0.886 . . . . 0.66000000000000003 108.608 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -104.75 45.6 0.95 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.107 -0.996 . . . . 0.68999999999999995 109.831 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.42 -35.89 51.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.336 -1.506 . . . . 0.58999999999999997 109.336 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -64.11 -44.2 93.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.309 -1.112 . . . . 2.71 109.468 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.506 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 4.3 m120 -80.27 -25.06 39.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.221 -0.925 . . . . 1.1799999999999999 109.355 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.18 62.8 2.66 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.78 -1.728 . . . . 0.57999999999999996 108.78 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -152.37 168.54 31.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.23 -1.548 . . . . 0.41999999999999998 109.23 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.8 t -91.14 143.64 10.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.275 -1.132 . . . . 0.65000000000000002 109.129 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.449 ' HB3' HG11 ' A' ' 32' ' ' VAL . 92.2 m -86.1 83.98 7.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.305 -0.872 . . . . 0.34000000000000002 109.579 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 6.7 mt -96.24 128.57 36.32 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.181 -0.95 . . . . 0.5 108.866 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.16 179.07 6.88 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.442 2.094 . . . . 0.48999999999999999 110.309 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.6 mt 61.29 -101.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.705 -0.622 . . . . 0.77000000000000002 109.415 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.36 160.91 40.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.615 -1.303 . . . . 1.3600000000000001 109.374 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -78.84 131.04 68.43 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.334 -0.854 . . . . 0.48999999999999999 109.435 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.78 120.15 4.21 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.625 2.217 . . . . 0.69999999999999996 109.535 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.1 m -57.32 153.48 26.81 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.822 . . . . 0.81999999999999995 109.334 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.85 10.69 30.11 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 123.606 -1.414 . . . . 0.72999999999999998 111.626 -0.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.5 tpp -61.35 118.78 7.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.929 -1.107 . . . . 1.0800000000000001 108.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' CYS . 1.5 ptp85 -90.03 175.99 6.96 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.94999999999999996 109.839 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.07 132.47 52.11 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.701 -0.851 . . . . 1.3400000000000001 108.701 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.525 HD11 ' HA3' ' A' ' 10' ' ' GLY . 8.2 pt -120.27 -0.08 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.73999999999999999 110.361 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 169.63 -159.27 31.95 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.424 -1.471 . . . . 0.40000000000000002 109.424 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 20.2 p -137.17 165.34 26.34 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.351 -1.088 . . . . 0.55000000000000004 109.612 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 76.6 m -126.9 148.1 50.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.38 109.228 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 55.02 41.56 31.73 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.045 -0.724 . . . . 0.73999999999999999 109.045 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 -130.9 10.52 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.938 -2.065 . . . . 0.51000000000000001 107.938 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.731 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.6 mtm180 -113.75 10.48 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.186 -1.185 . . . . 2.6000000000000001 113.341 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.731 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.7 Cg_endo -77.56 -45.25 0.16 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 120.162 1.093 . . . . 0.5 109.681 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 46.1 t -98.47 154.72 3.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.265 -1.013 . . . . 0.35999999999999999 108.265 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 4.1 mttp -117.91 157.88 25.89 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.028 -1.045 . . . . 1.1100000000000001 110.057 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 81.4 m -97.25 104.34 16.35 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.494 -0.928 . . . . 0.5 108.494 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 14.7 m -100.05 143.0 30.77 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.131 -0.981 . . . . 0.44 109.826 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.502 ' HB2' HD13 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -143.66 158.69 43.48 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.519 -0.738 . . . . 0.92000000000000004 109.205 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.59 -27.96 51.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.335 -0.853 . . . . 0.93000000000000005 109.429 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.422 ' CE2' ' HD2' ' A' ' 36' ' ' ARG . 37.0 p90 . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 117.894 -1.05 . . . . 1.3100000000000001 109.264 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.557 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.081 -0.711 . . . . 1.53 109.081 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.557 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 36.1 Cg_endo -81.23 153.56 18.69 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.592 2.194 . . . . 1.4199999999999999 110.704 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.2 mt 54.56 41.77 31.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.925 -0.484 . . . . 1.2 110.77 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.02 168.16 16.2 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.873 -1.142 . . . . 1.1799999999999999 108.799 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.43 49.18 1.04 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.108 -0.995 . . . . 0.66000000000000003 109.747 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.28 -34.48 69.22 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.217 -1.553 . . . . 1.01 109.217 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -64.1 -23.93 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -1.17 . . . . 1.47 109.762 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.555 ' HB3' HG13 ' A' ' 24' ' ' ILE . 14.8 m120 -103.51 -11.7 17.61 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.98999999999999999 109.579 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.05 32.18 66.12 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.504 -1.438 . . . . 0.81999999999999995 109.504 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.557 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -122.91 164.17 15.99 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.43 -1.468 . . . . 0.47999999999999998 109.43 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.8 m -96.26 154.63 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.41 -1.053 . . . . 0.65000000000000002 109.275 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.551 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.2 m -91.65 93.62 9.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.432 -0.793 . . . . 0.5 109.43 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.591 HD12 ' HB3' ' A' ' 17' ' ' CYS . 4.0 mt -102.18 122.58 46.34 Favored Pre-proline 0 C--N 1.302 -1.5 0 O-C-N 121.291 -0.881 . . . . 0.47999999999999998 108.947 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 166.98 23.57 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.64 2.227 . . . . 0.58999999999999997 110.797 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.1 mt 61.42 -94.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 109.439 -0.578 . . . . 0.84999999999999998 109.439 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.58 165.7 26.87 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.799 -1.188 . . . . 1.72 108.928 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.591 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.3 m -119.37 163.58 26.16 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.229 -0.92 . . . . 0.46000000000000002 109.509 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.1 Cg_endo -79.16 170.64 17.39 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.671 2.247 . . . . 0.72999999999999998 109.609 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.63 152.19 93.17 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 121.453 -0.779 . . . . 0.65000000000000002 109.248 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 34.1 Cg_endo -79.13 -5.57 38.05 Favored 'Cis proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.19 -1.587 . . . . 0.63 111.504 0.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.9 ttm 61.85 65.7 0.89 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 1.27 109.648 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -89.91 90.19 8.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.166 -0.959 . . . . 1.46 108.506 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.75 117.64 12.52 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.615 -0.678 . . . . 1.0800000000000001 109.828 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.557 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.24 31.21 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.881 -0.785 . . . . 0.58999999999999997 108.881 179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 137.35 -167.66 24.66 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.912 -1.675 . . . . 0.42999999999999999 108.912 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.8 p -141.09 169.01 18.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.242 -1.152 . . . . 0.52000000000000002 109.517 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 78.5 m -126.28 147.6 49.67 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.295 -0.878 . . . . 0.52000000000000002 109.285 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 58.62 34.38 23.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.659 -0.497 . . . . 1.0600000000000001 109.659 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.505 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 96.73 -134.52 11.83 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.605 -1.798 . . . . 0.64000000000000001 108.605 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.752 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 1.1 mtp85 -105.02 4.82 0.09 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.312 -1.11 . . . . 1.6699999999999999 113.358 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.752 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 34.6 Cg_endo -75.82 -50.28 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 CA-C-N 120.137 1.085 . . . . 0.52000000000000002 110.142 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 12' ' ' CYS . 16.2 t -93.47 147.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.01 -1.056 . . . . 0.41999999999999998 108.757 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -115.34 156.61 25.18 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.206 -0.934 . . . . 0.62 109.83 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 95.8 m -98.95 92.51 5.55 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.369 -0.832 . . . . 0.45000000000000001 108.897 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.6 m -99.51 147.34 25.41 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.147 -0.971 . . . . 0.41999999999999998 109.951 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 7.1 ttp180 -130.97 161.12 32.63 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.763 -0.829 . . . . 1.0700000000000001 108.763 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.515 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -89.79 -18.68 25.83 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.325 -0.859 . . . . 0.94999999999999996 109.645 179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 40.9 p90 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 117.713 -1.137 . . . . 1.02 108.734 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.074 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.597 -0.519 . . . . 1.3500000000000001 109.597 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 1.074 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 34.6 Cg_endo -77.33 161.42 31.87 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 121.888 1.726 . . . . 0.95999999999999996 109.774 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 75.2 mt -113.72 49.03 1.01 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.3 -0.875 . . . . 1.1100000000000001 109.188 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.63 119.19 31.15 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.375 -0.828 . . . . 0.81000000000000005 109.638 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 25.1 t -87.47 83.67 7.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.244 -0.91 . . . . 0.40000000000000002 108.681 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.43 -24.51 76.7 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.354 -1.098 . . . . 0.73999999999999999 110.354 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -62.21 -48.3 80.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.979 -1.307 . . . . 1.3600000000000001 109.901 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.421 ' HB2' HD12 ' A' ' 24' ' ' ILE . 17.9 m120 -102.5 -4.33 25.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 1.0800000000000001 110.161 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.62 60.31 3.76 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.349 -1.5 . . . . 0.79000000000000004 109.349 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.66 -166.49 16.45 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.894 -1.682 . . . . 0.37 108.894 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 20.6 m -96.41 172.51 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.144 -1.209 . . . . 0.68000000000000005 109.057 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.487 ' HB3' HG11 ' A' ' 32' ' ' VAL . 21.7 m -125.78 111.17 14.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.366 -0.834 . . . . 0.34999999999999998 109.572 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.711 HG22 HG13 ' A' ' 15' ' ' ILE . 1.2 mt -98.87 121.85 54.65 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 121.208 -0.932 . . . . 0.35999999999999999 108.94 179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HA ' HG22 ' A' ' 32' ' ' VAL . 36.4 Cg_endo -79.65 38.26 0.72 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.792 2.328 . . . . 0.48999999999999999 111.494 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.711 HG13 HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -157.31 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.84 -1.162 . . . . 0.57999999999999996 108.942 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -149.97 173.2 14.09 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 1.49 108.89 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 t -102.95 110.64 63.93 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.388 -0.82 . . . . 0.46999999999999997 108.954 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.69 135.39 11.49 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.597 2.198 . . . . 0.84999999999999998 110.294 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 20' ' ' PRO . 35.5 m -67.55 159.46 78.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.379 -0.825 . . . . 0.65000000000000002 108.928 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HA ' ' HB ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -79.63 5.29 32.73 Favored 'Cis proline' 0 C--N 1.308 -1.592 0 C-N-CA 123.53 -1.446 . . . . 0.47999999999999998 111.512 0.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.724 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 7.7 tpp -62.74 139.08 58.66 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.883 -1.136 . . . . 1.45 109.119 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -114.03 147.72 38.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.316 -0.865 . . . . 0.73999999999999999 109.37 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.78 144.3 50.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.408 -0.808 . . . . 0.96999999999999997 109.284 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 8' ' ' ASN . 0.9 OUTLIER -138.61 37.9 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.335 -0.853 . . . . 0.57999999999999996 109.838 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.63 -173.62 21.97 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.605 -1.398 . . . . 0.44 109.605 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 41.3 p -126.11 163.13 23.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.368 -1.078 . . . . 0.73999999999999999 109.408 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.651 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 34.1 m -128.0 137.54 52.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 0.37 109.624 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 52.89 43.82 31.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.883 -0.511 . . . . 0.83999999999999997 110.123 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 26' ' ' THR . . . 93.62 -132.59 11.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.49 -1.844 . . . . 0.63 108.49 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.737 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 5.4 mtm180 -111.54 4.91 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.177 -1.19 . . . . 2.9100000000000001 113.628 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.737 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.3 Cg_endo -75.27 -43.51 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.338 1.157 . . . . 0.57999999999999996 109.776 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.651 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 49.5 t -107.13 152.55 8.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.113 -1.069 . . . . 0.33000000000000002 108.113 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 2.1 mttp -124.31 156.74 36.44 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.993 -1.067 . . . . 0.64000000000000001 110.133 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 71.9 m -90.0 143.59 26.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.933 -1.136 . . . . 0.32000000000000001 107.933 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.724 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 21.8 m -138.81 138.81 37.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.96 -1.088 . . . . 0.34999999999999998 110.021 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -150.11 162.37 40.56 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.433 -0.792 . . . . 0.97999999999999998 109.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -33.98 27.0 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.413 -0.805 . . . . 0.57999999999999996 109.23 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 33.6 p90 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 117.789 -1.1 . . . . 1.01 108.851 179.775 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.161 -0.681 . . . . 3.2799999999999998 109.161 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.505 ' HB2' HG12 ' A' ' 11' ' ' VAL . 34.5 Cg_endo -78.47 128.94 9.09 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.614 2.209 . . . . 2.46 110.584 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 tp -96.31 166.92 11.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.392 -0.817 . . . . 2.2000000000000002 108.874 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.35 117.11 4.83 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.556 -0.715 . . . . 1.1100000000000001 109.245 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 20.8 p -128.05 162.4 26.95 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.211 -0.93 . . . . 0.42999999999999999 109.241 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.94 175.74 43.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.093 -1.603 . . . . 0.64000000000000001 109.093 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.02 46.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -1.181 . . . . 1.9299999999999999 109.579 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 24' ' ' ILE . 5.5 m-80 -75.27 -25.48 58.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.79000000000000004 109.953 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.81 65.01 0.95 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.506 -1.438 . . . . 0.56000000000000005 109.506 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 36' ' ' ARG . . . -106.37 -152.97 19.99 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.539 -1.824 . . . . 0.51000000000000001 108.539 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.505 HG12 ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -127.61 149.39 32.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.15 -1.206 . . . . 0.93000000000000005 108.882 179.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 92.2 m -75.0 92.03 2.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.46999999999999997 109.472 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.558 HD12 ' HB3' ' A' ' 17' ' ' CYS . 2.3 mt -102.6 125.43 35.91 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.291 -0.881 . . . . 0.58999999999999997 108.939 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -78.11 173.57 13.74 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.57 2.18 . . . . 0.59999999999999998 110.258 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 mt 54.21 -119.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.957 -0.757 . . . . 1.24 108.957 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -119.12 154.94 32.45 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.634 -1.291 . . . . 2.4399999999999999 109.068 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.558 ' HB3' HD12 ' A' ' 13' ' ' ILE . 1.8 m -101.4 159.72 28.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.318 -0.863 . . . . 0.62 109.329 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.4 167.67 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.679 2.253 . . . . 1.0600000000000001 110.235 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER -60.46 147.23 83.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.294 -0.632 . . . . 0.81000000000000005 109.294 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.583 ' HD2' ' HA ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -79.91 -3.05 39.91 Favored 'Cis proline' 0 C--N 1.311 -1.423 0 C-N-CA 123.55 -1.437 . . . . 0.71999999999999997 111.351 -0.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.2 ttm 62.47 56.22 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 1.05 109.629 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.2 ttm-85 -90.17 87.08 6.72 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.176 -0.953 . . . . 2.2599999999999998 108.53 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 7.3 pt20 -71.87 129.57 38.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.816 . . . . 1.3400000000000001 109.486 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 8' ' ' ASN . 0.0 OUTLIER -130.39 38.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.319 -0.863 . . . . 0.44 108.697 179.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.76 -179.82 24.35 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.645 -1.782 . . . . 0.39000000000000001 108.645 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 22.7 p -132.97 160.76 36.18 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.081 -1.246 . . . . 0.65000000000000002 109.816 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 61.7 m -130.03 140.83 50.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.482 -0.761 . . . . 0.46000000000000002 109.534 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 55.77 37.14 28.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.885 -0.51 . . . . 1.1200000000000001 110.178 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.36 -133.55 11.56 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.487 -1.445 . . . . 0.52000000000000002 109.487 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -103.7 -3.22 0.11 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.371 -1.076 . . . . 2.2599999999999998 113.71 -179.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 32.9 Cg_endo -74.85 -43.05 0.45 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 CA-C-N 120.205 1.109 . . . . 0.68999999999999995 110.832 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.645 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 4.6 t -103.81 147.47 9.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.835 -1.166 . . . . 0.56999999999999995 108.853 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -131.07 156.38 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.011 -1.056 . . . . 0.68999999999999995 110.022 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 55.8 m -90.09 82.18 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.812 -0.81 . . . . 0.40999999999999998 108.812 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 73.7 m -91.78 140.99 29.15 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.133 -0.979 . . . . 0.44 109.843 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -110.0 152.21 26.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.625 -0.88 . . . . 0.82999999999999996 108.625 179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.583 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -90.09 -7.95 52.56 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.316 -0.865 . . . . 0.85999999999999999 110.018 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 25.7 p90 . . . . . 0 N--CA 1.487 1.375 0 O-C-N 121.062 -1.024 . . . . 1.1899999999999999 108.719 -179.911 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.424 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.927 -0.768 . . . . 3.04 108.927 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 33.7 Cg_endo -77.29 87.71 1.48 Allowed 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.683 2.255 . . . . 3.0699999999999998 109.877 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 78.7 mt -75.96 135.46 40.05 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.435 -0.791 . . . . 1.8300000000000001 110.117 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.72 177.65 10.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.31 -0.996 . . . . 1.0800000000000001 108.31 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 0.3 OUTLIER -104.7 37.51 2.12 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.005 -1.06 . . . . 0.41999999999999998 109.59 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.28 -49.8 24.66 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.191 -1.564 . . . . 0.67000000000000004 109.191 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -74.79 -36.11 62.49 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.19 -1.182 . . . . 2.29 109.254 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -70.45 -30.41 67.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.383 -0.823 . . . . 0.80000000000000004 109.366 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.46 50.08 6.35 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.329 -1.509 . . . . 0.47999999999999998 109.329 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -136.86 -170.69 11.99 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.347 -1.501 . . . . 0.42999999999999999 109.347 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.3 157.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -1.144 . . . . 0.87 109.25 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.489 ' HB3' HG11 ' A' ' 32' ' ' VAL . 59.2 m -93.23 87.36 5.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.405 -0.809 . . . . 0.42999999999999999 109.482 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.441 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 8.3 mt -97.14 131.44 27.56 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.46000000000000002 108.92 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.26 172.55 15.82 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.445 2.096 . . . . 0.54000000000000004 110.246 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.9 mm 63.02 -95.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.734 -0.604 . . . . 0.73999999999999999 109.551 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 164.41 35.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.659 -1.275 . . . . 1.71 109.368 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 18.7 m -87.31 132.9 39.84 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.352 -0.843 . . . . 0.5 109.068 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 34.9 Cg_endo -78.33 132.56 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 C-N-CA 122.501 2.134 . . . . 0.81000000000000005 109.737 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.6 m -63.12 155.02 75.42 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.36 -0.837 . . . . 0.75 109.132 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.5 7.68 34.39 Favored 'Cis proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.45 -1.479 . . . . 0.66000000000000003 111.621 0.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 18.6 ttm -63.81 121.49 14.15 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.777 -1.202 . . . . 1.1699999999999999 109.145 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -95.54 177.55 5.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.68000000000000005 109.491 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' SG ' ' A' ' 17' ' ' CYS . 1.4 tt0 -92.0 147.19 23.14 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.673 -0.862 . . . . 1.25 108.673 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.643 HD13 ' HD3' ' A' ' 36' ' ' ARG . 0.7 OUTLIER -145.33 42.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.482 -0.761 . . . . 0.55000000000000004 109.716 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.74 -166.61 22.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.38 109.472 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 16.5 p -138.98 166.79 23.56 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.325 -1.103 . . . . 0.56000000000000005 109.176 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.636 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 78.6 m -129.0 140.19 51.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.241 -0.912 . . . . 0.47999999999999998 109.921 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 55.53 40.84 31.2 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.763 -0.458 . . . . 0.82999999999999996 109.763 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.58 -130.63 10.38 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.38 -1.888 . . . . 0.62 108.38 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.73 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -111.8 9.58 0.08 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.086 -1.243 . . . . 1.54 113.386 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.73 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 35.1 Cg_endo -76.55 -50.52 0.1 Allowed 'Trans proline' 0 C--O 1.214 -0.7 0 CA-C-N 120.166 1.095 . . . . 0.62 109.766 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 51.2 t -99.31 155.51 4.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.196 -1.039 . . . . 0.46999999999999997 108.196 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -122.2 160.0 26.08 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.963 -1.085 . . . . 0.87 109.892 -179.492 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.7 m -93.54 133.78 36.49 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.954 -1.128 . . . . 0.39000000000000001 107.954 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.456 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 19.5 m -126.04 142.46 51.51 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.088 -1.007 . . . . 0.42999999999999999 109.834 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.643 ' HD3' HD13 ' A' ' 24' ' ' ILE . 4.4 mtp180 -139.03 141.24 38.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.895 -0.78 . . . . 0.88 108.895 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.25 -22.56 60.38 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.337 -0.852 . . . . 0.60999999999999999 109.739 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 34.6 p90 . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 117.788 -1.101 . . . . 0.79000000000000004 108.943 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.811 -0.811 . . . . 1.3600000000000001 108.811 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 34.2 Cg_endo -77.28 171.85 17.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.574 2.183 . . . . 1.3200000000000001 110.113 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 70.69 132.61 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.317 -0.623 . . . . 1.1699999999999999 109.317 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.42 85.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.285 -0.885 . . . . 1.1200000000000001 109.695 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB3' ' H ' ' A' ' 10' ' ' GLY . 93.4 m 55.22 41.26 31.59 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.452 -0.78 . . . . 0.41999999999999998 110.071 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.87 -6.03 89.26 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.854 -1.298 . . . . 0.64000000000000001 109.854 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -64.18 -60.59 3.02 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.976 -1.308 . . . . 0.80000000000000004 109.542 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.493 ' HB2' HD13 ' A' ' 24' ' ' ILE . 30.6 m120 -119.97 13.12 12.15 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.157 -0.964 . . . . 1.3600000000000001 110.092 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.31 70.19 1.15 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.635 -1.386 . . . . 0.52000000000000002 109.635 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.634 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -127.02 -156.72 9.25 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.057 -1.617 . . . . 0.34999999999999998 109.057 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.05 147.14 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -1.152 . . . . 0.97999999999999998 109.432 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 65.7 m -84.33 88.99 7.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.536 -0.727 . . . . 0.48999999999999999 109.329 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 mt -97.85 130.05 29.8 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.11 -0.994 . . . . 0.52000000000000002 109.307 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.1 Cg_endo -77.65 178.03 8.11 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.457 2.105 . . . . 0.59999999999999998 110.047 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.411 HG22 ' HG2' ' A' ' 16' ' ' ARG . 23.5 mm 59.68 -98.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.717 -0.614 . . . . 0.82999999999999996 109.472 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.411 ' HG2' HG22 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -148.94 160.47 43.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.556 -1.34 . . . . 2.6000000000000001 109.367 179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -71.84 146.21 90.31 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.497 -0.752 . . . . 0.52000000000000002 109.671 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 35.5 Cg_endo -78.53 -165.13 0.31 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.726 2.284 . . . . 0.57999999999999996 110.063 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.44 ' HA ' ' N ' ' A' ' 21' ' ' MET . 0.5 OUTLIER -135.64 140.86 35.1 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.166 -0.959 . . . . 0.77000000000000002 109.588 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -83.95 109.23 1.39 Allowed 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.183 -1.59 . . . . 0.75 110.53 -1.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.476 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 3.8 ttm -150.8 118.82 6.26 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.82 -1.175 . . . . 1.01 108.725 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -93.69 178.64 5.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 1.6899999999999999 109.616 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.2 144.77 25.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.541 -0.725 . . . . 0.84999999999999998 109.195 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.634 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -142.03 49.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.505 -0.747 . . . . 0.56000000000000005 109.277 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.49 -174.39 17.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.411 -1.475 . . . . 0.41999999999999998 109.411 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 11.4 p -133.19 166.11 23.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.323 -1.104 . . . . 0.64000000000000001 109.467 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 95.2 m -133.67 136.99 45.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.54000000000000004 109.866 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 56.18 37.59 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.798 -0.564 . . . . 0.89000000000000001 110.144 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.472 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.98 -132.8 11.28 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.934 -1.666 . . . . 0.77000000000000002 108.934 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 20.8 mmm-85 -105.98 1.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.284 -1.127 . . . . 1.5700000000000001 113.608 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.4 Cg_endo -75.05 -50.85 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.585 0 CA-C-N 120.217 1.113 . . . . 0.76000000000000001 109.865 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 17.2 t -100.12 150.01 5.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.035 -1.098 . . . . 0.54000000000000004 108.035 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -127.66 163.33 24.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.01 -1.056 . . . . 0.62 109.728 -179.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.2 m -92.67 130.45 38.29 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.293 -1.003 . . . . 0.47999999999999998 108.293 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 35.4 m -125.23 141.82 51.86 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.062 -1.023 . . . . 0.40999999999999998 109.818 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.427 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 10.8 mtp180 -141.05 134.49 29.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.432 -0.792 . . . . 1.29 108.932 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.86 -26.12 37.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.261 -0.899 . . . . 0.88 109.551 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.8 p90 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 117.796 -1.097 . . . . 1.0600000000000001 108.822 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.051 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.37 -0.604 . . . . 3.98 109.37 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 1.051 ' HD3' ' HB3' ' A' ' 1' ' ' ALA . 36.3 Cg_endo -77.59 82.36 2.42 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 121.657 1.571 . . . . 3.1000000000000001 110.369 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 3' ' ' LEU . 91.5 mt -80.86 -61.86 1.84 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.618 -0.882 . . . . 2.2200000000000002 108.618 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.5 p 57.46 -171.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.626 0.727 . . . . 0.82999999999999996 110.494 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 m -107.07 -26.33 11.18 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.447 -0.783 . . . . 0.67000000000000004 109.309 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.35 -46.58 25.89 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.508 -1.437 . . . . 0.79000000000000004 109.508 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -41.16 99.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -1.118 . . . . 1.8799999999999999 109.651 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -75.65 -25.36 56.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.026 . . . . 0.83999999999999997 109.816 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.21 29.65 12.19 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.631 -1.388 . . . . 0.72999999999999998 109.631 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 24' ' ' ILE . . . -103.81 156.52 17.57 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.613 -1.795 . . . . 0.65000000000000002 108.613 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.95 158.43 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.193 -1.18 . . . . 0.90000000000000002 109.645 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.5 m -79.17 93.18 5.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.521 -0.737 . . . . 0.52000000000000002 109.241 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 17' ' ' CYS . 1.3 mt -101.53 123.74 43.29 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.357 -0.84 . . . . 0.46999999999999997 109.195 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.49 170.64 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.561 2.174 . . . . 0.64000000000000001 110.137 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt 56.88 -107.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.659 -0.65 . . . . 1.1000000000000001 109.321 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.58 177.58 5.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.56 -1.338 . . . . 1.8600000000000001 109.067 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.646 ' HB3' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -127.31 157.98 70.87 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.205 -0.934 . . . . 0.58999999999999997 109.131 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.73 169.97 19.89 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.643 2.229 . . . . 0.70999999999999996 109.988 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.54 153.4 95.0 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.495 -0.753 . . . . 0.81000000000000005 109.33 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -79.48 4.72 32.47 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.378 -1.509 . . . . 0.67000000000000004 111.177 0.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.4 ttp 61.0 57.77 2.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 1.46 109.805 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -89.93 90.32 8.11 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.195 -0.941 . . . . 1.23 108.591 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 119.41 18.5 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.465 -0.772 . . . . 1.23 109.536 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.714 HD11 ' HA3' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -121.58 31.59 2.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.455 -0.778 . . . . 0.78000000000000003 109.232 179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 147.8 -177.38 26.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.906 -1.678 . . . . 0.59999999999999998 108.906 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 13.1 p -135.31 161.14 36.24 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.145 -1.209 . . . . 0.65000000000000002 109.775 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.8 m -126.18 141.93 51.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.248 -0.908 . . . . 0.55000000000000004 109.705 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 56.26 35.12 25.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.805 -0.56 . . . . 1.1100000000000001 110.12 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.476 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 94.6 -132.42 11.14 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.083 -1.607 . . . . 0.76000000000000001 109.083 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.75 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -105.16 0.71 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 1.7 113.685 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.75 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.91 -44.2 0.36 Allowed 'Trans proline' 0 C--N 1.327 -0.602 0 CA-C-N 120.247 1.124 . . . . 0.65000000000000002 109.925 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -106.21 146.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.129 -1.063 . . . . 0.57999999999999996 108.129 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -128.03 155.46 44.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.993 -1.067 . . . . 0.73999999999999999 109.937 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 77.6 m -89.93 81.33 6.3 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.241 -1.022 . . . . 0.56000000000000005 108.241 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 46.4 m -92.82 143.33 26.38 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.345 -0.847 . . . . 0.5 109.806 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -103.57 145.44 30.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.598 -0.889 . . . . 0.91000000000000003 108.598 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.9 19.86 9.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.384 -0.822 . . . . 0.84999999999999998 109.466 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 . . . . . 0 C--N 1.307 -1.255 0 N-CA-C 108.173 -1.047 . . . . 1.02 108.173 -179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' HB1' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.067 -0.716 . . . . 3.79 109.067 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 1' ' ' ALA . 30.9 Cg_endo -75.47 133.55 16.03 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.407 2.071 . . . . 2.5299999999999998 110.641 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 60.0 mt -76.53 116.0 16.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.476 -0.765 . . . . 2.54 109.675 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.14 124.34 20.58 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.301 -1.0 . . . . 1.3400000000000001 108.301 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HA ' ' HA3' ' A' ' 9' ' ' GLY . 25.8 m 59.23 28.1 17.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.53 -0.731 . . . . 0.54000000000000004 109.794 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.95 -60.94 1.71 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.038 -1.625 . . . . 0.73999999999999999 109.038 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -69.45 89.81 0.51 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -1.07 . . . . 1.55 108.684 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.08 63.87 2.07 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.864 -0.791 . . . . 1.4099999999999999 108.864 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.649 ' HA3' ' HA ' ' A' ' 5' ' ' CYS . . . -121.23 -62.1 0.23 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.87 -1.292 . . . . 0.38 109.87 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 36' ' ' ARG . . . 99.03 -97.43 1.84 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.212 -1.555 . . . . 0.40000000000000002 109.212 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.41 141.64 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.103 -1.233 . . . . 0.46999999999999997 109.522 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 5' ' ' CYS . 58.0 m -82.92 94.45 7.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.40999999999999998 109.206 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.43 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.9 mt -101.7 123.55 43.69 Favored Pre-proline 0 C--N 1.303 -1.449 0 O-C-N 121.174 -0.954 . . . . 0.53000000000000003 109.328 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 35.3 Cg_endo -78.5 175.75 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.648 2.232 . . . . 0.51000000000000001 109.912 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 53.75 -120.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.87 -0.789 . . . . 1.1799999999999999 108.87 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -126.18 135.35 51.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.511 -1.368 . . . . 1.24 109.35 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 3.3 m -75.95 161.88 73.92 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.366 -0.834 . . . . 0.41999999999999998 108.91 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 34.3 Cg_endo -77.02 160.29 33.56 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.512 2.141 . . . . 0.58999999999999997 110.368 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -61.67 147.76 88.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.616 -0.677 . . . . 0.84999999999999998 109.221 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.676 ' HD2' ' HA ' ' A' ' 38' ' ' TRP . 35.7 Cg_endo -77.89 -11.98 32.04 Favored 'Cis proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.48 -1.467 . . . . 0.46000000000000002 111.177 -0.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.448 ' HG3' ' HB2' ' A' ' 17' ' ' CYS . 43.5 ttp 61.68 86.19 0.11 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 0.93999999999999995 110.286 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.84 89.33 3.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.874 -1.141 . . . . 0.69999999999999996 108.491 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.6 109.89 4.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.35 -0.844 . . . . 0.58999999999999997 109.226 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 9.7 pt -111.01 -3.74 10.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.397 -0.815 . . . . 0.5 109.804 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.06 -171.84 31.78 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.988 -1.645 . . . . 0.38 108.988 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 33' ' ' LYS . 17.1 p -129.55 166.94 18.69 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -1.174 . . . . 0.51000000000000001 109.414 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.641 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . 97.3 m -138.74 126.17 21.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.191 -0.943 . . . . 0.46000000000000002 109.519 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 56.12 39.07 30.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.721 -0.612 . . . . 0.88 109.972 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.52 ' C ' ' HD2' ' A' ' 31' ' ' PRO . . . 95.62 -136.97 13.16 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.381 -1.487 . . . . 0.62 109.381 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.745 ' N ' ' CD ' ' A' ' 31' ' ' PRO . 24.4 mmm180 -101.32 -1.84 0.1 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.337 -1.096 . . . . 1.0800000000000001 113.77 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.745 ' CD ' ' N ' ' A' ' 30' ' ' ARG . 33.0 Cg_endo -74.39 -52.52 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 CA-C-N 120.24 1.121 . . . . 0.51000000000000001 109.698 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 3.6 t -98.19 148.27 6.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.397 -1.334 . . . . 0.46000000000000002 107.397 178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HD3' ' C ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -131.71 156.8 45.27 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.89 -1.131 . . . . 0.35999999999999999 110.282 -178.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.527 ' SG ' ' SG ' ' A' ' 27' ' ' CYS . 21.8 m -90.61 97.21 11.05 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.453 -0.943 . . . . 0.40000000000000002 108.453 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.9 m -101.13 142.18 32.94 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.296 -0.878 . . . . 0.37 109.364 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.501 ' HG3' ' HA3' ' A' ' 10' ' ' GLY . 5.7 ttp85 -144.49 -172.22 3.76 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.523 -0.917 . . . . 0.62 108.523 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.08 49.95 18.93 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.039 -0.726 . . . . 0.46999999999999997 109.039 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.676 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 16.6 p90 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 118.026 -0.987 . . . . 0.88 109.091 -179.861 . . . . . . . . 1 1 . 1 stop_ save_